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Abstract 
Background: Current malaria control tools, long lasting insecticidal nets and indoor 
residual spraying have had a significant impact on malaria transmission in sub-Saharan 
Africa. However these tools will not be able to eradicate malaria and there is need for 
complementary tools if this goal is to be attained. This work focused on evaluating and 
recommending tools that can be used to complement current control tools with emphasis on 
outdoor and early evening transmission. The main tool evaluated in this thesis was a topical 
repellent to be used in the early evening. Other tools recommended were spatial repellents 
and permethrin- impregnated clothing. 
 
Methods:  A repellent efficacy trial was conducted in the semi-field and field setting to 
evaluate the protection from early evening biting given by a topical repellent lotion 
containing 15% N.N-diethyl-m-toluamide (DEET). A cluster randomized, placebo controlled 
clinical trial, designed to assess the effect of 15% DEET against malaria transmitted in the 
early evening was then conducted in a village in rural Tanzania. A total of 940 households 
were recruited and randomized, with 462 households randomized to the intervention arm and 
462 households randomized to the control arm. The feasibility of lotion repellent use was 
assessed using entry and exit questionnaires. Focus group discussions were conducted 3 years 
after a clinical trial to assess the community knowledge, attitude and practice towards a 
different set of repellents to those used during the clinical trial. A systematic review was then 
conducted to put the results of this trial in context with other repellent trials. An attempt was 
made to design a clinical trial taking into account the shortcomings of the current and other 
repellent trials reviewed. 
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Findings:  Topical repellents containing 15% DEET provided >80% protection against 
early evening biting over four hours. According to protocol analysis of the cluster 
randomized trial found no difference between the intervention and control arms after 
accounting for socio-economic status, education of household head and household 
construction materials (Wilcoxon rank sum z = 0.529, p = 0.596). The most important 
predictor of malaria in this study was age, with younger age categories significantly 
associated with greater malaria risk. Socio-economic status was not associated with malaria. 
Compliance to repellent use was reported to be 80% during the study. From the FGDs, it 
emerged that community knowledge was the major barrier to repellent use, followed closely 
with availability. The community preferred using long lasting insecticidal nets (LLINs) 
because of their cost effectiveness. However, the community preferred using repellents in the 
early evening before employing LLINs.  
Interpretation: This study demonstrates that topical repellents have no effect against 
early evening malaria transmission in this community.  However, shortcomings in the design 
and implementation might have masked the treatment effect and better-designed studies are 
required to establish repellents effect in this setting. Topical repellents provided protection 
against early evening biting and were readily accepted and used in this community, indicating 
the potential of using repellents complimentary to LLINs in this setting. The short-term 
duration of effect of this repellent, required frequent reapplication and therefore impacted 
compliance, emphasizing that future studies should consider using longer lasting tools such 
as spatial repellents.  
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ABSTRACT 
Background: Currently, the major malaria vector control tools, long lasting 
insecticidal nets (LLINs) and indoor residual spraying (IRS) predominantly target 
vectors biting and resting indoors. Therefore, despite the impact of these tools on 
malaria transmission as a result of their extensive use, there is still some substantial 
transmission taking place outdoors and in the early evenings, when and where their 
impact is diminished. Consequently, current malaria control tools will not be able to 
eliminate malaria and there is need to develop new tools and strategies targeting this 
residual transmission if this goal is to be achieved 
Objectives and Methods: The main objective of this PhD is to evaluate the 
additional benefit of using 15% DEET topical repellent to LLINs in preventing 
malaria transmission in the early evening, assessed through a cluster randomized, 
placebo-controlled clinical trial in a rural village in Tanzania. The efficacy of 15% 
DEET topical repellent was assessed by conducting human landing catches in the 
semi field system (SFS) as well as the field against laboratory reared Anopheles 
arabiensis and wild mosquitoes respectively. The acceptability of 15% DEET topical 
repellent as a mosquito control tool was assessed using before and after studies and 
focus group discussions (FGDs). A literature review on the impact of repellents on 
disease transmission was also conducted to align the results of this work in context 
with findings from other trials.  
Results and conclusions: Analysis of the randomized clinical trial demonstrated a 
non-significant 11.4% reduction in malaria incidence when the repellent arm was 
compared to the placebo arm (Wilcoxon rank sum z = 0.529, p = 0.596). It was 
therefore deduced that 15% DEET topical repellent did not have any impact on 
malaria transmission in the early evening. However, 15% DEET topical repellents 
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provided >80% protection against laboratory reared An. arabiensis and wild mosquito 
bites in the SFS and field setting respectively. The repellent was also readily 
acceptable, with >99% of the community reporting willingness to use the repellent. 
The reported monthly compliance was 79%. Cost and accessibility/availability were 
found to be the main barriers to use of repellents in rural Tanzania. Results from this 
trail of no effect of 15% DEET on malaria transmission was consistent with a study 
conducted in Lao-PDR using exactly the same repellent. However these findings were 
inconsistent with studies carried out in Bolivia, Pakistan, Ethiopia and Ghana.  
 
Interpretation: The results demonstrated that topical repellents did not have 
additional benefit to LLINs in preventing early evening malaria transmission in rural 
Tanzania. However, there are several factors that might have confounded the findings 
of this trial. First, the trial lacked any statistical power to observe any discriminatory 
difference between the two treatment groups. Secondly, compliance to repellent use 
could not be effectively established. There was also an imbalance in socio-economic 
status between the treatment arms. During the study period there was low malaria 
transmission as a result of a drought in Tanzania. However, repellent use was readily 
accepted in the community and therefore has the potential to be used as a control tool 
against early evening mosquito biting.  
This thesis outlines the shortcomings of the study design of this trial and gives 
recommendations on how they can be addressed in future trials. A detailed outline of 
a protocol on how a study using similar interventions (repellents – spatial or topical) 
should be conducted has been included in this body of work in an attempt to 
standardize the design and implementation of future trials so that outcomes are 
considered robust and of good quality. I believe that this information will be critical in 
 15 
designing future trials using similar interventions and will add to the body of 
knowledge of repellents that already exists. 
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Chapter 1: General Introduction 
 
1.1 Malaria epidemiology in Africa 
There are several factors that propagate malaria transmission in sub-Saharan Africa. 
First, the climate in sub Saharan Africa offers ambient optimal conditions for the 
Anopheles sub-genus mosquito to thrive by offering adequate rainfall for proliferation 
of breeding sites around human populations and ambient temperatures and humid 
conditions to prevent desiccation of mosquitoes during blood meal foraging [1, 2]. As 
a result mosquitoes belonging to the Anopheles gambiae complex and the Anopheles 
funestus group continue to be the most widely distributed malaria vectors in sub- 
Saharan Africa (Figure 1:1) and are the major vectors transmitting malaria in this 
region [3]. The An. gambiae complex is made up of 6 sibling species, An. gambiae 
sensu stricto. , An. arabiensis, An. quadriannulatus A, An quadriannulatus B, An. 
melas, An. merus and An. bwambae [4]. The Anopheles funestus group is made up of 
nine sibling species: An. funestus s.s., Anopheles rivulorum Leeson, An. leesoni 
Evans, Anopheles vaneedeni Gillies & Coetzee, An. parensis Gillies, An. confusus 
Evans & Leeson, An. aruni Sobti, An. fuscivenosus Leeson, and An. brucei Service, 
which are all difficult to distinguish morphologically at the adult stage [4]. All 
members of the Anopheles sub-genus are capable of being infected with the 
plasmodia parasite, and hence can potentially transmit malaria [4, 5]. The major 
malaria transmitting vectors in Africa are An. gambiae s.s. and An. arabiensis (An. 
gambiae s.l.) from the An. gambiae complex and An. funestus s.s. from the An. 
funestus group [4, 5]. An. gambiae s.s. and An. funestus are known to be 
predominantly anthropophagic (prefer to feed on humans) [4, 5], endophagic (prefer 
to feed indoors) [4, 6], endophilic (prefer to rest indoors ) [4] and bite late at night [4]. 
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An. arabiensis, thought to be previously zoophagic (prefer to feed on bovines) has 
been shown to exhibit an elastic biting behaviour, feeding either on cattle [6] or 
humans depending on the available hosts [4, 5], resting indoors [6] in the absence of 
outdoor resting sites or outdoors if resting sites are available [6, 7] .  An. arabiensis 
has also been shown to feed either indoors [8] or outdoors[6]. An. gambiae s.l. (An. 
gambiae s.s and An. arabiensis), predominantly breeds in transient aquatic habitats 
like hoof prints, car ruts and in rice paddies (man- made habitats) [4]. As a result, 
these vectors are found in great densities and close proximity to humans [4, 5, 9].  On 
the other hand, An. funestus breeds in large, clear and semi-permanent water bodies 
like swamps, rice paddies and ponds. Owing to its anthropophagic, endophagic and 
endophilic behaviour [6, 8, 10], this vector colonizes habitats that are close to human 
dwellings, like rice paddies [10].  
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Figure 1:1 Map of Africa showing distribution of An. funestus and An. gambiae 
s.l. species complex mosquitoes. Source [4, 11] 
All the above parameters; extensive distribution of these vectors, close proximity to 
man due to man-made breeding sites and high survival rates as a result of ambient 
conditions, combine to create optimal conditions for transmission of malaria parasites 
by An. gambiae s.l. and An. funestus vectors, and is known as vectorial capacity [2, 3].  
Vectorial capacity  (VC) is described as the number of secondary cases that arise from 
one infective case per day in a susceptible human population and is dependent on; 
ratio of mosquito populations to humans (m), the human biting rate per day (a), 
survival rate of the mosquito per day (p) and the length of the gonotrophic cycle (n):  
   
 
C = ma2pn 
 -loge p 
 
Secondly, mosquitoes belonging to the Anopheles sub-genus are the only mosquitoes 
known to transmit to Plasmodium falciparum [4], the most virulent form of the 
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parasite that causes malaria and is predominantly found in sub-Saharan Africa [1, 12, 
13].   
Then there is the problem of underdeveloped health systems and poor infrastructure in 
most sub-Saharan African countries to drive any substantial campaign against malaria 
[14]. 
All these factors: the most competent malaria vector, coupled with the most virulent 
malaria parasite pitted against a poor and under developed infrastructure and health 
system, combine to create an efficient malaria transmission system that requires 
considerable financial and political resources and commitment to have any significant 
impact on transmission.  
1.2 Change in Malaria epidemiology in sub Saharan Africa 
 The last two decades has seen substantial financial and political commitment 
employed in malaria control. The funding committed to malaria control was estimated 
to be US $ 2.5 billion in 2012, up from US $ 100 million committed in 2000 [15]. 
This increase in funding has led to extensive scaling up vector control tools like 
LLINs and IRS as well as cost-effective diagnosis kits, (rapid diagnostic tests – 
RDTs) and Artemisinin-based combination therapy (ACT) drugs for prompt diagnosis 
and treatment of malaria. Targeted prevention of malaria among the groups at risk, 
such as pregnant mothers and infants using intermittent preventive treatment (IPTp 
and IPTi) is also being extensively used [15]. As a result of scale up of malaria 
control tools, several regions of malaria endemic sub-Saharan Africa have observed a 
decline in malaria related morbidity and mortality.  
In the Horn of Arica, surveys carried out in Ethiopia demonstrated a decline in the 
prevalence of malaria morbidity [16] and under five morbidity and mortality [17]. In 
Eritrea LLINs, IRS and larviciding were associated with decline in malaria cases from 
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1998 to 2003 [18] while a retrospective study using HMIS data to assess the impact of 
ITNs and IRS and a longitudinal study assessing the impact of LLIN scale up both 
demonstrated declining trends in malaria morbidity [19, 20] and mortality [20]. 
However, it should be noted that malaria prevalence was already declining before the 
scale up of mosquito control tools and the decline might have been associated with 
climatic factors [18, 21] alongside scale up of malaria control tools. 
In East Africa, studies exploring malaria trends have reported declines in malaria 
morbidity and mortality along the Kenya coast after 18 years of surveillance [22], and 
in outpatient malaria cases in Central Kenya after long term implementation of 
integrated malaria management (IMM) [23]. A country wide survey assessing the 
trend of malaria related hospital admissions in 17 district hospitals reported an 
average overall decline of 49% from 1999 to 2008 [24], although this temporal trend 
was not observed in all hospitals indicating that there were different factors affecting 
transmission in the different hospital settings [21, 25]. Declines in malaria trends have 
also been reported from highland areas in Kenya indicating that malaria is declining 
even in areas of unstable transmission further reinforcing the finding of declining 
malaria transmission in sub-Saharan Africa. Declines in malaria trends associated 
with scaling up of malaria control tools in other parts of East Africa have also been 
reported in Burundi [26] and Tanzania [27]. 
In Southern Africa, integrated malaria control by use of IRS and ACT (Artemether- 
Lumefantrine), in Kwa Zulu Natal in South Africa was associated with declines in 
malaria morbidity and mortality [28], while in Swaziland use of IRS was associated 
with declines in malaria related morbidity [29]. Concurrent use of LLINs, IRS, ACT 
and RDTs was also associated with a decline in malaria morbidity in Zambia [30].  
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In West Africa, declines in malaria trends associated with scaling up of control tools 
have been reported in The Gambia [31] and Gabon [32].  
Declines in malaria trends have also been observed on the African Islands of Zanzibar 
[33], Bioko Islands in Equatorial Guinea [34] and Sao Tome and Principe [35]. 
In addition to having reduced the burden of malaria in sub-Saharan Africa, scaling up 
of malaria control tools have also had an impact on entomological parameters relating 
to malaria transmission, such as vectors density, parasite prevalence and 
entomological inoculation rate (EIR). Extensive use of LLINs has been associated 
with declines in EIR and vector densities in Tanzania [36-38], Kenya [24, 39, 40], 
Solomon Islands [41] and Nigeria, while IRS has been shown to reduce EIR in 
Tanzania [37], Solomon Islands [41] and Nigeria [42]. Even the Kilombero valley, 
historically one of the places with the highest malaria transmission in the world, has 
reported up to a 4-fold decline in EIR [43]. In addition to their impact on EIR, malaria 
control tools have also been shown to reduce parasite prevalence [44-46]. 
However, not all areas where malaria control tools have been implemented have 
demonstrated a decline in malaria trends [19, 20, 24], indicating that malaria 
transmission is influenced by a variety of factors [21, 25].   
Urbanization, rapidly taking place in sub- Saharan Africa, has also affected malaria 
transmission and a negative linear relationship has been observed between EIR and 
the level of urbanization [47, 48]. This is mainly a result of the impact of urbanization 
on larval habitats, access to better health facilities, awareness of protective methods 
against mosquito bites, and more effective larval control as breeding sites are well 
defined and therefore easier to manage [48].   
Long lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) 
predominantly employ the use of pyrethroid insecticides. As a result, scale up of these 
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tools for universal coverage has led to extensive use of pyrethroids. Inevitably, 
malaria vectors have developed resistance to pyrethroids, thereby influencing further 
the transmission dynamics in sub-Saharan Africa [49], so that areas where malaria 
transmission had once declined are reporting disease resurgence [34, 50, 51] and the 
re-emergence of previously eliminated malaria vectors [11]. However, there are areas 
where LLINs and IRS continue to demonstrate effectiveness despite high frequencies 
of pyrethroid resistant alleles being observed in the local malaria vector population 
[26, 52, 53] reinforcing the fact that more research is needed in understanding 
mechanisms of resistance development in malaria vectors [49]. 
Lastly, extensive use of LLINs and IRS has been implicated in modifying mosquito 
behaviour and species composition. Apart from reducing the indoor resting densities 
of mosquitoes as a result of mosquito control tool-induced mortality [54, 55], these 
tools have also been reported to shift the peak biting times of malaria vectors [56-58], 
feeding preference from either endophagy to exophagy or vice versa [42, 58-61],  and 
resting preference from either endophily to exophily or vice versa [62-64]. Reduction, 
up to elimination of species of the local predominant vector has also been observed 
and associated with scale up of control tools, leading to colonization of a once 
predominant species by alternative vector species [65-67]. Larval sampling in places 
where there has been extensive LLIN and IRS employment also demonstrate a shift in 
the sub-populations of the local malaria vectors [63, 64]. 
All these factors above have had a great impact on malaria transmission in sub- 
Saharan Africa and as a result, most of sub-Saharan Africa is continually evolving 
from a region of high endemicity with homogenous transmission to a region of 
moderate to low endemicity with heterogeneous transmission, characterized with 
transmission hotspots [68, 69]. Consequently, further scale up of current control tools 
 23 
will not be able to have any additional impact on these localized foci of residual 
transmission [68, 70]. Therefore new tools and strategies targeting these residual 
transmission foci will need to be developed if malaria is to move from sustained 
control to elimination. One area of residual transmission focus that presents a 
challenge for control is outdoor and early evening malaria transmission[70, 71]. As 
such, the main theme of this thesis was therefore to explore supplementary tools that 
could be used to address outdoor and early evening transmission with emphasis on 
using repellents as a means of personal protection outdoors and in the early evening. 
 
1.3 Statement of the problem 
Current vector control tools, LLINs and IRS predominantly target intra-domiciliary 
malaria vectors. However, as a result of extensive use [15], these tools are 
increasingly being implicated in shifting malaria vector species composition, so that 
vector populations of indoor biting and resting vectors are being diminished, while 
populations of outdoor biting and resting vectors become dominant [71]. This shift in 
behaviour presents a challenge for malaria control, as LLINs and IRS are unlikely to 
impact on the transmission mediated by these outdoor biting and resting vectors.  
Other factors that are likely to attenuate the impact of LLINs and IRS is the 
development of insecticide resistance [49]. As a result, despite reduced transmission, 
malaria is unlikely to be eliminated in such a scenario with continuous 
implementation of these tools (LLINs and IRS) and a new strategy needs to be 
developed. To tackle increasing insecticide resistance the WHO recommends 
development of new insecticides and rotation of current ones where cross-resistance 
has not developed [49]. For outdoor transmission, there is need to develop novel tools 
or strategies to tackle this residual transmission foci. In the context of this work, 
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outdoor and early evening transmission will be defined as a transmission focus and 
will form the basis of this PhD thesis. 
One potential strategy is the use of topical repellents outdoors and in the early evening 
before employment of LLINs and IRS. Repellents have been previously described as 
chemicals that induces oriented vector movement away from the chemical source 
[72]. However, repellency in the context of this work is described broadly as a range 
of insect behaviours induced by airborne chemicals that result in a reduction in 
human-vector contact and therefore offering personal protection and includes 
movement away from the repellent, interference with host detection as well as feeding 
inhibition [73]. Repellents can be either be topical (chemicals applied on the skin that 
prevent vector-host contact) [72] or spatial (chemicals diffused in the air to prevent 
vector-host contact in a defined space) [74]. Repellents are classified as either natural 
(plant-based) or synthetic [75]. Most plant-based repellents are derived from 
pyrethrum (Chrysanthemum cinerafoluim) flowers and can either be used to knock 
down or repel disease vectors. Other plant-based repellents include lemon eucalyptus 
(derived from Eucalyptus maculata citriodon), citronella (Cymbopogon genus) and 
neem (Azidaratcha indica). However, most plant based repellent have a short residual 
effect [76]. The need for longer lasting repellents therefore led to development of 
synthetic repellents. 
N, N-diethyl-3-methylbenzamide (DEET), the most widely used synthetic repellent 
(over 200 million annual applications) to date, was developed in the 1950’s by the 
United States Department of Agriculture (USDA). Currently, a number of synthetic 
repellents exist, but DEET is considered the gold standard topical repellent, because it 
is broad-spectrum (efficacy against a variety of arthropods) as well as long lasting. 
This work particularly focused on the efficacy of DEET topical repellent on malaria 
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transmission in the early evening.  
 
1.4 Safety and toxicity of DEET  
N, N-Diethyl-3-methylbenzamide (DEET) was used in this study because it has been 
extensively tested for safety and toxicity for human use [77-79] and its efficacy 
against a broad variety of arthropod vectors [76, 80, 81]. DEET was first registered in 
1957. However reports of DEET related side effect prompted reviews and 
investigations into DEET safety. It was found that for over 50 years since DEET was 
discovered there were only 43 case reports of DEET toxicity to the Poisons and 
Control Centers in the US [76], of which 26 severe cases occurred between 1995-
1997 [82] and 14 from 1985-1989 [79] (Tables 1:1 & 1:2). Of all these reported cases, 
5 patients died, of which the deaths were due to incorrect use of DEET like ingestion 
and inhalation, while the rest resolved without any sequelae [83]. There have also 
been concerns on effect of DEET on children, pregnant and lactating mothers. 
However recent studies have conclusively demonstrated that DEET is safe for use by 
these groups [84-86]. 
Despite its long-term and extensive use, the exact mode of action of action of DEET 
is yet to be established. Existing theories have suggested the following modes of 
action: Inhibiting response to an otherwise attractive host signal [87, 88], switching 
the sensory message from attraction to repulsion [89], activating a receptor system 
that controls a competing behaviour [89], activating a noxious odour receptor [90, 91] 
and activating different receptor types simultaneously causing loss of the specific 
signal for host finding [89].  
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Table 1:1 Summary of reported cases with severe outcomes or death that occurred from 1986-1989. Source: [104, 106] 
Effects  No. of 
patients  
Age (sex)  Deet level 
(%)  
Symptoms  Reference  
Death  1a  17 months (female)  20  Acute encephalopathy  [92] 
Death  1a 6 years (female)  15  Abdominal pain, vomiting, lethargy, headache, ataxia, 
general convulsions  
[93] 
Death  1a 6 years (female)  10  Headache, agitation, atethosis, disorientation, involuntary 
movements and convulsions  
[94]  
Encephalopathy  1b 5 years (female)  95  Convulsions  [95] 
Encephalopathy  1b 8 years (male)  Unspecified  Convulsions  [78] 
Encephalopathy  5b 3-7 and 29 years 
(male)  
Unspecified  Seizures, one developed urticaria  [96] 
Encephalopathy  1b 18.5 months (female)  20  Tremors, progressive ataxia and weakness, bizarre 
movements  
[97] 
Encephalopathy  1b 8 years (female)  100  Seizures, convulsions, erythematous and pruritic rash, 
unusual restlessness  
[98] 
Encephalopathy  1b 3.5 years (female)  15  Convulsions, incoherent speech, stiff arms and legs  [99] 
Acute manic 
psychosis  
1b 30 years  Unspecified  Psychomotor hyperactivity, rapid and pressured speech, 
tangentiality, flight with ideas and grandiose delusions  
[100] 
Cardiovascular 
toxicity  
1b 61 years (female)  Unspecified  Light-headedness, nausea, vomiting, explosive diarrhoea, 
hypotension  
[101] 
Anaphylaxis  1b 42 years (female)  52  Generalized angioedema, nausea, loss  [102] 
Reproductive 
toxicity  
1b 4 years (male)  Unspecified  Mental retardation, impaired sensory-motor co-
ordination, cranio-facial dysmorphology  
[103] 
Encephalopathy  1b 17 months (female)  20  Opisthotonos, respiratory difficulty, coma [92] 
Seizures  1b 1.5 years (Male)  10  Opisthotonos, respiratory difficulty, coma  [104] 
Encephalitis  1b 1.5 years (female)  10  Agitation, opisthotnos  [94]  
None  1b 14 (female)  95  Coma, hypotension, hypertonia  [105] 
None  1b 1 (female)  47.5  Coma, seizures, hypertonia, opisthonos  [105] 
None  1b 16 (female)  95  Coma  [105] 
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Table 1:2 Summary of the reported cases with severe outcomes or death that occurred from 1993-1997. Source: [107] 
Effect  No. of 
patients  
Age category  Deet level  Symptoms  Reference  
Death  1 a  Adult (female)  >50%  Dermal  [107] 
Death  1 a  Adult (male)  >50%  Gastrointestinal, neurological, cardiovascular, 
respiratory  
[107] 
 1 b  Infant (male)  Unknown  Neurological  [107] 
 1 b  Infant (male)  Unknown  Respiratory  [107] 
 1 b  Infant (female)  Unknown  Neurological  [107] 
 1 b  Child (male)  Unknown  Ocular  [107] 
 1 b  Child (male)  Unknown  Unknown  [107] 
  1 b  Child (male)  11-50%  Neurological  [107] 
  1 b  Child (male)  <11%  Unknown  [107] 
 1 b  Child (male)  Unknown  Unknown  [107] 
 1 b  Child (male)  11-50%  Ocular  [107] 
 1 b  Child (female)  11-50%  Ocular  [107] 
 1 b  Teen (male)  Unknown  Gastro-intestinal, hematologic/hepatic, neurological  [107] 
 1 b  Teen (male)  11-50%  Neurological  [107] 
 1 b  Teen (female)  11-50%  Neurological, miscellaneous other  [107] 
 1 b  Adult (male)  Unknown  Neurological  [107]  
 1 b  Adult (male)  11-50%  Unknown  [107] 
 1 b  Adult (male)  11-50%  Cardiovascular, neurological, respiratory,  [107] 
 1 b  Adult (male)  11-50%  Unknown  [107] 
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 1 b  Adult (male)  11-50%  Unknown  [107] 
 1 b Adult (female)  Unknown  Unknown  [107]  
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However, before any topical repellent can be recommended for use, their efficacy has to be 
tested and established. There are several ways in which repellents can be tested. The efficacy 
of repellents can be tested in the laboratory to determine its complete protection time (CPT): 
the time between repellent application and first mosquito landing or effective dose (ED): the 
concentration of repellent required to protect against a given proportion of mosquito bites. 
Laboratory tests are usually conducted as per guidelines provided by the WHO Pesticide 
Evaluation Scheme (WHOPES), [108]. Several laboratory experiments have shown DEET to 
be efficacious against a wide range of arthropods [80, 109-113]. 
The efficacy of repellents can also be estimated in the semi field and field against laboratory 
reared and wild mosquito species respectively [114], usually assessed by determining the 
reduction in proportion of mosquitoes biting a volunteer using a repellent (DEET) relative to 
the control [114-116].   
Apart from assessing the efficacy against mosquito bites, repellent efficacy against disease 
transmission should be determined. The most credible method of assessing repellent efficacy 
against disease transmission is through randomized controlled trials where one group of 
participants are given the repellent being tested, while another group with similar baseline 
characteristics are given a placebo or no intervention and the proportion of disease between 
these two groups is determined.  
There are several randomized controlled trials that have reported efficacy of topical repellents 
against malaria transmission: A household-randomized, double blind, placebo-controlled 
clinical trial was conducted in Bolivia. All participants of the study were given ITNs so as to 
standardize the malaria interventions used among the participants. The participants in the 
intervention arm were then issued with a repellent lotion containing 30% p- methane-3-8-diol 
(PMD), a repellent derived from lemon eucalyptus). In the control group, participant were 
issued with 0.1% clove oil. PMD was associated with an 80% reduction in Plasmodium vivax 
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malaria and a non-significant reduction of 82% in P. falciparum malaria [117]. In a refugee 
settlement in Pakistan, a household randomized trial of Mosbar (a soap containing 20% 
DEET and 0.5% permethrin) compared to a placebo lotion demonstrated a statistically 
significant 56% reduction in Plasmodium falciparum malaria [118]. In another refugee camp 
in Thailand, a double-blind randomized clinical trial evaluating the effect of DEET mixed 
with thanaka (a root paste made from pulp of the wood of apple tree) compared to thanaka 
alone in pregnant women, demonstrated a 28% reduction in malaria incidence in women who 
used thanaka and DEET, compared to the ones who used thanaka alone [84]. In addition to 
randomized trials, a case control study of Mosbar, similar to the one used in the Pakistan 
refugee camp was conducted in Afghanistan. Use of Mosbar was associated with a 92% 
reduction in the odds of contracting malaria [119]. 
In Africa, the use of repellents as malaria control tools has been scanty and only recently has 
the efficacy of topical repellents on malaria transmission been evaluated. A cluster 
randomized controlled trial was conducted in Ethiopia to determine the effect of Buzz Off 
repellent on malaria. The use of Buzz Off repellent was associated with a 43% reduction in 
the odds of contracting malaria [120]. In a community-wide study conducted in Ghana to 
determine the effect of NO-MAS mosquito repellent on malaria prevalence, use of NO-MAS 
was associated with a 60% reduction in malaria prevalence in the repellent village relative to 
the control village where no repellent was issued [121].  
In line with achieving the millennium development goal (MDG) of reversing malaria by 75%, 
Tanzania has rapidly scaled up use of LLINs to all at risk groups [122]. While this is likely to 
have a significant impact on malaria transmission, it might also lead to a situation where 
vectors adapt to feeding at times and places when and where LLINs are not employed. As a 
result, new tools will be needed to impact on this transmission foci where LLINs are not 
effective. Therefore, and following from the findings of other repellent trials above, the main 
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objective of this work was to assess the impact of using 15% DEET topical repellent on early 
evening malaria transmission in a rural village in Tanzania. However, as the efficacy of 
topical repellents is highly dependent on daily compliance which is likely to impact on the 
uptake of topical repellents and therewith its efficacy, a feasibility study of topical repellent 
uptake was also conducted using before and after studies and focus group discussions 
(FGDs). Further, the shortcomings of this work are also outlined and recommendations on 
how to conduct future trials given. 
 
1.5 Hypothesis 
To test the hypothesis that use of 15% DEET topical repellent in conjunction with LLINs 
significantly prevents malaria transmission in the early evening in rural Tanzania, compared 
to the null hypothesis that use of 15% DEET topical repellents with LLINs has no significant 
impact on malaria transmission in the early evening, [84, 117-121], a cluster-randomized, 
placebo controlled clinical trial was conducted in a rural village in Tanzania. The efficacy of 
15% DEET topical repellent against mosquito bites was also assessed in the semi-field and 
field against laboratory- reared and wild An. arabiensis mosquitoes respectively. The 
feasibility of using topical repellents as a malaria control tool in rural Tanzania was assessed 
through a Knowledge attitude and practice (KAP) survey. 
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1.6 Objectives 
The overall aim of this study was to determine whether topical repellents are a suitable 
intervention against malaria in rural Tanzania. The specific objectives are: 
 
1. To determine the efficacy of 15% formulated DEET topical repellent under semi-field 
and field conditions against laboratory-reared and wild An. arabiensis mosquito 
populations respectively. This work made up in chapter 2 of this thesis 
2. To evaluate the incremental benefit of using 15% formulated DEET topical repellents 
in addition to LLINs against RDT-confirmed malaria transmission in the early 
evening as compared to areas of exclusive LLIN use. This work made up chapter 3 of 
this thesis 
3. To assess the community uptake and acceptance of topical repellents as a protective 
method against mosquito bites and therefore determine its feasibility as an 
intervention tool against malaria in Tanzania.  This work made up chapter 4 of this 
thesis. 
4. To perform an in-depth literature review, on existing studies on the impact of 
repellents against disease transmission, with a focus on malaria. This work made up 
chapter 5 of this thesis. 
5. To develop a protocol outlining the design and implementation of a study evaluating 
the impact of permethrin-impregnated clothing on outdoor malaria transmission. This 
work made up chapter 7 of this thesis. 
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Chapter 2: Use of a semi-field system to evaluate the efficacy of topical 
repellents under user conditions provides a disease exposure free technique 
comparable with field data 
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2.1 Abstract 
Background 
Before topical repellents can be employed as interventions against arthropod bites, their 
efficacy must be established. Currently, laboratory or field tests, using human volunteers, are 
the main methods used for assessing the efficacy of topical repellents. However, laboratory 
tests are not representative of real life conditions under which repellents are used and field-
testing potentially exposes human volunteers to disease. There is, therefore, a need to develop 
methods to test efficacy of repellents under real life conditions while minimizing volunteer 
exposure to disease. 
Methods 
A lotion-based, 15% N, N-Diethyl-3-methylbenzamide (DEET) repellent and 15% DEET in 
ethanol were compared to a placebo lotion in a 200 sq m (10 m × 20 m) semi-field system 
(SFS) against laboratory-reared Anopheles arabiensis mosquitoes and in full field settings 
against wild malaria vectors and nuisance-biting mosquitoes. The average percentage 
protection against biting mosquitoes over four hours in the SFS and field setting was 
determined. A Poisson regression model was then used to determine relative risk of being 
bitten when wearing either of these repellents compared to the placebo. 
Results 
Average percentage protection of the lotion-based 15% DEET repellent after four hours of 
mosquito collection was 82.13% (95% CI 75.94-88.82) in the semi-field experiments and 
85.10% (95% CI 78.97-91.70) in the field experiments. Average percentage protection of 
15% DEET in ethanol after four hours was 71.29% (CI 61.77-82.28) in the semi-field system 
and 88.24% (84.45-92.20) in the field. 
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Conclusions 
Semi-field evaluation results were comparable to full-field evaluations, indicating that such 
systems could be satisfactorily used in measuring efficacy of topically applied mosquito 
repellents, thereby avoiding risks of exposure to mosquito-borne pathogens, associated with 
field-testing. 
Keywords 
Repellent, Anopheles arabiensis, Semi-field system, Efficacy, N, N-diethyl-3-
methylbenzamide (DEET) 
2.2 Background 
Evaluations of topical repellent efficacy against blood feeding arthropods require 
standardized laboratory and field tests [1-3]. However, conditions in the laboratories are not 
representative of real life settings where repellents are used. Therefore, experiments carried 
out in the laboratory may not accurately estimate the efficacy of repellents in the field [4]. 
Environmental factors such as temperature, humidity and wind speed, all of which affect the 
effectiveness of repellents, are controlled in the laboratory, but in the field these factors may 
fluctuate and affect repellent efficacy [5]. As a result, tests carried out in the laboratory 
ideally should be verified using representative field tests. On the other hand, field 
evaluations, albeit representative of conditions under which repellents are normally used, can 
expose volunteers participating in these experiments to mosquito-borne pathogens [6]. 
Therefore, there is a need to develop methods to test efficacy of repellents under 
representative user conditions while minimizing volunteer exposure to vector-borne diseases. 
There are several techniques that have been proposed for testing topical repellents while 
reducing human exposure to mosquito bites. These options include: 1) use of synthetic 
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mosquito attractants that mimic human volunteers [7]; 2) use of animals instead of human 
volunteers [8,9]; 3) use of in vitro blood feeding membrane [10-12]; 4) In vitro olfactometry 
[13]; and, 5) use of a semi-field system (SFS) [14,15]. Although techniques 1 to 4 are 
convenient because of their high throughput in screening of repellents and do not use human 
participants, they have well-documented limitations: as the skin is the site of action of topical 
repellents, and mosquitoes are attracted to cues produced by the host, different hosts will 
elicit varying degree of responses in the mosquito which will affect both duration and degree 
of repellency observed [8,10]. The use of in vitro blood-feeding membrane is unlikely to give 
similar results to repellents applied to human skin, as the feeding membrane used in these 
tests are structurally and physiologically different from the human skin and produce no odour 
[10]. Use of in vitro olfactometry, used mainly to test spatial repellents, is more suitable for 
screening purposes as it’s used in confined spaces and shorter distances in the laboratory and 
results cannot be correlated to the field, where there are wide open spaces for the mosquitoes 
to forage [13]. The use of synthetic blends to test repellency has also proved unreliable as 
different repellent-blend combinations produced disparate results [7]. Use of SFS may 
overcome these shortcomings because efficacy tests can be performed in a large enclosure 
under ambient conditions, allowing mosquitoes to elicit similar behavioural responses as 
under field conditions. The other advantage of SFS is that it uses mosquitoes reared under 
laboratory conditions and therefore does not expose volunteers to potential mosquito-borne 
disease. The species, numbers and physiological status of mosquitoes used in the SFS are 
standardized to provide more controlled conditions and therefore reduce data variability 
associated with field studies. However, the effectiveness of SFS has not been evaluated 
against full-field conditions when testing topical repellents. This study examined whether 
tests carried out in a SFS would yield comparable results to tests conducted in field setting. 
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2.3 Methods 
2.3.1 Study area 
Semi-field evaluation of repellents was carried out at Ifakara Health Institute (IHI), 
Morogoro, Tanzania. The field evaluation of repellents was conducted in Mbingu village, 
Ulanga district, situated 55 km west of Ifakara town at 8.195°S and 36.259°E. Rapid 
diagnostic test (RDT) results from passive case detection at a local clinic between December 
2012 and July 2013 confirmed malaria incidence estimates from the village were 0.67 
cases/person-years, (Jabari Mohammed Namamba, pers comm), only one-and-half years after 
the end of a national campaign to achieve universal coverage with long-lasting, insecticide-
treated bed nets (LLINs) [16]. There is high malaria transmission all year round, with peak 
transmission occurring in the months of May and June after the long rains. The village 
experiences an annual rainfall of approximately 1,200-1,800 mm and an annual temperature 
range of between 20 and 32.6°C. The village borders an extensive field cleared for irrigation, 
which provides an ideal breeding site for malaria vectors [17]. 
2.3.2 Semi-field evaluations of topically applied repellents  
The semi-field evaluation was carried out in the IHI SFS. A SFS is an enclosed environment, 
situated in the natural ecosystem of a target vector and exposed to ambient conditions 
necessary for the completion of the life cycle of the vector. It is made up of a greenhouse 
frame with walls of mosquito netting and a polyethylene roof, mounted on a raised concrete 
platform [14,15]. 
2.3.3 Mosquitoes 
The mosquitoes used in these experiments were laboratory-reared Anopheles arabiensis 
(Ifakara strain, originally sourced from Sagamaganga village, Kilombero district in 2008) 
from the IHI insectaries. The larvae were fed on Tetramin® fish food and maintained at 
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temperatures of 28 ± 1°C. Pupae were placed in emergence bowls inside a 30 × 30 × 30 cubic 
cm netted cage in a separate room where temperatures were maintained at 27 ± 3°C and 
relative humidity at 70-90%. A 10% glucose solution was supplied in the cages for the 
emergent adults. The insectary was maintained at 12:12 (light: dark) photoperiod, from 0600 
hrs to 1800 hours (light period) and 1800 hrs to 0600 hrs (dark period). The mosquitoes used 
in these experiments were three to eight day-old nulliparous females. The mosquitoes were 
starved from sugar solution for six hours. 
2.3.4 Volunteers 
Male volunteers, aged between 18 and 40 years were educated on aims, benefits and risks of 
the study and recruited on written informed consent. The use of strictly male volunteers was 
to prevent potential risk of malaria infection to pregnant female volunteers. All volunteers 
were highly experienced in performing human-landing catches. During the SFS experiments, 
volunteers were screened daily for parasitaemia using RDTs and if found positive, excluded 
from participating any further in the experiments and treated with artemether-lumefantrine 
(ALU), first-line drug for treatment of malaria in Tanzania. During the field evaluation, in 
addition to daily screening, volunteers were provided with mefloquine prophylaxis. The 
volunteers were instructed not to use any fragranced soap or perfume, tobacco or alcohol 12 
hours before the start and throughout the experiments. 
2.3.5 Repellents 
The repellent tested was donated by SC Johnson & Sons Inc (Racine, WI, USA). Three 
treatments were tested: 1) a lotion-based formulation containing 15% DEET as the active 
ingredient, being the test product; 2) 15% DEET diluted in absolute ethanol, being the 
standard control, and 3) a placebo made of a similar lotion formulation as the test product, but 
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lacking the active ingredient, being the negative control. Technicians were blinded to the 
repellent application. 
2.3.6 Repellent application 
To establish the amount of repellent required for application in the SFS experiments, surface 
area of the lower limbs of three adult male volunteers was determined by first measuring the 
length from ankle to the knee and the circumference of the ankle and knee using a tape 
measure. The surface area was then calculated using the formula that expresses the lower 
limb surface as a trapezium or cylinder: 
Area = 0.5(ca + ck)Dka  (1) 
where ca is the circumference of the ankle in cm, ck circumference of the knee, and D is the 
distance between ca and ck. 
Three volunteers were initially asked to apply the repellent ad libitum (the amount they felt 
was safe to protect from mosquito bites) to their legs. While applying the repellent, the 
volunteers wore latex gloves to avoid absorption of repellents into their skin, which would 
otherwise reduce the net quantity of repellent applied. The product bottles were then weighed 
using a precision weighing balance (Ohaus Corp, Pine Brook, NJ, USA) after this initial 
application to determine the amount applied by each volunteer. The average amount of 
repellent per volunteer was then calculated from these results. The average amount applied 
per volunteer was determined to be 2 mg per volunteer-leg. The average surface area of a 
volunteer’s leg was 1,041 cm2. The amount of DEET applied was 0.002 mg/cm2 (2 mg/1,041 
cm2). After amount of repellent required for application was determined, the PI (SO) 
premeasured these amounts in a Petri dish for each volunteer every evening. The volunteers 
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were then asked to wear latex gloves and apply their respective amounts on their lower limbs 
every evening before the start of each experiment. 
2.4 Study design 
The SFS experiments used a partially randomized, 3 × 3 unbalanced Latin square design. The 
three treatments used in these experiments were assigned numbers: 1 (15% DEET lotion), 2 
(15% DEET ethanol) and, 3 (placebo lotion). Three volunteers were used in these 
experiments and were randomly assigned to each of the three treatments using the lottery 
method. The volunteers were also randomly assigned sitting positions inside the SFS using 
the lottery method, and moved between the positions in the same order every night. One 
round of repellent evaluation was made up of three nights of mosquito collections, with each 
volunteer wearing a different treatment and sitting at a different position on each of these 
nights. A single set of three volunteers conducted these experiments for six nights (two 
rounds of repellent evaluation). For logistical reasons, the second set of three volunteers 
conducted the experiments for three nights (one round of repellent evaluation). Therefore, the 
mosquitoes were collected for a total of nine nights in the SFS, but with two different sets of 
volunteers. Data from the three rounds was pooled. The authors are aware that this limitation 
may have increased data variance because of individual variability in attraction of mosquitoes 
and efficiency in mosquito collections. 
The PI (SO) premeasured the amounts of treatments 15 min prior (17.45), to the start of the 
experiments and asked the volunteers to apply their respective amounts on their lower limbs 
while wearing latex gloves. The volunteers had also been asked to put on knee-length shorts 
and ankle high boots, so as to standardize the area of exposure. The volunteers sat on low 
stools 10 m equidistant from each other in a triangular formation. A cage holding 100 
mosquitoes was placed at the centre of this triangle formation. It was determined from 
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literature that the biting rate in the study area was 62.5 bites /person/night [18]. Therefore, 
100 mosquitoes were released in each hour in the SFS containing three volunteers to simulate 
the high biting pressure of the field setting. It was assumed that only half the number of all 
mosquitoes released would bite the volunteers. Therefore, each volunteer would have 
received approximately 67bites/person/night. The average landing rates/volunteer/hour was 
also determined. At the top of every hour (18.00 h-22.00) the mosquitoes were released by 
one of the volunteers. The experiments were conducted from 18.00 because this was the 
reported time of the start of biting activity of vectors in the study area [19]. In total, four 
cages containing 100 mosquitoes each were used during each night of the SFS experiment. 
Each volunteer was given a head torch, which they switched on only when they felt a 
mosquito landing on their limb or when scanning the legs every 30 seconds for mosquitoes 
[20]. The volunteers were also given four paper cups, marked from the first to the fourth 
hour, and instructed to place the catches for each hour in their respective cups. The paper 
cups were covered with netting that had a hole at the centre to place the mosquitoes into the 
paper cups, which were plugged using a cotton wool to prevent mosquitoes from escaping. At 
the end of the experiment (22.00), the mosquitoes collected in the four paper cups were 
stored in the freezer at the IHI laboratory until the next morning. At 09.00 the next day, the 
mosquitoes in each paper cup were counted and recorded for each hour. The mosquitoes were 
then discarded and the paper cups cleaned ready for the day’s experiment. 
2.4.1 Field evaluation of topically applied repellents  
Field evaluation of repellents was conducted in Mbingu village, described above. The 
experiments were conducted next to the rice fields and away from human dwellings to avoid 
potential bias in the number and behaviour of mosquitoes [21]. 
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The field evaluation of repellents was conducted using a partially randomized, 3 × 3 balanced 
Latin square design, in the same manner as the SFS repellent evaluation described above. All 
field experiments were conducted at the site identified and described above. Six volunteers, 
two of whom had also performed the SFS evaluations, were recruited for field evaluation of 
repellents. A first set of three volunteers conducted the repellent evaluation for nine nights, 
followed by the second set of volunteers who also conducted the experiment for nine nights 
at the same site. Therefore six volunteers evaluated the repellents for a total of 18 nights in 
the field as it was hypothesized that there would be greater variability in field data and more 
replicates would be required. The volunteers sat 20 m equidistant from each other in a 
triangular formation. They collected mosquitoes from 18.00 to 22.00, and placed them in the 
different paper cups marked one to four hours. At the end of the collections, the paper cups 
holding the mosquitoes were placed in a cool box containing a piece of cotton wool 
impregnated with chloroform, which killed the mosquitoes. The next morning the mosquitoes 
in each paper cup were counted by the respective volunteer and the numbers recorded. The 
mosquitoes were sorted into anophelines and culicines and stored in separate Petri dishes that 
were layered with cotton wool and silica gel to prevent desiccation. The mosquitoes were 
brought back to the IHI laboratory where the culicines were identified to species level by an 
experienced entomologist using taxonomic keys [22]. The Anopheles gambiae complex was 
identified to species level using polymerase chain reaction (PCR) [23]. 
2.5 Statistical analysis 
2.5.1 Calculation of percentage protection 
Data from the SFS and field trials were recorded in a Microsoft Excel spreadsheet (Microsoft 
Corporation), with columns for the date, name of volunteer, treatment the volunteer was 
wearing, position the volunteer was sitting and the number of mosquitoes caught during each 
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hour. This data was then exported into STATA 11 (StataCorp LP, College Station, Texas, 
USA), where the total number of mosquitoes caught when using 15% DEET lotion and 15% 
DEET in ethanol were compared to the total number of mosquitoes caught when using the 
placebo lotion for each night regardless of who was using it, and an average was calculated. 
The reductions in number of mosquitoes in these two treatments (15% DEET lotion and 15% 
DEET in ethanol) were designated protection and expressed as a percentage, (percentage 
protection). The formula used to calculate percentage protection is shown below: 
P = [C‐T]/Cx100  (2) 
where C is the number of mosquitoes caught when the volunteer was using the placebo lotion 
and T is number of mosquitoes caught when the volunteer was using either the 15% DEET 
lotion or 15% DEET ethanol. 
These results for each night of collection were then aggregated and the average percentage 
protection when using either 15% DEET ethanol or 15% DEET ethanol calculated using 
STATA 11. 
2.5.2 Poisson regression analysis  
Count data was then fitted into a Poisson model in STATA 11, with a log link function and a 
random intercept for each row of data to account for over dispersion, so as to determine 
relative risk of being bitten by a mosquito. A Poisson model was chosen because it is used to 
model count data over a specified period of time, i.e. the number of mosquito bites occurring 
in one hour. It is also used to model rare events (mosquito bites), which is what was expected 
when a volunteer was wearing either 15% DEET lotion or 15% DEET ethanol. A Poisson 
model also allowed for analysis of repeated measures over time on the same individual, i.e. 
the number of mosquitoes caught by each individual on each day while wearing a different 
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repellent and sitting at a different position. The number of mosquitoes caught/hour was fitted 
as the dependent variable, and interaction of repellent with time, individual variability and 
position fitted as predictors. Day (which also accounted for confounders like temperature, 
humidity and wind speed), was fitted as a random covariate, and a random intercept, in this 
case a Unique ID, was fitted into the model to account for over dispersion of the data. 
The percentage protection of 15% DEET lotion and 15% DEET ethanol per hour and 
regression coefficients relative to the placebo (Incidence Rate Ratio, IRR) were determined to 
assess the decay of repellents through time. 
2.6 Ethical considerations 
The volunteers used in these experiments were recruited on written informed consent. In case 
of any positive blood slide for malaria parasites, ALU combination therapy, the first-line drug 
for malaria treatment in Tanzania, was available. The volunteers were also informed of the 
study objectives and that they were free to withdraw their participation at any time during the 
experiments. The volunteers were experienced in human landing catch techniques and were 
issued with loose net jackets to prevent the mosquitoes biting the upper parts of the body. For 
field experiments, the volunteers were provided with mefloquine prophylaxis to protect them 
against contracting malaria. Ethical approval was granted by the Ethical Review Boards of 
Ifakara Health Institute (IHRDC IRB A46), the Tanzanian National Institute of Medical 
Research (NIMR/HQ/R8a/VOL IX/780), and London School of Hygiene of Tropical 
Medicine (LSHTM 5174). 
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2.7 Results 
2.7.1 Semi-field experiments 
2.7.1.1 Average percentage protection 
The average percentage protection of 15% DEET lotion in the SFS as calculated from 
Equation 2 above was 82.13% (95% CI 75.93-88.82) and 71.29% (95% CI 61.77-82.28) for 
15% DEET in ethanol over four hours of mosquito collection. 
2.7.1.2 Poisson regression analysis 
The relative risk of being bitten by a mosquito over the four-hour test when using 15% DEET 
lotion compared to placebo lotion was reduced by 91.8% (95% CI 85.73-95.79%, IRR = 
0.082 z = −8.23, P <0.0001). When 15% DEET ethanol was compared to the placebo lotion, 
the relative risk of being bitten by mosquitoes was also reduced by 92.30% (95% CI 85.06-
95.45%, IRR = 0.077, z = −8.21, P <0.0001) (Table 1). The relative risk of being bitten 
increased in hours two and three relative to hour one, although these differences were not 
significant. There was, however, a significant increase in the risk of being bitten in hour four 
compared to hour one for both 15% DEET lotion IRR = 3.71 (95% CI 1.78-7.78, z = 3.47, P 
= 0.001) and 15% DEET ethanol IRR = 3.43 (95% CI 1.60-7.39, z = 3.17, P = 0.002). This is 
an indication of repellent decay over time. There was location bias, with position 3 having a 
higher risk of being bitten compared to location one, IRR 2.00 (95% CI 1.51-2.66, z = 4.79, P 
<0.0001). Position 3 within the SFS was located closest to a nearby restaurant and the 
mosquitoes were probably more attracted to the light and human cues. There was variability 
in individual attractiveness to mosquitoes, (Table 2:1). 
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Table 2:1 Effect of 15% DEET repellent over time, treatment, position and person on Anopheles 
arabiensis in a four-hour repellent evaluation in the semi-field system at Ifakara Health Institute 
Treatments  Hours Incidence rate ratio (IRR) 1[95% 
CI] 
Z-test statistic 
2 
P-value  
3 
15% DEET in ethanol 1 - - - 
2 1.744 [0.796-3.819] 1.39 0.164 
3 1.223 [0.559-2.675] 0.51 0.613 
4 3.708 [1.767-7.780] 3.47 0.001 
15% formulated DEET 
repellent 
1 - - - 
2 0.877 [0.359-2.140] −0.29 0.774 
3 1.674 [0.756-3.709] 1.27 0.204 
4 3.439 [1.601-7.386] 3.17 0.002 
Treatments      
Placebo - - - - 
15% DEET in ethanol - 0.082 [0.045-0.149] −8.23 <0.0001 
15% DEET in lotion format - 0.077 [0.042-0.142] −8.21 <0.0001 
Position     
1 - - - - 
2 - 0.818 [0.587-1.139] −1.19 0.236 
3 - 2.000 [1.506-2.656] 4.79 <0.0001 
Person     
1 - - - - 
2 - 0.619 [0.441-0.868] −2.78 0.005 
3 - 2.372 [1.796-3.133] 6.08 <0.0001 
 
1 The data for position one, person one and effect of treatments in hour one were used as a 
reference values for calculating the incidence rate ratios (IRR) for mosquito bites. 2 The test 
statistic z is the ratio of the Coefficient to the Standard error of that respective predictor and 
is used to test against a two-sided alternative hypothesis that the Coefficient is not equal to 
zero. 3 The probability (P) that a particular z test statistic is different to what has been 
observed under the null hypothesis. 
Field trial experiments 
2.7.1.3 Mosquito species composition in the study area 
A total of 4,844 mosquitoes were caught in 72 hours over 18 nights. The catch included: 295 
(5.4%) An. gambiae s.l., 3,082 (64.6%) Mansonia africanus, 467 (9.8%) Mansonia uniformis, 
673 (14.1%) Coquillettidia aureus, 210 (4.4%) Culex univattus and 177 (3.7%) other Culex 
species (Figure 2:1). 
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Figure 2:1 Pie chart showing mosquito species composition caught in Mbingu village 
during human landing catches sampled over 18 nights in field experiments 
 
2.7.1.4 Anopheles gambiae s.l. composition in the study area 
All the An. gambiae s.l. caught were identified to species level by PCR. Out of the 295 
successful PCR amplifications, 12.88% (n = 38) were An. gambiae s.s, while 87.12% (n = 
257) were An. arabiensis. 
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2.7.1.5 Average percentage protection 
The average percentage protection, of 15% DEET lotion in the field was 85.10% (95% C.I. 
78.97-91.70) and 88.24% (95% C.I. 84.45-92.20) for DEET ethanol over four hours of 
mosquito collection, as calculated from Equation 2. 
2.7.1.6 Poisson regression analysis 
The relative risk of being bitten by a mosquito over the four hour test when using 15% DEET 
lotion was reduced by 94.78% (95% CI 91.46-96.81%, IRR = 0.052, z = −11.74, P <0.0001) 
compared to the placebo lotion and 96.41% (95% CI 93.94-97.88%, IRR = 0.035, z = −12.42, 
P <0.0001) while using 15% DEET in ethanol (Table 2:2). 
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Table 2:2 Effects of 15% DEET repellent over time, treatment, position and person on total 
number of mosquitoes in a four-hour repellent evaluation in Mbingu village  
Treatments  Hours  Incidence Rate Ratio1 [95% CI] Z-test statistic2 P-value 3 
15% DEET in lotion format 1 - - - 
2 0.839 [0.422-1.667] −0.50 0.618 
3 1.133 [0.578-2.222] 0.37 0.714 
4 1.699 [0.873-3.307] 1.56 0.118 
15% DEET in ethanol 1 - - - 
2 0.791 [0.381-1.641] −0.63 0.529 
3 2.049 [1.027-4.090] 2.04 0.042 
4 3.027 [1.524-6.011] 3.17 0.002 
Treatments      
Placebo - - - - 
15% DEET in lotion format - 0.052 [0.038-0.085] −11.74 <0.0001 
15% DEET in ethanol - 0.035 [0.021-0.060] −12.42 <0.0001 
Position     
1 - - - - 
2 - 1.091 [0.851-1.400] 0.69 0.498 
3 - 0.876 [0.684-1.123] −1.04 0.299 
Person     
1 - - - - 
2 - 4.892 [3.511-6.816] 9.38 0.000 
3 - 1.392 [0.973-1.987] 1.81 0.070 
4 - 1.065 [0.624-1.820] 0.23 0.815 
5 - 0.933 [0.54 0–1.611] −0.25 0.804 
6 - 1.377 [0.808-2.347] 1.18 0.239 
 
1 The data for position one, person one and effect of treatments in hour one were used as a reference 
values for calculating the incidence rate ratios (IRR) for mosquito bites. 2 The test statistic z is the 
ratio of the Coefficient to the Standard error of that respective predictor and is used to test against a 
two-sided alternative hypothesis that the Coefficient is not equal to zero. 3 The probability (P) that a 
particular z test statistic is different to what has been observed under the null hypothesis. 
The risk of being bitten in the fourth hour increased three-fold compared to the first hour 
when using 15% DEET in ethanol IRR = 3.03 (95% CI 1.52-6.01, z = 3.17, P = 0.001). There 
was, however, no significant increase in the risk of bitten through hours 1 to 4 when using 
15% DEET lotion repellent (Table 2:2). There was lower variability in individual 
attractiveness to mosquitoes, with only volunteer 2 being significantly more attractive to 
mosquitoes, IRR = 4.89 (95% CI 3.51-6.82, z = 9.38, P <0.0001). This individual was 
consistently more attractive in all field experiments. In this field study, the volunteers 
recruited had differing body mass. There were volunteers who had a larger body mass than 
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this individual but caught fewer mosquitoes when they were compared. Also, even though all 
team members were highly experienced, there were more experienced field technicians who 
did not catch as many mosquitoes as this individual. All volunteers used the same 
concentration and gram/cm2 repellents per body surface area, ruling out the potential bias of 
one volunteer applying more repellent. Studies have shown variable responses of mosquitoes 
to singular or constituent host attractive cues. It is therefore likely that, the combination of 
this volunteers body cues/odours [24], made him more attractive to mosquitoes than the 
combination of cues that were emitted by the other volunteers. 
2.7.1.7 Anopheles gambiae experiments 
Data on An. gambiae s.l. from the study area was analyzed separately to determine the 
efficacy of repellents on this species of major medical importance. 
2.7.1.8 Average percentage protection 
The average percentage protection of 15% DEET lotion in the field was 93.40% (95% C.I. 
89.21-97.79) and 91.45% (95% C.I. 85.79-97.47) for 15% DEET in ethanol over four hours 
of mosquito collection, as calculated from Equation 2. 
2.7.1.9 Poisson regression analysis 
The relative risk of being bitten when using 15% DEET lotion was reduced by 82.86% (95% 
CI 53.26-93.71, IRR = 0.171, z = −3.45, P = 0.001) when compared to placebo lotion and by 
83.43% (95% CI 55.81-93.79, IRR = 0.165, z = −3.59, P <0.0001) when using15% DEET in 
ethanol over the four hours of the test. There was no significant difference in the average 
number of An. gambiae s.l. caught at the different positions in the field, in each hour or by 
each treatment in each hour over the four hours of mosquito collections demonstrating 
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consistent protection. There was however a significant difference in the average number of 
An. gambiae s.l. caught by volunteer 2: IRR = 2.66 (95% CI 1.42-4.98, z = 3.06, P = 0.002) 
and volunteer 6: IRR 0.26 (95% CI 0.81-0.84, z = −2.25, P = 0.025) relative to volunteer 1 
(Table 2:3). 
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Table 2:3 Effects of 15% DEET repellent over time, treatment, position and person on 
Anopheles arabiensis in a four-hour repellent evaluation in Mbingu village  
Treatments  Hours Incidence rate ratio (IRR) 1 [95% 
CI] 
Z-test statistic 
2 
P-value  
3 
15% DEET in lotion 
format 
1 - - - 
2 0.403 [0.083-1.956] −1.13 0.260 
3 0.326 [0.068-1.550] −1.41 0.159 
4 0.722 [0.185-2.812] −0.47 0.639 
15% DEET in ethanol 1 - - - 
2 1.229 [0.343-4.399] 0.32 0.750 
3 1.963 [0.583-6.621] 1.09 0.277 
4 1.370 [0.400-4.693] 0.86 0.500 
Treatments      
Placebo - - - - 
15% DEET in lotion 
format 
- 0.171 [0.063-0.467] −3.45 0.001 
15% DEET in ethanol - 0.165 [0.062-0.441] −3.59 <0.0001 
Position     
1 - - - - 
2 - 0.932 [0.542-1.602] −0.25 0.800 
3 - 1.262 [0.750-2.126] 0.88 0.380 
Person     
1 - - - - 
2 - 2.660 [1.420-4.979] 3.06 0.002 
3 - 1.801 [0.924-3.510] 1.73 0.084 
4 - 0.381 [0.127-1.141] −1.72 0.085 
5 - 0.328 [0.106-1.015] −1.93 0.053 
6 - 0.262 [0.081-0.841] −2.25 0.025 
 
1 The data for position one, person one and effect of treatments in hour one were used as a 
reference values for calculating the incidence rate ratios (IRR) for mosquito bites. 2 The test 
statistic z is the ratio of the Coefficient to the Standard error of that respective predictor and is 
used to test against a two-sided alternative hypothesis that the Coefficient is not equal to zero. 
3 The probability (P) that a particular z test statistic is different to what has been observed 
under the null hypothesis. 
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2.7.1.10 Comparison of full field and semi-field system data 
Decay of repellent from the Poisson regression equations (Tables 2:1 and 2:2) and the 
linear regression demonstrated that 15% DEET in lotion format decayed at a slower 
rate than 15% DEET in ethanol in both the SFS and field settings. A linear regression 
also demonstrated a similar trend with regression coefficients showing a more rapid 
decay of 15% DEET in ethanol in the SFS and against all mosquitoes in the field, 
with equal decay of the two formulations against An. gambiae s.l. in the field (Table 
2:4). However, the results from the linear regression equations (regression 
coefficients) should be interpreted with caution as the data were over dispersed even 
after transformation to a proportion (percentage protection) and also linear regression 
is a parametric test that assumes equal variance around the mean. The percentage 
protection provided by 15% DEET lotion and 15% DEET in ethanol was similar in 
the SFS and field settings and on both occasions both treatments provided greater 
protection in the field than in the SFS (Figure 2). When the two treatments (15% 
DEET lotion and 15% DEET ethanol) were compared statistically there was no 
difference between the two measured in the SFS IRR = 0.904 (95% C.I. 0.44-2.80, p 
= 0.833) or the field IRR = 0.621 (95% C.I 0.316-1.221, p = 0.168). 
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Table 2:4 Comparison of rate of decay of repellents, percentage protection and log-
transformed means of mosquito catches per hour in the semi-field system against 
Anopheles arabiensis and in the field against all mosquito species and Anopheles 
arabiensis 
Experiment Hour Regression 
equation 
Treatments  GEOMEAN Percentage 
protection 
(CI)* 
Semi-field evaluation 
against An. arabiensis 
1 Y = −0.0765 + 
1.0315 
Lotion-based 15% 
DEET repellent 
2.69 90.88 (84.25-
98.03) 
2 1.7 91.85 (84.85-
99.43) 
3 3.1 82.60 (70.39-
96.93) 
4 R2 = 0.29138 4.63 65.97 (52.28-
83.24) 
1 Y = −0.119x = 
0.9685 
15% DEET in 
ethanol 
4.65 75.55 (51.79-
110.20) 
2 3.63 70.76 (54.63-
91.65) 
3 R2 = 0.08181 3.17 82.18 (61.19-
110.36) 
4 6.26 58.42 (40.45-
84.36) 
Field evaluation 
against all mosquito 
species 
1 Y = −0.0077x 
+ 0.8921 
Lotion-based 15% 
DEET repellent 
4.77 87.39 (76.49-
99.83) 
2 4.03 88.92 (79.15-
99.88) 
3 5.44 85.99 (76.30-
96.90) 
4 R2 = 0.00174 8.03 83.98 (73.78-
94.19) 
1 Y = −0.0427x 
+ 1.0009 
15% DEET in 
ethanol 
4.22 91.98 (84.14-
100.55) 
2 5.94 95.11 (91.02-
99.37) 
3 R2 = 0.11871 10.89 87.87 (83.08-
92.95) 
4 13.5 79.03 (69.14-
90.33) 
Person      
Field evaluation 
against An. arabiensis 
1 Y = 0.0311x + 
0.7904 
Lotion-based 15% 
DEET repellent 
1.22 92.58 (83.18-
103.05) 
2 1.25 100.00 (100.00-
100.00) 
3 1 92.60 (84.30-
101.72) 
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0.06763 
4 1.64 88.02 (76.15-
101.75) 
1 Y = 0.0208 + 
0.6235 
15% DEET in 
ethanol 
0.72 95.20 (87.33-
103.78) 
2 0.94 94.93 (87.85-
102.57) 
3 R2 = 0.045263 1.5 82.26 (61.18-
110.61) 
4 1.17 91.15 (83.82-
101.31) 
 
 Some confidence intervals exceed 100% because the ranges were calculated by 
regression analysis using continuous data. They should therefore be read as 100% 
efficacy  
 
 
 
 
 
 
Figure 2:2 Comparison of percentage protection of 15% DEET lotion and 15% 
DEET ethanol against An. arabiensis in the semi-field system, all mosquito 
species and An. arabiensis in the field after four hours of mosquito collection  
L-Field total is 15% DEET lotion tested against all mosquito species in the field. L-Field 
Arabiensis is 15% DEET lotion against An. arabiensis in the field. L-SFS is 15% DEET 
lotion against An. arabiensis in the semi-field system. D-Field total is 15% DEET in ethanol 
tested against all mosquito species in the field. D-Field Arabiensis is 15% DEET in ethanol 
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against An. arabiensis in the field. D-SFS is 15% DEET in ethanol against An. arabiensis 
semi-field system. 
2.8 Discussion 
The epidemiology of malaria in sub-Saharan Africa is experiencing a subtle shift. 
Before the advent of LLINs and indoor residual spraying (IRS), malaria transmission 
was mediated indoors and late in the night mainly by An. gambiae s.s. This species of 
the An. gambiae complex is known to be predominantly anthropophilic, endophagic 
and endophilic [25,26]. This characteristic is responsible for the success of LLINs and 
IRS in controlling An. gambiae s.s., as these tools predominantly target indoor biting 
and resting malaria vectors. However, An. arabiensis, the other dominant vector 
species of the An. gambiae complex [26] exhibits a more plastic behaviour [27]. In 
areas where the host is predominantly human and found indoors, this vector displays 
anthropophilic, endopahgic and endophilic behaviour, similar to its sibling species, 
An. gambiae s.s. However in areas where the host is found outdoors and is non-
human, An. arabiensis readily shifts to exophagic, exophilic and zoophagic behaviour 
[25]. Therefore, extensive and long-term employment of LLINs and IRS is likely to 
significantly diminish and in some situations completely eliminate the populations of 
An. gambiae s.s., thereby selecting for the highly adaptable An. arabiensis that 
predominantly bites early in the evening and outdoors [27]. As a result, even though 
LLINs and IRS will decrease malaria transmission as a whole, there will be a 
substantial proportion of residual transmission occurring outdoors and in the early 
evenings that these intradomiciliary tools cannot tackle [27]. 
Consequently, there is a need to develop novel tools or methods that can tackle this 
residual transmission. Repellents, both topical and spatial, provide a promising 
solution for controlling outdoor transmission [28-30]. However before topical 
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repellents are employed in the community, their performance needs to be correctly 
and accurately measured under user conditions. It is, therefore, essential to develop a 
robust methodology for testing repellent efficacy that is representative of conditions 
under which the repellents are used (the community), but does not expose individuals 
conducting these experiments to potential malaria vectors [1,2]. It was hypothesized 
that locating the SFS in regions representative of ambient conditions for the targeted 
disease vector and testing repellents on humans against these vectors is likely to yield 
results that correlate well with field tests. Therefore, to qualify the effect of these 
treatments in these two settings, data for An. arabiensis in the SFS was analyzed 
against data of An. gambiae s.l. in the field experiments (as > 80% of this species 
complex was found to be An. arabiensis). 
The findings demonstrated that 15% DEET lotion protected against 82.13% (95% CI 
75.93-88.82) of the bites in the SFS compared to 93.40% (95% C.I. 89.21-97.79) 
protection against bites in the field, while 15% DEET in ethanol protected against 
71.29% (95% CI 61.77-82.28) bites in the SFS compared 91.45% (95% C.I. 85.79-
97.47) bites in the field against An. gambiae s.l. These results demonstrate that both 
15% DEET lotion and 15% DEET repellent were more efficacious in the field than in 
the SFS. A plausible explanation for this might be the high biting pressure observed in 
the SFS compared to the field. Mosquitoes were exposed to fewer hosts than they 
normally would in the field and their numbers were continuously increased from 100 
mosquitoes in the first hour to 400 mosquitoes in the fourth hour (Table 2:5 & 2:6). 
By simulating high biting pressure that increased over time as is seen in the field due 
to the circadian rhythm of the local malaria vectors [19], the authors ensured that the 
repellent worked extremely well against the predominant malaria vector species 
before going to the more dangerous field setting. It is known that repellents have 
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varying effects on the other mosquito species present in the field [6,31]. As a result, 
the effect of the repellent in the field might be over or underestimated depending on 
the other species present in the field. It is, therefore, prudent, that before the effect of 
a repellent is established, it should be tested against different mosquito species to 
assess its efficacy. These data showed that DEET efficacy against one Anopheline 
species only in the SFS was similar to that for a range of non-anophelines in the full 
field although this needs to be validated for other repellent classes, as not all 
repellents are broad-spectrum. 
Table 2:5 Mean landing rates (MLR) of Anopheles arabiensis/volunteer/hour in a four-
hour repellent evaluation in the Semi-field system at Ifakara Health Institute  
 Volunteer 1 Median 
(IQR) 
Volunteer 2 Median 
(IQR) 
Volunteer 3 Median 
(IQR) 
Placebo    
Hour 1 17 (6–20) 22 (11–27) 41 (19–46) 
Hour 2 16 (13–19) 18 (8–18) 17 (16–43) 
Hour 3 14 (10–24) 24 (6–29) 37 (18–56) 
Hour 4 14 (11–30) 16 (8–20) 28 (12–36) 
15% DEET in ethanol    
Hour 1 0 0 12 (1–13) 
Hour 2 1 (0–3) 1 (0–5) 8 (7–10) 
Hour 3 1 (0–1) 0 (0–1) 9 (6–19) 
Hour 4 4 (1–10) 4 (0–4) 19 (7–18) 
15% DEET in lotion 
formulation 
   
Hour 1 2 (0–4) 0 (0–1) 4 (2–6) 
Hour 2 1 (1–5) 2 (0–2) 1 (1–5) 
Hour 3 3 (2–15) 2 (0–2) 3 (2–4) 
Hour 4 3 (2–17) 3 (2–5) 8 (4–10) 
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Table 2:6 Mean landing rates (MLR) of Anopheles gambiae s.l/volunteer/hour in a four-
hour repellent evaluation in Mbingu village  
 Volunteer 1 
Median 
(IQR) 
Volunteer 2 
Median 
(IQR) 
Volunteer 3 
Median 
(IQR) 
Volunteer 4 
Median 
(IQR) 
Volunteer 5 
Median 
(IQR) 
Volunteer 6 
Median 
(IQR) 
Placebo       
Hour 1 10 (2–10) 2 (0–3) 4 (1–5) 0 (0–2) 0 (0–6) (0) 
Hour 2 2 (1–7) 4 (2–4) 3 (1–4) 2 (0–5) 1 (0–3) 1 (0–3) 
Hour 3 4 (1–22) 3 (0–6) 10 (1–13) 0 (0–3) 0 (0–4) 0 (0–4) 
Hour 4 4 (0–6) 3 (1–7) 11 (3–12) 0 (0–8) 2 (0–3) 0 (0–5) 
15% 
DEET in 
ethanol 
      
Hour 1 0 (0–0) 2 (1–9) 0 (0–1) 0 (0–0) 0 (0–0) 0 (0–0) 
Hour 2 0 (0–1) 1 (0–7) 2 (0–6) 0 (0–0) 0 (0–0) 0 (0–0) 
Hour 3 0 (0–3) 4 (1–8) 2 (0–4) 0 (0–5) 0 (0–0) 0 (0–0) 
Hour 4 0 (0–0) 4 (1–5) 3 (1–6) 0 (0–0) 0 (0–0) 0 (0–1) 
15% 
DEET in 
lotion 
      
Hour 1 0 (0–0) 0 (0–1) 0 (0–1) 0 (0–1) 0 (0–2) 1 (0–1) 
Hour 2 0 (0–0) 0 (0–2) 0 (0–0) 1 (0–1) 0 (0–0) 0 (0–0) 
Hour 3 0 (0–1) 1 (0–1) 0 (0–0) 0 (0–0) 0 (0–1) 0 (0–0) 
Hour 4 0 (0–0) 2 (0–3) 0 (0–2) 0 (0–0) 0 (0–0) 0 (0–0) 
It is often assumed that formulated repellents provide longer protection against 
arthropod bites, especially those that have a high vapour pressure. However, findings 
from this study demonstrate that this may not always be true, and that different 
formulations of repellents containing the same amount of active ingredient (AI) 
provide relatively similar efficacy against arthropod bites. These findings are similar 
to a study carried out to test the efficacy of different formulations of repellents against 
ticks [32,33]. 
This is the first study known to have compared the efficacy of topical repellent in both 
the SFS and field and to determine a correlation between these two settings. However, 
the current study did suffer from some shortcomings, and an attempt to outline a 
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rationale procedure for conducting future studies incorporating the lessons learnt from 
this study is suggested below. 
A fully randomized, balanced Latin square design should be employed, so that each 
volunteer tests each of the repellents in all positions available in the SFS. Each 
volunteer should test each treatment for an equal number of days in each position. The 
treatments and positions should be randomly assigned to the volunteers and the 
movement through these positions should be also be randomized. The exact number 
volunteers testing the repellents should be established, and this number used to 
calculate the average repellent dose to be applied per individual/surface area. This is 
to avoid under or overestimating the repellent dose required per person in a case 
where fewer or more individuals are used to establish the amount of repellent required 
than those actually testing the repellents. Each group of volunteers testing the 
repellents should perform an equal number of replicates so that the results are not 
confounded by individual variability in attractiveness of mosquitoes, a bias that is 
minimized when all volunteers have equal number of replicates. All repellent 
application should be done by an individual wearing gloves, either by the volunteers 
themselves or an assistant, to prevent repellent absorption into the skin, thereby 
reducing net amount of repellent being applied. The local dominant vector species, 
the biting rate per night and time of biting should be established and the number of 
mosquitoes representative of the biting rate used in the study. The experiments should 
also be started at the beginning of peak biting activity of the dominant vector in the 
local area, to avoid interfering with the circadian rhythm. Varying the biting pressure 
and peak biting times may vary the results of the SFS. 
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Using a new model of repellent efficacy as a function of user compliance and malaria 
intensity developed by SJM and Briet (personnal communication), the predicted 
reduction in malaria provided by the repellent in this scenario would be 44%, 
assuming 80% repellent efficacy and 80% compliance among users with a sporozoite 
index of 0.005637 (Okumu, personal communication), a transmission season of 200 
days per year and biting pressure of 32 bites per night from the major malaria vector 
An. arabiensis [34]. 
2.9 Conclusion 
The findings of this study support the hypothesis that repellent testing conducted in 
SFS yields similar results to field tests, and could be used in place of field tests, to 
avoid unnecessary exposure of volunteers to potentially infectious disease vectors, 
provided repellent efficacy is established against a range of representative mosquito 
species. 
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Chapter 3: A cluster-randomized controlled trial to assess the 
effectiveness of using 15% DEET topical repellent with long-lasting 
insecticidal nets (LLINs) compared to a placebo lotion on malaria 
transmission 
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3.1 Abstract 
Background 
Long-lasting insecticidal nets (LLINs) have limited effect on malaria transmitted 
outside of sleeping hours. Topical repellents have demonstrated reduction in the 
incidence of malaria transmitted in the early evening. This study assessed whether 
15% DEET topical repellent used in combination with LLINs can prevent greater 
malaria transmission than placebo and LLINs, in rural Tanzania. 
Methods 
A cluster-randomized, placebo-controlled trial was conducted between July 2009 and 
August 2010 in a rural Tanzanian village. Sample size calculation determined that 10 
clusters of 47 households with five people/household were needed to observe a 24% 
treatment effect at the two-tailed 5% significance level, with 90% power, assuming a 
baseline malaria incidence of one case/person/year. Ten clusters each were randomly 
assigned to repellent and control groups by lottery. A total of 4,426 individuals older 
than six months were enrolled. All households in the village were provided with an 
LLIN per sleeping space. Repellent and placebo lotion was replaced monthly. The 
main outcome was rapid diagnostic test (RDT)-confirmed malaria measured by 
passive case detection (PCD). Incidence rate ratios were estimated from a Poisson 
model, with adjustment for potential confounders, determined a priori. According-to-
protocol approach was used for all primary analyses. 
Results 
The placebo group comprised 1972.3 person-years with 68.29 (95% C.I 37.05-99.53) 
malaria cases/1,000 person-years. The repellent group comprised 1,952.8 person-
years with 60.45 (95% C.I 48.30-72.60) cases /1,000 person-years, demonstrating a 
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non-significant 11.44% reduction in malaria incidence rate in this group, (Wilcoxon 
rank sum z = 0.529, p = 0.596). Principal components analysis (PCA) of the socio-
economic status (SES) of the two groups demonstrated that the control group had a 
higher SES (Pearson’s chi square = 13.38, p = 0.004). 
Conclusions 
Lack of an intervention effect was likely a result of lack of statistical power, poor 
capture of malaria events or bias caused by imbalance in the SES of the two groups. 
Low malaria transmission during the study period could have masked the intervention 
effect and a larger study size was needed to increase discriminatory power. 
Alternatively, topical repellents may have no impact on malaria transmission in this 
scenario. Design and implementation of repellent intervention studies is discussed. 
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3.2 Background 
In the past decade, considerable financial and political resources have been mobilized 
for malaria control [1]. This has in turn led to extensive coverage and use of existing 
control tools, like long lasting insecticidal nets (LLINs) and indoor-residual spraying 
(IRS) [1]. Implementation of these highly effective vector control tools has resulted in 
substantial decrease in malaria transmission, morbidity and mortality [2-4]. Despite 
both extensive coverage and use, the sole use of these tools has not and will not be 
able to eliminate malaria in all malaria endemic regions [5]. Because LLINs and IRS 
target mainly indoor biting and indoor resting vectors their implementation may select 
for outdoor resting and biting vector populations that often become dominant, so that 
even though there is a diminished malaria transmission as a result of extensive LLINs 
and IRS use, there is likely to be a larger proportion of this residual transmission 
occurring outdoors compared to indoors [6]. 
Increased urbanization and rural electrification programmes have also had an impact 
on malaria transmission dynamics. As a result of this, individuals stay up later in the 
evenings than they usually would in a situation where electricity was not available 
[7], and are, therefore, exposed to potentially infective mosquito bites for longer. 
With the renewed push for malaria elimination [8], it is evident that new tools need to 
be developed to augment existing vector control tools to achieve this goal. Topical 
repellents provide excellent personal protection [9] and could potentially be used to 
complement LLINs for additional protection from residual transmission [5]. Several 
studies demonstrated that topical repellents offer additional protection from malaria 
transmission either when used alone, or in combination with LLINs, in areas with 
high early evening and outdoor malaria transmission [10-12]. 
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This study assessed the potential additional benefit of using topical repellents in 
combination with LLINs compared to using only LLINs on early evening malaria 
transmission in a rural community in Kilombero valley, south-west Tanzania. 
This community mainly relies on subsistence farming of rice, which provides for a 
large breeding site for both malaria vectors and nuisance biting mosquitoes [13]. It is 
customary that the community in the study area cooks outdoors in the early evenings, 
a situation that is likely to expose them to mosquito bites and potential malaria 
transmission. Rural development is also rapidly taking place in this study area. As a 
result, many members of the community usually gather in the early evening and stay 
late into the night at local entertainment spots that are springing up in the study area 
owing to rural electrification programmes, thereby increasing the potential of malaria 
transmission at these times. A recent report estimates a malaria incidence rate of 0.67 
cases/person/year confirmed by rapid diagnostic test (RDT) from passive case 
detection at a local clinic between December 2012 and July 2013 (Jabari Mohammed 
Namamba, pers. comm.). 
In the past two decades, extensive malaria intervention programmes have taken place 
in this area, and it is therefore expected that the community be highly sensitized on 
malaria transmission and control methods [14-17]. There is high LLIN use in the 
study area [18]. Repellent awareness and knowledge as assessed using a Knowledge, 
Attitude and Practice (KAP) baseline questionnaire at the inception of the clinical trial 
determined that this community did not use topical repellents as a mosquito control 
tool. Awareness and availability were reported as the major reasons for not using 
topical repellents  
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The major malaria vector in the study area is Anopheles arabiensis [19], which has 
been shown to exhibit elastic feeding behaviour depending on the availability and 
location of the host [6] and is known to exhibit early evening biting [20]. The 
dominance of this vector in this area is also likely to be the result of extensive LLIN 
use in the study area [21,22]. 
A field study conducted in the study area to determine the efficacy of this repellent 
(15% DEET) against An. arabiensis demonstrated >80% protection from bites over 
four hours of mosquito collection [19]. Therefore, 15% DEET was considered 
appropriate to provide protection against early evening biting. 
This study area was chosen because there are no studies that have been conducted to 
assess the additional benefits of topical repellents to LLINs in malaria control in East 
Africa, although this technology has been shown to work elsewhere in sub-Saharan 
Africa [23,24]. Also, the vectors present in the area, An. arabiensis, exhibit early 
evening biting [20], a trait that made the use of repellents in the early evening ideal in 
this area. Therefore, even though extensive employment of current control tools will 
lower malaria transmission in this area, its is likely that residual transmission will 
continue occur at times when the effectiveness of these tools is diminished, like 
outdoors in the early evenings and mornings, [6] and will require supplementary tools 
that target this scenario. 
Therefore, it was hypothesized that combined use of LLINs and topical repellents in 
this community would have a greater impact on malaria transmission in the early 
evening compared to sole use of LLINs. 
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3.3 Methods 
3.3.1 Study area 
The study was carried out in Mbingu village, Ulanga district, situated 55kms west of 
Ifakara town at 8.195°S and 36.259°E. At the time of the study inception, (July 2009), 
the village was estimated to have 7,609 inhabitants [25]. There is moderate malaria 
transmission in the study area, with peak transmission occurring in the months of May 
and June after the long rains. The village experiences an annual rainfall of 
approximately 1,200-1,800 mm and an annual temperature range of between 20 °C 
and 32.6 °C. The village borders an extensive field cleared for rice irrigation, which 
provides an ideal breeding site for malaria vectors [13]. 
3.3.2 Sample size rationale  
The only available data from the study area were community reported fever incidence 
rate estimates of 3.2 cases/person/year for children under the age of five years [26]. 
Assuming fever rates in children under five years are higher than the rest of the 
population, and that not all fevers reported are caused by malaria, a rate of one 
malaria case/person/year was used to calculate the sample size needed for this study. 
Available reports also indicated that 30% of mosquito bites occurs in the early 
evening [20]. Therefore, assuming that mosquitoes have an equal probability of 
carrying sporozoites regardless of time of night, it was assumed there was a potential 
30% malaria transmission occurring in the early evenings. Expecting that repellents 
would reduce 80% of this potential 30% early evening transmission, as observed from 
the field study [19], it was reasoned that repellents would reduce the overall 
transmission of malaria from one case/person/year to 0.76 cases/person/year. Using 
the methods of Hayes et al. [27] for sample size calculation for cluster randomized 
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trials, it was estimated that to observe this treatment effect (24%), with 90% power at 
the two-tailed 5% significance level, 10 clusters of 47 households with five members 
each was required per treatment group. A coefficient of variation (k) of 0.20 was used 
based on published recommendations, as the inter-cluster variation could not be 
estimated [28]. 
3.3.3. Household recruitment 
Households were recruited into the study in two phases. In phase one, the study 
investigators and field team visited the study village for reconnaissance and 
introduction to the community leaders and members in December 2008. A week later, 
the study team returned to the study village and aided by community leaders, 
identified the centre of the village. Here, the field team spun a ballpoint pen and 
visited all the households that the writing end of the pen pointed to with the intention 
of recruiting all consenting households into the study. After all households in this 
direction had been exhausted, the field team went back to the village centre and spun 
the pen to choose the next direction in which to visit the households. If the pen 
pointed in the direction where the households were already visited, then, the pen was 
spun again until a new direction was identified. This progression was repeated until 
approximately, 1,000 households had been visited and recruited. The village had 
2,000 households [25] and, therefore, by visiting and potentially enrolling at least 
50% of the households, the study team were confident that they had captured a 
representative sample of households in the study area. 
3.3.4 Enrolment of households into the study 
During the household recruitment visits, each household head was informed of the 
purpose of the visit. They were educated on the objectives, risks and benefits of the 
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study to their household and the community. They were encouraged to ask questions 
and after all their concerns had been addressed, they were asked if they were willing 
to participate in the study. If willing, each household head was asked to sign a written 
informed consent form, confirming their participation and that of all household 
members. As data was being collected at the household level, only the household head 
was asked for informed consent. It was assumed that once that household head gave 
consent then all household members would likely comply with repellent use following 
instructions of the household head as the authority in each household. A structured 
questionnaire on the socio-economic status (SES) of the household and knowledge, 
attitude and practice (KAP) in relation to malaria and repellents was then 
administered. The GPS coordinate of the household enrolled was then recorded using 
a handheld GPS receiver (Garmin eTrex Legend® H). These coordinates were then 
plotted using Arc GIS software (Arc GIS 9.0, ESRI, UK), to generate a map of all the 
households enrolled in the study area. 
3.3.5 Second phase of household recruitment, household enrolment and cluster 
generation 
In phase two, the map generated during the first phase of recruitment was used to 
delineate 20 clusters of households, while ensuring a buffer zone of 200 metres 
between clusters to prevent diversion of mosquitoes from the intervention group to 
the control group. As a result of creation of this buffer area, some households that had 
been recruited in the first phase fell within this 200 meter buffer area. These 
households were excluded from the study during this second phase of recruitment. 
Therefore, even though about 1,000 households were recruited in the first phase, more 
households needed to be recruited in the second phase as a result of loss of 
households within the buffer area. These households were excluded because they 
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would have potentially confounded the outcome of the study in case of diversion of 
mosquitoes. All households within the buffer area were issued with an LLIN per 
sleeping space to protect them from potentially greater than normal bites from 
diverted mosquitoes. In practice, the second phase of recruitment proceeded as 
follows: The field team visited the 20 clusters, using the household considered to be at 
the centre of these clusters (identified from the Arc GIS map), as the starting point. 
The household head of the central household in the cluster was informed of the 
purpose of the visit. If the household had been enrolled during the first phase of 
household recruitment, then the field team issued an LLIN for every sleeping space, 
stapled a unique identifier number on the doorframe and moved to the next nearest 
household. If the households had not been enrolled, the household head was informed 
of the objectives, risks and benefits of the study, enrolled on written informed 
consent, provided with a unique household identifier and LLINs for each sleeping 
space, and a SES and KAP questionnaire administered. This progression was repeated 
until 47 households close together were enrolled to form a single cluster. All 47 
households in each of the 20 clusters were enrolled in this manner. The newly 
enrolled households that did not appear on the map generated in the first phase of 
recruitment were plotted and the map updated to produce the final map of households 
recruited into the study (Figure 3:1). 
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Figure 3:1 Map of household recruited into the trial in the study village 
Clusters were used as the unit of randomization for three reasons: 1) since the 
intervention would be applied to a community, if proven to be effective, 2) to limit 
contamination of treatments between households, and 3) to avoid diversion of 
mosquitoes from individuals who used repellents to those who did not use repellent 
within the same household of from households using repellents to households that 
used the placebo, thereby putting non-repellent using individuals and households at a 
potentially higher risk of contracting malaria [29,30]. 
3.3.6 Eligibility criteria 
All households were eligible to be recruited into the trial and no household was 
excluded on the basis of household structure, asset or livestock ownership. All 
individuals older than six months of age were eligible to be recruited into the trial. 
This age cut-off was used because re evaluation of DEET insect repellent [31] 
 94 
estimated the margin of exposure (MOE) in children less than six months to be less 
than 100. Margin of exposure is defined as the ratio of dose of DEET used daily to the 
no observed effect level dose recommended by regulation agencies, which usually 
consider doses, which result in MOEs of less than 100, unacceptable. Based on this 
risk assessment, use of DEET was not recommended for children under six months 
[32]. 
3.3.7 Randomization of clusters to treatments  
All the 20 clusters in the map (Figure 3:1) were assigned numbers 1 to 20, starting 
from the left hand side to the right. The cluster numbers were then written down on 
small pieces of paper, which were placed in a bowl. The principal investigator (PI) 
and project leader (PL) then drew the pieces of paper from the bowl one at a time. 
Two three digit numbers (258 and 305) were used to classify clusters in to two 
groups. The first cluster number to be drawn was assigned treatment 258 and the 
second cluster number assigned treatment 305. This progression was repeated until all 
the clusters had been assigned to one of the two groups. 
3.3.8 Blinding 
The repellent and placebo lotion smelt and felt the same and were placed in identical 
tubes, distinguishable only by the two three-digit numbers known only to the 
independent code keeper (SC Johnson and Sons). However, the PI and PL had 
previously conducted efficacy test of these two treatments [19], and could identify the 
repellent and placebo from the results of this study. Therefore, it was only the field 
team, study statistician and study participants who were blinded in this study. 
Blinding was broken after analysis. 
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3.3.9 Repellent issuance, application and compliance  
In June 2009, the field team visited all households enrolled in the study to distribute 
treatments to study participants. The treatments, (15% DEET and placebo), both 
formulated as a pourable lotion that is applied by hand, were supplied by SC Johnson, 
Racine, USA, and packaged in 100 ml plastic tubes. During this visit, the field team 
informed the household members on how to apply the treatments provided on 
exposed areas of the body. They also advised the participants not to apply the 
treatments on open wounds, eyes, mouth and areas with mucous membranes. The 
repellent lotion was applied at an approximate rate of 0.002 mg DEET / cm2, the 
quantity of repellent that prevented >80% mosquito bites for 4 hours in a controlled 
environment and in the study area [19]. Even though a repellent with a higher 
concentration would have provided greater protection, the Tanzania National Institute 
of Medical Research ethical approval board did not allow the use of a repellent that 
had more than 15% DEET due to safety concerns, despite the initial request of the PI 
to use 30% DEET and submission of detailed experimental justification and dossier of 
safety data justifying the use of a higher concentration. 
The participants were issued measuring caps, with amounts of repellent required for 
adults (7mls) and children below 12 years (3mls) marked on the cap. Each tube held 
100mls of repellent. Therefore, two tubes were considered enough to last an adult 
one-month, i.e. if they applied the recommended dosage of 7 mls per day, while one 
tube was enough to last a child < 12 years for one month, if they used 3mls per day. 
Children > 12 years were advised to use up to 7mls a day, and were therefore issued 
with 2 tubes for the month. All the tubes issued per cluster and households were 
identical, and it is possible that the household members shared a single tube of 
repellent until it ran out. As all households member were issued with enough 
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treatment to last them month, either 15% DEET repellent lotion or placebo, and 
dosages for adults and children had been marked out, it was assumed that sharing of 
repellents within the household would have no effect on the outcome as long as there 
was daily compliance to the recommended dose by the participants. The amounts 
recommended were adjusted to accommodate for individuals with greater than 
average body mass as it was determined from semi-field and field experiments that an 
average sized volunteer required 6 mls [19]. This amount was, therefore, adjusted 
upwards by an extra milliliter. The community members were instructed to apply the 
repellent at dusk (1800 hrs) and to reapply it if they felt any mosquito bites or 
remained active for more than four hours after sunset. 
Compliance to lotion use (both repellent and placebo) was assessed by the field team 
visiting the enrolled households at the beginning of each subsequent month (monthly 
monitoring surveys) to issue new tubes of repellent and placebo lotion. Therefore 
compliance was assessed on a monthly basis using a short structured questionnaire, 
where the household head or an adult household member, was asked if all household 
members had used the repellents and reasons for non-compliance where relevant. 
However, as self-reported data are unreliable, the number of repellent/placebo tubes 
issued every month was also recorded as a secondary measure of compliance, to 
determine if there was a difference in the number of tubes issued in each month per 
treatment group. Data on use of LLINs the previous night, malaria infection, recalled 
febrile illness and visit to the health centre during that month was also collected. If, 
during these monthly monitoring surveys, the household head or any other adult 
household member was not available to answer the questionnaire on compliance, the 
field team visited that particular household daily for seven consecutive days. If still no 
household member able to take the monitoring survey was available during these 
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repeated visits, then that household, and all it members, was excluded from the 
calculation of person-time for that month. 
In addition to the compliance, malaria and recalled febrile illness data collected 
during each month of the study period, an after study questionnaire was administered 
at the close of the study to assess the participants’ knowledge, attitudes and practice in 
relation to repellents. These results are reported elsewhere. 
3.3.10 Clinical data collection 
A single government health facility in the study area was recruited into the study. At 
this facility, health services were provided for free by the project if the participants 
showed their project identification card with a household unique identification 
number on it. Community members that were not enrolled into the study were issued 
with a different kind of identification card to also allow them free consultation and 
treatment at the recruited health facility. This was done to discourage community 
members attending the health facility under the guise of being a study participant and, 
therefore, contaminating the study by recording malaria status of community 
members not enrolled in the study as participants. It was assumed that since services 
were provided for free at this facility, it would attract most community members 
seeking health services. A clinical officer (CO) and a nurse were employed by the 
project at this health facility. A ledger with the household unique identifier and names 
of each household member was drawn up and placed at this health facility. When a 
study participant visited the health facility with febrile illness, the CO checked against 
their name and household unique ID in the health facility ledger. This way household 
and health facility data could be reconciled using the household unique identifier. 
Febrile participants were tested for malaria using rapid diagnostic test (RDT) (ICT 
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Malaria cassette tests HRPII/pf test kit). A proportion of participants also had 
diagnosis by thick film microscopy to confirm the accuracy of the RDTs for diagnosis 
under field conditions. The result of the RDT and the date of diagnosis were marked 
against the Household ID on the health facility ledger. Those found positive for 
malaria parasites were given artemether-lumefantrine (ALu), the first-line drug for 
treatment of malaria in Tanzania. Only participants that were RDT or slide positive 
for malaria parasites were treated. This was to avoid treating non-malaria patients 
with ALu, which might have affected malaria incidence rate in the village. The RDT’s 
were labelled with the patient’s unique identifier, date and status (+ve or –ve) and 
stored for verification. These were later checked against the clinical trial database to 
ensure that no cases had been incorrectly entered into the database by the clinic staff. 
3.4 Data management 
Data from the structured questionnaires on SES of households and KAP in relation to 
malaria and repellents administered at baseline; follow-up data on compliance and 
recalled febrile illness administered throughout the study period; and the after study 
KAP survey, were double entered into a computer using an Epi –Info™ template with 
a drop down lists of values that corresponded to the format of the questionnaires. Data 
was then exported to Microsoft Access 2008 (Microsoft Corporation), to check for 
lack/excesses of data, inconsistencies and outliers. All data from the above mentioned 
questionnaires were linked using the household unique identifier. The household 
unique identifier was made up of the household number, cluster number and treatment 
number. 
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3.5 Statistical analysis 
Data was collected and presented at household and cluster level as the study aimed at 
assessing the effectiveness of the repellents at the community level. Individual level 
data was not collected. 
3.5.1 Socio-economic status (SES) 
All data cleaning and analysis was performed using STATA 11.2 software (StataCorp 
LP, College Station, Texas, USA). Baseline household-level socio-economic 
indicators were collected using a structured questionnaire. All variables representing 
asset ownership, household construction materials, source of fuel and light and the 
education level of the household head were examined individually before being 
combined using principal component analysis (PCA) to generate the socio-economic 
index of each household, [33], and are presented in here: (Appendix 1:Stata output 
showing Eigen scores of each variable used in calculation of socio economic status of 
households). The households were grouped into quintiles of the socio-economic index 
generated and ranked from the poorest to the least poor. This data was cross tabulated 
with treatment group using Pearson’s chi-square (χ2) to assess whether there was a 
significant difference in the socio-economic status of the households in the two 
treatment groups (not accounting for the clustered design due to the exploratory 
nature of this analysis). 
The number of treatment tubes issued was analyzed by linear regression against 
month, treatment and an interaction of month and treatment to determine if there was 
a significant difference in the number of tubes issued in each month and per treatment 
group. 
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3.5.2 Clinical data 
Clinical data was adjusted for covariates identified a priori to be confounders and 
analyzed using the according-to-protocol approach, where person-time at risk was 
excluded when a participant reported or was observed to be non-compliant to the 
lotion (placebo or repellent) and for those with malaria for three weeks after they 
were diagnosed. The total number of cases in each treatment group was divided by the 
sum of person years at risk to give the incidence rates in person years at risk. Rate 
ratio and rate differences were then estimated. 
For comparison, a secondary analysis using the intention-to-treat approach, where 
malaria incidence rates in the clusters were compared using all person-time at risk 
regardless of whether they complied with the study protocol but also adjusted for 
covariates identified a priori as confounders. Such an approach would be expected to 
underestimate the treatment effect. It was not possible to effectively blind the PI and 
PL as they had carried out both the semi field and field efficacy evaluations of these 
treatments [19] and could identify the intervention and placebo. The clinical data was 
therefore re-blinded by an independent statistician (ET), who was not aware of the 
intervention and placebo codes. 
3.5.3 Person-time at risk estimation for according-to-protocol analysis 
The study was conducted for 14 months from July 2009 to August 2010. To calculate 
the person-time at risk, a closed cohort was assumed, so that the number of household 
members above six months recorded at baseline for each household was assumed to 
be constant throughout the study period. Monitoring surveys were conducted for each 
month of the study to establish compliance. 
 101 
Person time at risk of each household was estimated according to one of the following 
three possible scenarios: 
1. In a case where all individuals were susceptible to malaria infection and 
complied with the study protocol by applying the treatment issued on a nightly 
basis, each individual in the household was assumed to contribute one-person 
month at risk to the study. 
2. In a case where the household head or an able household member was not 
available to take the monthly monitoring surveys, it was assumed that all 
members of that household did not comply with lotion (repellent or placebo) 
use for that month and one-person month at risk for each member of that 
household was excluded from the person time at risk of the study. 
3. In a case where a household member contracted malaria, that individual was 
excluded from calculation of person time at risk for three weeks. 
Person-time for all household members was calculated according to the appropriate 
scenario above. 
3.5.4 Malaria incidence rates and regression analysis of the intervention effect 
Using data on the total number of confirmed malaria cases and person-time for each 
household, we used a two-stage approach to estimate intervention effects 
(recommended by Hayes et al. for studies with fewer than 15 clusters/group) [27]. In 
the first stage, cluster-specific incidence rates were calculated using random effects 
Poisson regression modelling with adjustment for confounding variables. Specifically, 
the outcome of total number of confirmed cases of malaria/household was regressed 
on the set of confounding variables (age categories of the household, education of the 
household head, and quintile of SES), with an offset for person-time at risk per 
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household and a random intercept for cluster to account for the clustered study design. 
As per Hayes et al., treatment was not included as a factor in the model. In the 
second-stage, residuals, calculated from the regression model were aggregated by 
clusters. The covariate-adjusted treatment effect was then estimated by comparing the 
residuals in the intervention relative to the control group using the Wilcoxon rank sum 
test, because the data were not normal. 
3.5.5 Knowledge attitude and practice (KAP) of community members in relation to 
malaria and repellent 
Baseline data on knowledge of malaria and malaria prevention practices and 
knowledge and practice in relation to repellents were analyzed using descriptive 
statistics in STATA 11.2 to assess whether there was an imbalance between the 
treatment arms. Data that recorded attitude with regards to repellents, perceived 
effectiveness and willingness to continue use and pay were also analyzed and these 
results are presented elsewhere. 
3.6 Ethical and safety considerations 
During recruitment, the household head was asked for written informed consent for 
themselves and all household members. If consent was obtained, all members of the 
household were recruited into the study. Study participants were free to withdraw 
from the trial at any time. All households in the village were issued with an LLIN for 
every sleeping space to ensure equity. All individuals from the study village were 
allowed free consultation, treatment and drugs (ALu) from the village dispensary at 
project cost. Participant confidentiality was maintained by using generated unique 
identifiers instead of individual names during analysis. 
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Participants were educated on correct repellent use and application. Children under 6 
months were excluded from the trial. An illustrated label giving instructions in the 
native language (Swahili) on safe repellent use was provided on each tube. DEET 
repellent used in this study has undergone extensive toxicological tests and has been 
endorsed as safe for human use [32]. The concentration of DEET (15%), used in this 
trial was approved by the Tanzanian Pesticides Research Institute, the Tanzanian 
Bureau of Standards and is available in Tanzanian shops. Guardians to children < six 
months were reminded to put their children under an LLIN early to prevent them 
contracting malaria. A clinical officer (CO) was employed at the village dispensary by 
the project to perform RDTs and to investigate and treat any adverse effects arising 
from repellent use. 
Ethical approval for the study was obtained from Ifakara Health Institute (IHI) 
(IHRDC IRB A46), Tanzanian National Institute of Medical Research 
(NIMR/HQ/R8a/VOL IX/780) and the London School of Hygiene and Tropical 
Medicine Ethical Review Board (LSHTM ERB 5174). IHI provided study 
monitoring. 
3.7 Results 
3.7.1 Trial profile and baseline data 
The trial profile is summarized in Figure 3:2. In the intervention group 2,224 
individuals were enrolled and 2,202 in the placebo group. Loss-to-follow up was 
higher in the placebo group: n = 34 versus n = 16, and no individuals withdrew from 
the trial. Similar numbers of person-years were analyzed: 1952.81 in the intervention 
group and 1972.38 in the control group of the trial. Baseline household level socio-
economic data on education and gender of household head, age-groups of all study 
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participants, household construction material, source of cooking fuel and lighting and 
asset ownership were examined individually and are presented in Table 3.1. The 
gender of the household heads was comparable between the two treatment groups, 
with 55.33% (n = 514) females and 44.67 (n = 415) males. Most of the household 
heads had received some form of formal education, 82.81% (n = 702) while only 
17.18% (n = 161) had no formal education. Of all participants recruited in the study, 
17.55% (n = 771) were children under five years of age, 34.37% (n = 1,510) were 
between five to 18 years of age and 48.08% (n = 2,112) were above 18 years of age 
and age-category distribution was similar in the two treatment groups. The 
predominant source of energy used by the households was wood fire, 89.96% (n = 
883), while the predominant source of lighting used was the traditional lamp, 93.76% 
(n = 871). Assessment of household construction materials demonstrated that most 
households in the study area had floors made from mud, 82.78% (n = 769), while tin 
and thatch were used equally as roofing materials, 49.35% (n = 457). Also, most 
households in the study area had walls made from bricks, 79.87% (n = 742). Socio-
economic indices generated from PCA suggested an imbalance between the two 
treatment groups, with the control group demonstrating a higher SES than the 
intervention group, (Pearson’s χ2 = 17.5519, p = 0.002), (Table 3:2). 
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Figure 3:2 Trial profile
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Table 3:1 Baseline household characteristics by treatment group 
 Intervention arm n 
(% ) 
Control arm n 
(% ) 
Totals n (% ) 
No. of households 469(50.05) 468(49.95) 937(100) 
No. of participants 2224(50.05) 2202(49.95) 4426(100) 
Gender of household head    
Male 215 (46.24) 200 (43.10) 415 (44.67) 
Female 250 (53.76) 264 (56.90) 514 (55.33) 
Education of household head    
No education 83 (17.74) 78 (16.63) 161 (17.18) 
Educated 385 (82.26) 391 (83.37) 702 (82.82) 
Age group distribution of all 
participant/household 
   
Under 5’s  412 (18.50) 359 (16.57) 771 (17.55) 
5-18 years 721 (32.38) 789 (36.43) 1510 (34.37) 
Above 18 years 1094 (49.12) 1018 (47.00) 2112 (48.08) 
Source of energy    
Wood fire 431 (92.89) 402 (86.83) 883 (89.86) 
Other sources 33 (7.11) 61 (13.17) 94 (10.14) 
Source of lighting    
Traditional lamp 445 (95.70) 426 (91.81) 871(93.76) 
Other source 20 (4.30) 38 (8.19) 58 (6.24) 
Flooring material    
Mud 404 (86.88) 365 (78.66) 769 (82.78) 
Cement 61 (13.12) 99 (21.34) 160 (17.22) 
Roofing materials    
Thatch 256 (55.41) 201 (43.32) 457(49.35) 
Tin 203 (43.94) 254 (54.74) 457(49.35) 
Other 3 (0.65) 9 (1.94) 12 (1.30) 
Wall materials    
Mud 121 (26.08) 66 (14.19) 187 (20.13) 
Bricks 343 (73.92) 399 (85.81) 742 (79.87) 
Assets ownership    
Motorbike    
Yes 72 (15.48) 52 (11.18) 124 (13.33) 
No 393 (84.52) 413 (88.82) 806 (86.67) 
Bicycle    
Yes 246 (52.90) 198 (42.58) 513 (55.16) 
No 219 (47.10) 267 (57.42) 417 (44.84) 
Stove    
Yes 344 (73.98) 314 (67.53) 658 (70.75) 
No 121 (26.02) 151 (32.47) 272 (29.25) 
Mobile phone    
Yes 197 (42.37) 211 (45.38) 408 (43.87) 
No 268 (57.63) 254 (54.62) 522 (56.13) 
Radio    
Yes 140 (30.11) 156 (33.55) 296 (31.83) 
No 325 (69.89) 309 (66.45) 634 (68.17) 
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The use of repellents as a mosquito control tool was low in the study area, with only 
1% (n = 6) of those interviewed reporting to have ever used repellents. Results on 
KAP of repellents are presented in detail elsewhere. 
The average number of tubes issued per household was 6.73 (95% C.I. 6.51 – 6.95) 
and 6.92 (95% C.I 6.68 – 7.16) in the intervention and control groups respectively and 
there was no significant difference per treatment group, 1.68 (95% C.I. 0.32 – 84.25, 
P = 0.803) from linear regression analysis. Likewise there was no significant 
difference on the number of treatment tubes issued per month throughout the study 
period. 
Table 3:2 Ranking of households using Socio-economic scores generated for PCA 
analysis by treatment group 
 Intervention arm n 
(%) 
Control arm n 
(%) 
Total n 
(%) 
Pearson’s 
Chi2 
P 
value  
SES generated from 
PCA 
     
Poorest 39 (8.33) 28 (5.97) 67 (7.15)   
Poor 164 (35.04) 121 (25.80) 285 
(30.42) 
17.5519 0.002 
Median 165 (35.26) 174 (37.10) 339 
(36.18) 
  
Less poor 77 (16.45) 107 (22.81) 184 
(19.64) 
  
Least poor 23 (4.91) 39 (8.32) 62 (6.62)   
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3.7.2 Clinical outcomes 
3.7.2.1 According-to-protocol analysis 
When data was analyzed as per protocol, there was a non-significant difference in 
cluster and household malaria incidence rates among repellent users and non-users 
(Table 3:3). In the cluster-level analysis (data averaged over cluster specific rates), the 
malaria incidence rates differed by 11.48%; with 68.29 (95% C.I 37.05-99.53) cases/ 
1,000 person-years in the control group and 60.45 (95% C.I 48.30-72.60) cases /1,000 
person-years (95% C.I. 44.55 – 81.73) in intervention group, (Wilcoxon rank sum z = 
0.529, p =0.5967). For household-level malaria incidence rates (data averaged 
separately over household specific rates), the incidence rates differed by 28.88%: with 
84.54 (95% C.I 61.04-108.05), cases/1,000 person-years in the control group and 
60.12 (95% C.I 45.08-75.15) cases/1,000 person-years in the intervention group, 
(Wilcoxon rank sum z = −1.267, p = 0.2051). These result should however be 
interpreted with caution as there is still an ongoing debate on whether it is correct to 
estimate incidence rate ratios using regression models on less than 10 clusters [28]. 
Cluster aggregated rates were reported because it measured the overall effect of the 
intervention at the population level [34] and this was the major objective of the study. 
Age was a significant risk factor with risk decreasing with increase in age. SES did 
not influence the risk of malaria in the model. 
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Table 3:3 Estimated incidence rate by treatment arm and estimated intervention effects  
 Intervention 
arm 
Control arm % Reduction 
in rates  
Wilcoxon rank-sum 
on residuals (p-value) 
Malaria cases 115 137   
ATP analysis      
Individuals 
randomized 
2208 2168   
Households 
randomized 
463 462 
Total person-years 1952.81 1972.38   
Average Household 
rates/1000 person-
years 
60.12 (95% C.I 
45.08-75.15) 
84.54 (`95% 
C.I 61.04 
108.05) 
24.42% −1.267 (0.2051) 
S.D. 164.42 257.07   
Average cluster 
rates/1000 person-
years 
60.45 (95% C.I 
48.30 72.60) 
68.29 (95% 
C.I 37.05-
99.53) 
8% 0.529 (0.596) 
S.D. 16.98 43.66   
ITT analysis      
Individuals 
randomized 
2224 2202   
Households 
randomized 
468 469 
Total person-years 2580.44 2554.92   
Household 
rates/1000 person-
years 
47.26 (95% C.I. 
35.49-59.04) 
68.21 (95% 
C.I. 49.59-
86.84) 
20.95% −1.268 (0.2047) 
S.D. 129.60 205.23   
Cluster rates/1000 
person months 
45.43 (95% C.I 
36.02–59.79) 
53.21 (95% 
C.I. 30.98–
104.16) 
7.78% 0.227(0.8206) 
S.D. 11.32 34.90   
 
3.7.2.2 Intention-to-treat analysis 
Cluster-level analysis of malaria rates in the two treatment arms demonstrated a non-
significant, 14.62% difference in malaria rates with 53.21 cases/1,000 person-years 
(95% C.I. 30.98 – 104.16) in the control group and 45.43 cases /1,000 person-years 
(95% C.I 36.02 – 59.79) in the intervention group, (Wilcoxon rank sum z = 0.227, p = 
0.8206), (Table 3:3). Household-level analysis of malaria incidence rates 
demonstrated a 30.71% difference in malaria incidence rates, with 68.21 cases/1,000 
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person-years (95% C.I. 49.59 to 86.84) in the control group and 47.26 cases/1,000 
person-years (95% C.I. 35.49 – 59.04), in the intervention group, (Wilcoxon rank sum 
z = − 1.268, p = 0.2047). Age was a significant risk factor: malaria risk decreased 
with increase in age although SES did not influence the risk of malaria in the model. 
3.8 Discussion 
This randomized controlled trial demonstrated that 15% DEET topical repellents have 
no effect on malaria incidence transmitted in the early evening. Although there was a 
consistent decrease in malaria risk among repellent users in both the cluster and 
household malaria rates, as seen from the results above, this reduction was not 
significant. This finding is consistent with a study carried out in southern Lao PDR 
using an identical 15% DEET repellent [35]. It should be noted that, findings from 
other studies using a higher concentration of 20% DEET with Permethrin in soap that 
gave over 12 hours of complete protection from mosquito bites [11] and Para-
menthane 3–8 diol repellents with close to 100% efficacy for over six hours [30,36] 
did demonstrate a significant protective effect in Pakistan [11], Bolivia [10] and 
Ghana [23] and this could be one of the potential explanations for the observation of a 
treatment effect in these studies. It can be argued that in the Lao-PDR study, 15% 
DEET provided ~ 100% protection against mosquito bites. However, the number of 
major malaria vectors, Anopheles minimus and Anopheles maculatus, caught in 
entomological collections in the Lao-PDR study was very low and that the effect 
observed, was probably that of 15% DEET against Stegomyia and Culex mosquitoes 
which made up the bulk of the collections. Therefore, as Anophelines are known to 
show less response to repellents compared to Stegomyia and Culex mosquitoes 
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[37,38], the repellent effect observed in the Lao-PDR study was greater than at higher 
densities with a greater proportion of Anophelines as tested in Tanzania [19]. 
3.8.1 Power 
There are several factors that are likely to have masked the treatment effect in this 
study, the most likely being the lack of power to discriminate a statistically significant 
difference between study arms. The lack of power in the study was likely caused by 
four factors: 
First, rapid scale-up of LLINs to achieve universal coverage has been actively taking 
place in Tanzania [16]. This had led to a substantial decline in malaria in the country 
and by extension the study area [39]. As a result, the incidence of malaria in the 
village was likely lower than the incidence assumed for calculation of sample size for 
this study. This likely led to an underestimation of the sample size required to observe 
a difference between the two treatment groups. Secondly, during the study period, 
Tanzania experienced a drought that likely further reduced malaria transmission, and 
as a result, there were too few malaria episodes in the study area to accurately 
discriminate any reduction in malaria attributable to the repellent [40], highlighting 
the need for such studies to be carried out for more than one transmission season to 
avoid such problems. Third, most of the participants recruited in to the study come 
from a farming community. Therefore, during the planting and harvesting seasons, 
these participants relocated to their farmhouses [41]. As a result it was difficult to 
establish compliance during these periods and those participants were excluded from 
the study. This lowered the study sample size further and with it the power to detect a 
treatment effect. Lastly, there was the likely overestimation of the assumed malaria 
incidence in the study area that was used for sample size calculations. Malaria 
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incidence in this study was estimated from reported fever rates in children less than 5 
years of age in the study area [26]. Therefore, even though scale up of LLINs and the 
drought experienced during the study might have lowered the malaria incidence in the 
study area, it is also likely malaria rates used for estimation of sample size might have 
been overestimated and hence undermined the study power to observe a difference 
between the treatment groups. 
3.8.2 Compliance 
Compliance in this study was measured by self-reporting of use every evening by the 
household head or a household member that was able to engage with the field workers 
during the monitoring surveys. However self-reporting is an unreliable measure of 
compliance, as it has been shown to overestimate compliance [42]. As a result, the 
ATP analysis used to measure malaria incidence is likely to underestimate the actual 
malaria incidence in the intervention and control arms, as a larger value of person-
time will be used than that of individuals that actually complied to the study reducing 
discriminatory power. However, if the randomization between the two treatment 
groups was done correctly then the overestimation of compliance and its resultant 
effect on the study outcome, is likely to be similar in both treatment groups, ruling out 
the likelihood of overestimation of the treatment effect. This underlines the 
importance of correctly estimating the compliance in studies of personal protection in 
order to avoid confounding the outcomes of such studies. 
3.8.3 Active versus passive case detection 
Due to logistical reasons, this study recruited a single government health facility for 
collection of clinical data by passive case detection. As a result, the study is likely to 
have lost malaria cases to the other health facility present in the area. Anecdotally, 
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some participants complained that they went to the other health facility because the 
study facility always told them that they did not have malaria even though they knew 
they had malaria, so they did not trust the diagnosis. Also some individuals might 
have opted to use traditional medicine, treat diseases at home or buy drugs directly 
from the numerous drug stores in the study area if they felt sick. All these are 
potential malaria cases that the study might have lost, lowering both the sample size 
and estimates of malaria incidence in the area. It would have been advantageous to 
collect data from both health facilities or carry out active case detection. Since 
malaria was still most common in children under five years in the study site as seen 
elsewhere [43,44], targeted active case detection in under fives may have gathered 
more reliable and realistic data on the true impact of repellents in this scenario. 
Performing supplementary testing of blood spots from all participants attending the 
health facility with polymerase chain reaction (PCR) diagnosis of subclinical malaria 
parasitaemia may have also yielded more accurate estimation of transmission 
prevention by repellents [45]. 
3.8.4 Sources of bias 
Bias was introduced into the study by an imbalance in socio-economic status between 
the two study groups. The control group demonstrated a higher socio economic status 
than the control arm. This study did not demonstrate a statistically significant 
association between SES and malaria incidence. However, it is well known that 
improved housing, whose representative covariates had been adjusted for during 
analysis, is protective against malaria [46]. A plausible explanation for this is that the 
participants in this study came from a single village or from villages located closely 
together. As a result, they were exposed to the same levels of malaria transmission 
regardless of their socio-economic status. As socio-economic status is positively 
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associated with seeking treatment at a medical facility [47], it is likely that 
participants with higher SES sought treatment at the health facility in the study area at 
a higher rate compared to participants in the lower SES. Therefore as malaria data 
was only collected from a single health facility, it is likely that more cases of malaria 
were observed in participants with higher SES relative to participants from lower 
SES. Another reason that no association was seen may be because studies using 
material ownership as a proxy for measuring SES, to evaluate the relationship 
between SES and malaria incidence have yielded inconsistent results, at the 
household level [48]. 
The study participants were blinded up to some point after allocation of treatments, 
because of the identical packaging labelled with a three-digit code. However, after a 
while, field workers reported that study participants in the placebo group complained 
that they wanted to swap treatment. Participants could differentiate the intervention 
from the placebo, as mosquitoes would still bite them after applying the ‘treatment’ 
while those in the treatment group bragged to their neighbours that they got the good 
lotion that was effective. This is a source of bias and could have caused treatment 
contamination between clusters. This problem would have been better overcome with 
clusters that were geographically isolated, for instance randomization on a village 
scale, so that individuals were less likely to be able to compare their treatment 
allocation. Some participants may have sold or given their repellent to relatives in 
other clusters. 
Another potential confounder may have been diversion of mosquitoes from the 
intervention group to the placebo group. However, this was controlled by allowing for 
a buffer area of 200 metres between clusters. Diversion in repellent studies has 
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usually been recorded over short distances, (one meter, 1m) [30]. However, distances 
of 15–20 metres are recommended as the limit for short range attraction of host 
seeking mosquitoes [49,50] and, therefore, distances of 200 metres between clusters 
were thought to be adequate to prevent diversion. Treatments were also issued at the 
household level to prevent intra and inter-household diversion within the cluster. It 
was later observed in the study area that mosquito diversion between households does 
occur [29] and could have confounded data if compliance with the intervention was 
low by diverting mosquitoes from complying to non-complying households or 
individuals. 
The community was highly knowledgeable about malaria transmission, prevention 
and control. This is likely a result of the malaria intervention programmes that have 
taken place in the study village for over two decades [14,17]. The community 
awareness about topical repellents as a mosquito control tool was poor at the study 
inception. However, after the study, the community was highly aware of repellents 
and community members were willing to take up this intervention against malaria if 
available. This finding demonstrates the feasibility of topical repellents as a potential 
tool to supplement LLINs to prevent early evening transmission. In a separate study, 
the community members reported bite avoidance as the major reason for using 
repellents in the early evenings. 
A posteriori analysis of data for children under six months was carried out to check 
whether this age group experienced higher malaria transmission because of 
mosquitoes diverted to them as it was recommended that they not use the repellent 
[29,30]. This might also have affected the incidence of malaria in the treatment 
groups if there was uneven distribution of this age category between these groups. 
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However, it was observed that there were only three children and a single case of 
malaria in this age category, and it can be confidently concluded that this age group 
did not have any influence on the outcomes observed. 
Net usage was also analyzed to determine whether there was a difference between the 
two treatment groups, which would have confounded the outcome. It was observed 
that reported net usage the previous night was 100% in both treatment groups. These 
results are presented in detail elsewhere. 
3.9 Recommendations 
It was observed that estimation of a sample size with sufficient power was a major 
shortcoming of this study. Therefore, it is advisable to establish baseline disease 
incidence rates if a similar study is to be implemented in the future to avoid under 
powering the study. This can be established from health facility records. However 
these records may not necessarily be accurate and the more appropriate measure may 
be to conduct a small cross-sectional or longitudinal survey of the community disease 
prevalence or incidence and then power accordingly. Another important factor when 
testing personal protection tools is accurate establishment of compliance. Better 
methods of establishing compliance are needed. This can be done through frequent 
follow-up and spot checks or use of indirect methods, such as mosquito saliva 
antigens, that are a proxy of individual exposure to mosquito bites [51]. Also, 
development of new tools that require reduced compliance such as long lasting spatial 
repellents [52] would likely offer greater protection because people often forget to 
comply daily with a topical repellent unless they feel mosquito bites [53]. Finally, in a 
time when malaria is becoming more scant due to successful control, active case 
detection using RDT for clinical diagnosis followed up by PCR for malaria parasites 
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is most likely the most appropriate means of measuring the impact of additional 
malaria control tools used in combination with LLINs. 
3.10 Conclusion 
Findings of this trial could not demonstrate if 15% DEET topical repellents had any 
impact on incidence of malaria transmission in the early evening because the study 
lacked sufficient statistical power and had several important sources of bias. A better-
designed study with sufficient power and fewer sources of bias and ideally a higher 
concentration of repellent is required to fully understand if topical mosquito repellents 
are a feasible malaria control tool in the early evenings in Eastern Africa, particularly 
as repellents have reduced malaria transmission elsewhere in sub-Saharan Africa 
[23,24]. The acceptability of this intervention is an encouraging finding toward 
exploring supplementary malaria control tools. 
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Chapter 4: Feasibility of repellent use in a context of increasing 
outdoor transmission: a qualitative study in rural Tanzania 
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4.1 Abstract 
Background 
Extensive employment of long-lasting insecticidal nets (LLINs) and indoor residual 
spraying (IRS) has substantially reduced malaria morbidity and mortality in sub-
Saharan Africa. These tools target indoor resting and biting vectors, and may select 
for vectors that bite and rest outdoors. Thus, to significantly impact this residual 
malaria transmission outdoors, tools targeting outdoor transmission are required. 
Repellents, used for personal protection, offer one solution. However, the 
effectiveness of this method hinges upon its community acceptability. This study 
assessed the feasibility of using repellents as a malaria prevention tool in Mbingu 
village, Ulanga, Southern Tanzania. 
Methodology 
Change in knowledge, attitude and practice (KAP) in relation to repellent use was 
assessed before and after the implementation of a cluster randomized clinical trial on 
topical repellents in rural Tanzania where repellent and placebo lotion were provided 
free of charge to 940 households for a period of 14 months between July 2009 and 
August 2010. Compliance, defined as the number of evenings that participants applied 
the recommended dose of repellent every month during the study period, was assessed 
using questionnaires, administered monthly during follow up of participants in the 
clinical trial. Focus group discussions (FGDs) were conducted in the same community 
three years later to assess the community’s KAP in relation to repellents and 
preference to different repellent formats. 
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Results 
At baseline, only 0.32% (n = 2) households in the intervention arm and no households 
in the control arm had ever used topical repellents. During follow-up surveys, 
significantly more households, 100% (n = 457) in intervention arm relative to the 
control, 84.03% (n = 379), (p = <0.001) perceived the repellent to be effective. 
Post-study, 99.78% (n = 462) and 99.78% (n = 463), (p = 0.999) in the intervention 
and control arms respectively, were willing to continue repellent use. Mosquito 
nuisance motivated repellent use. From the FGDs, it emerged that most respondents 
preferred bed nets to repellents because of their longevity and cost effectiveness. 
Conclusion 
High repellent acceptability indicates their feasibility for malaria control in this 
community. However, to improve the community’s uptake of repellents for use 
complimentary to LLINs for early evening and outdoor protection from mosquito 
bites, longer lasting and cheap formats are required. 
Keywords 
Repellent, Malaria, Knowledge, Attitude, Perceptions, Practice 
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4.1 Background 
Long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) have had a 
great impact on malaria morbidity and mortality in the past decade in sub-Saharan 
Africa [1-3]. While effective, these tools are intra-domiciliary and predominantly 
target indoor biting and resting vectors [4]. This favours outdoor resting and biting 
vectors as IRS and LLINs are less effective against those vectors that exhibit exophily 
and exophagy [5]. Therefore, as malaria moves from sustained control to elimination, 
new tools that tackle residual outdoor malaria transmission are needed. 
Repellents used outdoors and in the early evenings and mornings, where IRS and 
LLINs cannot be employed, present one strategy that can be used to push towards the 
goal of eradication. Topical (skin applied) repellents have been used as a form of 
personal protection for hundreds of years [6], and have been shown to protect against 
malaria in South America (80% reduction) [7] and Southern Asia (60% reduction) [8], 
and more recently in Ghana (34% reduction) [9] and Ethiopia (19% reduction) [10]. 
The major drawback to using topical repellents is compliance. Topical repellent use 
requires daily use and frequent re-application as their effect is usually short-lived over 
a few hours and therewith a change in daily routine (personal behaviour). While 
changing personal behaviour to use new interventions is not impossible as has been 
demonstrated in bed net campaigns [11], oral hygiene [12] and hand washing 
strategies [13], it is influenced by a number of other factors including: cost, perceived 
quality of the intervention, accessibility, information and ease of use. An intervention 
is likely to be used by the community if its affordable, perceived to be effective, the 
community is aware and has knowledge of its uses and finally, the intervention is 
simple to apply, i.e. it does not require considerable deviation from daily routine [14]. 
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Therefore to influence behaviour change towards uptake of interventions: the 
community must be educated to improve information on the appropriate measures to 
employ to prevent disease e.g. use of bed nets to prevent mosquito bites and hence 
malaria infection. Secondly, the interventions must be made physically accessible to 
the community, such as considering the distance to shops where bed nets are sold or 
re-treated. Third, the cost of the intervention must be affordable and perceived as 
reasonable among community members to encourage use. Perception of the 
effectiveness of the intervention will also influence uptake, with the community more 
likely to use interventions they perceive as beneficial to them, for instance LLINs 
prevent mosquito bites. Lastly is the ease of use of the intervention being 
implemented, as the community is more likely to use interventions that require the 
least deviation from daily routine, like use of drugs with simple dose regimens 
compared to those that have complicated regimens [14]. 
Therefore, in an effort to determine the feasibility of using repellents as a mosquito 
control tool, this study assessed the knowledge/awareness, acceptability, perceptions 
on effectiveness and preference to different kinds of repellents in a rural community 
in Kilombero valley, Southwest of Tanzania. The community in this setting has 
experienced extensive malaria research projects and intervention programmes 
spanning two decades [15-17] and was expected to be highly knowledgeable about 
malaria prevention and control. Cooking mainly takes place outdoors and in the early 
evening, a situation that exposes the community to nuisance mosquito bites and 
potential malaria transmission before they have employed bed nets. Further, like the 
rest of sub-Saharan Africa, the study area is experiencing rapid rural development, 
shifting the spaces and protocols of social behavior. Where once it was customary to 
retire shortly after sundown, now, owing to rural electrification programmes, residents 
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usually gather in the early evening and stay late into the night at local bars and social 
centers springing up in the study area, thereby increasing perception of mosquito 
nuisance and malaria transmission potential at these times. 
The dominant vector in this area is Anopheles arabiensis [18] that has been shown to 
shift to early evening and outdoor biting when hosts are unavailable late in the night 
indoors as a result of high bed net use [19,20]. The presence of rice fields in the study 
area, as the community’s main occupation is farming, provides for a large breeding 
site of mosquitoes [21]. The presence of this large breeding site is likely increase 
mosquito abundance in the study area, and with it potential malaria transmission and 
nuisance biting. 
Before the start of the clinical trial, the community was sensitized to the potential for 
repellents as a malaria prevention tool through skits, community meetings and 
leaflets. Therefore, they are likely to understand the importance of topical repellents 
in prevention of early evening malaria transmission potentially occurring in the study 
area before they go to sleep under bed nets, and are therefore more likely to be 
receptive to this intervention. Secondly, the customary practice of cooking outdoors 
as well as presence of electricity exposes this community to nuisance biting in the 
evenings as a result of the extensive rice fields present in the area, a situation likely to 
encourage use of repellent. Finally, repellents were provided free so the community 
was likely to use them and form an opinion on their efficacy. 
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4.2 Methods 
4.2.1 Study area and population 
This study was conducted in Mbingu village, Kilombero district, Tanzania, situated 
55kms west of Ifakara town at 8.195°S and 36.259°E. There is malaria transmission 
all year round, with peak transmission occurring in the months of May and June after 
the long rains. The village experiences an annual rainfall of approximately 1,200-
1,800 mm and an annual temperature range of between 20°C and 32.6°C. The village 
borders an extensive field cleared for irrigation, which provides an ideal breeding site 
for malaria vectors. The houses in the village are clustered in groups of 3–5 
households, which mainly belong to one family, but in a few instances the houses 
may be rented by different families. In July 2009 (at the inception of the clinical trial), 
the population of the study area was estimated to be 7, 609, with each household 
having approximately 5 members [22]. Most houses are constructed from mud walls 
and thatched roof, with one‐third made from brick walls and corrugated iron roof. 
4.2.2 Outline of study 
Between July 2009 and August 2010, a placebo-controlled cluster randomized clinical 
trial was conducted in the study village where 15% DEET (N, N-Diethyl-3-
methylbenzamide) topical repellent and an identical placebo lotion were randomly 
issued to 940 households in the study village [23]. The clinical trial participants were 
also issued with double size LLINs per sleeping space to ensure equity. Treatments 
were issued to two study arms of 10 clusters with 47 households each. One study arm 
was issued with topical repellent lotion while the other study arm received a placebo 
lotion and both arms were followed up for 14 months to assess the malaria incidence 
between these two groups. Concurrent with the clinical trial, a knowledge, attitude 
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and practice survey (KAP) of the repellents issued during the clinical trial was 
conducted by administering a questionnaire (Appendix 2: Repellent KAP survey tool) 
at the baseline of the clinical trial (before/entry survey) to assess community 
knowledge of repellents; at the beginning of every month when field workers visited 
the households to replace repellents that had run out (follow-up survey) throughout 
the study period, to assess the acceptance and compliance of the community to the 
repellent issued and perceived effectiveness; and at the end of the clinical trial 
(after/exit survey) to assess willingness to continue use of repellents. This tool was 
designed such that respondent were allowed a single answers to multiple questions 
like; e.g.: why did you not use repellents last night and were expected to pick one 
answer from multiple choices outlined (Appendix 2: Repellent KAP survey tool). It 
should also be noted that there are several questions that might have been subject to 
Hawthorne’s effect, where the respondent’s likely answered questions according to 
what they thought the investigators desired to hear. These questions are; Perceived 
effectiveness, compliance and whether they like repellents or not (Table 4:1, 4:2 & 
4:3). A separate Focus Groups study was conducted three years later in June 2013. 
4.2.3 Baseline survey 
At baseline, written informed consent was sought from the household heads that were 
willing to participate in the clinical trial. The household heads gave consent for all 
household members who were below 18 years. Household members above 18 years 
were asked to sign their own written consent forms. As the household was analyzed as 
a unit, a structured questionnaire of KAP in relation to repellents was administered to 
the household head. A unique ID was stapled on the door of each household that was 
recruited into the study. 
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4.2.4 Follow-up survey 
To assess acceptability and use, at the beginning of every month after the baseline 
survey, field workers visited the households recruited in the study to replace the tubes 
of repellent issued the previous month. A KAP questionnaire was administered during 
these visits, where the households were asked if they liked the repellent issued and 
their perceptions on the effectiveness of the repellent. The fieldworkers also 
administered a compliance questionnaire, where household members were asked if 
any household member had skipped a day of repellent use in the past month and 
reasons for missing that day. However, if during the follow up survey there were no 
household members present to answer the questionnaire on compliance, and 
continued to be absent for seven consecutive days after the first visit to assess 
compliance, that household was considered non-compliant to repellent use for that 
month. If the households reported that any household member did not use the 
repellent, that household member was removed from follow up time for the period 
they did not use the repellent. Thus, if all household members reported using repellent 
each night in the past week and an adult member of the household was present to be 
issued with new repellent, that household was considered compliant for the previous 
month. In addition, the number of treatment tubes (repellent and placebo tubes) issued 
per month was recorded, to determine if there was a difference in the number of tubes 
issued in each month per treatment group. Differences between recalled and observed 
compliance were not measured. 
4.2.5 Post-study survey 
At the end of the clinical trial, (August 2010), an exit KAP (post-study) questionnaire 
to assess perceptions on effectiveness and willingness to pay if repellent was provided 
at cost was administered. In particular, the respondents were asked what was their 
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perceived cost for the repellent issued during the clinical trial. They were also asked 
how much they were willing to pay for the tube of repellent they were given during 
the clinical trial. 
4.2.6 Focus group discussions 
4.2.6.1 In-depth discussions 
Seeking an in-depth understanding of the knowledge, attitude, perceptions and 
practice in relation to repellents as a vector control intervention, a descriptive 
exploratory study, consisting of seven Focus-Group-Discussions (FGDs) and one 
Small Group Interview (SGI) was conducted in the study village from 10 th – 28th June 
2013, three years after the clinical trial. The participants may or may not have 
participated in the initial clinical study of topical repellents, as prior participation in 
the previous trial was not an inclusion or exclusion criterion. Several different formats 
of repellents were provided to participants to measure perceived preferences in 
delivery formats of repellents among members of a community that had previous 
familiarity with repellents. 
4.2.6.2 Sampling of FGD participants 
This study initially used convenient sampling to enroll household heads in the village. 
A purposive sample of households with the following characteristic were drawn from 
the community: 
• Households that had the males as household heads. 
• Households that had females as household heads (widows, divorced, separated 
etc.). 
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• Households that had males as household heads but from which their female 
partners were invited for the FGDs and SGI. 
• Households that had children of school going age (both primary and secondary 
schools). 
From this sample, 6 – 12 individuals from households with each of the above 
characteristics were interviewed in seven FGDs and one 5-member SGI. The FGDs 
were dynamic in nature consisting of individuals from 10 to 60 years of age and 
sampling was stopped at the ‘point of saturation’ (no further ‘new’ information 
generated). 
4.2.6.3 Study tools 
Based on literature on knowledge and practice in relation to repellent use and on a 
priori experience of repellent work with the community in the study area, an 
interview guide on perceptions and practices around repellent use in Mbingu village 
was developed for conducting the FGDs. This guide was pre-tested on four villagers, 
two men and two women before undergoing further changes based on the feedback 
from these villagers. The outcome was a simple interview guide that consisted of six 
open ended questions that were structured in a flexible manner to allow for any 
emerging ideas from the participants to be incorporated there in. 
4.2.6.4 Repellents explored 
The different types of repellents issued to the participants of this study were; 
Permethrin impregnated ‘kangas’ (a sheet of fabric worn around the waist by women 
in Africa), 15% DEET (N, N-Diethyl-3-methylbenzamide) topical repellent in 
petroleum jelly format, 15% DEET topical repellent in spray format, 30% PMD 
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(Para-Methane 3-8-diol) topical repellent in lotion format, 30% PMD topical repellent 
in spray format, 2% transfluthrin impregnated sisal strip (sack), that was hung in a 
common area where all household members sat, (Figure 4:1) and 2% permethrin 
impregnated net fencing that was designed to protect individuals sitting outdoors, 
especially around the cooking area (Figure 4:2 ). 
 
 
Figure 4:1 Testing the efficacy of transfluthrin impregnated sisal strip in the 
semi-field system at the IHI 
 
 
 
Figure 4:2 Installation of permethrin-impregnated fencing around an outdoor 
kitchen/cooking area in the study area 
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4.2.7 Procedures 
Participants were verbally informed on the objectives and aims of the study, its 
voluntary nature, risks and benefits. Thereafter verbal informed consent was sought 
from the purposive and final sample of participants after all ethical considerations of 
the study had been outlined. Interview schedules, including convenient interview 
times and venues were then negotiated between the study investigators and 
participants and the study commenced from the 10th to 28th of June 2013. The 
interviews were all conducted in Swahili and lasted between 30mins and 1 hour in the 
various local settings preferred by the participants. Consent was sought to use a tape 
recording device for the sessions with all villagers agreeing to be tape recorded prior 
to commencement of the interviews. First, four FGDs with the four different 
respondent groups: households that had the males as household heads, households 
that had females as household heads (widows, divorced, separated etc.), households 
that had males as households heads but from which their female partners were invited 
for interviews, and households that had children of school going age (both primary 
and secondary schools), were conducted where community knowledge (familiarity) 
and use of repellents as a mosquito control tool was assessed. At the end of these first 
four FGDs, the respondent groups were issued with different formats of repellents to 
use for a week. After using the different repellent formats for one week, these 
respondents groups were recalled for a further three FGDs and a single SGI where 
experiences of repellent use and preference to different repellent formats were 
assessed. 
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4.3 Data management 
Data from the baseline, follow-up, and post-study surveys were linked using the 
household unique identifier. Data from these questionnaires were entered into and 
coded using an Epi-info template that corresponded to the format of the 
questionnaires. All data was double entered into Epi-info, where it was checked for 
excesses or missing of data. Data was then exported to Microsoft Access 2010 
database where it was checked for duplicates. Data from the FGDs was collected 
using tape recorders and imported into the computer where they were stored as audio 
files ready for transcription and analysis. 
4.4 Data analysis 
All data analysis was carried out in STATA 11.2 (StataCorp LP, College Station, 
Texas, USA) software. Data from the baseline, follow-up and post-study surveys were 
analyzed using descriptive statistics and are presented in tables (Tables 4:1, 4:2 & 
4:3). 
Data from the socio-economic status (SES) was analyzed using principal component 
analysis (PCA). A socio-economic index was generated using PCA and the generated 
score used to show wealth index of each household. Indicators of (SES) used were; 
asset ownership, household construction materials and education level of household 
head. These results are reported in detail elsewhere [23]. Data for KAP collected 
during the follow-up survey was analyzed by determining trend over time, using 
descriptive statistics. Compliance data collected using the follow-up survey was also 
stratified by SES quintiles to determine if there was a difference in repellents use by 
SES quintile. 
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Data for KAP collected at baseline and post-study survey was analyzed by comparing 
the before and after studies using descriptive statistics. Likewise, in the post-study 
survey, willingness to pay was compared across the SES quintiles. 
The number of repellent and placebo tubes issued was analyzed by linear regression 
against month, treatment group and an interaction of month and treatment group to 
determine if there was a significant difference in the number of tubes issued in each 
month and per treatment group. 
Data collected over the study period (follow-up survey) was used to report outcomes 
on compliance, community liking the repellent and perception of effectiveness of 
repellents because it was assumed to be less prone to recall bias compared to data 
collected at the end of the clinical trial (post-study survey). 
Audio files from FGDs were transcribed verbatim in Microsoft Office and imported 
into Nvivo 9 (QSR international Pty Ltd 2006–2010) qualitative analysis software. 
The data was the then coded into themes as they emerged from the response data in 
the transcripts. This content analysis also allowed for themes emerging from the data 
to be considered during iterative coding. The final coding tree (structure of 
categorizing data) consisted of identified themes from the data as well as 
unanticipated themes from the respondents. The final stage of the analysis involved 
re-organization of the themes into larger categories of themes communicating the key 
messages from each of the smaller themes under them (Table 4:4). 
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4.5 Ethical consideration 
Participants were recruited on written informed consent. Ethical approval for the 
study was obtained from Ifakara Health Institute (IHI) (IHRDC IRB A46), Tanzanian 
National Institute of Medical Research (NIMR/HQ/R8a/VOL IX/780) and the London 
School of Hygiene and Tropical Medicine Ethical Review Board (LSHTM ERB 
5174). IHI provided study monitoring. 
4.6 Results 
4.6.1 Baseline survey 
At baseline, only 0.32% of the households had ever used repellents in the intervention 
arm, while no households had ever used repellents in the control arm (Table 4:1).  
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Table 4:1 Baseline perceptions on malaria and repellents 
 Repellent n 
(%) 
Placebo n 
(%) 
Totals n 
(%) 
P- 
value  
What is malaria     
Disease 285 (93.44%) 270 (95.07%) 555 
(94.23%) 
0.397 
Don’t know 20 (6.56%) 14 (4.93%) 34 (5.77%)  
Causes of malaria     
Mosquitoes 302 (99.01%) 280 (98.59%) 582 
(98.81%) 
0.634 
Other 3 (0.99%) 4 (1.41%) 7 (1.19%)  
Knowledge of malaria prevention 
methods 
   0.664 
Bed nets 286 (94.38%) 271 (95.42%) 557 
(94.89%) 
 
Environmental management 7 (2.31%) 3 (1.05%) 10 (1.70%)  
Going to hospitals 4 (1.32%) 2 (0.70%) 6 (1.02%)  
Using repellents 1 (0.33%) 1 (0.35%) 2 (0.34%)  
Don’t know 5 (1.65%) 7 (2.46%) 12 (2.04%)  
Knowledge of mosquito breeding site    0.998 
Water puddle 291 (95.40%) 270 (95.40%) 561 
(95.41%) 
 
Other 14 (4.60%) 13 (4.60%) 27 (4.59%)  
Protection methods used     
Bed nets 294 (95.14%) 277 (96.85%) 571 
(95.97%) 
0.600 
Mosquito Coils 3 (0.97%) 3 (1.04%) 6 (1.01%)  
Environmental management 7 (2.26%) 5 (1.74%) 12 (2.02%)  
Covering oneself 4 (1.29%) 1 (0.34%) 6 (0.84%)  
Using repellents 1 (0.32%) - 1 (0.17%)  
Reasons for using protection methods     
Effective 174 (56.31%) 154 (54.03%) 328 
(55.22%) 
0.008 
Readily available 34 (11.00%) 22 (7.71%) 56 (9.34%)  
Cheap 23 (7.44%) 8 (2.80%) 31 (5.22%)  
Easy to use 76 (24.59%) 100 (35.08%) 176 
(29.63%) 
 
Other 2 (0.64%) 1 (0.35%) 3 (0.51%)  
Reasons for not using repellents     
Don’t understand use 139 (45.27%) 118 (41.40%) 257 
(43.41%) 
0.057 
Not aware of repellents 38 (12.37%) 28 (9.82%) 66 (11.15%)  
Not available 109 (35.50%) 115 (40.35%) 224 
(37.84%) 
 
Expensive 16 (5.21%) 24 (8.42%) 40 (6.76%)  
Other 5 (1.62%) - 5 (0.84%)  
Willingness to use repellents     
Yes 309 (99.67%) 286 (100%) 595 
(99.83%) 
0.336 
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No 1 (0.32%) - 1 (0.17%)  
Two households reported burning mosquito coils, five households repelled 
mosquitoes with a smoky fire and one household reported using repellent plants (data 
not shown). Most households (95.7%) used bed nets as these had been delivered 
through various governmental and non-governmental schemes from 1997 onwards. 
When asked about malaria a similar proportion of the households in the intervention 
and control arms reported that malaria is a disease: 93.44% (n = 285) and 95.50% (n = 
284), respectively. When asked about malaria transmission, most households in the 
intervention arm 99.01% (n = 302) and control arm 98.59% (n = 280) reported that 
mosquitoes transmit malaria. Bed nets were the major prevention tool used in the 
study village, with a similar proportion of reported bed net use in the intervention 
95.14% (n = 294) and control arm 96.85% (n = 277). When households that reported 
bed net use, were further asked why the preferred bed nets to other tools, a 
significantly larger proportion cited effectiveness relative to other reasons: 56.31% (n 
= 174) and 54.03% (n = 154) in the intervention and control arm, respectively. Other 
reasons for use of bed nets as well as other mosquito bite protection methods are 
reported in Table 4:1. It should be noted that the bed nets reported by the respondents, 
were not those issued during the clinical trial, but they were reporting on tools they 
used before the onset of the clinical trial. However, bed nets were given at the start of 
the clinical trial to ensure equity between the study arms. An equal proportion of 
households in both the intervention 95.40% (n = 291) and control 95.40% (n = 270), 
arms reported that mosquitoes breed in standing water. The major barrier to repellent 
use in this community was lack of knowledge on how to use repellents, with 45.27% 
(n = 139) households in the intervention and 41.40% (n = 118), in the control arm 
reporting that they did not understand how topical repellents were used. Lack of 
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awareness of repellents was also reported as a barrier to repellent use, with 35.50% (n 
= 109) and 40.35% (n = 115) of the households in the intervention and control arms 
respectively, indicating that they were not aware of repellents as a mosquito control 
tool. 
However, when repellents were made available knowledge was no longer a barrier to 
compliance. All households were willing to use repellents to prevent mosquito bites: 
99.67% (n = 309) of the households in the intervention and 100% (n = 286), (p = 
0.336), in the control arm were willing to use repellents, even though this tool was 
novel in this community after community sensitization, (Figure 4:3). 
 
Figure 4:3 Community sensitization meeting on repellents conducted by the 
social marketing team from IHI. 
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4.6.2 Follow-up survey 
A follow up survey was conducted to assess household compliance to repellent use. 
Compliance in this context is defined as having recalled use of the repellent every 
night in the past month. However, if during the follow up survey there were no 
household members present to answer the questionnaire on compliance, and 
continued to be absent for seven consecutive days after the first visit to assess 
compliance, that household was considered non-compliant to repellent use for that 
month. If the households reported that any household member did not use the 
repellent, that household member was removed from follow up time for the period 
they did not use the repellent. Reported household compliance with repellent use was 
not significantly different between the study arms: 81.50% (n = 379) in the 
intervention and 78.13% (n = 361) in the control arm, (p = 0.202) during the study 
period. Significantly more households liked using the repellent in the intervention arm 
99.35% (n = 462) compared to the control arm, 84.41% (n = 390), (p = <0.0001). 
When asked about effectiveness, significantly more households in the intervention 
arm, 100% (n = 465) compared to the control arm 84.03% (n = 379), (p = <0.0001), 
perceived repellents to be effective (Table 4:2). Also, significantly more households 
that perceived the repellent to be effective complied with repellent use (72.31%) 
compared to those households that did not comply (27.68%), (p = <0.0001). This 
indicates that relief from mosquito bites was a motivating factor in repellent 
compliance. 
When the perceptions of effectiveness of repellents were analyzed over the study 
period, it was observed that there was an increase in the number of households 
reporting the repellent to be effective over time. This trend was also observed for 
households that reported to like the repellents. Compliance was observed to increase 
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over the study period, with more households reporting repellent use at the end of the 
study compared to the start of the study. Because the repellents were given out for 
free there was no difference in repellent compliance between the most poor and least 
poor socioeconomic quintiles (p = 0.369), data not shown. 
There average number of tubes issued per household was 6.73 (95% C.I. 6.51 – 6.95) 
and 6.92 (95% C.I 6.68 – 7.16) per household per month in the intervention and 
control groups, respectively and there was no significant difference between the 
treatment arms: Odds Ratio 1.68 (95% C.I. 0.32 – 84.25, P = 0.803) and this remained 
constant for the duration of the study period. 
Table 4:2 Assessment follow-up of households, repellents use and perceptions 
during the study period  
 Repellent n (%) Placebo n (%) Total proportions/treatment P value  
Like repellent     
Yes 462 (99.35%) 390 (84.41%) 852 (91.91%) <0.0001 
No 3 (0.65%) 72 (15.59%) 75 (8.09%)  
Compliant     
Yes 379 (81.50%) 361 (78.13%) 740 (79.83%) 0.202 
No 86 (18.49%) 101 (21.86%) 187 (20.17%)  
Perceived effectiveness     
Yes 457 (100.00%) 379 (84.03%) 836 (92.07%) <0.0001 
No 0 (0.00%) 72 (15.96%) 72 (7.93%)  
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4.6.3 Post-study survey 
The main reason for non-compliance to interventions was forgetfulness, with 70% (n 
= 35) of the households in the intervention and 60% (n = 89), (p = 0.241) in the 
control arm reporting that the major reason they did not comply with the intervention 
at some point during the study was because they forgot to apply the repellent. Travel 
also lead to non-compliance with 26% of households in the intervention arm and 
37.83% of households in the control arm not complying for a month because they had 
gone to work in the fields. 
When asked why they liked using the repellents, significantly more households in the 
intervention arm 98.69% (n = 455) relative to the control arm 45.56% (n = 208) cited 
effectiveness, (p = <0.0001). It is worth noting that all households who mentioned 
nice smell and smooth feeling on the skin as reasons for using repellents were from 
the placebo arm of the trial. When asked if anyone in their household suffered from 
malaria during the trial, significantly more participants from the placebo arm 
answered yes: 32.9% versus 15.5%, (p < 0.0001). 
Equal proportions of households were willing to continue using repellents after the 
clinical trial (Table 4:3). When asked if they would be willing to pay if the repellent 
was made available at a fee, 99.78% (n = 458) of the households in the intervention 
and 98.48% (n = 455), (p = 0.999), in the control arm reported that they were ready to 
pay a small fee, with majority of the households in the intervention, 84.34% (n = 388) 
and control arms 87.77% (n = 402), (p = 0.347) willing to pay at most $ 0.30 for a 
tube of repellent (Table 4:3), even though all participants perceived that the value of 
the repellent was at least double that figure. There was no difference in willingness to 
pay when SES quintiles were compared (p = 0.668). 
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Table 4:3 Assessment of perceptions on repellent use, effectiveness and cost after 
the study period  
 Repellent n (%) Placebo n (%) Total 
proportions/treatment 
P- value  
Reasons for non-compliance     
Forgot 35 (70.00%) 89 (60.13%) 124 (62.63%) 0.241 
Away in the field 13 (26.00%) 56 (37.83%) 69 (34.85%)  
Don’t like repellent 1 (2.00%) - 1 (0.51%)  
No mosquitoes 1 (2.00%) 2 (1.35%) 3 (1.52%)  
Ran out of repellent - - -  
Other - 1 (0.67%) 1 (0.51%)  
Perceptions about repellents     
Effective 455 (98.69%) 208 (45.61%) 663 (72.30%) <0.0001 
Easily available 5 (1.08%) 50 (10.96%) 55 (6.00%)  
Nice smell - 99 (21.71%) 99 (10.80%)  
Smooth on skin - 98 (21.49%) 98 (10.69%)  
Other 1 (0.21%) 1 (0.21%) 2 (0.22%)  
Willingness to use repellent again     
Yes 462 (99.78%) 463 (99.78%) 925 (99.78%) 0.999 
No 1 (0.21%) 1 (0.21%) 2 (0.22%)  
Willingness to pay     
Yes 458 (99.78%) 455 (98.48%) 913 (99.13%) 0.034 
No 1 (0.21%) 7 (1.51%) 8 (0.87%)  
Perceived cost of repellent     
< 0.6 USD 99 (21.80%) 111(26.74%) 210 (24.17%) 0.023 
0.6 – 1.2 USD 280 (61.67%) 212 (51.08%) 492 (56.62%)  
1.2 – 1.8 USD 61 (13.43%) 75 (18.07%) 136 (15.65%)  
1.8 – 3.05 USD 13 (2.86%) 17 (4.09%) 30 (3.45%)  
> 3.05 USD 1(0.22%) - 1 (0.12%)  
Amount participants were willing 
to pay 
   0.347 
< 0.30 USD 388 (83.43%) 402 (87.77%) 790 (86.06%)  
0.30 – 0.60 USD 64 (13.91%) 52 (11.35%) 116 (12.64%)  
0.60 – 1.20 USD 7 (1.52%) 4 (0.87%) 11 (1.20%)  
1.20 – 1.52 USD 1 (0.21%) - 1 (0.11%)  
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4.6.4 Focus group discussions 
4.6.4.1 Perceptions around malaria control and transmission 
To provide a general picture of the community’s knowledge, attitude and practice in 
relation to malaria and ways to control malaria, participants were questioned about 
their knowledge of malaria transmission and methods of prevention and control used. 
Some of the participants had a comprehensive understanding of malaria and control, 
as observed from the response of one female respondent below: “Malaria is caused by 
a female mosquito when it bites you at midnight” (Meeting group 5, 16th June 2013). 
Interestingly however, and especially in a region where there has been consistent 
malaria control, research and intervention implementation by both non-governmental 
and governmental organizations for over 20 years [15-17], the community members 
did not appear to have an in depth knowledge of malaria transmission. In trying to 
assess the depth of community knowledge on the malaria transmission process, the 
respondents were asked how many times a mosquito had to bite a person for it to 
transmit malaria. Most of the respondents did not seem to know: 
“ We do not know unless you tell us”- (Meeting group 4, 14th June 2013). 
“ Many times”- (Meeting group 1, 14th June 2013). 
This indicates the community knowledge on malaria transmission is superficial, so 
that whilst the community is aware that mosquitoes transmit malaria, their knowledge 
on this transmission process is scant. These gaps in knowledge might suggest a bias 
during implementation of malaria control programmes, so that, rather than promoting 
community sensitization and education on the objectives of the intervention, the link 
between intervention and disease, and the benefits of the intervention to the individual 
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and the community, these programmes likely focus more on coverage of the control 
tools. 
4.6.4.2 Preference of malaria prevention tools used in the community 
All respondents had used some form of personal protection against mosquito bites 
even for those who weren’t quite sure what malaria was. It also emerged that they had 
been using these tools for a long time and were convinced that the tool each one of 
them had been using was the most effective. The most commonly reported malaria 
prevention tool used was the bed net, when respondents were asked which tool they 
used to protect themselves from mosquitoes and malaria: 
“We use nets” – (Meeting group 1, 14th June 2013). 
Even though some of the respondents were aware of mosquito repellents and/or had 
acquired topical and spatial repellents at some point in the past 2 years, during or after 
the clinical trial, most of them still preferred using the bed net; 
“ I would prefer the net” – (Meeting group 3; 25th June 2013) 
When the respondents were questioned on why they preferred the bed net to other 
mosquito control tools, two major reasons were given. The first was cost 
effectiveness: 
“Because mosquitoes will not bite you when you are sleeping under a net but for the 
repellents they last for a short time and when the smell wears off then the mosquitoes 
bite you” – (Meeting group 2, 26th June 2013). 
The second was generally the ease of use: 
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“MG: FR: 03: Because it is not cumbersome”- (Meeting group 3, 25th June 2013). 
4.6.4.3 Familiarity of topical repellents 
At the onset of the FGDs, most respondents’ awareness of repellents was thin, with 
almost half of them largely unaware of topical repellents as a malaria control tool. 
However, those who had heard of topical repellents had adequate knowledge on the 
proper technique of using/applying the repellents as illustrated by the following 
quotes when respondents were asked how repellents were used; 
“You can apply and then it stays for a few hours after that it is no longer effective and 
the mosquitoes can bite you. After you apply it you have to wash your hands well with 
soap” – (Meeting group 5, 16th June 2013). 
For those who knew about repellents, the primary source of information was outreach 
from the Ifakara Health Institute (IHI), previously Swiss Tropical Institute Field 
Laboratory (STIFL), which is the institute under which the clinical trial project was 
conducted. When asked how they came to know of repellents most respondents 
mentioned the clinical trial, which distributed the repellents free of charge: 
“They were being distributed by people from STIFL (IHI)” – (Meeting group 1, 14th 
June 2013). 
4.6.4.4 Reported experience of use after topical repellent distribution and use 
After repellent distribution, all respondents reported that they had used the repellent 
intervention issued to them during the second phase of FGDs. The most commonly 
reported reasons for continued use of the repellents by the respondents were mainly 
 152 
because of their effectiveness against mosquito bites and also because of the appeal in 
odour and presentation: 
“ I liked it because it prevented mosquitoes and its smell did not affect us in any way 
like causing flu or any other effects”- (Meeting group 3, 20th June 2013). 
Another reason that emerged from the interviews was that every member of the 
household could use the repellent as opposed to other interventions issued which only 
a few household members used: 
“ I would choose the applying repellent because it can be used by the children, my 
husband and even visitors”- (Meeting group 3, 20th June 2013). 
There was one report of side effects to repellent use, however this was during the 
clinical trial and not in the FGD study: 
“Yes I know my sibling he used to get rashes all over the body so he was told not to 
apply the repellents anymore”- (Meeting group 5, 16th June 2013). 
4.6.4.5 Preference for different applications of repellents 
After exposing the respondents to typical topical repellents containing active 
ingredients such as DEET and PMD and in various formats such as lotion, jelly, 
spray, permethrin impregnated clothing, (kanga), transfluthrin impregnated sack cloth 
and permethrin impregnated net fencing, the respondents expressed the following 
views and preferences; 
“I found the smell to be too strong” when asked about DEET in spray format –
(Meeting group 2, 25th June 2013). 
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“I liked the smell “ when asked about PMD in lotion and spray formats – (Meeting 
group 2, 25th June 2013). 
“I did not like the smell because it was too strong “ when asked about DEET in jelly 
format – (Meeting group 2, 25th June 2013). 
“The applying repellent because everyone can use it but the kangas cannot be used by 
everyone” when asked to choose between topical repellents and insecticide treated 
clothing ‘kanga’ – (Meeting group 3, 20th June 2013). 
“If you sat near the sack repellent then the mosquitoes couldn’t bite you but if you sat 
just a distance away then they would bite”– when asked about the transfluthrin 
impregnated sack, (Meeting group 6, 20th June 2013). 
“I got the net so I used to sit inside it and the mosquitoes were very few. They used to 
bite the feet only but I could stay for like half an hour without bothering with any 
mosquitoes” – when asked about the permethrin impregnated net fencing, (Meeting 
group 6, 20th June 2013). 
4.6.4.6 Factors that determine the continued use of topical repellents 
For those who did not use repellents during the clinical trial, repellents were generally 
not popular. There were a several barriers to repellent use in this community; the first 
being access to the repellents: 
“We were given repellents for applying but after they got finished I have not used 
anything else apart from nets” – (Meeting group 1, 16th June 2013). 
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Repellents were provided for free during the clinical trial. However after the clinical 
trial, the community was unable to access repellents as they were not available in 
shops and drugs stores in the study area, as was highlighted by the respondent above. 
The cost of the repellents according to most respondents limited their affordability 
with most respondents prioritizing other living essentials over the repellents. When 
asked to choose between buying a soda or the repellent (subject to availability), most 
of the respondents opted to buy the refreshment: 
“I would buy the refreshment or a net otherwise I would just use a lot of clothing to 
cover myself ” – (Meeting group 1, 16th June 2013). 
4.6.4.7 Community recommendations on improving repellent use 
In an effort to understand how to improve the use of repellents, participants were 
questioned on what they felt was necessary to make the interventions better. While 
most of the responses revealed that the repellent application was fine the way it was, 
other recommendations included the cost of the repellent: 
“I wouldn’t buy them because that is expensive unless you sold them in 500 shillings 
bottles ” – (Meeting group 1, 16th June 2013). 
It should be noted that the bottle the respondent was recommending to be sold for 500 
TZS/$0.30 contained 120 ml of repellent. 
Odour of DEET repellent: 
“I did not like the smell because it was too strong” – (Meeting group 2: Male 
respondent). 
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Issuing extra insecticides so that they could re-treat the impregnated clothing issued: 
“I also think that you should give us repellents for the kangas so that we can treat 
them once we wash them” – (Meeting group 3, 25th June 2013). 
Table 4:4 Major themes generated from the focus group discussions (FGD's) and 
small group interview (SGI)  
Major results theme  
Theme 1 Respondents were aware of the link between malaria and mosquitoes, 
but their knowledge on malaria aetiology and transmission was shallow. 
This did not however, effect their compliance with an intervention that 
was available free of charge 
Theme 2 Although respondents had adequate knowledge of repellents as a 
mosquito control tool, they preferred to use the bed net over repellents 
Theme 3 Those respondents aware of topical repellents had adequate knowledge 
on their proper use 
Theme 4 Availability (access) and cost of repellents were major barriers to 
repellent use after the trial ended and repellents were no longer supplied 
Theme 5 The respondents perceived the repellents to be effective against 
mosquito bites, mostly in the early evenings 
Theme 6 Respondents recommended repellents be made more available and 
insecticides (permethrin) used to treat clothing be provided to enable self 
treatment 
 
4.8 Discussion 
Despite the proven efficacy and acceptability of repellents for prevention of malaria 
[7-10], knowledge and utilization of repellents as a malaria control tool is low in sub-
Saharan Africa. Lack of awareness of repellents as a malaria control tool is one of the 
major barriers to repellent use in sub-Saharan Africa. As observed from the baseline 
survey at the start of this study, most respondents had not used repellents before the 
implementation of the clinical trial. Therefore, use of topical repellents was 
completely new in this community similar to several other studies conducted in the 
African continent [24-26]. It is evident that improving community knowledge and 
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awareness [25-28] as well as retooling interventions to community needs and 
preferences [29] will improve the acceptability and uptake of interventions being 
advocated. The most commonly used malaria control tool in the study area was bed 
net. Social marketing of LLINs started in Kilombero and Ulanga district in July 1997, 
under the KINET project. At the launch of this programme the community was 
educated on malaria transmission and control [15]. This campaign was followed by 
the launch of the Tanzania National Voucher System (TNVS), implemented by the 
National Insecticide Treated Nets programme (NATNET), under the National Malaria 
Control Programme (NMCP) of Tanzania, from 2004. In 2007, the Ministry of Health 
and Social Welfare (MoHSW), collaborating with other partners launched the under 
five Catch-up Campaign, parallel to the TNVS programme. In 2008, the MoHSW and 
partners launched the Universal Coverage Campaign (UCC) [30]. Therefore, if 
repellents and indeed any other novel tools are to be accepted and used to 
complement LLINs and IRS, there will be a need for social marketing, community 
education and sensitization to be employed for a substantial period of time. It is also 
essential to determine community preferences. Tools that require daily compliance are 
initially likely to have limited uptake, as the community has to remember to adhere to 
them on a daily basis. As observed from the FGDs study, ease of use was one of the 
reasons why the community preferred bed nets to repellents. This was because, once 
hung, the bed net was used over a long period of time as you simply pull it down 
when you get into bed, compared to having to remember to apply the repellent every 
evening. However, ease of use was not the only factor that effected compliance. In the 
follow-up surveys, it was observed that there was lower compliance in the control arm 
relative to the intervention arm. Likewise, in the after study, it was observed that more 
households in the intervention arm relative to the control arm used the repellent 
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because it was effective. This finding demonstrates that compliance to interventions 
does not only depend on its availability and ease of use but also on its effectiveness. 
In the FGDs it was also observed that even though sisal impregnated sisal strips did 
not require daily compliance and were easy to use, they were reported to be effective 
over very short distances, and this discouraged the community from using it. 
These finding demonstrates that to impact compliance, the efficacy of the tools being 
recommended need to be established. A recent mathematical model demonstrated that 
the effectiveness of any repellent is extremely dependent on two factors: efficacy and 
compliance (Moore and Briet, in preparation). The most effective tools are those that 
have high efficacy and require little user compliance such as house screening [31]. 
The major reason for use of topical repellents by the community in Mbingu village is 
to prevent nuisance biting by mosquitoes. Although a proportion of the community 
could associate mosquito bites with malaria, the results of this study imply that they 
used repellents to avoid being bitten by mosquitoes rather than to avoid contracting 
malaria. These results were similar to a study carried out in a coastal community in 
Mexico, where 80% of the respondents said they allowed IRS in their households to 
reduce mosquito bites while only 2% said they allowed IRS to avoid contracting 
malaria [32]; and in rural Tanzania, where respondents reported that main reason for 
using LLINs was to prevent mosquito bites: 73% of the respondents reported they 
allowed IRS in their households to reduce mosquito bites and only 17% related 
protection from mosquito bites with reduction of malaria in the family [24]. These 
findings demonstrate that tools being advocated as interventions, especially in malaria 
control should address both short and long-term goals, i.e. address the problem of 
nuisance biting or mosquito densities (efficacious to enhance uptake) as well as 
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reduce disease prevalence/incidence in the long run (resultant effectiveness). This is 
likely to encourage uptake and acceptability as opposed to tools whose benefits are 
realized in the long-term, and highlights the need to test new vector control 
interventions against nuisance biting insects as well as target vectors during 
development for a better understanding of how effective that tool will be in the real 
world for disease control purposes. 
The major reason for not using repellents in this community was reported to be lack 
of knowledge of repellent use and is similar to findings in other studies [25], where 
low repellents use was associated with poor knowledge of repellents. Availability of 
repellents in this community was another barrier to repellents use as observed from 
the baseline survey. 
Also, in the FGDs, after the clinical trial, when asked why they did not use repellents, 
the respondents cited availability as a barrier, reporting that they did not know where 
to access repellents. Observations carried out by the study investigators during the 
clinical trail and FGDs, indicated that no topical repellents were available in the shops 
and drug stores in the study area. Therefore, despite most households indicating 
willingness to continue repellent use, and even pay a small fee, access to repellent 
was a major barrier to repellent use. 
Another barrier to the use repellents was cost [33]. During the FGDs, even though all 
respondents were aware of repellents as a mosquito control tool, they all preferred 
using LLINs as they reported that repellents were more expensive in the long run 
because they had to be replaced every end of the month compared to LLINs, which 
could last up to five years before replacement, if well taken care of. This finding was 
consistent with outcomes from other KAP studies assessing uptake of interventions 
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[24,27,34]. As seen from the above studies, cost of mosquito control interventions 
greatly influences the acceptability and uptake in communities where they are to be 
employed. In rural and urban areas in Tanzania, a 150 ml bottle of 15% DEET 
repellent costs USD $1.00. On average, respondents were willing to pay $0.32 for a 
150 ml tube of repellent that would last one adult less than one month. The current 
price of repellents is too expensive for the subsistence farmer, who lives on $1.50 
USD per day. Therefore, even though incorporation of repellents into malaria control 
programmes on a community scale, is likely to use a cheaper but efficacious option of 
repellent, as was the case in Ghana [10], it is unlikely that the repellents would be 
subsidized down to or lower than $ 0.32. Also, scale up and extensive use of 
repellents under programmatic conditions as well as emergence of a repellent market 
is bound to drive the cost of repellents down. However these cost are unlikely to be 
lower than the cost of delivering a single LLIN, which costs USD $5.30 and protects 
two people for up to 5 years ($0.50 per person per year) [30]. Therefore if we are to 
encourage up take of repellents as a malaria control tool, the cost needs to be greatly 
reduced, potentially through government and non-governmental organizations 
offering subsidies on repellents following the example of LLINs [23]. The 
government may also encourage local production of repellents through tax exemption 
for local repellent manufacturers. 
From the FGDs, it was observed that knowledge on malaria transmission and control 
was relatively superficial. While most respondents associated mosquitoes with 
malaria, when probed, few were able to detail processes of transmission, aetiology 
and prevention in any depth. Therefore, although all respondents from the FGDs 
reported that they used the repellents issued, it is likely that they did so with only a 
superficial understanding of the objectives of using repellents. This might have been 
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because the community was more concerned with preventing mosquito bites than 
contracting malaria, as observed in other studies [24,32]. As all respondents reported 
that they had complied with repellent issued it was not possible to assess the 
relationship between compliance and level of knowledge of malaria transmission. The 
superficial knowledge of malaria transmission observed in this community 
underscores the importance of incorporating community education and sensitization 
before implementation of any intervention to achieve its desired objective. Social 
marketing the product, and neglecting key messages regarding how these 
interventions benefit the communities in which they are being implemented, is likely 
to negatively effect uptake of that intervention. It is therefore essential for the 
community to be involved in designing and implementation of intervention 
programmes so that they have a better understanding of the objectives and use of tools 
being employed. 
Several studies have shown that there has been better uptake of interventions in 
communities where awareness and sensitization have been conducted [35]. Promoting 
knowledge and awareness also deters any misconceptions that the community may 
have towards a particular intervention and it is essential for effective implementation 
of that intervention [36,37]. During FGDs for this study, some respondents reported 
that they had ‘heard’ that LLINs caused infertility and also claimed that if/when they 
use repellents then their skin pores will be blocked and they will get sick. However in 
a KAP study in Rukungiri, Uganda, women who had previous knowledge of the use 
of ivermectin were more involved in making decisions of how ivermectin should be 
distributed to the community compared to those women who had no prior knowledge 
of this drug [38]. It is therefore essential to acknowledge and address the 
community’s misconceptions and misinformation about intended interventions in 
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order to improve acceptability, uptake and effectiveness. Rather than the 
implementing organizations solely marketing the product to achieve extensive 
coverage, it is beneficial to also educate the community on the safe use of these 
interventions and the correlations between their products, the disease and its benefits. 
The respondents’ preference of LLINs to repellents is attributable to cost 
effectiveness, convenience of use and availability. The major reason given for non-
compliance to repellent use was that the respondents ‘forgot’ to use it, while ease of 
use was ranked second among reasons why respondents preferred using bed nets. It 
was cumbersome to remember to re-apply the repellent after every few hours, unlike 
simply sleeping under a LLIN. Repellents should therefore be presented in a format 
that will encourage uptake. As the major occupation in the study area is subsistence 
farming, most community members bathe in the evening after coming from their 
farms. Repellents can be incorporated into body lotions so that they are applied after 
taking the evening bathe. Repellents can also be impregnated in clothing, especially in 
kangas used by women in the evening when cooking outdoors. Development of tools 
that do not require daily compliance such as long lasting spatial repellents that act 
over long distances should also be explored [39]. 
Respondents also preferred LLINs because it protected them when they were asleep 
and vulnerable to mosquito bites as opposed to when they were awake and could 
chase mosquitoes away. The community however preferred to use repellents in the 
early evenings when sitting outside their houses to have a chat with other family 
members and friends without being bothered by mosquito bites. This finding is 
important because it suggests that repellents can be used complimentary to LLINs in 
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the early evening, before LLINs are employed, which was the major objective of this 
study. 
Perceived irritating odour of DEET topical repellents reduced its use by the 
community in this study, a finding similar to studies in North Tanzania and Mexico 
where participants refused to use IRS because of the ‘bad smell’ of insecticides used 
[24,32], emphasizing that interventions should be tailored to be perceived as pleasing 
by users. PMD was perceived as pleasant as found in several other studies [7,10,40]. 
The most salient recommendation that came out of this study was that interventions 
advocated to the community should fit the community needs, such as providing 
repellents that have a pleasant smell and feels good when applied to the skin. 
Respondents that were issued with Permethrin impregnated kangas, reported that even 
though effective, it only protected a single individual at a time and suggested that all 
members in the household be issued with a treated kanga, and like LLINs, be issued 
with the ‘chemicals’ (insecticides) used for re-treatments so that when the effect of 
the insecticide was diminished they could treat the clothing on their own. Insecticide 
Treated Clothing (ITC) has been successfully implemented in other settings [41-44] 
and therefore this tool would easily be introduced in this community. Another 
outcome of this study was the effectiveness of the topical repellents that were issued. 
The respondents found topical repellents to be effective in protecting against early 
evening biting outdoors. This finding is similar to other studies, where repellents have 
been used to protect against vectors biting outdoors and by extension reduce the 
incidence of malaria [7,8,45]. Therefore both topical repellents and ITC, if designed 
to meet the needs and preferences of the community, could offer potential 
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interventions that could be introduced for malaria control and would be readily 
accepted by the community. 
4.9 Conclusion 
In this setting, the major limitations to use of repellents, similar to those identified 
from other studies were lack of knowledge, availability of repellent, cost and need to 
remember to use it every evening or even more than once in a single evening. While 
the community was highly knowledgeable about malaria, their knowledge was found 
to be superficial, indicating poor community education and sensitization. Although 
currently LLINs are the most commonly used and preferred malaria prevention and 
control tool, their introduction to the community was initially marked by similar 
limitations emerging from this study such as the need to use it daily and the cost being 
prohibitive. When repellents were provided free of charge to all trial participants 
compliance was high. It is therefore likely that uptake will improve if accessibility of 
repellents is improved through lower costs and greater availability through the 
commercial sector, comprehensive social marketing and community sensitization on 
use of repellents, as well as delivery of repellents in formats that respond to 
community desires. Even though LLINs were the preferred mosquito protection tool, 
the community saw a benefit in the use of topical repellents in the early evening, 
especially to prevent mosquito nuisance indicating the potential of using repellents 
complimentary to LLINs. However, longer lasting repellents are an essential 
requirement to avoid the need for frequent reapplication that most people find off-
putting. The difference in compliance reported during and after the study is likely due 
to recall bias at the end of the study. Other avenues such as long lasting spatial 
 164 
repellents might be used if they are effective enough to protect the peridomestic space 
occupied by the family and visitors in the evening. 
4.10 Limitations to the study 
A ranking of repellent preference had previously been reported in this study, but as 
there were too few repellents types/formats to issue to each FGD participant, these 
results were discarded along with some themes that had earlier been reported as they 
did not represent true results of community preference to different repellent formats. 
As the participants were only issued with one repellent, it was not possible to explore 
whether the participants would use the repellents complimentary to each other if they 
had been issued with different formats of repellents. However, findings from the 
FGDs indicated the community members used the tools complimentarily. 
Another limitation of this study is that compliance, during the follow up and post-
study surveys, was established by self-reporting of use by the study participants. It 
was not logistically possible to observe compliance of households to repellents use for 
each household every evening and therefore observed and reported compliance could 
not be compared, and this should be taken into consideration when interpreting the 
results of this study. 
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Chapter 5: Literature review: Evaluation of repellent efficacy in 
reducing disease incidence 
5.1 Background. 
Repellents, used throughout pre-history [1] are currently used by millions of people 
worldwide to prevent nuisance bites from blood-feeding insects, and is now a multi-
million dollar, global industry [2]. Several groups of animals including passerine birds 
and white faced capuchin monkeys anoint themselves with leaves, fruit and even 
millipedes that contain compounds that are proven deterrents of ticks and mosquitoes 
[3, 4]. This behavior is observed to increase at times when attack from such 
arthropods is higher as observed in capuchin monkeys of South and Central America 
[5]. This observation is an indication that the use of personal protection from blood-
feeding arthropods must improve the biological fitness of the animal that applies such 
repellents through reducing energy expended on “host defensiveness” or reducing its 
susceptibility to arthropod borne diseases [6]. However, until recently, there has been 
limited scientific evidence on the efficacy of repellents to reduce disease. 
The majority of research into the highly effective mosquito repellents available today 
was carried out by scientists employed or funded by the military to protect troops 
stationed in high disease risk areas. Some of the world’s most important programs 
into the understanding and prevention of insect borne disease have risen as a result of 
conflict in tropical regions that lead to massive loss of life from diseases such as 
yellow fever, louse borne typhus and malaria [7]. Two of these discoveries: DEET, a 
topical repellent [8] and long lasting permethrin treated clothing [9] will be reviewed 
in this chapter. Two other repellents will also be reviewed: Para-methane 3,8 diol 
(PMD), a topical repellent discovered in China [10] and mosquito coils that were 
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developed by the private sector in Japan [11] and are an example of area or spatial 
repellents. 
Topical repellents are oils or lotions applied to the exposed skin or clothes of the 
consumer, with the most safe and effective being DEET, Picaridin and PMD. 
Picaridin will not be reviewed here, because there is, to date, no epidemiological 
evidence of its efficacy, although a well-designed trial to evaluate its efficacy against 
malaria is currently underway with results available in 2014 [12]. Permethrin treated 
clothing is clothing impregnated with a safe pyrethroid insecticide and binding agent 
to allow the permethrin to adhere to the fabric even after several washes. Permethrin 
is a synthetic pyrethroid, which has been extensively tested by the Military [13-16] 
and is the only insecticide approved for this use category by the United States 
Environmental Protection Agency (USEPA) [17]. It is non-staining, odorless, 
resistant to UV-light and safe for regular use and is therefore an excellent tool for 
longer-term prevention of arthropod bites. Mosquito coils are spiral shaped products 
made from organic fillers, binders and additives that allow the organic components to 
smolder evenly and continuously, to which a volatile pyrethroid insecticide is added 
that evaporates as the coil smolders over several hours after it is ignited. They are 
classified as area (spatial) repellents. Spatial repellency is used here as a general term 
to refer to a range of insect behaviors induced by airborne chemicals that result in a 
reduction in human-vector contact. This can include knock-down, interference with 
host detection (attraction- inhibition) or movement away from a chemical stimulus 
[18]. Other forms of spatial repellents include vaporizers and mats that have available 
extensive phase II (laboratory) data demonstrating excellent efficacy [19] but no 
epidemiological evidence of efficacy to date [20]. Vaporizers and mats require 
electricity to evaporate insecticide from a small liquid reservoir containing insecticide 
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or cellulose mat impregnated with insecticide, respectively. This feature limits their 
application for disease prevention in the rural tropics where the majority of vector 
borne disease occurs, since electricity is not available. Another intervention of note is 
passive emanators that have a large surface area allowing the passive diffusion of 
insecticide from the surface. There is extensive evidence from studies with dichlorvos 
that passive emanation of insecticides is effective against malaria vectors (Table 5:1). 
However, dichlorvos does not have a suitable toxicity profile for use for public health 
[21]. The discovery of the extremely non toxic pyrethroid insecticides, metofluthrin 
and transfluthrin, means that passive emanation of such compounds is an area of 
current research interest [22, 23] and large scale epidemiological trials will begin in 
the near future. Development of such products will be of great value because while 
the pyrethroid insecticides used in the coils is not known to be harmful to humans, 
often the smoke produced from combustion of coils is a nuisance to people reducing 
consumer acceptance and some brands generate Products of Incomplete Combustion, 
(PIC), which are harmful to humans [24, 25].  
The annual market value of personal protection consumer products is over $2billion 
for powders, gels and repellents and $2.6 billion for spatial repellents including 
vaporizers and coils. It is estimated that 45 to 50 billion mosquito coils are used 
annually by approximately 2 billion people worldwide [26], mainly in Southeast Asia, 
but with a growing market in South America and Africa. These products present a 
great opportunity for public health, because such products could provide a means of 
disease control that is already proven highly acceptable to end-users, since those that 
can afford them are willing to buy them.  
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5.2 Vector behaviour modification for disease prevention  
The World Health Organization (WHO) has recommended that all travelers to disease 
endemic areas should minimize exposure to insect bites by selecting a combination of 
personal protection methods including insect repellents, mosquito nets, mosquito 
coils, aerosol sprays, protective clothing, screening and air-conditioning [27]. The 
United States Department of Defense (DoD) spent $4 million in developing the insect 
repellent system that comprises the proper wearing of a permethrin treated uniform, 
and the application of extended-duration DEET lotion to exposed skin which, 
provided it is used correctly, provides close to complete protection from arthropod-
borne diseases [28]. However, there has been no discussion on the implementation of 
repellents for public health use. The main explanation behind this is that until 
recently, there were insufficient studies conducted to convincingly demonstrate that 
repellents can be effective against disease transmission.  
Public health vector control tools such as indoor residual spraying (IRS) and the use 
of Long lasting insecticide treated nets (LLINS) are extremely effective in sub-
Saharan Africa [29]. Massive mobilization of both financial and political resources of 
the past decade [30] has resulted in scale up of LLINs and IRS and has had a great 
impact on malaria transmission [31]. However, there is a substantial amount of 
disease transmission both within and outside of Africa, where vector behavior evades 
control through conventional means such as insecticide treated materials, because 
vectors bite outdoors and at times when people are still active (Table 5:2 and 5:3). 
Recent estimates are that 16% of global malaria burden and 8% of malaria mortality 
occurs outside of Africa [32], while outbreaks of dengue and other arboviruses are 
increasing and spreading geographically [33]. Thus, tools targeting these outdoor and 
day biters are required. With the new impetus for malaria eradication of the past 
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decade and the realization that the existing controls tools LLINs and IRS cannot 
solely achieve this, repellents are increasingly being considered as the supplementary 
tool in appropriate scenarios [34]. Modern repellents are extremely effective at 
preventing man-vector contact.  The burden of vector-borne disease remains elevated 
despite substantial gains in control. There remains a challenge to develop repellency 
as a vector control option to complement existing tools in scenarios where the vector 
[35] (Table 5:2) or the human population [36] (Table 5:3) exhibit behaviors that 
require their use.  
5.2.1 How repellents work to reduce vectorial capacity and vector borne disease  
 
When considering vector control for disease prevention it useful to consider how 
repellents could reduce the vectorial capacity of the disease vector population of 
interest and thus reduce disease transmission. The concept of vectorial capacity was 
derived from models of malaria transmission first devised by Ross, and was 
developed to guide the first global malaria eradication plan [37]. Vectorial capacity is 
described by an equation (Figure 5:1) and is defined as “the average number of 
inoculations with a specified parasite, originating from one case of malaria in unit 
time, that the population would distribute to man if all the vector females biting the 
case became infected” [38].  
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Figure 5:1 Equation describing vectorial capacity 
The concept of vectorial capacity is sufficiently simple that it can be applied with 
some modifications to account for varying vector behavior, competence, and ecology 
as well as differences in the dynamics of infection, disease, and immunity in 
vertebrate hosts, and has been used to understand transmission of other vector borne 
diseases including dengue [39] bluetongue [40] onchocerciasis [41, 42] bancroftian 
filariasis [43, 44] and schistomiasis [45]. Vectorial capacity describes the potential 
intensity of transmission by mosquitoes as a function of 1) the man biting rate, 
representing the incidence of biting contact between the mosquito and humans in 
terms of the number of bites per person per day and indicates the number of vector 
females that could become infected per case per day 2) the expectation of infected 
life, which is days of infective life per mosquito infected with the given parasite 
species and 3) the man biting habit, which is bites on a person per day by an 
individual female mosquito [46] all of which can be simply measured using standard 
field collection techniques [47].  This exceedingly elegant means of considering the 
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process and impact of vector control on man vector contact and mosquito survival has 
been verified with field data [38] and provides a convenient logical framework to 
consider the impact of new vector controls. The majority of work involving the 
vectorial capacity equation has considered insecticides that reduce both mosquito 
numbers and life expectancy of mosquitoes and have an excellent impact on reducing 
malaria intensity. However, in the original paper where VC was described the author 
demonstrated that by reducing man-biting rate by 50% there was a consequent 75% 
reduction in the vectorial capacity of the mosquito population [46]. Vectorial capacity 
is extremely sensitive to changes in the biting rate because a vector needs to bite twice 
in order to obtain and then transmit a pathogen – hence man biting is squared in the 
equation (Ma2). Thus the use of repellents will have a strong effect on overall 
vectorial capacity by reducing the probability of infecting or being infected by a 
vector – as described by Ma2. Therefore, when considering disease control we will 
define repellents as those interventions that reduce man vector contact without killing 
a large proportion of the vector population, i.e. those interventions that keep the 
human population and the vector population apart. 
5.3 Randomised Controlled Trials for measuring the disease impact of 
repellents  
Different kinds of evaluations have been conducted to determine the effect of 
repellents on disease incidence. Randomized controlled trials (RCTs) are currently 
considered to be the gold standard for testing the effectiveness of interventions for 
disease reduction in a population [48], provided that they are well conducted [49]. 
The most important feature of an RCT is that those individuals recruited into the trial 
are randomly assigned to the intervention or a control thereby minimizing selection 
and allocation bias to control as much as possible for both known and unknown 
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confounders that could influence the correct measurement of impact of the 
intervention [50]. Other advantages of well-conducted RCTs are that it facilitates 
blinding of treatments, from investigators, participants and assessors to prevent bias in 
estimation of intervention effect [51]. It allows for the use of probability theory that 
any difference seen between the different arms outside the treatment effect is due to 
chance. There is a large body of guidance available to researchers on the importance 
of correct trial design [52], implementation [53-55] and reporting [56].  
The main disadvantage of RCTs is the limitation of external validity i.e. the results of 
the RCT may not be applicable to the general population, due to differences in 
geographical location, characteristics of patients recruited, trial procedures and 
methods of measuring the outcomes in the trial. For this reason, it is advised that 
standard methods to ensure quality and reporting guidelines are followed that will 
allow systematic review and meta-analysis which aims to collate and synthesize data 
from multiple studies that meet pre-specified eligibility criteria using methods that 
attempt to minimize bias [52]. The other disadvantages are cost and time. RCTs are 
quiet expensive [57] and takes several years until the results are published; thus, they 
may be less relevant at the time of publication [58]. However, when considering the 
public health implementation of a new vector control product, the investment in RCT 
is small when considering the importance of implementing a proven intervention that 
will save lives rather than wasting money on implementing an ineffective intervention 
(Christian Lengeler, pers. comm.). The cost of the series of RCT used to generate 
evidence that bed nets prevented malaria [59] was less than $10 million; but between 
2004 and 2010, $17 billion was spent on bed nets [60].  
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5.4 Randomized controlled trials of topical repellents 
5.4.1 Southeast Asia 
  
In a refugee settlement in Pakistan, a household randomized trial of Mosbar, (a soap 
containing 20% DEET and 0.5% permethrin that is lathered on but not rinsed off) vs. 
a placebo lotion demonstrated a 56% reduction in Plasmodium falciparum (P. 
falciparum) malaria, Odds Ratio (O.R)=0.44 (95% C.I. 0.25 – 0.76, P = 0.004) and a 
non-significant effect on Plasmodium vivax (P. vivax) malaria O.R.=1.29 (95% C.I. 
0.86 –1.94, P = 0.226) [61]. The study was carried out on a waterlogged land endemic 
for malaria and transmission was effected by Anopheles culicifacies, Anopheles 
stephensi, Anopheles nigerrimus and Anopheles pulcherrimus, which are 
predominantly early evening biting vectors [61]. This characteristic makes topical 
repellent use ideal as it is applied in the early evening coinciding with peak activity of 
these vectors. This local vector bionomic may have meant that the repellents reduced 
a substantial amount of malaria transmission and demonstrated the importance of 
studying the local vector bionomics to determine if the proposed intervention will 
have any impact on the vector population. The study employed simple randomization 
to allocate treatment to the participants. Randomization minimizes the allocation bias 
of the treatments and confounding factors that have not been taken into account. 
Passive case detection of malaria cases was used, which might have led to loss of 
cases that did not report to the health clinic. Compliance was established by self-
reporting of use, every fortnight and therefore could not be conclusively ascertained. 
Field staff, laboratory technicians and participants were blinded to the intervention. 
Even though this study demonstrated an effect of repellents, it did not take into 
account the whole malaria transmission season. This study took place for only 6 
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months, during P. falciparum transmission season and therefore demonstrated an 
effect only against P. falciparum malaria. No effect was shown against P. vivax 
malaria because study was carried out when transmission of P. vivax malaria was low 
and there weren’t enough cases to demonstrate a treatment effect. This study would 
have been stronger if it had been carried out for longer to take into account both P. 
falciparum and P. vivax malaria transmission seasons.  As P. vivax malaria is known 
to recrudesce, the study investigators should have cleared all malaria cases through an 
appropriate treatment regimen after checking for glucose-6-phosphate dehydrogenase 
(G6PD) deficient individuals [62], so that any cases that were observed would be 
classified as new malaria cases and not recurrent P. vivax cases. Thus, the 
investigators would have avoided losing malaria cases that they classified as 
recrudescent cases while they were actually new cases, which reduced the power of 
the study. It would also have been prudent if the investigators had employed active 
case detection, where they visited all households recruited into the study and screened 
for malaria, instead of waiting for study participants to report to the camp’s health 
facility. This way, the investigators would have captured malaria cases of those 
individuals who visited alternative health facilities or chose to buy drugs directly from 
the drug stores. Active case detection would also allow for inclusion of individuals 
who were too weak to visit the health facility for treatment or found the facility to be 
too far to seek services. Compliance could also have been better established by 
conducting frequent spot checks to determine if the study participants did indeed use 
the treatments they were issued. 
In another refugee camp in Thailand, a double blind, randomized clinical trial on the 
effect of DEET mixed with thanaka (a root paste made from pulp of the wood apple 
tree, Limonia acidissima, used locally as a cosmetic) compared to thanaka alone in 
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pregnant women demonstrated a 28% reduction in malaria incidence: 10.6% (95% 
C.I. 7.5% - 13.5%) in women who used thanaka + DEET, compared to the arm that 
used thanaka alone 14.8% (95% C.I. 9.9% - 19.7%) in P. falciparum malaria although 
the difference was not statistically significant [63]. There was also no significant 
difference in the transmission of P. vivax malaria between the 2 treatment arms. The 
lack of a treatment effect was most likely due to malaria transmission being too low to 
demonstrate a treatment effect as a result of effective and timely diagnosis and 
treatment of malaria in the camp. As women who were parasitaemic during the study 
were more likely to be anaemic on admission than women who had no documented 
malaria, the authors concluded that they were probably infected before the start of the 
study, although randomization was performed correctly because anaemia was similar 
between those allocated to treatment or control. By treating all the malaria cases 
before the start of the study so that all cases seen were contracted during the study 
period may have reduced prior infection status to bias results, although this would 
have required a larger sample size and longer study period in order to observe any 
treatment effect. The study employed both active and passive case detection, which 
were well correlated. This demonstrates that among individuals with lower immunity 
to malaria and thus more likely to suffer symptoms, and where malaria screening and 
treatment was accessible, free passive case detection may be closely related to the 
actual malaria burden existing in the community and this method can be used as an 
effective malaria surveillance tool in the community. Under other conditions, e.g. 
where there are non-symptomatic malaria carriers or where health care is of low 
quality or costly to the user this may not be case. The principal vectors in this area are 
Anopheles maculatus and Anopheles minimus, vectors which exhibit a tendency to 
bite in the early evenings [64]. This vector behavior demonstrates a circumstance 
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where repellent use is beneficial, and the fact that no treatment effect was observed 
suggests that the sample size used was too small to observe the treatment effect, or 
that it may have been useful to use a higher concentration than 20% DEET to increase 
the duration of nightly protection. However, the major finding of the study was that 
there was no difference in the proportion of congenital abnormalities following the 
use of DEET between the treatment and control arms. Also no DEET was detected in 
the umbilical cord of 46 of 50 samples that were analyzed and none of the 30 samples 
of urine analyzed were found to contain more DEET than the acceptable levels of 
0.1g/ml. This study reaffirms that DEET is safe to use in the second and third 
trimesters of pregnancy [63]. 
In another household randomized, double blinded placebo-controlled trial recently 
conducted in Lao-PDR, to determine the effect of 15% DEET lotion topical repellent 
in addition to use of Permanet 2.0 LLINs on incidence of malaria did not demonstrate 
any intervention effect [65]. Field trials of 10-20% DEET carried out in the study area 
demonstrated a > 96% protection against all mosquito bites. The major malaria 
vectors in this region are the Anopheles dirus complex and Anopheles minimus, which 
are both outdoor and early evening biting vectors in the area [66], a characteristic 
which made repellent an ideal tool for control of malaria transmission in this setting. 
However, although the repellent was well received with over 90% of participants 
reporting that they liked using the lotions, compliance was still low with fewer than 
60% of participants using the lotions more than 90% of the time. Focus group 
discussions (FGDs) revealed that the assumption that local populations were protected 
from night biting if they were provided with LLINs was not always true. Adult men 
and children reported spending time outdoors at night hunting and fishing and may 
have benefitted from using a longer-lasting repellent or even permethrin treated 
 184 
clothing when engaging in night time outdoor activity. These behavioral factors, no 
doubt, increased bias and reduced the power of the study to detect an effect, if any. 
The treatment and placebo lotions both smelt and felt the same when applied on the 
skin and were presented in identical bottles, identifiable only by a three digit 
numerical code. Households were randomized to the treatments by drawing straws 
labeled with the codes of either repellent or placebo lotion. Follow up visits were 
done on random dates in order to ascertain compliance, and the field staff, data entry 
clerks and participants were blinded. However, it may have been possible for the 
participants to distinguish between the 2 treatments because placebo users were more 
likely to experience mosquito bites [67]. Treatments were administered at household 
level and to no more than 25% of households in any one village. This minimized the 
chances of treatment contamination, through diversion of mosquitoes from repellent 
to placebo users and confusion of treatments if individuals in the same household 
would have been issued with different treatments. However, this might have led to 
treatment contamination, which can occur through treatment non-adherence (not 
using the recommended intervention because of perceived lack of effect) and 
treatment crossover (receiving the intervention intended for the other group in a trial 
e.g. repellent users might give or sell their repellent to a neighbor). Both of these 
scenarios are common in repellent trials and create bias resulting in an 
underestimation or overestimation of the treatment effect in either arm of the study. In 
future trials this shortcoming can be addressed by using clusters of participants that do 
not interact with each other e.g. villages far apart, minimizing the chances of 
participants interacting with each other. 
A study carried out in a forest fringe in India to determine the effect of 12% DEET 
used in conjunction with Insecticide treated mosquito nets (ITNs) on malaria 
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incidence demonstrated a protective efficacy of the intervention in the first and 
second year of the study respectively when compared to the control arm [68]. This 
study demonstrated a substantial effect of use of mosquito repellent and ITNs against 
malaria. The major malaria vectors in this area are Anopheles dirus, Anopheles 
philippinensis and Anopheles minimus which are generally early evening biting 
vectors [69], and so the repellents would protect against early evening biting which 
may explain why the repellents were additionally effective in reducing malaria among 
users of ITNs and repellents compared to ITNs only users. ITNs may confer 
communal protection by reducing vector populations [70], with additional protection 
from repellent use. This integrated management of vectors (IVM) using different tools 
(repellents and ITNs) would therefore have reduced vector populations and host 
parasite reservoirs by reducing human-vector contact, thereby lowering malaria 
transmission in the community. The study investigators collected baseline data on 
malaria incidence and vector bionomics before implementation of the intervention 
and were therefore able to establish the correct baseline incidence, reducing the 
chances of under-powering the study by using a smaller sample size. The study was 
also carried out for 2 years after 1 year of baseline data collection. This increased the 
sample size of the study, further minimizing the chances of under powering the study. 
The study had several positive features: it employed active case detection, minimizing 
the chances of missing malaria cases in the community making the estimation of 
treatment effect more robust. The research team also conducted random sniff checks 
to ascertain compliance to use of mosquito repellents and ITNs. Another aspect of this 
study that might have led to such a big treatment effect being observed is the 
promotion of the interventions through information, education and communication 
(IEC). For an intervention to be effective it has to be acceptable by the community. 
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Unlike other repellent studies, this study employed the use of IEC, which motivated 
the community to take up the intervention. This approach demonstrates that repellents 
can be an effective malaria control strategy if the community is well informed and 
educated and the intervention made available. Another finding of significance of this 
study is the further reduction of malaria incidence in the second year of the study 
implementation compared to the first year. This demonstrates that continuous 
implementation of an effective integrated vector management (IVM) tool can have a 
great impact on malaria transmission. However, the major shortcoming of this study 
is the paucity of information on how the findings were analyzed. This omission makes 
the findings questionable and surprising that the paper was published owing to the 
lack of information on even what method was used to analyze the data, the lack of 
data on slide positivity rates for the second and third years of the study and the highly 
questionable reliance on a converse interpretation of the risk ratio that was presented 
in the publication. The authors should have provided: 1) raw data on the number of 
cases per 100 man years per cluster or slide positivity rates in years two and three, 2) 
information on which model was used to analyze the findings, 3) why this model was 
preferred over other models 4) how the data was interpreted, 5) how bias was 
accounted for in order to make the findings credible to readers without having to rely 
upon the interpretation of the authors. The study as presented could not be used in a 
systematic review.  
5.4.2 South America 
 
A household randomized, double blind, placebo-controlled clinical trial conducted in 
Bolivia among users of a freshly impregnated ITN (25 mg/m2 deltamethrin) plus 
either the insect repellent (Corymbia maculata citriodon) with a p-menthane 3,8 diol 
(PMD) concentration of 30% (MASTA, UK) for the treatment group or 0.1% clove 
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oil for the placebo group [67]. The study demonstrated an 80% reduction (IRR=0.2, 
95% C.I. 0.11 – 0.38, P < 0.001) in Plasmodium vivax malaria. However the effect on 
Plasmodium falciparum malaria was not significant most likely due to lack of power 
as the number of Plasmodium falciparum cases was too low to demonstrate any 
treatment effect. This might be because of an unexpected round of fogging as 
explained by the authors, but they also offer the more likely explanation that the study 
took place when transmission of Plasmodium falciparum was low. Sequential 
randomization of households was used to allocate treatments and both the participants 
and field staff were blinded. Both these attributes increased the robustness of the 
study, as there was a minimal chance of selection bias by the field staff or the 
participants not using the placebo. The use of a clove oil repellent was useful in this 
circumstance as both PMD and clove oil have a strong odour, which would suggest to 
the users that both were active repellents. However, there was always the chance of 
the control group realizing that they were issued with the placebo as the trial went on 
and dropping out of the study, thereby reducing the power the study because of 
decreased sample size. The study took place for only 4 months and thus effect of 
repellent over the whole malaria transmission period could not be determined. Had 
the study been conducted for longer to take into account the whole transmission 
season, then a treatment effect is more likely to have been observed against 
Plasmodium falciparum malaria, or even a larger, more robust estimate of treatment 
effect observed as the sample size would have been larger consequently reducing 
sampling error and improving effect estimates. The major vector found in this region, 
Anopheles darlingi, has a peak biting time from 8 - 10p.m. [71] and is strongly 
exophagic and endophillic [72], and therefore it is recommended that repellents be 
used at this time as people are not under their LLINs. PMD is extremely effective 
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against even high densities of local malaria vectors and is likely to have provided 
users relief from high densities of mosquitoes during the wet season [73]. Overall, the 
study demonstrates that mosquito repellent used in the early evening in conjunction 
with LLINs in regions of early evening vector biting can impact on malaria incidence, 
strengthening the case for employment of IVM in malaria control. The compliance of 
the study participants was reported to be very high, underlined by their preference for 
PMD measured by focus groups [74] and this was confirmed by random sniff checks 
by the field staff. The large treatment effect observed was likely a combination of a 
well designed and implemented trial methodology conducted in an area where vector 
bionomics preclude control by other means and where the repellent was well 
complied with because it was both highly effective against mosquitoes and 
cosmetically acceptable to the local population. 
5.4.3 Sub-Saharan Africa 
 
In a cluster randomized controlled trial conducted in Ethiopia, to determine the effect 
of Buzz Off repellent on malaria, the odds of contracting malaria was reduced by 43% 
(OR=0.57, 95% CI 0.35-0.94, P = 0.028) for the participants using repellents to 
supplement Permanet 2.0 LLINs [75]. In this study, data was collected by 3 cross-
sectional surveys during the 4-month study. It would have been more prudent for the 
study investigators to conduct the study throughout the year so as to take into account 
the whole malaria transmission season and during the wet and dry seasons. This 
would have produced a more realistic estimate of malaria in this region. It would also 
have increased the sample size of the study thereby decreasing the chances of a type II 
error. Also, some cases of malaria may have been omitted as data was collected for 
only part of the transmission season.  The authors of this trial did not also outline the 
active ingredient (AI) and amount present in the repellent. Information on how 
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randomization was conducted was missing. Although there was good similarity of 
socioeconomic variables between the treatment arms, randomization could not have 
been performed correctly because at baseline the 2 treatment groups were not similar 
in terms of malaria prevalence – there was twice as much malaria in the repellent arm 
of the trial, the control arm complied with and had more LLINs, and two of the eight 
clusters had been sprayed with DDT (to which arm of the study these were allocated 
is not stated) and this might have confounded the results of the trial. This resulted in 
the investigators altering the analysis plan of the study. When the authors followed 
the analysis plan outlined in their protocol there was no difference seen between 
treatment arms. As a consequence, the authors changed their analysis, which might 
have altered the treatment effect observed since the data was not designed to be 
analyzed in this way.  
A double blind, placebo-controlled cluster-randomized trial of 15% DEET topical 
repellent carried out in south-west Tanzania, demonstrated a non-significant 
protective effect of 27% reduction in household malaria rates from 91.17 cases/1000 
person years [95% C.I. 198.42 – 380.76] in the control arm to 65.37 cases/1000 
person years [95% C.I. 110.10 – 240.84] in the intervention arm, (p=0.40, z=0.84) 
using intention to treat analysis [76, 77]. These findings were however not significant, 
possibly because the study was underpowered. The major vector in this area is 
Anopheles arabiensis, which bites both indoors and outdoors from 6 am to 6 pm and 
it was estimated that a repellent could reduce around 30% of exposure based on the 
average time to bed of 9 pm. Both semi-field and field evaluations of the efficacy of 
15% DEET repellent, demonstrated > 80% protection against mosquito bites for four 
hours against Anopheles arabiensis mosquitoes. However, effectiveness of an 
intervention is a component of both efficacy and acceptability of that intervention by 
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the community. Therefore, to ensure effectiveness, the study team conducted 3 rounds 
of social marketing of the repellent in the study area to encourage uptake. This had 
positive results as uptake was reported at 95%. However, despite all these checks put 
in place during project implementation, a treatment effect was still not observed. This 
was mainly due to two reasons; first, the study team overestimated the baseline 
malaria incidence by extrapolating incidence from all cause fever data and therefore 
estimated a sample size smaller than was needed to observe a treatment effect. 
Second, a drought that had occurred during the study period, lowered malaria 
transmission such that a treatment effect could not be observed. In future studies, it 
would be useful to conduct baseline malaria incidence studies so as to establish the 
correct incidence estimates for sample size calculation. Compliance was determined 
by self-reporting, which was done at the end of every month when field workers 
visited the households to issue new bottles of repellent/placebo. Therefore compliance 
in-between the monthly visits could not be ascertained. However a few random sniff 
checks were conducted and these spot checks ascertained that the participants did 
indeed use the treatments issued. It would, however, been practical to conduct the 
checks every fortnight and compare them with self-reported compliance so as to 
establish a correlation between the two methods of determining compliance. Passive 
case detection of malaria by Rapid diagnostic tests (RDTs) was employed at the local 
dispensary where participants were offered free diagnosis and treatment. People did 
not believe the results of negative RDTs and some stopped attending the dispensary, 
preferring to self medicate with anti-malarial drugs or attend the other health facility 
in the village that used clinical diagnosis. Also, the health dispensary recruited into 
the trial may have been sufficiently far from the homes of some participants to prompt 
them to access alternative health facilities or go to a nearby drugstore. In future it 
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would be useful to recruit all health facilities and drug stores in the study area to 
avoid loss of malaria cases and to carry out active case detection. All these factors 
might have contributed to reduction of malaria cases, lowering the sample size, 
thereby under powering the study. The randomization of interventions and blinding 
was done as effectively as possible for this case by using treatment and placebo 
lotions in identical bottles identifiable only by a three-digit code. Even then, as time 
went by, participants realized that they were issued with a placebo because they were 
continuously being bitten. As result there might have been some treatment 
contamination where placebo users did not use their intervention and repellent users 
sold their repellents to their neighbors lowering the power of observing a treatment 
effect. It was also suspected that study participants gave their ID cards to relatives and 
friends to benefit from free health care. This would also lead to treatment 
contamination that could be overcome with the use of a fingerprint scanner or 
photographic ID to identify study participants. 
A field clinical trial conducted in Isfahan, Iran, to determine the effectiveness of 
DEET sticks against Leishmaniasis, in 430 students (50% male, 50% female) did not 
demonstrate any treatment effect [78]. The intervention was a DEET stick reported as 
effective for 18-20 hours and it’s minimum effective concentration was 55-77 g/cm2. 
DEET was randomized to 330 individuals and placebo stick was randomised to 100 
controls and the treatment allocation code of sticks was revealed only at the end of 
study. The children were followed up for 10 months. The efficacy of these sticks were 
evaluated in terms of reduction in infection by leishmaniasis using relative risk (RR). 
Confusingly, in the results section, the study reported a different number of treatments 
and controls: out of 200 students that were protected using placebo pen, 2 students 
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acquired leishmaniasis and out of 230 students that were protected using DEET pen, 8 
students acquired leishmaniasis. Thus the study cannot be accurately interpreted. 
5.5 Case control studies 
Apart from RCTs, there have been case control studies that have been conducted to 
evaluate the impact of repellents on disease. Case controls are observational studies of 
persons with disease and a suitable control group of persons without the disease, 
where a potential risk factor is examined by comparing the frequency of occurrence of 
the risk factor between these two groups [79]. There have been a number of case 
control studies that have been conducted to determine the effect of repellents on 
malaria incidence. 
In Afghanistan, a case control study was conducted through social marketing of 
Mosbar, a repellent soap containing 20% DEET and 0.5% permethrin [80]. Cases and 
controls were recruited through passive case detection at the local clinic. The 
combined use of Mosbar and ITNs demonstrated a 69% reduction in the odds of 
contracting malaria (O.R.= 0.31, 0.13 - 0.72, P = 0.007), when compared to control 
(neither Mosbar nor ITN). The local mosquito vectors, Anopheles stephensi and 
Anopheles nigerimmus bite shortly after dusk, and through out the night, a 
characteristic that makes repellents a suitable control tool for early evening protection 
before LLINs can be employed. The repellent selected was highly efficacious and 
gave 100% protection for the whole night, which might have promoted the 
observation of the treatment effect. However as a hospital based case-control, this 
study was prone to selection bias and therefore could not be generalized to the rest of 
the population, as individuals attending the clinics recruited into the trial might have 
had different characteristics from individuals in the general population [80].  
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There are a number of anecdotal case control studies that were not specially designed 
to measure the effect of repellents as the above study, but to identify risk factors 
among those with malaria.  
In a case control study of risk factors among British travellers returning from the 
Gambia, less use of repellents was associated with a greater risk of contracting 
malaria [81]. The use of repellents, applied either on the skin or on clothes, is a key 
strategy of bite avoidance recommended in travel medicine. This finding illustrates 
the importance of the use of repellents when travelling to malaria endemic regions. 
All individuals travelling to malaria prone areas should therefore be advised to 
employ malaria control strategies to protect against malaria. Also, tourist destinations 
should provide information on the vectors that are present in these regions so that the 
tourist can be better advised and prepared on which tools to employ. It also 
emphasizes the importance of having international guidelines for travellers visiting 
malaria endemic regions to avoid importing malaria cases to their mother countries. 
 
In Kilifi Kenya in a large, (>1,500 participants), well-designed case control study, use 
of local repellents, mosquito coils and insecticide sprays was significantly associated 
with protection from developing severe malaria after adjusting for confounders (OR= 
0.57, 95% CI 0.35-0.94, p=0.02). The cases and the controls were chosen from the 
same area in the community. Consequently, these results could also not be 
generalized to the whole population, as the individuals from this area of the 
community might be different from the other members of the community. It would 
have been better to select more than one study area to make the findings more general 
to the population [82]. A study from the Gambia using almost identical design to the 
study in Kenya showed an association with the use of coils in preventing severe 
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malaria in a univariate analysis but this association was not observed after multiple 
logistic regression [83]. 
The overall evidence generated by the above studies demonstrated that use of 
repellents can be effective against malaria transmission if these interventions are used 
correctly and with sufficient frequency. In studies where an association cannot be 
established it is usually because of poor study design. The following series of studies 
are inconclusive due to a number of factors including poor matching; poor attention to 
sample size: and poor measurement of compliance, which is the single most important 
factor in the effectiveness of any repellent. 
In another case study in India, individuals who did not use repellents had non-
statistically significant lower odds of malaria, (O.R.= 0.85, 95% C.I. 0.57 – 1.28, P  = 
0.41) compared to those who used repellents. This finding is not consistent with other 
repellent trials and there are various factors that might have led to this conclusion, 
especially as those exposed to higher levels of mosquito bites are more likely to use 
mosquito prevention tools. In addition, the cases and controls were not matched 
because the controls were recruited from the same clinic, assumed to have come from 
the same socio-economic, demographic and geographical area as cases. Because of 
the study design there was no way to establish compliance to repellent use. Also 
longevity and quality of these repellents could not be established although the 
mosquito coils and mats were reported to be allethrins and topical repellents used 
were diethyl toluamide (DEET) – for which the concentration was not mentioned. The 
bionomics of the local vectors was not discussed to determine whether use of 
repellents would be an appropriate tool [84].  
Similarly in another case – control study in Burkina Faso, use of mosquito coils and 
burning smoke (spatial repellents) was not associated with a lower risk of malaria; 
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(O.R.=1.24, 95% C.I. 0.73 – 2.00, P = 0.47) and (O.R= 0.74, 95% C.I. 0.35 - 1.56, P 
= 0.43) in the treatment and control groups respectively. Like the aforementioned 
study, use of mosquito coils and burning of plant leaves for smoke were self-reported. 
The study participants might have over reported or under reported compliance, 
biasing the findings on the study. The controls were recruited from the same 
residential area. As a result, these findings cannot be generalized to the whole 
population, as the individuals from this area might not have similar characteristic to 
the general population. The controls from this study were not actively tested for 
malaria and were assumed to be malaria negative. This might have biased the study 
toward the null hypothesis if the controls were positive for malaria [85].  
In Ecuador and Peru, a community randomized trial of Mosbar, a mosquito-repellent 
soap containing 20% DEET and 0.5% permethrin did not show any significant 
reduction in malaria incidence between the intervention and control groups [86]. The 
effect of the repellent soap was studied under different settings. It was found to be 
efficacious only when individuals wearing the soap were inactive after application. 
This contrasts with the findings from Pakistan [61] where the repellent was extremely 
effective in preventing mosquito bites and this might be due to the higher relative 
humidity in the Ecuadorian site, that caused more rapid loss of repellent through 
sweating. Compliance to repellent use was not established and lack of treatment effect 
may have been due to poor compliance, as many people did not like the smell of the 
repellent, and in Ecuador, because of humidity, a thick layer of soap remained on the 
skin, which was not pleasing to the users. As compliance requires high degree of 
motivation, it was necessary for the study team to socially market their intervention to 
encourage use and user acceptability. Interestingly, user compliance was drastically 
reduced when the soap was only made available from shops and was no longer 
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available free of charge. This was similar to findings in other studies and underscores 
the importance of developing low cost or highly subsidized interventions that can be 
accessed by those of low-socio-economic status in disease endemic countries and who 
are also most at risk from disease morbidity and mortality. For an intervention to be 
effective it has to be acceptable to the community, affordable or free to the 
community.  
5.6 Cross sectional studies 
Cross-sectional studies are research methods that involve observation of all of a 
population or a representative subset at a specific point in time. They collect data on 
outcomes and/or exposures from each participant at one moment in time. Thus while 
they are simple and quick to perform they are more robust at measuring associations 
with chronic diseases because they measure prevalent rather than incident outcomes. 
Cross sectional studies that collect data on both outcome and exposure are not very 
robust in establishing causal effect of an intervention, as they are prone to bias from 
confounding factors, but they can be used to test hypotheses about interventions and 
to justify a research objective.  
A cross-sectional survey was carried out in the Thai-Myanmar border in Northern 
Thailand to determine risk factors that contribute to malaria infection. Malaria 
prevalence was extremely high in 46% of participants. It was a well designed study 
that had correctly used sample size calculation and demonstrated a clear relationship 
between working or staying overnight in the forest and having malaria in univariate 
and multivariate analysis, while use of topical repellents and long clothing was 
protective against contracting malaria on univariate analysis, but this treatment effect 
was not seen when all confounders were taken into account. This study shows some 
of the practical scenarios where topical repellents can be employed, like individuals 
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working in the forest or in the crop fields who are not able to employ the conventional 
control measures like LLINs [87].  
A cross-sectional survey to determine the effect of Personal Protective Measures 
(PPMs) against malaria in travellers, demonstrated a significant reduction in malaria 
among travellers who used protective clothing, covering their arms and legs. 
However, no significant reduction was associated with use of repellents and coils. As 
explained in this study, compliance to PPMs was very poor with a large proportion of 
the study participants. This would likely explain the lack of treatment effect. Also, it 
is advisable that more stringent measures by the responsible agencies be introduced to 
ensure compliance to PPMs by people travelling to malaria endemic regions to avoid 
exposing non immune individuals to malaria and also reduce importation of cases to 
their mother countries [88]. Compliance to personal protection is surprisingly low 
among those with access to the correct preventative measures. A recent survey among 
2,205 individuals from the French Military during and after their stay in malaria-
endemic areas, demonstrated a malaria incidence of 2.98 cases per 100 subject-years 
[89]. The “correct” compliance rates were 48.6% (95% CI: 46.5 – 50.7%); ranging 
from 2.6% to 88.2%, 50.6% (95% CI: 48.5 – 52.7%); ranging from 1.7% to 97.3% 
and 18.5% (95% CI: 16.8 – 20.1%); ranging from 4.9% to 59.6%; for wearing long 
clothing at night; using LLIN while sleeping and using insect repellents, respectively. 
Factors that often influenced compliance were gender, the rainy season, mosquito bite 
burden, and perceived mosquito attractiveness compared with other people, while 
perception of the severity of malaria was not associated with regular use of any of the 
methods measured. In a further cross sectional survey of 89,617 travellers returning 
from East Africa between 1988 and 1991 [88], only 2% of respondents stated that 
they regularly complied with air-conditioned rooms and/or bed nets, adequate 
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clothing, and use of insecticides and/or coils. Regular use of personal protection 
resulted in a small, but significant reduction of malaria incidence when travellers were 
interviewed 12 weeks after returning home, but each method alone showed no 
significant effect. Unlike the situation among the French military, the holiday makers 
increased their compliance in periods when more mosquito bites were noticed, but 
similar to the French study, gender had no significant influence on compliance, and 
surprisingly, neither did diagnosed or suspected pregnancy. Those using no 
chemoprophylaxis were not more vigilant in preventing mosquito bites. Compliance 
diminished continuously with length of stay in Africa: among those who stayed up to 
2 weeks, the compliance rate was 77.2%, while in those staying 2 months or more, the 
rate was 63.3% (p<0.001). 
5.7 Outbreak reports  
In South Africa, topical application of 15% DEET to feet and ankles reduced overall 
Anopheles arabiensis bites by 69% in field observations. This led to testing of this 
intervention under operational conditions during a malaria outbreak in Mpumalanga, 
15kms South of the Kruger national park. The implementation of the intervention was 
associated with an immediate drop in malaria incidence from 42 cases per week to 10 
cases per week. This effect is however difficult to interpret as it could have been due 
to the repellent but it may also be due to the fact that the epidemic curve had peaked 
and was dropping naturally. The repellent may however have helped in maintaining 
the low incidence of malaria. This study does however give situations where 
repellents can be employed. The most likely reason why the more effective LLINs 
were not used in this particular scenario is that the major vector in this area, 
Anopheles arabiensis had behaviourally adapted to outdoor biting and the secondary 
vector, Anopheles funestus had developed resistance to IRS [90]. Although the results 
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are not clear, this study represents a useful scenario in which repellents might be 
employed against malaria. 
In an outbreak report to describe the outbreak of P.vivax malaria in Far North 
Queensland, Australia, individuals who used topical repellents (DEET) were at 0.01 
(95% C.I. 0.00 – 0.19) the odds of developing malaria when compared to non-
repellent users. The findings of this study reinforce the need to use other personal 
protection measures in areas where conventional malaria control tools are not 
applicable [91].  
During an outbreak in India, a well-designed investigation was conducted where 
malaria cases were slide-confirmed and compared with matched neighborhood 
controls. For both groups, information on personal protection use was collected using 
questionnaires and data was compared using matched odds ratios (MORs) [92]. In 
total, 7,303 cases and 17 deaths were reported between April 2005 and March 2006 
with a peak during October rains (Attack rate: 50 per 1,000, case fatality: 0.2%), and 
half of the cases were detected by active case detection. Use of repellents was 
associated with an odds of 0.1 (95% C.I. 0.06-0.3) of contracting malaria and failure 
to use repellents was associated with 69% of malaria cases in the population. 
Compared with controls, cases were more likely to sleep outdoors (MOR: 3.8, 95% 
CI 2.2 - 6.5) and less likely to use mosquito nets and repellents (MOR: 0.3, 95% CI 
0.1 - 0.5). In this outbreak investigation, the villagers reported the use of repellents 
and coils and therefore correct and consistent compliance could not be established. 
This might have biased the treatment effect seen. Also, being a retrospective case-
control, this study might have been prone to recall bias. Despite these shortcomings, 
this study demonstrated a protective trend of mosquito repellents against malaria. 
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There are a large number of disease outbreak reports among military personnel related 
to non-compliance with the standard personal protection measures (PPMs) [93]. A 
report from the French army monitoring leishmaniasis among troops stationed in 
Guinea demonstrated four separate outbreaks of leishmaniasis in which troops 
admitted that they did not use personal protection correctly [94]. In a malaria outbreak 
in French Guiana, a retrospective cohort study found that malaria was associated with 
low compliance to impregnated battle dress uniforms (BDUs) [95]. This study also 
brings to the fore the problem of compliance to repellent use. As studies mentioned 
earlier have shown, for repellents to be effective, then they must be acceptable to the 
individuals to which they have been issued and they must be used correctly and 
consistently. Similarly, in a malaria outbreak in Sierra Leone among British soldiers, 
a case control study demonstrated that use of insecticide treated clothing offered 
significant protection against malaria with almost 50% fewer cases being reported 
among those individuals who used their impregnated battle dress (OR=0.57, 95% CI 
0.20 – 1.05 p = 0.0450. Interestingly, the use of multiple protective measures gave 
even better protection (OR=0.29 95% CI 0.10 - 0.80 p=0.007). However, use of 
repellents and chemoprophylaxis showed no significant effect [96]. In a malaria 
outbreak in 2003, 44 U.S. Marines were evacuated from Liberia with either confirmed 
or presumed Plasmodium falciparum malaria [97]. An outbreak investigation showed 
that only 19 (45%) used insect repellent, 5 (12%) used permethrin- treated clothing, 
and none used bed netting, demonstrating further the importance of compliance in 
personal protection from vector borne disease.  
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5.8 Permethrin-treated clothing evaluation: Randomized controlled trials 
5.8.1 Southern and South East Asia 
 
In Afghanistan, a randomized controlled trial of 1g/m2 permethrin- impregnated 
chaddars (cloth used as a head covering [and veil and shawl] by Muslim and Hindu 
women) reduced the odds of having P. falciparum and P. vivax malaria by 64%, 
(O.R.= 0.36, 95% C.I. 0.20, P = 0.001) and 38%, (O.R.=0.62. 95% C.I. 0.36 – 1.06, P 
= 0.069), respectively. There was a significant effect in the 0-10 year and 10 – 20 year 
age group. This trial, however, showed no effect on malaria incidence in refugees > 
20 years of age [98]. In this study, no information was given on how the [98] 
randomization was carried out. The trial took place over 5 months and therefore did 
not capture the effect of repellents over the entire malaria transmission season. Since 
the study was carried out at the end of P. vivax transmission season and the start of 
the P. falciparum season, this might explain why there was a larger treatment effect 
seen on P. falciparum transmission compared to P. vivax transmission. It is possible 
that, had the study been carried out for longer, then a larger effect would have been 
observed. As P. vivax malaria is known to recrudesce, the study investigators should 
have cleared all malaria cases through an appropriate treatment regimen after 
checking for glucose-6-phosphate dehydrogenase (G6PD) deficient individuals [62], 
so that any cases that were observed would be classified as new malaria cases and not 
recurrent P. vivax cases. The study employed passive surveillance of malaria cases; 
consequently some cases not reporting to the health clinic might have been missed, 
lowering the sample size and power of the study to observe a treatment effect. This 
might explain why a treatment effect was not seen among females, because they were 
less likely to leave the home due to the practice of purdah. In the evening they might 
also have been using their chaddars as bedding for their children as a protective effect 
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was only seen among those individuals less than 20 years of age. Compliance was 
established by visiting the households every 2 months. As frequent compliance 
inspection was not done, compliance in between the months cannot be ascertained, 
and hence the findings of the study are less robust. As with all intervention studies, 
compliance is essential for the intervention to be considered effective, although the 
chaddar is a piece of clothing used on a daily basis. 
A second single blind RCT by the same group, that investigated the effect of 
insecticide-treated nets (ITNs), insecticide-treated chaddars used to sleep in, and 
residual pyrethroid spraying of individual houses for the prevention of cutaneous 
leishmaniasis (CL) in Kabul, Afghanistan, also demonstrated a significant protective 
effect [99]. The incidence of CL among those randomized to the control was 7.2%, 
amongst ITN users, 2.4% (OR 0.31, 95% CI 0.2-0.5), amongst impregnated chaddar 
users, 2.5% (OR 0.33, 95% CI 0.2-0.6), even better than that among those living in 
lambdacyhalothrin sprayed houses 4.4%(OR 0.60,95% CI 0.3-0.95). ITNs and 
impregnated chaddars were equally effective, providing about 65% protective 
efficacy, with approximately 40% protective efficacy attributable to individual house 
spraying. The study was well powered: it was conducted in 1997/98 amongst a non-
immune population of 3666 people over 15 months. New cases of CL were diagnosed 
based upon clinical inspection of lesions, but parasitological confirmation could not 
be completed after aid organizations were ejected from Kabul in July 1988. Another 
difficulty of working in such a challenging environment was that compliance could 
not be measured, because spot-checking would have invaded privacy customs 
strongly upheld in the region. No significant differences for age or sex were found 
between new cases in the intervention and control groups. No serious side effects 
were reported and interventions were generally popular; ITNs were the most popular, 
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followed by residual spraying and then impregnated chaddars. Both ITNs and 
chaddars are useful in this region, as the population tends to be quite mobile. This 
population mobility caused massive loss to follow up (45%) as people moved out of 
the study area, but the study investigators had anticipated this and accounted for it 
during recruitment of study participants. This demonstrates the importance of 
recruiting the appropriate sample size in any study. 
A double blind, placebo-controlled trial to determine the efficacy of permethrin-
impregnated uniforms among Iranian soldiers, in Isfahan, Iran, demonstrated a 
reduction in the odds of contracting Cutaneous Leishmaniasis (C.L.). However this 
effect was not significant, possibly because the study had only 134 people per 
treatment arm for 3 months exposure in the field (1,608 person weeks per arm). 
Compliance was high, as the soldiers were required to wear the uniforms day and 
night and was monitored. As compliance was ascertained, the results of this study 
may be credible. The method used for randomization was however not described. 
This may have been done incorrectly, biasing the study and hence the observation of 
no treatment effect in the treatment arm. Both the participants and study investigators 
were blinded to the treatments, reducing chances of selection bias [100]. The study 
shows that permethrin impregnated uniforms are safe for human use and no adverse 
effects were observed. Therefore, they present a potential tool that can be explored for 
malaria control. Of importance is to note is the fact that all the lesions (sites of 
infection) among the treated uniform group were on sites unprotected by the uniform 
(face and wrist), while in the control group the lesions were found on the arm[100] 
and trunk. If the soldiers had been using full personal protection including a topical 
repellent on their face and hands [14], they may not have contracted leishmaniasis. 
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In the Thailand-Cambodia border, a randomized placebo-controlled trial evaluating 
the effect of 2g permethrin per uniform on preventing malaria versus kerosene treated 
uniforms among the Royal Thai army demonstrated no effect. The population was 
403 male soldiers on active duty for 6 months. The randomization method was not 
outlined in this study and compliance could not be established at all times. Both these 
factors could have confounded the findings of this study as the selected study 
participants might have confounding characteristics. Also, as compliance could not be 
established, both groups might not have used the repellent, therefore biasing the study 
towards the null. One study arm may also not have complied with the intervention 
similarly driving the effect towards the null [101].  
5.8.2 South America 
 
A double blinded placebo controlled study in Colombia among 86 soldiers 
randomized to 600-712mg/m2 permethrin treated uniforms and 86 soldiers 
randomized to water-treated uniforms over 4.2 weeks showed the uniforms to be 79% 
protective against malaria, 3% versus 14% among treated and control group, 
respectively and 75% protective against cutaneous leishmaniasis 3% versus 12% 
among treated and control group, respectively [102]. 
The same double blind, RCT carried out in Colombia to determine the efficacy of 
permethrin- impregnated uniforms against both malaria and CL demonstrated a 
reduction in relative risk of malaria (RR=0.29, p=0.015) and CL (RR=0.21, p=0.002) 
[102]. As adherence to instructions to wear the permethrin treated clothing day and 
night could not be monitored, the findings of this study might be debatable as with all 
studies where compliance could not be established. However, the monitoring of 
disease was actively done everyday and it’s unlikely that any cases of malaria or CL 
could have been missed. There were very few reports of adverse effect of insecticide 
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treated clothing. This is similar to the other studies where very few adverse effects 
have been reported; reinforcing the proposition that insecticide- impregnated clothing 
is safe for human use. This intervention can be applied to normal clothing thereby 
tackling the problem of adherence so often seen when using topical repellents. 
5.8.3 Sub-Saharan Africa 
 
In a randomized community trial, 198 Somali refugees of all ages and both genders 
with no known allergies or respiratory problems at the Dadaab refugee camp, were 
randomised to either 0.37% permethrin treated clothing and bedding or water placebo 
(retreated every three weeks) for a period of three months. All clothing and bedding 
were treated including, Diras, Saris, Jalbaabs, Ma'awis, shirts sheets and blankets. 
Use of the permethrin treated clothing and bedding significantly reduced the odds of 
contracting malaria by 70% (CI not reported) [103]. Methods for randomizing 
treatments was described as systematic random sampling of households within 
treatment and control blocks 1.5 km apart, and compliance was maintained by regular 
retreatment of all clothing and bedding. The participants and laboratory technicians 
were blinded to the treatments. These aspects of the design are positive. However, the 
study was small and the statistical reporting was not good as it was unclear, over-
reliant on models and p values and OR’s were reported without confidence intervals. 
However, the study reported the proportion positive in the intervention and control 
group and the number of people tested, and therefore this data could be used for a 
meta-analysis.  
In another randomized community trial in Kenya to determine the effect of 
appropriate permethrin impregnated clothing against malaria, it was found that the 
incidence rate ratio (IRR) of contracting malaria in those aged over 5 years in the 
intervention group was (IRR=0.187, 95% C.I. 0.046-0.770, p = 0.02) compared to the 
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control group [104]. For those under 5 years of age, however, no effect was seen. A 
total of 472 individuals were enrolled in the randomized community trial where the 
unit of randomization was the hamlet (manyatta) with 234 and 238 in the intervention 
and control arms, respectively. Baseline data included socio-demographic data, 
parasite prevalence data from thick and thin blood smears, and clinical measures of 
malaria. The intervention involved the dipping of shukas owned by the intervention 
group in permethrin although the dose was not available in the publication. The 
prevalence of malaria in the study population (based on slide confirmation) was 
considerably lower than that used for the power calculation based on clinical 
estimates (2.2% versus 20%). For those aged 6 years or over, the rate of malaria cases 
(events per 10 000 person-days at risk) was 1.41 in the experimental group versus 
7.49 in the control group (IRR=0.187, 95% CI: 0.046– 0.770). For children less than 5 
years of age, results were imprecise with no clear benefit of the intervention. An 
attempt was made to impregnate all shukas in the experimental group. However, some 
children refused to have their shukas dipped in the cold early morning hours, as it was 
their only clothing. Other children, one-third of the 5 years and under in both groups 
owned no shuka. The researchers had been aware of this prior to the study but had felt 
that this should not affect results since preliminary research indicated that children 
without shukas slept under their mother’s shuka at night. Of the four cases that 
occurred in the intervention group, three did not own their own shuka and the fourth 
owned a shuka that was not impregnated. This incomplete coverage, coupled with the 
fact that the study investigators did not establish the local baseline incidence rate led 
to an underestimation of the sample size required to observe a treatment effect. This 
shortcoming underlines the importance of establishing baseline factors before any 
study is implemented. Clinic reports implied that 35% of all patients were seen for 
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malaria, and the clinicians’ predicted prevalence of parasiteamia was even higher 
(50%). Although a more conservative 20% was used to calculate sample size, the 
2.2% parasiteamia observed at baseline clearly reduced the statistical power of the 
study. This highlights the unreliability of malaria reports based on clinical diagnoses, 
which was also one of the reasons for the Tanzanian study of DEET repellent being 
underpowered.  
5.9 Other studies 
In a clinical trial in Myanmar, the use of treated scarves and hand-bands were 
significantly associated with lower incidence of malaria compared to the control arm 
where these interventions were not employed [105]. The major local vector is 
Anopheles minimus, an outdoor and early evening biting vector. This makes treated 
scarves and hand bands an appropriate control tool in this setting, as conventional 
tools cannot be employed at these places and times. The study was carried out for a 
short period of time and did not take into account the low transmission season and it 
was therefore not possible to establish the seasonal effect of this intervention. 
Compliance assessment was carried out in 10% of the study participants. From this 
sample the compliance of the entire study population could be inferred. Also the 
investigators carried out bimonthly checks on compliance and random spot checks. 
The compliance monitoring of this study was well conducted and the results can be 
considered credible. The results from toxicity evaluations of this intervention did not 
demonstrate any adverse effect. This was in agreement with other studies that 
assessed the toxicity of insecticide treated clothing.  
All the earlier mentioned studies are associated with a protective trend of repellents 
against malaria. Most studies had questionable study designs and therefore the results 
of these studies could not be conclusively relied upon. However, the fact that a 
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protective trend was observed in all of them reinforces the need to conduct a well-
designed large-scale trial to ascertain the effect of repellents on disease incidence. 
5.10 Mosquito coils: Randomised controlled trials in South-east Asia 
There have been 2 randomized trials that have evaluated the impact of burning 
mosquito coils every evening on malaria transmission, both conducted in Southeast 
Asia. The first study [67] was a single blind, cluster-randomised, comparative control 
clinical trial conducted in Ruili district, Yunnan Province, Peoples Republic of China, 
close to the Myanmar border between April and October 2007. Yunnan is one of only 
two provinces in China that still has malaria cases and Ruili district has a particularly 
high number of cases. The area is heavily forested, with a high proportion of migrant 
populations moving over the border between countries and has many remotely located 
minority group habitations, making implementation of vector control and public 
health programs extremely difficult. All communities enrolled were in rural areas.  
The trial was designed to measure and compare the protection against malaria 
provided by mosquito coils, LLIN or a combination of the two. The study recruited 
2,052 households comprising 7,341 individuals, excluding individuals under 6 years 
and pregnant women. Households were randomized to one of four groups; Coils 
(0.03% transfluthrin coils, SC Johnson), deltamethrin LLIN (TianJin-Yorkool Ltd, 
Tianjian, PR China, and Lantrade Global Supplies Ltd, Gerrards Cross, UK), coil plus 
LLINs and a control group without intervention than whatever control intervention 
they were already using. At baseline, and every month post intervention, each 
individual was actively screened for malaria (both P. falciparum and P. vivax) by 
RDT. At the end of the 6-month study there were 69 confirmed malaria cases in the 
control group, 16 in coil group, 14 in the LLIN group and 5 in combined coil plus 
LLIN group. In the coils only group the age adjusted odds ratio for P. falciparum 
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malaria was (OR=0.23, 95% CI 0.11-0.50 p = 0.0002) and protective efficacy against 
P. vivax was 80%, (O.R =0.20, 95% CI 0.09 -0.44, p<0.0001) and was not 
significantly different to that for LLINs or LLINs plus coils. The level of compliance 
with the allocated intervention was high: > 94% of individuals used the coils and/or 
LLINs for > 90% of the month prior to the surveys. Conversely, those in the control 
arm were less compliant, with 13-19% using local coils for 3 or more days per month. 
According to protocol analysis including only those with > 90% compliance gave 
almost identical results to the intention-to-treat analysis. 
A second, more recent double blind, placebo controlled cluster randomized trial in 
Sumba, Indonesia, to evaluate 0.0097% metofluthrin mosquito coils only (no LLINs 
were used in either study arm) against malaria [106] comprised  two clusters (1000 
people) allocated to treatment arm and two clusters (1000 people) allocated to control 
arm. Of these, 45 Healthy males > 17 years, >40 kg, G6PD normal residents in the 
study village for the study period in the two clusters per arm (n=90 per arm) were 
followed up as the study cohort for 26 weeks. Compliance was monitored daily and 
active case detection was monitored weekly in addition to malaria vector abundance 
by location, distance and time by indoor and outdoor human landing catch and larval 
collection, parity rates by detinova ovarian dissections, and sporozoite rate by ELISA. 
Malaria incidence among the treatment group was 0.904 versus 2.324, which equates 
to a 61.1% protective efficacy (95%CI =37%-75%, p<0.00001).  
5.11 Conclusions 
These two trials of spatially acting pyrethroids used as mosquito coils were tested in 
isolation – without the addition of LLINs and provided unambiguous evidence that 
individual malaria risk is significantly reduced by > 60% simply through avoiding 
mosquito bites. These trials were conducted under rigorous conditions that should set 
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the bench mark for future trials because they were designed, powered and analyzed 
with the help of a statistician; had adequate randomization; were placebo controlled 
allowing adequate blinding (Sumba study) and used active case detection with RDT 
and PCR confirmation throughout the study. In addition, essential to the success of 
any repellent intervention, very high compliance was observed throughout the study, 
carefully monitored by study staff. Furthermore, both studies were conducted in 
suitable field sites. In both cases, a large proportion of mosquito bites occurred before 
bedtime (Table 4) and mosquito coils were culturally acceptable (a smoky 
environment is tolerated). In addition, repellents may be more effective in Southeast 
Asia because malaria transmission is low and seasonal and the main malaria vectors 
are opportunistic and will feed on other hosts.  
Future trials should attempt to match the high standards of these trials and also 
include some further information on community level measurements of the impact of 
mosquito coils on malaria vector population dynamics. These data were collected in 
some extremely detailed studies on dichlorvos during the 1960s and demonstrated that 
at high enough coverage of repellent interventions there can be a community 
protection demonstrated by decreased man-vector contact, vector infectiousness and 
vector longevity.  
This is the key piece of information that should be collected from any future trials of 
personal protection tools if they are ever to be considered as public health tools 
applied at a community scale to prevent disease transmitted outdoors, in the day or 
evening, rather than just niche tools for particular lifestyles or occupations. 
Furthermore, dichlorvos is an example of a repellent tool that required little 
compliance – just replacement of dispensers every two weeks. It is essential that 
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future research looks into such low compliance interventions that will help address 
the two greatest barriers to repellent implementation: cost and compliance. 
Findings from the review strongly support the theory that use of repellents has a 
beneficial protective effect against transmission of disease, mainly, malaria and 
leishmania, as there is very little data available on dengue. Even though individual 
studies had varying outcomes, the combination of all the available evidence does 
support the notion that specific repellents should be incorporated into current vector 
control strategies where appropriate. We recommend the use of repellents (both 
spatial and topical) for use at times when current control measures cannot be 
implemented. The other key finding from this review was the paucity of high quality 
data that exists. In order to improve the speed at which products are developed and 
approved by bodies such as WHO, there is a clear need for harmonization of 
methodologies and outcomes measured in new trials for evaluation of vector control 
tools, in particular the way they are reported. Researchers need to be encouraged to 
see their piece of research as a contribution to the overall picture in a research field. 
Clear reporting of outcomes and use of guidance available for this task e.g. using 
CONSORT guidelines [107] should make future trials more robust and data easier to 
assimilate by means such as systematic review and meta-analysis for use by policy 
makers. It was also clear from this review that those trials collecting data through 
active case detection were far more powerful than those employing passive case 
detection because the latter was prone to bias. Important secondary endpoints of any 
trial are entomological correlates of reduced infection i.e. man-vector contact, parity 
rate, sporozoite rate through regular human landing catches and human compliance 
with the intervention. An exposure free measurement of human landing is especially 
needed for large-scale epidemiological work especially in areas where Dengue or 
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other arboviruses are prevalent. Measurements of compliance such as salivary antigen 
markers of exposure to mosquito bites [108] are a key research need for rigorous and 
ethical research into disease prevention using vector control tools as it may be used as 
both a measure of exposure and compliance.
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Table 5:1 Summary of evidence demonstrating that repellency can have an effect at a community level by reducing vector survival. Data is for 
Dichlorvos - a spatially active organochloride - that is no longer licensed for this purpose  
Study Region Vector Concentration Duration Mosquito 
density 
Mosquito 
biting 
activity 
Place of 
biting 
Sporozoite rate 
 
Malaria 
prevalence  
(before 
Malaria 
prevalence 
after 
[109, 
110] 
Haiti Anopheles 
albimanus 
25% in Wax, 1 
dispenser per 
4.67 m3 
100% caged 
mosquito 
mortality 
for 8 weeks, 
>90% 
mortality up 
to 15 weeks 
25 bites / hour 70% 
before 
9pm 
75% 
outdoors 
 6.5 (<1 year) 
 
10(>1 year) 
2.2(<1 
year) 
 
2.5 (>1 
year) 
[111, 
112] 
Nigeria An. 
gambiae, 
An. funestus 
20% in Wax 
1 dispenser per 
15 m3 
9-10 weeks 1/49 in treated 
and control, 
respectively 
Late 
night 
peak 
Indoors 3.5% time to first 
infection 19.6 
weeks in control 
and 25.8 in the 
treatment 
 
[113-
116] 
Burkina 
Faso 
(Upper 
Volta) 
An. 
gambiae, 
An. funestus 
25% in Wax 1 
dispenser per 
15 m3 
12 weeks in 
wet season 
and 20 
weeks in 
the dry 
season 
50% lower 
indoor resting 
density in 
treated areas 
but no change 
in biting 
pressure 
Late 
night 
peak 
Indoors Reduced the 
Sporozoite Rate 
and correlates 
well with 
parasitological 
outcomes.  
Consistent 
reduction in 
prevalence of 20 
to 50%. Was 
insufficient to 
control malaria 
in the highest 
transmission 
months 
 
[117] Iran An. 
stephensi, 
20% in Wax 
1 dispenser per 
3-13 weeks 
depending 
Larval density 
halved, indoor 
   Malaria declined 
from 10% slide 
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An. 
fluviatilis, 
An. 
superpictus 
7 m3 in 
ventilated 
spaces and 1 
dispenser per 
21 m3 in un-
ventilated 
spaces 
on the 
ventilation 
density 
declined > 5 
fold. 
Population 
became 
“younger”. 
Fewer bites 
received from 
An. stephensi 
positive to 3% 
slide positive in 
second season 
when application 
occurred before 
the rains but 
there was no 
effect in the first 
season when 
application 
occurred during 
the rains 
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Table 5:2 Overview of insect vectors of disease, their behaviour and means of preventing bites  
Sub Saharan Africa: SSA; North Africa and Middle East: NAf &ME; South Central Asia: SCA; Southeast Asia: SEA; Australia: AU; Pacific 
Islands: PI; North America: NA; Central America: CA; Caribbean: CAR; South America: SA; Europe: EU 
 
Vector  Disease Location Time of biting Indoors/outdoors Transmission 
season 
Recommendation  
1.Anopheles 
mosquitoes 
 
 
 
 
 
 
 
 
Malaria  
 
 
SSA Dusk to dawn 
with late night 
peak 
Indoors & Outdoors All year with peak 
during and 
following the 
rainy season 
Avoid mosquito bites especially 
after sunset by using insect 
repellents containing DEET or 
PMD and long clothing 
impregnated with permethrin. Sleep 
beneath insecticide-impregnated 
bed nets. Sleep in air-
conditioned/screened rooms where 
possible and use mosquito coils 
containing transfluthrin, d-allethrin 
SA Dusk to dawn 
with early evening 
peak 
 
Mainly outdoors During and 
following the 
rainy season 
 
CA Indoors & Outdoors 
 SEA 
SCA 
Lymphatic 
filariasis  
Mainly SSA (75% 
of cases) some  
Dusk to dawn 
with late night 
Indoors & Outdoors 
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SCA, CA, SA,– 
mainly in 
residents and long 
term travellers 
>1month 
peak 
 
or metofluthrin if possible outdoors 
after dark 
2. Aedes 
mosquitoes 
 
 
Dengue fever 
 
SSA Daytime and early 
evening 
  
Indoors and outdoors 
 
All year round, 
but especially 
following the 
rainy season and 
during epidemics 
Prevention of mosquito bites during 
daytime using a repellent with 
DEET or PMD is essential during 
epidemics. Use of mosquito coils or 
heated mats indoors and sleeping in 
screened accommodation is advised 
SCA 
SEA 
CA  
CAR  
SA 
Rift Valley 
Fever 
SSA, ME During epidemics 
related to very 
high rainfall. Chikungunya SSA, NAf & ME, 
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SEA, EU Chikungunya 
Entering EU with 
climate change. 
 
Yellow fever SSA, SA Can occur year 
round, but mainly 
during and 
following the 
rainy season and 
during epidemics 
Ensure vaccination for Yellow 
Fever before travelling to endemic 
areas. 
3. Culex 
mosquitoes 
 
Japanese 
encephalitis 
SEA  Mainly outdoors All year round, 
risk mainly 
among residents 
and travellers to 
rural areas  
Ensure vaccination for JE before 
travelling to endemic areas. Avoid 
mosquito bites especially after 
sunset by using insect repellents 
containing DEET or PMD and long 
clothing impregnated with Lymphatic SSA, SCA, SEA, Dusk to dawn Indoors and outdoors All year round, 
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filariasis SA (Haiti, the 
Dominican 
Republic, Guyana 
and Brazil) 
with early evening 
peak 
risk mainly 
among residents 
and long-term 
travellers 
permethrin. Sleep beneath 
insecticide-impregnated bednets. 
Sleep in screened rooms where 
possible and use mosquito coils 
containing transfluthrin, d-allethrin 
or metofluthrin if possible outdoors 
after dark 
West Nile fever SSA, NAf & ME, 
SCA, NA, EU  
All year round in 
tropics, warmer 
months in 
northern 
hemisphere 
4. Sandflies 
 
 
 
 
Leishmaniasis 
 
SSA, SCA, CA, 
SA  
90% of visceral 
leishmaniasis 
cases occur in 
India, Bangladesh, 
Nepal, Sudan, 
Most species are 
active at dawn and 
dusk and during 
the night, but in 
forests and dark 
rooms they may 
also attack in the 
Most species feed 
outdoors but a few 
feed indoors 
All year round Use long clothing in areas where 
sandflies are common, as their short 
mouthparts cannot bite through 
clothes. Avoid sandfly bites, 
particularly after sunset, by using 
insect repellents containing DEET 
or PMD and by wearing long 
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Ethiopia and 
Brazil 
90% of cutaneous 
leishmaniasis 
cases occur in 
Afghanistan, 
Algeria, Iran, 
Saudi Arabia, 
Syria, Brazil, 
Bolivia, Colombia 
&  Peru . 
daytime. clothing impregnated with 
permethrin. Sleep under insecticide-
impregnated bed nets (small mesh) 
and in screened accommodation if 
possible. 
5. Black flies 
 
River blindness Mainly SSA 
(West Africa) also 
CA, SA, 
mountainous wet 
areas and southern 
Daytime Outdoors All times of the 
year but more 
common in 
residents and long 
term travellers 
Avoid areas where black flies are 
active – near large and fast flowing 
rivers. Wear long, light coloured 
clothing treated with permethrin if 
habitat cannot be avoided 
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Yemen >3months 
6. Deer flies 
 
Loiasis SSA (West and 
Central Africa) in 
rain-forested areas 
Daytime Outdoors All times of the 
year but 
especially the 
rainy season and 
more common in 
residents and long 
term travellers 
Avoid areas where deer flies are 
active – near muddy rivers. Deer 
flies are attracted to wood smoke so 
avoid campfires. Wear long, 
clothing. Treat clothing with 
permethrin if habitat cannot be 
avoided 
7. Biting 
midges 
 
No disease, but 
severe nuisance 
AU, NA, CA, EU 
Most northerly 
temperate regions 
Crepuscular 
during dawn and 
dusk, but for most 
species, biting 
activity peaks in 
the early evening. 
Biting in the 
daytime if 
 Outdoors Spring, summer 
and Autumn when 
adults are present 
Avoid areas where midges are 
active – breeding grounds are acid, 
boggy soils or coastal salt marsh.  
Use repellents of choice. Wear 
midge hoods. Wear long, light 
coloured clothing and treat clothing 
with permethrin if habitat cannot be 
avoided 
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conditions are 
humid, still and 
cloudy. 
8. Tsetse 
flies 
 
 
African 
sleeping 
sickness 
SSA mainly 
Tanzania, 
Uganda, Malawi, 
and Zambia (East 
African form)                  
Democratic 
Republic of 
Congo, Angola, 
Sudan, Central 
African Republic, 
Chad, and 
northern Uganda 
(West African 
Daytime. East 
African tsetse 
prefer wooded 
thickets and west 
African tsetse are 
found in forests 
and vegetation 
along streams  
 
Outdoors All times of year Avoid wearing dark blue or black 
clothing. Keep car windows closed 
when travelling through areas of 
woodland. Wear long permethrin 
treated clothing if outdoors in tsetse 
habitat.  
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form) 
9.Triatomine 
bugs 
 
Chagas disease CA and SA, 
mainly Bolivia 
Night Indoors in rural 
forested areas, 
especially in poor 
housing (mud walls 
and thatched roofs). 
All times of year Sleep under insecticide-
impregnated bed nets. Move the 
bed away from the wall. 
 
10. Fleas 
 
Plague SSA, SCA, NA 
 
Day or night Indoors or outdoors All times of year Avoid areas of high rodent density 
(primary host). Wear a repellent 
containing DEET and tuck trousers 
into socks to avoid bites around the 
ankles. Use an insecticide treated 
bed net if sleeping in endemic areas  
11. Hard 
Ticks 
 
Tick-borne 
encephalitis,  
(TBE) 
SCA, EU, SEA 
(China and Korea) 
 
 Day and night Outdoors Tropics: any time 
Temperate: 
Spring and 
summer although 
Vaccine available in Europe and 
Canada, but not licensed for use in 
the USA  
Avoid areas where ticks are 
 223 
season extending 
due to climate 
change 
abundant in woody and bushy areas 
with high grass and leaf litter. Walk 
in the centre of trails. 
Examine clothes and skin for ticks 
regularly (at least daily) and remove 
them with forceps. 
Wear long clothing and tuck 
clothing into boots. 
Use repellent containing DEET and 
permethrin on clothing  
 
Rickettsial 
diseases 
including 
spotted fevers 
and Q fever  
SSA SCA, SEA, 
NA, EU, 
 
Tularaemia 
Lyme 
borreliosis 
SSA, NA, EU  
Soft ticks 
 
Relapsing 
fever, 
Borreliosis 
SSA, SCA, SEA, 
NA, EU 
 
Chigger 
mites 
Scrub typhus SEA Any time Outdoors All times of the  
year 
As for ticks 
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Table 5:3 Examples of occupational exposure to disease that can be prevented through the use of repellents  
Activity Region Disease Increased risk of disease Vector Reference Prevention strategy Reference 
Illegal Gold 
Mining 
Amazon 
(Brazil) 
Malaria Prevalence of malaria 
among individuals involved 
in gold mining activities 
(67%) odds ratio 1.92 
(1.05-3.50); who came 
from non-endemic areas 
(43%) 1.56 (1.06-2.29); and 
who reported being out- 
side after 5 p.m. (37%) 2.04 
(1.06-3.95).  
Anopheles 
darlingi 
[118] [119] Health education, provision of free 
repellents and or permethrin treated 
clothing plus long lasting insecticide treated 
hammock nets to miners.  
 
Topical repellents in this region prevent 
80% of malaria among users in the Bolivian 
Amazon odds ratio: 0.20, 95% confidence 
interval 0.11 to 0.38) 
 
Permethrin treated uniforms prevented 
malaria odds ratio 0.24 (95% CI 0.07-0.87) 
among soldiers in Colombia – part of the 
Amazon region 
[67] 
[102] 
Open gold 
mining 
Amazon 
(Bolivar state 
Venezuela) 
Malaria Malaria was almost absent 
until the beginning of 
mining activities in the 
1980s. Now between 2001 
and 2010 72.3% (22,746 
cases) are among men of 
working age mainly from 
An. darlingi 
and An. 
marajoara 
[120, 121] 
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mining camps 
Overnight forest 
activities e.g. 
hunting, travel 
Amazon 
(French 
Guiana) 
Malaria 3.3, 95% confidence 
interval [CI] = [1.1–9.5] 
Anopheles 
darlingi 
[122] 
Agricultural 
expansion into 
forested areas 
Amazon ( 
Brazil) 
Malaria Possibly as a result of their 
more frequent involvement 
in forest-related high-risk 
activities such as clearing 
land males had a higher 
malaria incidence (30.7 
[95% CI 27.6–34.0] 
episodes per 100 person-
years at risk) than females 
(21.4 [95% CI 18.7–24.3] 
episodes per 100 person-
years at risk), with a rate 
ratio of 1.39 (95% CI 1.17–
1.64, P < 0.001 by Fisher’s 
exact test) 
Anopheles 
darlingi 
[123] [124] 
Migrant Forest 
workers 
Mekong 
(Thailand) 
Malaria Overnight stays in the 
forest carried a higher risk 
of malaria infection OR 
4.13 (95% CI 1.29-13.13).  
 [125]   
Overnight forest 
activities e.g. 
hunting, travel 
Mekong 
(Lao PDR) 
Malaria Overnight stays in the 
forest carried a higher risk 
of malaria infection OR 
2.12 (95% CI 1.14—3.95) 
An. dirus [126]   
Collecting food 
in the forest 
bamboo, nuts, 
berries, game 
animals and 
Vietnam Malaria Forest work carried a 
higher risk of malaria 
infection OR 2.86 [95% CI 
1.62- 5.07] in men but not 
women OR 0.71 (95% CI 
  Only 2.3% of the population used malaria 
prevention methods as they cannot afford 
them. Even after adjusting for the effect of 
forest work, ethnic group, age, and 
education, women were still significantly 
[127] 
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birds 0.59-0.86)  less at risk of malaria. Compared to men, 
women usually remain well- covered, 
particularly when working outside, thus 
reducing the risk of exposure to mosquito 
bites.  
Rubber tapping Mekong 
(Thailand) 
Malaria In an area where LLINs and 
IRS are applied those 
earning daily income by 
performing labor activities 
mostly in agriculture such 
as rubber tapping and 
rubber sheet processing at 
the smallholdings of rubber 
plantations were at high 
risk of malaria odd ratio  
2.92 (95% CI 1.14-7.44)  
An. dirus, 
An. 
maculatus, 
An. minimus,  
[128]   
Orchards in 
tropical forested 
areas 
Mekong 
(Thailand) 
Malaria up to 30% acquired 
orchards planted on former 
forested areas 
An. dirus, 
An. minimus,  
[129] Use of personal protection such as 
repellents and permethrin treated long 
clothing if working at dawn or dusk 
 
Organised gold 
and copper 
mining 
Sumatra 
(Indonesia) 
Malaria 90% of imported malaria 
between 2009 and 2012 in 
Sukambumi health centres 
(West Java) was among 
miners from Sumatra who 
worked night shifts in 
mines 
 [130, 131] Provision of permethrin treated work wear 
by companies for those on night shift 
recommended. 
 
Use of permethrin treated uniforms did not 
prevent malaria among soldiers in Thailand 
although the design of the study may have 
influenced the results (see section XXX) 
[101]  
Organised open 
pit gold mining 
Iduapriem, 
Obuasi Ghana; 
Siguri, 
Guinea; 
Sadioloa/ 
Malaria 2010 Malaria incidence per 
100 employees Iduapriem 
104.62 
Obuasi 19.4 
Siguri 22.74 
An. gambiae, 
An. funestus, 
An. 
arabiensis 
[132] [133] Permethrin treated work wear for night-
shift workers. Insecticide treated clothing 
prevented malaria by 70% Odds ratio 0.31 
(95% CI not reported) in Kenya with An. 
gambiae, An. funestus, An. arabiensis as the 
[103] 
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Yatela, 
Mali; and 
Geita, 
Tanzania  
Sadiola Yatela 9.04 
Geita 6.68 despite $2 
million annual investment 
in control at the sites in 
LLINs, IRS and health 
education. 
 
primary vectors 
Military Netherlands Lyme 
disease 
 Ixodes 
ricinus 
 Use of protective clothing and boots 
reduced the risk of lyme disease in Dutch 
soldiers based outdoors to that of the 
control group based indoors 
[134] 
 New Guinea Scrub 
typhus 
 Trombicula 
spp 
 Field tests with dibutyl phthalate applied 
every 2 weeks to uniforms of Australian 
soldiers resulted in a 60% and 70% 
decrease in scrub typhus when it was given 
to two brigades 
[135] 
 South Pacific Scrub 
typhus 
   Uniforms were sprayed with dimethyl 
phthalate or an emulsion formulation of 
dimethyl phthalate with an untreated 
control. All of the soldiers then performed 
combat operations for 7–10 days in areas 
with scrub typhus transmission. The 
dimethyl phthalate spray reduced the 
number of cases by 64% (from 45 cases in 
the control group to 16 cases in the sprayed 
group) and the emulsion reduced the 
number of cases by 94% (to 7 cases). 
[136] 
 Haiti Dengue 16 / 241 Italian army troops Stegomyia 
(Aedes) 
aegypti 
 Skin repellents protective OR 0.16 (95% CI 
0.05-0.56), permethrin treated uniform 
protective OR 0.35 (95% CI 0.11 – 1.17) 
[137] 
 30/406 US army troops   Although 93 (93.0%) of all febrile patients 
reported insect bites, only 18 (18.2%) and 
[138] 
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40 (40.4%) always used topical insect 
repellent and a bed net, respectively. Few 
had used permethrin to treat the bed net 
(30.3%) or uniform (13.1%) 
 Columbia Cutaneou
s 
Leishman
iasis 
Leishmani
a 
panamens
is 
 
 The greatest outbreak of 
CL occurred between 2005-
2009, with more than 
35,000 cases in the military 
forces, 80% caused by L. 
braziliensis and 20% 
caused by L. panamensis.  
Lutzomyia. 
trapidoi,  
Lu. gomezi,  
Lu. 
panamensis,  
Lu. yuilli  
[139] The soldiers with treated uniforms exposed 
in an area with infected sand flies for 6.6 
weeks had 83% less leishmaniasis (4 cases 
out of 143 soldiers) compared with soldiers 
with untreated uniforms (18 cases out of 
143 soldiers) 
[102] 
 Egypt Sand fly 
fever 
 Phlebotamus 
papitasi 
 The attack rate (probable immunes were 
disregarded from the data) among users was 
2/77 and among controls was 9/83 = 0.24, 
which is a 76% reduction  
[140] 
 Sierra Leone Malaria 93 cases among deployed 
UK troops within one 
month 
An. gambiae [96] Insecticide treated clothing was protective 
Odds ratio 0.47 (95% CI 0.20 – 1.05). Use 
of no personal protection increased the risk 
of malaria Odds ratio 2.20 (95% CI 0.79-
6.17) 
[96] 
Religious 
gatherings 
Venezuela Malaria Evangelic and Catholic 
Revivalist sects gather 
outdoors every evening for 
hymn singing late into the 
night 
An. albitarsis 
An. oswaldoi 
An. 
nunetztovari, 
An. 
triannulatus 
[141] Ensure adequate prevention from mosquito 
bites sing repellents and long clothing 
 
Missionaries Haiti Dengue After returning from a 1-
week missionary trip to 
Haiti DENV infection was 
confirmed in seven (25%). 
None practiced correct 
Stegomyia 
(Aedes) 
aegypti 
[142]  
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vector bite prevention 
strategies  
Workers in the 
Parks and 
Forestry 
Division 
North America Lyme 
disease 
6.3% sero-prevalence 
among forestry workers and 
the odds of a recalled tick 
bite were five times higher 
among outdoor workers 
Ixodes 
dammini 
 Those who reported that they always used 
repellent had a 2 - fold lower seropositivity 
for lyme disease  
[143] 
 Poland Lyme 
disease 
In In Poland in 2009, 664  / 
10,333 (6.4%) cases were 
certified as resulting from 
an occupational exposure 
among forest workers 
Ixodes 
ricinus 
[144] The use of permethrin treated work wear 
reduces the probability of tick bites by 93% 
[145] 
Hiking North America 
(Appalachian 
Trail)  
Lyme 
disease 
4% of long distance hikers 
contracted vector borne 
disease – principally Lyme 
disease 
 
 
Not 
mentioned 
but most 
likely Ixodes 
dammini 
[146] Subjects wearing treated summer-weight 
outfits (sneakers, socks, shorts, T-shirt) 
were 3.36 times (odds ratio 3.36 with a 
95% confidence interval (CI) [2.499, 
4.526]) less likely to have nymphal I. 
scapularis attach to their body than subjects 
wearing untreated clothing. The odds of 
nymphal attachment, below the waist on the 
leg where ticks were applied to shoes, were 
74 times less (odds ratio 73.60, 95% CI 
[2.4, 551.45]) for the permethrin-treated 
group than the untreated group. 
[147] 
Outdoor 
recreation –  
walking, 
camping, 
hunting 
North America 
(northwest 
California) 
Lyme 
disease, 
human 
granulocy
tic 
ehrlichios
is  
Number of nymphs 
attaching from sitting on 
logs: 1.44 per hour; 
gathering wood: 0.42 per 
hour; 
sitting against trees: 0.52 
per hour; walking: 1.4 per 
hour; stirring and sitting on 
litter: 0.32 per hour;  
sitting on leaf litter: 0.24 
per hour. 
Ixodes 
pacificus  
[148] 
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Table 5:4 Summary of Randomized Controlled Trials with strongest design for evaluation of repellents i.e. those interventions that break man-
vector contact: mosquito coils, topical repellents and permethrin treated clothing 
SPATIALLY ACTIVE VOLATILE PYRETHROIDS 
Trial Intervention EPI effect 
size (odds 
ratio) 
VEC effect size Primary 
Vector 
Vector feeding 
behaviour 
Compliance Other points 
Syafruddin 
2012 [106] 
4 x 0.00975 
metofluthrin coils 
per house per night 
0.39 (0.24-
0.62) 
32.9% reduction in 
mosquito landings by 
HLC  
An. sundaicus 33% of biting 
before 10pm 
[149] 
Nightly  
Hill 2007 [67] 2 x 0.03 
%transfluthrin coils 
per house per night 
0.22 (0.13-
0.39) 
88% reduction in 
indoor mosquito 
densities by CDCLT 
An. sinensis 47% of biting 
before 10pm 
[66] 
>90%  
TOPICAL REPELLENTS 
Trial Intervention EPI effect 
size (odds 
ratio) 
VEC effect size Primary 
Vector 
Vector feeding 
behaviour 
Compliance Other points 
Chen Hussey 
2012 [65] 
15% DEET lotion 
in addition to 
Permanet 2.0 
LLINs 
 
0.94 (0.59-
1.48) 
98.9% protection for 
5 hours in field tests 
Anopheles 
dirus, An. 
minimus and 
An. 
maculatus 
20 – 50% of 
biting before 10 
pm [150] 
About 50%  
Deressa 2010 Buzz off repellent 1.16 (0.75 > 80% effective An. 70% before No measured Repellent arm had 
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[151] plus Permanet 
LLIN 
– 1.80) against An. gambiae 
for 8 hours in 
laboratory tests 
arabiensis 10pm [152] more malaria to begin 
with. Effect size 
calculated by study 
accounting for 
imbalance was 0.57 
(0.35 – 0.94) p=0.028  
Hill 2007a 
[67] 
30% PMD lotion in 
addition to 
25mg/m2 
deltamethrin 
impregnated bed 
net. 
 
0.05 (0.01-
0.20) 
Repellent provided 
97% protection from 
An. darlingi for 4 
hours [73] 
An. darlingi 48% of biting 
before 21.00hrs 
[71] 
>90% (per 
protocol analysis) 
 
McGready 
2001 [63] 
Repellent lotion 
containing 20% 
DEET and thanaka 
(Limonia 
acidissima) 
0.72 (0.50 
– 1.05) 
Repellent provided 
65% reduction in 
exposure to An. 
minimus and 85% 
reduction in exposure 
to An maculatus 
[153] 
An. minimus 
and An. 
maculatus 
An. minimus 
22% and An. 
maculatus 62% 
before bed time 
Compliance 
actively detected 
at 84.6% 
 
 
Onyango 2013  
Not published 
15% DEET lotion 
in addition to 
Olyset LLINs 
0.89 (0.69 
– 1.13) 
Repellent prevented 
>80% bites from An. 
arabiensis over 4 
hours 
An. 
arabiensis 
30% before 
10pm  
>90% (per 
protocol analysis) 
but application not 
adequately 
measured 
 
Rowland 2004 
[61] 
20% DEET and 
0.5% permethrin 
soap 
0.42 (0.25 -
0.69) 
An. stephensi and An. 
culicifacies density– 
repellent prevented 
100% bites over the 
whole night 
100% 
effective 
80% of 
anophelines 
biting before 
midnight 
Self-reported 
compliance >95% 
 
PERMETHRIN TREATED CLOTHING 
Trial Intervention EPI effect VEC effect size Primary Vector feeding Compliance Other points 
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size (odds 
ratio) 
Vector behaviour 
Eamsila 1994 
[101] 
Treated uniform 
with 2g Permethrin 
per uniform once 
every 6 months 
0.96 (0.71 
– 1.29) 
100% effective for 3 
months, 84.45% 
effective up to 6 
months 
An. dirus Not measured 100% compliance 
although it is not 
known if the 
uniforms were 
worn “correctly” 
 
Kimani 2006 
[103] 
Clothing treated 
with 0.37% 
Permethrin – 
retreated every 
three weeks 
0.56 (0.36 -
0.86) 
41% reduction in 
blood fed mosquitoes 
in users’ houses and 
41% increase in fed 
mosquitoes in non-
users’ houses 
An. 
arabiensis 
Not measured not mentioned 
(assume all 
clothes were 
treated) 
Reported odds of 
malaria in treatment 
group is 0.314 
p=0.0002 
Rowland1999 
[61] 
1g/m2 permethrin 
treated chaddars 
0.55(0.38 – 
0.78) 
Reduced feeding 
success of An. 
nigerrimus, An 
stephensi and An. 
subpictus by 0-60% 
An stephensi 80% of 
anophelines 
biting before 
midnight 
Not measured 
 
 
Soto 1995 
[102] 
Treated uniform 
with 600-
712mg/m2 
permethrin 
0.24(0.07-
0.87) 
Not measured 
 
An. darlingi Not measured 
 
Not measured 
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Chapter 6: General discussion 
6.1 Malaria elimination 
Long lasting insecticidal nets (LLINs) and Indoor Residual Spraying (IRS) are 
currently the best methods of malaria control in sub-Saharan Africa [1]. 
Consequently, their impact on malaria transmission [2, 3] has led to their rapid scale 
up in the past decade leading to sustainable gains  in the control of malaria in most of 
sub-Saharan Africa [1, 4, 5]. As such, this achievement has encouraged renewed calls 
for malaria elimination [6]. However, the rapid scale up of these tools has also led to a 
shift from homogenous to heterogeneous malaria transmission characterized by 
transmission hotspots in sub-Sahara Africa [7, 8]. It follows therefore that; further 
scale up of current malaria control tools will not have any additional impact on 
malaria transmission in these residual transmission foci [9, 10].  
Accordingly, new tools and strategies will be needed to achieve this goal [11]. While 
development of parasite resistance is a major concern in South America [12], 
development of outdoor transmission presents a real challenge in sub- Saharan Africa 
[5], and is the focus of this thesis. LLINs and IRS cannot tackle transmission outdoors 
as they are predominantly intra-domiciliary control tools. A potential strategy would 
be the use of repellents when people are outdoors, either on their person (topical 
repellents) or in an area occupied by people outdoors (spatial repellents). Repellents 
can be used outdoors during the day and in the early evenings before users go into 
insecticide-sprayed households or under their LLINs.  
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6.2 Evaluating the efficacy of 15% DEET topical repellents against 
mosquitoes 
Efficacy of the 15% DEET topical repellent used for these experiments was 
established in the semi-field and field setting before it was implemented in the 
community. The topical repellent, 15% DEET, provided 85 % and 82 % protection 
against wild mosquitoes and laboratory reared An. arabiensis in the field and semi-
field setting for over four hours respectively. This finding is similar to several studies 
that have evaluated efficacy of DEET against mosquitoes in the field [13-22].  
This study is the first to evaluate the efficacy of repellents in a SFS and compare the 
findings to field evaluations and demonstrated that repellents provided greater 
protection in the field compared to the SFS even though there was higher biting 
density in the SFS [23]. This demonstrates that repellents that provide adequate 
protection in the SFS are more than likely to give greater protection in the field.  
However, it’s prudent to note that these experiments compared the efficacy of 15% 
DEET topical repellent against a single species of mosquito and findings should not 
be generalized for all mosquito species. It is important to assess repellents in the SFS 
against all available major vector species for the study area (e.g. for Tanzania both 
An. gambiae and An. arabiensis since An. funestus is not easy to colonize) and 
nuisance species such as Cx. quinquefasciatus if possible to ensure that the repellents 
work well to stop all bites and encourage compliance. Another interesting finding 
from this study was the effect of formulated against unformulated repellents. It has 
been often assumed that formulated repellents (polymer formulations and 
microencapsulation) last longer when applied on the skin, because the polymers and 
microencapsulation reduce volatility and skin penetration [24]. However, this study 
demonstrated that unformulated 15% DEET diluted in ethanol provided similar 
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protection against mosquito bites compared to formulated 15% DEET lotion in the 
field similar to other studies evaluating efficacy of repellents [25, 26]. These findings 
suggest that the concentration of active ingredient (A.I.) might be more important in 
determining the efficacy of repellents relative to the repellent formulation.  
It is also necessary to establish the correct effective doses required to provide 
effective protection for different time periods, against different vector species, to 
avoid exposing individuals to higher treatment doses than necessary.    
It would also be prudent that repellent evaluations are carried out throughout the night 
so that its possible to model half-life and effective doses of repellents for different 
time periods [13].  
6.3 Mode of action of DEET 
Despite its long-term and extensive use, the exact modus operandi of DEET is yet to 
be established, with a few existing theories attempting to explain its mode of action. 
The first theory suggests that DEET acts by inhibiting the response to a usually 
attractive chemical signal. It is suggested that, DEET interferes with the 
electrophysiological response of receptors for carbon dioxide, lactic acid and 1-octen-
3-ol, all of which are attractive mosquito odorants [27], so that the mosquito is not 
able to recognize and interpret these stimuli [28, 29]. This hypothesis has however 
been refuted by experiments showing that mosquitoes still avoid DEET in the absence 
of these odorants [30]. DEET does not interfere with the electrophysiological 
response of ORNs to 1-octen-3-ol, but rather reduces the amount of attractant 
reaching the receptor neurons, hence a false-positive inhibition of 1-octen-3-ol 
neurons [30].  
The second theory suggests that mosquitoes have olfactory receptor neurons that are 
specific to DEET, and as a result they detect and avoid DEET. This proposed mode of 
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action is supported by the fact that mosquitoes were observed to avoid DEET in the 
presence of physical stimuli only and the identification of DEET sensitive ORNs in 
the antennae of Culex quinquefasciatus [30]. The proponents of this theory also 
demonstrated that DEET might have a fixative effect when applied on the human 
skin, preventing the release of physiological compounds that are required for host 
location, e.g. lactic acid [30].  
The last mode of action proposed was that DEET acts by activating gustory receptor 
neurons (GRNs) that mediate aversive behaviour of the mosquitoes. It suggests that 
GRNs and not ORNs are used to detect DEET and cause the mosquito to move away 
from the source of DEET. This theory is supported by experiments that show 
mosquitoes in which ORNs that mediate DEET response, OR83b, have been ablated 
still avoid DEET. However this assessment is biased as mosquitoes in which GRNs 
that mediate DEET response, Gr33a should also have been inactivated and these 
mutant insects tested against DEET to determine if these mosquitoes were able to 
detect DEET.  
From the evidence presented above it is likely that DEET does not interfere with 
reception of signals, but instead there is a DEET-specific ORN in the mosquito 
maxillary pulp that mediates aversion to DEET. Its is also likely that DEET is 
detected by mosquitoes in the vapour-phase through olfactory chemo-receptors, 
ORNs, as well as contact chemo reception through GRNs [31].  
In the current study testing the efficacy of DEET [15], it was observed that DEET 
reduced bites from all mosquito species that were present in the field. Although tests 
were not carried out to assess the impact of 15% DEET against each mosquito 
species, results indicated that each mosquito species detected and avoided DEET. 
Further, one volunteer received twice as many mosquito bites as the other volunteers 
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[15]. An individual who is more attractive to mosquitoes is expected to produce more 
lactic acid, Co2 or 1-octen-3-ol than other volunteers. It is therefore logical to expect 
that if DEET interferes with the electrophysiological response to these odorants, then 
the individual would receive an equal number of bites as the rest of the volunteers 
when using DEET, as the effect of these odorants would have been neutralized. 
However this was not the case as this individual was found to receive more mosquito 
bites whether they were wearing the DEET repellent or not. This finding further 
reinforces the fact that DEET does not inhibit the attraction of these odorants.  
From the above theories, it is still not possible to determine the mode of action of 
DEET further research is recommended in this area. 
6.4 Characteristics of a good repellent 
Ideally a good repellent should be broad-spectrum; have an effect on multiple species 
of biting arthropods [32]. As observed from the efficacy study above (Chapter 3), 
15% DEET repellent used in this trial protected against a wide range of mosquito 
species including, Anophelines, Culicines, Mansonia and Coquillettidia species [15]. 
A good repellent should reduce biting by at least 80 % for 6-8 hours [33]. This 
characteristic would make this repellent ideal for integrated vector control  
strategy in this community, as it would offer the community protection from dawn up 
to the time bed nets are employed.  
It should also be non-irritating to the skin or mucous membranes after application and 
should have a pleasant odour or at least be odourless and greaseless, making it 
cosmetically appealing so as to encourage uptake of repellents. A good repellent 
should also be inert to commonly used plastics, i.e. it should not damage these 
surfaces. Lastly a good repellent should be easily available and economically 
accessible even to the poorest individuals in the society so as to improve its use. 
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To date, there is no repellent that meets all of the above criteria [34, 35]. Currently, 
the ‘gold standard’ repellent is N, N-diethyl-m-toluamide (DEET). Although DEET 
has been shown to be effective against a wide range of arthropod vectors [36] and to 
have adequate longevity [25], its often reported to have an unpleasant odour, irritate 
the mucous membrane and damage plastic, a characteristic that often makes this 
product be perceived as unsuitable for topical application. However, DEET has been 
evaluated and recommended by the EPA as safe for human use [14] and is currently 
the longest lasting and most widely used repellent available [37].  
6.5 Evaluating the effect of 15% DEET topical repellent agai nst malaria 
transmission  
The cluster-randomized trial of topical repellent did not demonstrate any significant 
impact on malaria incidence.  
These findings demonstrate that 15% DEET topical repellent may not have any effect 
on malaria transmission in the early evening in rural Tanzania, and are consistent with 
findings of a study carried out in Lao-PDR [38]. Both the current study [39], and the 
Lao-PDR study used 15% DEET repellent, while other topical repellent studies which 
have shown DEET to have an impact on malaria transmission used 20% DEET, [40, 
41]. It can be argued that concentration of 15% DEET repellent was too small to have 
an epidemiological impact on malaria.  However, the Lao-PDR study tested three 
different concentrations of repellents where 15% and 20% DEET gave a similar 
amount of protection, 98% against mosquitoes. Therefore the concentration of 
repellents used is unlikely to have resulted in the observation of no effect between the 
treatment arms in both the current and Lao-PDR studies. However, even though the 
above studies did not demonstrate a significant result, there are a few randomized 
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controlled studies where topical repellents have had varying outcomes on malaria 
transmission [41-44]. 
As all the above studies demonstrated varying effects of topical repellents against 
malaria transmission, the lack of effect observed in some of the above as well as the 
current and Lao-PDR studies were likely a result of flaws in the study design.  
6.6 Situations where repellents can be used to complement current control 
tools 
Albeit effective, LLINs and IRS have had an impact on malaria epidemiology in sub-
Saharan Africa, so that increased use of these tools has led to a shift to early evening 
biting, outdoor biting, zoophagic and outdoor resting vectors [46]. As a result, new 
tools will be needed to tackle transmission at these settings, and topical repellents 
may provide a practical solution in such settings. 
Topical repellents can be used in areas where there is early evening and outdoor 
biting [41, 47-52] of malaria vectors.   
There have been several reports of increased exophagy as a result of increased use of 
LLINs [50, 55-58]. All these reports illustrate the potential of these outdoor vectors 
mediating residual transmission despite extensive use of current tools, case in point 
being Benin [58] [58], where universal coverage of LLINs was achieved and yet there 
was still malaria transmission. Topical repellents can be applied in these situations so 
that individuals are protected in the early evening before they can employ LLINs. 
Different occupations such as plantation work and forest activities have been shown 
to expose the community to outdoor mosquito bites at times when LLINs and IRS 
could not be used [39, 59-65]. Long lasting and sweat resistant repellents can be 
employed at these times to protect these individuals by preventing human-vector 
contact.  
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Extensive use of LLINs and IRS has led to wide spread insecticide resistance [66-68]. 
Development of resistance is likely to have a great impact on the gains that have 
already been made in malaria control, such as was seen in the resurgence of malaria 
Kwa-Zulu Natal project that used deltamethrin on pyrethroid resistant An. funestus. 
[69]. Topical repellents can be used in areas where there is development of resistance, 
while efforts are being made to develop new insecticides. This strategy is likely to 
slow development of resistance, as repellents have low selection pressure because 
they do not kill vectors but only move them away from the hosts [70].  
Caution should however be taken when implementing topical repellent coverage. In 
areas incomplete coverage, diversion has been observed from repellent users to non- 
users [22]. It is therefore advisable that when topical repellents are being used, 
compliance and uptake are encouraged to avoid exposing non-users to more potential 
malaria than normal.  
6.7 Feasibility of topical repellents as a malaria intervention tool  
Mosquito repellents are used predominantly in developed countries [71], where 
malaria transmission has been eliminated, usually in cases of disease outbreaks [37], 
or by tourists travelling to malaria-endemic regions [72]. However, in sub-Saharan 
Africa, where malaria until recently has been endemic, repellents would likely not 
have any impact on transmission, because of their poor longevity and need for 
frequent reapplication, leading to poor uptake and hence effectiveness. As a result, 
other malaria control tools like LLINs and IRS, which have better longevity (up to 5 
years) and compliance (as it requires to be hung only once by the user) and therefore 
better impact on malaria transmission were advocated, socially marketed and 
implemented at the expense of repellents. Therefore, poor use of repellents is due to 
lack of awareness of this mosquito control tool [23]. 
 263 
However, in the current study, after community sensitization, repellents were readily 
used in this community in rural Tanzania, with self-reported compliance at  80% 
through out the study period, similar to other studies that reported better uptake and 
acceptability of interventions as a result of increased community awareness [73-76], 
further supporting the need for community sensitization before implementation of 
interventions.  
Bed nets were the preferred mosquito control tool used in the study area, mainly 
because of its reported cost effectiveness. The community found it cheaper to use a 
bed net that lasted  5 years before requiring replacement, than repellents that would 
require frequent replacement, mostly monthly, and therefore cost more in the long 
run, demonstrating that in a resource limited community, cost influences the choice of 
an intervention [74, 77, 78], and that cheaper cost-effective repellents are preferred to 
more costly interventions.   
Ease of use was another key reason for bed net preference.  Topical repellents require 
the user to remember daily applications. The community found this attribute 
cumbersome and preferred to use LLINs, which needed to be hung only once and 
used for up to 5 years. This finding demonstrates that interventions being advocated 
should be tailored to address user preferences. Apart from user friendliness, an 
intervention needs to be effective. In this study, interventions that were easy to use 
but not effective, like the sisal strip impregnated with transfluthrin, had poor uptake. 
This finding indicates that interventions need to be user friendly as well as effective, 
similar to findings of a mathematical model, which established that the effectiveness 
of any repellent was dependent on its efficacy and compliance [79],(Moore and Briet, 
in preparation).  
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The main reason for non-compliance to repellent use was forgetfulness. It is therefore 
necessary to explore the different formats under which repellents can be presented to 
promote uptake. When explored in this study, it was observed that insecticide treated 
clothing [80, 81] would yield better compliance. Additionally, presentation of 
repellents in formats that do not require the user to remember daily compliance such 
as spatial repellents need to be explored [70].   
However it should be noted that, despite all the above shortcomings, topical repellents 
were the preferred means of protection in the early evening before users retired under 
their LLINs. This finding demonstrates that with improved advocacy, cost, ease of use 
and better formats, repellents can be a feasible malaria control tool in this community 
in rural Tanzania in the early evening.   
6.8 Impact of repellents against malaria transmission 
Several randomised controlled trials have indicated an impact of topical repellents on 
malaria transmission [38, 40, 42, 44, 45, 82], when used in conjunction with LLINs 
compared to singular use of LLINs. Mosquito control is usually aimed at preventing 
the human-vector contact and thereby reducing the vectorial capacity of the mosquito. 
Even though topical repellents do not reduce vector density, by killing the 
mosquitoes, it reduces the biting rate of the mosquito on humans by preventing the 
human vector contact. A reduction in the man-biting rate has a two fold impact of the 
vectorial capacity compared to reduction in vector density [83]. Therefore, by 
lowering the biting rate, topical repellents will have a two-fold decrease on the 
vectorial capacity. Topical repellents will also influence the survival rate of the 
mosquito, as preventing human-vector contact impacts mosquito longevity [84]. 
Therefore while LLINs lower the vectorial capacity of the vectors throughout the 
night, using repellents in the early evening will impact on the vectorial capacity in the 
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early evening (through reduction of man biting rate and survival rates) and therefore 
reduce transmission further than in areas where repellents are not used in the early 
evening. 
Mathematical models have shown that combining DEET and LLINs increased 
protection against mosquito bites [85], further supporting the theory that combining 
these two strategies have greater impact on malaria transmission.  
This finding is further supported by the randomized repellent studies, which have 
demonstrated an epidemiological impact of repellents against malaria transmission 
[40-42, 44, 82].  
6.9 Conclusion and future work 
Repellents that protect against mosquito bites in the SFS are likely to provide greater 
protection in the field and it is recommended that evaluations of topical repellent be 
conducted in the SFS to avoid exposing volunteers to potential malaria infection. 
The cluster-randomized controlled trial of 15% DEET topical repellent against 
malaria in rural Tanzania found no evidence of an effect on malaria transmission in 
the early evening. The lack of treatment effect is likely a result of poor study design 
and implementation and better-designed studies should be conducted to evaluate the 
impact of topical repellents on disease.  
Community sensitization and education are required to encourage uptake of 
interventions introduced in the community. These interventions must however be 
cost-effective and user-friendly, tailored to meet the community needs and 
preferences. An additional and essential caveat is that interventions that require a 
change in human behaviour, like frequent application, have initial poor uptake hence 
effectiveness. Use of tools like insecticide impregnated clothing, which are likely to 
have better uptake need to be explored in this community. 
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Methodologies assessing the impact of similar interventions should be standardized to 
make the findings easy to assimilate and assess in systematic reviews and meta-
analyses so that the overall effect, (protective efficacy – PE), of such interventions 
can be easily established.  
Malaria transmission in sub-Saharan Africa is changing and there is need to develop 
tools that will tackle malaria at places and times beyond the control of current tools. 
Outdoor malaria transmission is quickly developing into a focus of malaria 
transmission and needs to be tackled to sustain control and possibly achieve 
elimination. Based on the findings of this work, 15% DEET repellent has been shown 
to protect against outdoor and early evening biting mosquitoes but not malaria 
transmission. Wide scale use of repellents cannot therefore be recommended based on 
the findings of this work alone without further research. Alternatively, the impact of 
other modes of repellent delivery formats like spatial repellents and insecticide treated 
clothing also need to be explored. 
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Chapter 7: Study Protocol: Evaluation of the efficacy Permethrin 
impregnated clothing (PIC) against malaria transmission outdoors in rural 
Tanzania; A cluster-randomised, placebo-controlled trial design. 
 
7.1 List of abbreviations 
 
ACT Artemisinin Combination Therapy 
AI Active Ingredient  
ATP According to Protocol 
CHW Community Health Worker 
CRF Case Report Form 
DED District Executive Officer 
DHMT District Health Management Team 
DMO District Medical Officer 
ELISA Enzyme-Linked Immunosorbent Assay 
EPA Environmental Protection Agency 
GCP Good Clinical Practice 
HIN Household Identification Number 
HLC Human Landing Catch 
IHI Ifakara Health Institute 
IRB Institutional Review Board 
IRS Indoor Residual Spraying 
ITT Intention to Treat 
LLIN Long lasting insecticidal net 
LTFU Loss to Follow up 
PCR Polymerase Chain Reaction 
PC Project Co-ordinator 
PE Protective Efficacy 
PI Principle Investigator 
PIC Permethrin- impregnated clothing 
PL Project Leader 
RDT Rapid diagnostic Test 
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SAE / AE Serious Adverse Events / Adverse Events 
SFS Semi Field System 
SOP Standard Operating Procedure 
SR Spatial Repellent 
TCU Ten Cell Unit 
TCUL Ten Cell Unit Leader 
UIC Unique Identification Code 
UIN Unique Identification Number 
VEO Village Executive Officer 
VHCW Village Health Care Worker 
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7.2 Background 
 
Extensive injection of financial and political resources in the last two decades into 
malaria control programmes [1], has led to scale up of current control tools, like long 
lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) [1]. Other tools 
being widely used in malaria control include rapid diagnostic tests kits (RDTs), used 
for prompt diagnosis of malaria cases [2]. Rapid diagnosis has led to timely treatment 
of malaria cases and reduction of the number of cases treated presumptively, hence 
lowering the risk of drug resistance development. Treatment of malaria with 
combination therapies (Artemisinin Combination Therapies – ACT), is also being 
expansively employed in sub-Saharan Africa [3, 4]. Use of combination therapies also 
lowers the risk of drug resistance development, which is often seen in areas where 
mono-therapies are used [3, 5]. As a result of large scale use of these control tools, 
there has been substantial decline in malaria morbidity and mortality in sub-Saharan 
Africa and other WHO regions [1] and consequently renewed calls for malaria 
elimination [6].  
Accordingly, extensive employment of these tools is likely to bring about rapid 
change in malaria epidemiology in sub- Saharan Africa [7]. First, wide spread use of 
LLINs and IRS, is likely to have a major impact on the malaria vector by selecting for 
vectors that bite outdoors and in the early evening before they are employed [8, 9].  
Therefore, despite extensive employment and significant impact on malaria 
transmission [10, 11], these tools will not be sufficient for malaria elimination. LLINs 
and IRS predominantly protect against intra-domiciliary malaria vectors that bite at 
night indoors, and rest indoors. Therefore, vectors that bite during the early evening 
or morning as well as during the day, when people are active, and not under bed nets 
and those that rest outdoors, will still maintain malaria transmission, albeit at low 
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levels, even with complete LLIN and IRS coverage [12-14]. Such a scenario may 
result in malaria epidemic outbreaks and resurgence because of diminished 
background immunity of the population as a result of reduced exposure to infection 
that results from successful malaria control [13].  
Secondly, urbanization, rapidly taking place in Africa, has led to electrification of 
rural communities, and as a result the community members stay awake for longer than 
they usually would, resulting in extended exposure to mosquito bites in the early 
evening [15]. 
Development of resistance of malaria parasite to currently used antimalarials has been 
detected in South Asia [16], and threatens to spread to other malaria endemic areas if 
not controlled at the initial stages [1, 17].  
Therefore, even though LLINs and IRS have had a far-reaching impact on malaria 
control, they are unlikely to eliminate malaria [10-12, 18] because the above factors 
are likely to attenuate their effectiveness. As a result, there is need to develop novel 
tools that can protect individuals and communities outside of sleeping hours and that 
can complement current control methods at times and places when their effectiveness 
is diminished.  
Use of topical repellents has demonstrated varying outcomes in complementing 
LLINs against early evening malaria transmission: 
In South America, a double blind, randomized controlled trial assessing the efficacy 
of 30% para-methane-3-diol (PMD) repellent, demonstrated a significant reduction in 
Plasmodium vivax malaria transmission, while there was no effect on Plasmodium 
falciparum malaria. The major reason given for no observation of an intervention 
effect on P. falciparum malaria was lack of statistical power as P. falciparum malaria 
cases were too few to observe a treatment effect. This was because the study took 
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place for only four months when P. falciparum malaria transmission was low. A study 
conducted for longer would have likely demonstrated an effect against P. falciparum 
malaria [19]. 
In another household-randomized, placebo controlled trial in a refugee camp in 
Pakistan, a topical repellent soap containing 20% DEET and 5% permethrin was 
evaluated for efficacy against P. falciparum and P. vivax malaria transmission. The 
DEET and permethrin containing soap demonstrated a 56% reduction in malaria 
transmission in the intervention group compared to the control group. There was 
however no impact on P. vivax malaria transmission as the study took place for only 
six months when P. vivax transmission was too low to demonstrate a statistically 
significant treatment effect. Similar to the above trial, a treatment effect would likely 
have been observed if the study was conducted through both the P. falciparum and P. 
vivax transmission seasons. This study also used passive case detection which might 
have led to loss of malaria cases not presenting at the hospital, consequently biasing 
the treatment effect downwards [20].  
In a case-control study in South Asia, carried out in Afghanistan villages, through 
social marketing of Mosbar, a repellent soap containing 20% DEET and 5% 
permethrin demonstrated a 69% reduction in the odds of contracting malaria in the 
intervention group. However, this study was conducted as a health-facility based 
study, which is likely to have biased the outcome, and therefore the findings could not 
be generalized to the whole population [21].   
In another double blinded randomized controlled trial in Southeast Asia, Thailand, use 
of DEET and thanaka did not demonstrate any impact on the transmission of P. 
falciparum or P. vivax malaria [22]. The lack of effect was likely a result of effective 
malaria management in the study area and an effect may have been observed if the 
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study took place in an area where no other malaria intervention was being 
implemented.   
In sub-Saharan Africa, a cluster randomized controlled trial in Ethiopia using of Buzz 
Off repellent with LLINs demonstrated a 34% reduction in malaria transmission. 
However, the amount of active ingredient used in the repellent is not given. Also the 
baseline malaria prevalence was higher in the intervention compared to the control 
group. The investigators also did not follow the analysis plan when analyzing the 
data. All these factors are likely to have biased the findings of the study and outline 
important details that should be taken into account when designing and implementing 
studies using similar interventions [23].  
In Ghana, efficacy of NO-MAS topical repellent, evaluated in a community trial in 
two villages demonstrated a 19.2% reduction in malaria in the intervention group 
compared to a 6.5% reduction in the control group.  However poor reporting of 
allocation concealment, baseline characteristic and blinding of participants will likely 
have biased the implementation and findings of this study [24].  
A recently conducted meta-analysis of randomized and non-randomized topical 
repellent trials suggested that use of topical repellents is ineffective against preventing 
malaria transmission. However, because of the heterogeneity of the ecological and 
entomological indices in the different study areas where these studies were conducted, 
it is prudent that a standardized methodology of implementing such studies be 
established so that it is easier to synthesize results of different studies and establish 
whether this intervention has any protective efficacy (PE) against malaria 
transmission [25].   
One of the major drawbacks of using topical repellents is ensuring compliance. 
Topical repellents require daily application, and at times, more than one application in 
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a day, which makes its use difficult, as users have to remember to apply the repellent 
frequently [26]. Secondly, topical repellents require frequent replacement as they are 
bound to run out at a faster rate than other control tools [27]. This attribute makes 
them more expensive compared to other control tools like LLINs, which can be 
bought once and used up to 5 years, or IRS, which lasts up to 6 months after one 
round of spraying [28]. These aspects of topical repellent makes its compliance 
challenging [27], which in turn lowers its effectiveness, a product of efficacy and 
uptake [29] (Moore and Briet et al, in preparation). 
 
Passively emanating spatial repellents is another tool that can be used to complement 
LLINs and IRS. Spatial repellents are likely to have better compliance compared to 
topical repellents, as they do not require daily applications. They only need to be put 
up once, like LLINs, and used for the period that the active ingredient (A.I) is 
effective. They are also more cost-effective than topical repellents as they can protect 
more than one individual in a designated area at any given time [30, 31].However SR 
repellents are still not as cost effective as LLINs and its implementation may not be 
sustainable in resource-limited communities, as they will need to be replaced more 
frequently than LLINs, and as a result, making it an expensive endeavor to both the 
users and to donor organizations and local governments in form of subsidies to the 
population. Also, SR products may divert mosquitoes, from users to non-users in 
incomplete coverage scenarios [32], thereby requiring complete coverage, an 
achievement which is unrealistic in intervention implementation programmes [33]. 
There have been two randomized controlled trials to assess the efficacy of spatial 
repellents against malaria.  
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In Yunnan province in China, a single-blind randomized controlled trial assessing the 
efficacy of 0.03% transfluthrin coils against malaria prevalence, demonstrated a 75% 
reduction between the intervention group and the control group where no intervention 
was employed. However, when use of coils was assessed against use of coils and 
LLINs, then there was no significant difference between these two groups, even 
though, the LLIN plus coil group demonstrated greater protection from malaria than 
the coils alone group [34].  
Another randomized, double-blinded, placebo controlled trial to determine the effect 
of metofluthrin coils on malaria incidence was conducted in Sumba, Indonesia. 
Metofluthrin was found to be 52% protective against contracting malaria. However, 
when adjusted to account for clustering, no difference was observed between the 
intervention and control groups [35]. 
Although these trials demonstrated a protective trend of coils against malaria, they did 
not conclusively demonstrate the effect spatial repellents, and both recommend that 
larger, statistically powered trials be conducted to establish the effect of spatial 
repellents on malaria transmission.  
Therefore to conclusively establish the effect of spatial repellents on malaria 
transmission, a multi centre, cluster randomized, double-blinded, placebo controlled 
trial using passive transfluthrin emanators is currently being conducted in Kenya, 
Tanzania, Zambia and Indonesia whose results are expected in 2016.  
 
Another potential strategy is the use of permethrin- impregnated clothing (PIC) to 
complement LLINs and IRS. Permethrin, the main insecticide recommended for 
impregnating clothing, was approved for this use in 1990 by the Environmental 
Protection Agency (EPA), [36], and has been evaluated for safety from 1970-1990. 
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The evaluations done during this period include: dermal and oral toxicity, 
mutagenicity and teratology, skin and eye irritation and determination of efficacy of 
impregnation with different concentrations. Further tests include evaluation of 
metabolites in urine after using permethrin- impregnated clothing and migration of 
permethrin from cloth to skin, fabric-skin contact and finally the effect of washing on 
permethrin retention and efficacy [37]. Permethrin has demonstrated low mammalian 
toxicity, hence recommended as safe for human use [37]. Permethrin is also 
considered safe for children as it’s widely used for treating head lice and scabies in 
children and neonates [38]. It is also a broad-spectrum insecticide that knocks down 
as well as repels arthropods [39, 40]. Compared to other pyrethroids, permethrin is 
very stable when exposed to U.V. light, making it a suitable insecticide for 
impregnation of clothing, as users will be exposed to sunlight when using this 
intervention. It is also non-staining on clothing and has a residual effect ranging form 
6 weeks to one year depending on the impregnation method used [41]. It is usually 
used with a binding agent during impregnation that enables the insecticide to bind to 
the clothing even after several washes.  
 
Several studies have been conducted to evaluate the efficacy of PIC against arthropod 
bites as well as disease transmission with varying outcomes:  
In Harford County, US, the efficacy of permethrin- impregnated, permethrin-sprayed 
and DEET-treated battle dress uniforms (BDU) was evaluated against biting ticks in 
the field and compared to an untreated control. The permethrin-impregnated, sprayed 
and DEET treated BDU reduced biting ticks by 97%, 98% and 60% respectively [42]. 
Field trials in Oklahoma District, US, evaluating the effectiveness of 0.5% permethrin 
single spray applications on cotton clothing for 15, 30 and 60 seconds provided 100% 
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protection for 1 hour each day, when tested for three consecutive days against tick 
bites [43].  
In a laboratory experiment in the US, evaluating the efficacy of five chemical 
repellents and a permethrin-impregnated fabric, permethrin was found to provide 
complete protection against Aedes albopictus and Aedes aegypti after 5 washings, 
while the other chemical repellents provided protection that lasted for only up to 10 
hours [44]. 
Field evaluations of permethrin-treated clothing and extended duration DEET against 
local mosquito vectors in Islamabad, Pakistan, demonstrated a 57% protection against 
mosquito bites for permethrin-treated clothing and 89% protection for the extended 
formulation DEET.  However, the combination of permethrin-treated clothing and 
DEET provided 100% protection against mosquito bites [45].  
In Zambia, permethrin- impregnated clothing and three DEET topical repellents 
evaluated against a natural population of tsetse flies demonstrated 34% and 76-87% 
protection respectively against tsetse fly bites. In addition, combining permethrin-
impregnated clothing and DEET repellent provided 91% protection against tsetse fly 
bites [46]. 
In Australia, use of DEET with permethrin-treated clothing provided greater 
protection against mosquito bites compared to use of either DEET or permethrin-
treated clothing alone. However permethrin treated clothing and DEET both 
significantly reduced the number of mosquito bites compared to the control [47].  
 
While field and laboratory evaluations demonstrate that permethrin-treated clothing is 
effective against mosquito and other arthropod bites, epidemiological studies have 
been more variable. 
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In a randomized controlled control in an Afghan refugee camp, in Pakistan, 
permethrin- impregnated chaddars reduced the odds of P. falciparum and P. vivax 
malaria by 64% and 38% respectively for individuals below 20 years, but had no 
effect on individuals above 20 years of age. The study was conducted for 5 months at 
the beginning of the P. falciparum transmission season, hence the observed low 
efficacy of the intervention against P. vivax malaria. This study also used passive case 
detection of malaria cases and it is likely that cases that did not present at the health 
facility were missed, thereby underestimating the intervention effect. Compliance was 
also established by self- reporting. A study conducted for longer, with better malaria 
data capture methods and establishment of compliance would have likely 
demonstrated a greater intervention effect [48].  
In another randomized controlled trial, in Afghanistan, insecticide treated chaddars 
reduced the efficacy of cutaneous leishmaniasis by 65%, and had similar efficacy to 
that of insecticide treated bed net use. This study was well powered as it had 
sufficient number of participants to demonstrate a treatment effect and was conducted 
for 15 months, which captured the heterogeneity of malaria transmission in different 
seasons. However, compliance to permethrin- impregnated chaddars could not be 
established and therefore the treatment effect observed could not be conclusively 
linked to the use of this intervention [49]. 
 A double blinded, placebo controlled trial, evaluating the effect of permethrin-
impregnated uniforms worn by the Royal Thai army, in the Thai-Cambodia border did 
not demonstrate any effect of permethrin- impregnated uniforms on malaria incidence 
Compliance to this intervention could not be fully established and it is likely that the 
lack of treatment effect was as a result of non-compliant participants biasing the 
intervention effect towards the null hypothesis. Randomization of the study 
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participants might also have been biased leading to the observation of no effect of 
permethrin-treated uniforms [50]. 
In Colombia, a double blinded, placebo controlled trial among Colombian soldiers 
using permethrin- impregnated uniforms demonstrated a 75% and 79% protection 
against cutaneous leishmaniasis and malaria transmission respectively. Active case 
detection was employed in this study and it is unlikely that any cases were missed. 
However, compliance could not be fully established, and therefore the treatment 
effect observed might have been confounded. Also, the sample size used and malaria 
and CL cases reported between the two groups were too small to yield credible 
findings [51].  
In a community trial conducted among Somali refugees, in Dadaab refugee camp, 
Kenya, use of permethrin treated clothing reduced the odds of contracting malaria by 
70%. Similar to the above study the sample size used in this study was small and 
reporting of treatment effect was unclear [52]. 
In another Kenyan community trial, use of permethrin- impregnated clothing was 
associated with 90% protection against malaria transmission in participants above 6 
years. There was however no intervention benefit for children less than 5 years. The 
sample size was calculated from health facility reports, which led to underestimation 
of sample size needed to observe a treatment effect. Further, there was incomplete 
intervention coverage for children under five years of age. These two factors, a small 
sample size and incomplete coverage might have biased the study and masked the 
effect of the intervention in children under five [53].  
 
As malaria control moves from sustained control to elimination, there is need to 
develop tools that attack transmission at times when the effectiveness of current 
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control tools are diminished. Topical and spatial repellents present potential options 
for this strategy. However, both these tools present challenges in their 
implementation. Topical repellents require daily and optimum applications by the 
user, hence resulting in difficulty in uptake and use. As effectiveness of interventions 
is largely dependent on uptake, poor uptake of topical repellent will likely diminish its 
effectiveness [29], making it unsuitable for large-scale implementation. 
While spatial repellents may overcome the challenges of daily application required for 
topical repellent implementation, and therefore resulting in better uptake, it requires 
complete coverage so that vectors are not diverted from users to non-users [32]. This 
presents a challenge, as complete intervention coverage is not feasible under real life 
conditions [33]. As a result, use of spatial repellents may expose non-users to more 
malaria than normal. 
On the other hand, all communities in the world already use some form of clothing. 
Therefore deployment of insecticide through the use of clothing that are already in use 
in the community is likely to have better uptake and higher coverage compared to 
topical and spatial repellents. As clothing is used throughout the day, it is expected 
that permethrin impregnated clothing will provide protection throughout the day and 
LLINs can be used to provide protection overnight. This way there will be an all-
round protection of PIC users from arthropod bites. In doing so, PIC cannot only be 
used to protect not only against malaria, but also against other arthropod-borne 
diseases like Dengue, which is emerging to be a disease of public health importance 
in Tanzania [54, 55]. As a result of arthropods having no access to human hosts, it is 
expected that transmission of arthropod-borne diseases, in this case malaria, will 
significantly decline. Another advantage of PIC is that it does not interfere with the 
daily activities of the users, which is also likely to encourage uptake.  
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A study conducted recently in rural Tanzania, assessing the feasibility of various 
intervention formats established that the community would readily use permethrin-
treated clothing [27]. 
Therefore, taking into account the potential benefits of PIC over topical and spatial 
repellents, and the shortcomings in the design and/or implementation of permethrin-
impregnated clothing studies outlined above, this study was designed to evaluate the 
benefits of using permethrin impregnated clothing (PIC) and LLINs in preventing 
transmission of Plasmodium falciparum malaria in a community in rural Tanzania. 
7.3 Rationale 
Current control tools, LLINs and IRS, will not be able to eliminate malaria mainly 
because they do not protect against populations of malaria vectors that bite before 
they are deployed. There is therefore need to develop novel tools to complement these 
current control strategies against mosquito populations biting at times and places 
when their effectiveness has been diminished if the goal of elimination is to be 
achieved. Permethrin- impregnated clothing require minimum compliance as clothes 
are already used worldwide and they can be used throughout the day compared to 
other complimentary tools like topical and spatial repellents, which are deployed 
mainly in the early evening or when individual are at designated locations where these 
tools are present. This integrated use of PIC and LLINs therefore presents a potential 
strategy for protecting against residual malaria transmission mediated by mosquito 
populations against which the effect of LLINs and IRS are attenuated. We propose to 
carry out a cluster-randomized, double blinded, placebo controlled intervention trial 
to evaluate whether there is any benefit of using PIC and LLINs combined compared 
to use of LLINs and a placebo against malaria transmission.  
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7.4 Objectives 
7.4.1 Clinical objectives 
 
7.4.1.2 Primary objectives 
 To assess and quantify the protective efficacy (PE) of permethrin 
impregnated clothing (PIC) in reducing the incidence of 
Plasmodium falciparum malaria infection in a rural community in 
Tanzania as measured by active case detection using PCR diagnosis  
 
7.4.1.3 Secondary objectives 
 To assess and quantify the protective efficacy (PE) of permethrin 
impregnated clothing (PIC) in reducing the incidence of malaria 
infection in a rural community in Tanzania, as measured by rapid 
diagnostic tests (RDT). 
7.4.2 Entomological objectives 
 
 To quantify a reduction in vector biting densities, sporozoite and 
parity rates of malaria vectors in the intervention group relative to 
the control group. 
 
 
 
 
7.5 Study endpoints 
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7.5.1 Epidemiological endpoints  
 
Primary: The incidence density of malaria infections among study participants over 
the follow-up period as detected by PCR, to inform the reduction of malaria incidence 
between intervention and control group based on an expected minimum effect size of 
30% using the formula:  
 
PE =[(Ip - Ia)/Ip]* 100%; where; 
Ip is the incidence density in the placebo (control) group 
Ia is the incidence density in the intervention (active) group.  
 
Secondary:  
Determine the PE of PIC against malaria infections as detected using RDT by 
comparing the incidence densities of malaria between the intervention and control 
group. 
Determine the PE of PIC against malaria related anaemia as measured by HemoCue, 
by comparing the incidence densities of anaemia between the intervention and control 
group. 
 
7.5.2 Entomological endpoints  
 
Primary: Proportion of adult malaria vector biting densities assessed via human-
landing catch (HLC) from households in the intervention and control group over the 
follow-up period.  
   
Secondary: Proportion of sporozoite-infected mosquitoes and parous vectors in the 
intervention and control group over the study period  
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   Assess the malaria vectors susceptibility levels to permethrin using standard 
WHO methods before, during and after the study.  
 
In addition, data collected from this study will be used to parameterize models which 
will allow simulation of effects of PIC against malaria transmission under specific 
vector bionomic ecologies (indoor, outdoor and/or day-biting and insecticide 
resistance status) and disease transmission dynamics (e.g. baseline transmission 
intensity) utilizing specific data to better inform where PIC are expected to provide 
protection beyond the study site [56].   
7.6 Methods 
7.6.1 Type of study and design 
 
A prospective, cluster-randomized, double blind, placebo controlled trial study design 
will be used to measure the impact of PIC and LLINs on clinical malaria, in all study 
participants in the study area relative to use of LLINs and a placebo impregnated 
clothing. The intervention will be applied at the community- level and the unit of 
randomization will be clusters. The study will be conducted for three years, where the 
first year will be used to establish the baseline malaria incidence and prevalence, 
entomological and socio-demographic indices in the study area. The two subsequent 
years will be used to capture variation in malaria transmission intensity between the 
treatment groups and cumulative effects of PIC on vector populations between the 
intervention and control group. A cluster-randomized design was used to prevent, 
intra and inter-household diversion of mosquitoes from compliant to non-compliant 
study participants [32, 57]. Also, the study aimed at measuring the community level 
effect of the intervention. The clusters will be selected from villages in Kilombero 
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district, in Southern Tanzania (Figure 1). All households in all the clusters will be 
recruited into the study and will be offered an LLIN per sleeping space at no cost to 
the recipient to enable all residents to benefit from this intervention and to minimize 
imbalance in use of malaria control interventions between intervention and control 
group of the study. This will also protect the community from higher than normal 
mosquito exposure as a result of potential diversion of mosquitoes from the 
intervention clusters as permethrin is known to have some repellency [32]. The 
clusters will then be randomized into two equal groups; all households in the clusters 
in one group will be assigned the PIC (intervention clusters) and those in the other 
group will be assigned the placebo-impregnated clothing (control clusters).  
Both the permethrin and placebo will be packaged in identical bottles, which will 
have unique identification codes (UIC), identifying the contents of the bottles as 
having permethrin or placebo, which will be used for blinding the treatments and will 
only be known to the industry partner supplying the treatments.  
To assess whether PIC and LLINs combined provide greater protection against 
clinical malaria in the community compared to LLINs and a placebo, 3000 study 
participants, as estimated from sample size calculations, will be recruited and enrolled 
into the study, after informed consent is requested and obtained from the household 
heads and household members above 13 years of age. The study participants will be 
followed for two years and will be screened for malaria by active and passive case 
detection every month. If malaria is detected by RDT, the subjects will be treated as 
per Tanzanian guidelines for each malaria infection [58]. Blood will also be collected 
using blood spots on filter paper for malaria PCR diagnosis [59], which will be 
carried out at the IHI laboratories. All members in the study-enrolled households will 
be instructed to seek treatment at dedicated study health facilities for any febrile 
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illness in between scheduled visits to test for malaria. Treatment at the dedicated 
study health facility will follow the national policy guidelines for malaria treatment 
[58]. 
Entomological end points will be monitored in the first year before intervention 
implementation to establish baseline entomological indices and in the two subsequent 
years after intervention implementation, in both the intervention and control clusters 
to assess the effect of the intervention (PIC) on vector density, parity, sporozoite and 
man biting rates. Adult sampling will be assessed using medically supervised HLCs.  
An independent entomological investigator will conduct entomological evaluations of 
the PIC so as to minimize the risk of premature unblinding of the epidemiological 
study team. The entomological investigator will conceal the assignment of product 
codes; GPS coordinates and cluster numbers before sending data to the study team 
(internal and external statisticians as well as study P.I) for analysis.  
7.6.2 Study area 
 
 
Figure 7:1 Map showing the planned study area [source: INDEPTH Monograph 
[60]] 
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This study will be conducted in, Ulanga district, Southeast Tanzania, located at 
8.195°S and 36.259°E. The district experiences an annual rainfall range of 1200mm-
1800mm and an average temperature range between 20 C. and 32.6 °C. 
Entomological surveys conducted in 2011 identified An. arabiensis as the major 
malaria vectors in the study area [26]. Malaria transmission occurs all year round, 
with the month of November through April experiencing the highest transmission due 
to the long rainy season. In 2011, a cluster randomized clinical trial reported malaria 
cluster incidence rates of 0.06 in the control arm of the study [61]. The study area has 
experienced extensive malaria intervention education and implementation and 
therefore has the infrastructure related to malaria research already set up, such as 
health facilities and trained community health workers [26, 61-65]. Bed net coverage 
in the study in the study area is estimated to be 60-80 % [66]. 
7.6.3 Sample size and power calculation 
 
Sample size estimates have been based on malaria incidence rates of 0.06 
cases/person/year determined from a cluster randomized clinical trial, conducted in 
the study area in 2011 [61], Assuming that the PIC will have a PE of 30% against 
malaria incidence, it is estimated that to observe this effect at the two-tailed 5% 
significance level, with 80% certainty, and an inter cluster correlation of 0.25, 10 
clusters of 30 households each per treatment group will need to be followed up for 
two years. A further 20% of the households will be recruited to account for loss to 
follow up (LTFU). Therefore a total of 600 households with  5 members each or a 
total of 3000 individuals will be recruited into this study. However, as estimates of 
malaria incidence used for sample size estimation were based on data collected in 
2011, a baseline malaria incidence survey will be conducted throughout the first year 
of the study, where all malaria cases from all health facilities recruited into the study 
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will be collected through passive case detection to determine a more valid malaria 
incidence rate in the study area. The study sample size will then be adjusted 
appropriately at the end of the first year of baseline data collection. (Appendix 1: 
Sample size calculation) 
7.6.4 Randomisation  
 
The unit of randomization will be the cluster made up of 30 households each. All 20 
clusters will be assigned numbers. A random number generator will then be used to 
randomly assign treatments to the clusters, where the first number generated will be 
assigned to receive PIC and the second number generated will be assigned the 
placebo-impregnated clothing. This progression will be repeated until all 20 clusters 
are randomized to receive the PIC or a placebo-impregnated clothing in addition to an 
LLIN provided per sleeping space to all enrolled households. The PI will be 
responsible for randomization of clusters to the treatments. An attempt will also be 
made to stratify each cluster by the presence of a study recruited health facility. 
Stratification by health facilities will minimize the bias brought about by access to 
health services, which might confound the results of the outcome.  
7.6.5 Blinding  
 
Industry partners will manufacture and package the permethrin and placebo in 
identical bottles distinguishable only by a 3-digit unique identification code (UIC), 
identifying the contents as having permethrin or placebo. As permethrin is odourless, 
the manufacturer will ensure that the placebo is also odourless and similar in 
consistency as the permethrin. The manufacturer will also ensure the delivery of these 
bottles to the IHI. The code identifying the contents of each bottle will be kept strictly 
confidential by the manufacturers to ensure that neither the study investigators nor 
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participants are aware of the product assignment. Only the study monitor and 
manufacturer will have access to the code sheet that identifies the permethrin or 
placebo for routine study monitoring. However an extra list of the UIC will be stored 
in a secure location at the study site with limited access to the site PI who will be 
instructed to use it only in case of emergencies, (such as severe adverse events).   
7.6.6. Controlling for confounders  
 
Treatments will be assigned at the cluster level.  All households within each cluster in 
the intervention group will be randomly assigned the PIC while all houses within each 
cluster in the control group will be assigned the placebo impregnated clothing. This 
will minimize the chances of diverting mosquitoes within and between households if 
treatments are assigned at individual or household level [32]. 
Analyses will follow a pre-defined analysis plan developed at the inception of this 
study. The investigators and statistician will be blinded throughout the analysis of the 
study. 
Baseline socio-demographic data collected in the first year will be analyzed, and if a 
difference in factors that are likely to confound the treatment effect is found between 
the two treatment groups, then that analysis of the outcomes will be stratified by these 
variables.  
Baseline malaria incidence data will be collected from all health facilities in the study 
area recruited into the study, using passive case detection to assess whether there are 
any imbalances in malaria rates between the intervention and placebo group and 
analysis of the final findings of the study adjusted accordingly.  
Investigator bias will be reduced by use UICs on the permethrin and placebo bottles 
supplied by the manufacturer.  
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In addition, entomological and efficacy data of the PIC will conducted by an 
independent entomological investigator, to minimize the chances of unblinding the 
investigators collecting the epidemiological data. This data will then be re-coded by 
an independent statistician before analysis where all investigators will be involved. 
Volunteers sampling adult mosquitoes will be rotated between households to 
minimize mosquito collector bias. Treatment allocation process will be randomly 
done and closely monitored by the P.I to minimize treatment allocation bias.   
7.6.7 Entomological data collections  
 
A sub-study will be conducted to assess the impact of PIC on the entomological 
endpoints of the study. The PIC will be evaluated against target vectors species in the 
study area to determine the duration of efficacy of the PIC under semi-field and field 
conditions.  
7.6.7.1 Treatments 
Permethrin-impregnated clothing (PIC) 
Permethrin- impregnated clothing will be developed by impregnating clothes 
belonging to study participants with permethrin purchased from local 
industries. The permethrin target application rate will range from 0.25g/m2 to 
0.5gm/m2, depending on the least application rate that is found to be the most 
effective from the semi-field and field efficacy experiments, so as to minimize 
the exposure of participants to permethrin. This range meets the WHO 
specifications for impregnating clothes with permethrin. 
(http://apps.who.int/disasters/repo/13389.pdf?ua=1) 
 
 
Long lasting insecticidal nets  
The long-lasting insecticidal nets (LLINs), (insecticide incorporated into 
filaments) distributed during this project will be Olyset Nets, from Sumitomo 
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Chemicals that meets WHO specifications with permethrin incorporated into 
the polythene fibers at 2% w/w giving adequate release of permethrin for up to 
five years. Participants will be offered the “family” rectangular (160cm wide x 
180cm l x 150 cm h) model. 
(http://www.who.int/whopes/Long_lasting_insecticidal_nets_Aug09.pdf)  
Packaging and labelling  
 The permethrin will be provided in suitable plastic bottles that will be 
logistically manageable, especially for transport to the field sites for 
impregnation on a monthly basis. The containers will be labelled with the 
manufacturer’s instructions in Swahili and the unique identification code 
(UIC) identifying the contents of the bottles as permethrin or placebo. 
 Olyset nets will be supplied in individual sachets labelled by the 
manufacturers and they will be distributed to participants in pre-opened 
individual sachets. 
Product storage and stability  
 The permethrin and placebo bottles will be stored at IHI until the day of 
impregnation, when they will be transported to the designated clusters for 
impregnation of participant clothing. They will be kept in tightly closed 
original shipping containers, that will provide a dry, cool and well-ventilated 
place accessible by authorized personnel only (study team) and away from 
food, drink and animal foodstuff. 
 Olyset LLINs will be stored at ambient temperature in locked rooms at the 
IHI. 
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7.6.8 Intervention application 
 
7.6.8.1 Impregnation shed 
After the baseline survey, recruitment of households into the study and formation of 
clusters, impregnation sheds will be put up in each cluster. Large, flat concrete 
troughs will be constructed in designated areas in each cluster, with drainage into a pit 
latrine with a soak pit. This way the wastewater from cloth impregnation containing 
permethrin will be drain into the pit latrine and eventually seep into the ground 
through the soak pit. Permethrin binds to soil and sediment and does not leach into 
soil and is therefore unlikely to contaminate ground water [67]. Permethrin is also 
known to be degraded by micro-organisms, hence the disposal into the pit latrine [68]. 
This method of disposal will be used as its similar to burying, the recommended 
method of disposing permethrin waste water [69] and was chosen because apart from 
providing safe disposal method of permethrin, it will also benefit the community 
members in the study area with pit latrines. The WHO also recommends that 
wastewater from permethrin net impregnation be disposed into pit latrines. 
http://www.who.int/water_sanitation_health/resources/vector088to118.pdf  
Caustic soda will be poured into the pit latrine to help in hydrolyzing the permethrin 
to safe levels. 
http://www.inchem.org/documents/hsg/hsg/hsg033.htm#SubSectionNumber:
4.5.1 
7.6.8.2 Impregnation of study participant clothing 
Apart from the UIC, the permethrin and placebo bottles will be labelled with their 
respective cluster number at the IHI as per randomization. The study participants from 
households in each cluster will be asked to bring all of their clothing to the 
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impregnation shed located within that cluster for impregnation. The clothing will then 
be impregnated with the appropriate amount of permethrin that will enable the 
permethrin to remain effective for one month assuming two washings per week, as 
determined from semi-field and field experiments following an outlined SOP. The 
study participants will also be advised to wash their clothing at the impregnation 
sheds to minimize contamination of the environment. Free detergent will be offered 
free of charge to all households washing their clothes at the impregnation shed to 
encourage compliance. The study participants will also be educated on the dangers of 
poor disposal of permethrin. A field worker will also be stationed daily at the 
impregnation shed within each cluster to record the number of households washing 
their clothes at the impregnation shed. Those households not observed/recorded at the 
impregnation shed for utmost two weeks will be visited and to determine why they 
did not use the impregnation shed for washing. Further, the ten-cell unit leader 
(TCUL) of each ten-cell unit (TCU) will be recruited to report any cases of washing 
away from the impregnation shed. 
Requirements 
The study team impregnating the clothing will be required to have:  
 Plastic gloves 
 Measuring vessel/cylinder 
 Dipping/mixing bowl 
 Soap 
 Water  
 Emulsifiable concentrate of treatment (either permethrin or placebo) 
 Plastic sheet with a large surface area 
 Large plastic disposal containers 
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Procedure 
 The area of clothing to be impregnated will be calculated 
 The volume of water absorbed per meter square of clothing will then be 
determined 
 The target application rate of the least amount of permethrin providing the 
greatest efficacy against mosquito bites as determined from semi-field and 
field experiments will be applied.  
 The emulsifiable concentrate formulation of the treatment will be mixed with 
water to achieve the target application concentration required for treating a 
square meter of clothing and only enough solution to impregnate the clothing 
presented for treatment will be prepared to reduce the amount of excess 
solution to be disposed. 
 The clothing will be dipped into the solution and any excess solution wrung 
out 
 The permethrin- impregnated clothing will be dried under a shade by spreading 
them horizontally on a spread out plastic sheet to prevent the permethrin 
depositing onto the soil and being washed off by surface run of into streams. 
Drying the clothing horizontally will also prevent patchy impregnation that 
might occur if clothing is hung vertically. 
 After impregnation, study team will wash the dipping bowls and hands with 
soap and put all empty permethrin bottles and remaining insecticide in the 
large disposal plastic containers to be transported to the IHI for incineration. 
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 Study participants will be instructed to wash the permethrin- impregnated 
clothing up to twice per week to avoid loss of permethrin from clothing as a 
result of frequent washing 
 The participants will be asked to bring their clothing at the beginning of every month 
for impregnation at the impregnating shed constructed in each cluster. Therefore,  
150 individuals will present their clothing for impregnation by an appropriate number 
of trained field workers every month in each cluster. 
The impregnation schedule will be done according to Figure 2.  
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Figure 7:2 Flowchart showing impregnation of clothing and study participants 
follow up 
7.6.8.3 Long lasting insecticidal nets (LLINs) 
The study team will distribute the LLINs at no cost to the participants. In advance of 
distribution, the number of beds/sleeping places in each household will be counted. 
Distribution will be at the household level to the household head or representative to 
achieve coverage of one LLIN per bed/ sleeping place. The bags that LLINs are 
delivered in will be cut open before issuance to the household head/ representative to 
reduce opportunities for sale of the nets. In order to maximize compliance, the study 
team will hang the LLINs in the households. Net use will be monitored on a monthly 
basis during active case detection.  The study participants will be sensitized on the 
correct net use and maintenance.  
7.6.7 Monitoring for compliance  
 
To assess compliance, study team field workers will be assigned households within 
the cluster where they will monitor use of PIC. The number of households assigned 
will be subject to logistics, i.e. how many households a single field worker can 
effectively oversee and funds available to hire an adequate number of field workers. 
Monitoring of intervention use will be conducted at the beginning of every month 
during cloth impregnation and during active case malaria detection two weeks after 
impregnation of the PIC. Random spot checks to assess whether the participants are 
compliant with this intervention will also be conducted by the field workers to ensure 
that households are not simply complying only when blood smear sampling and cloth 
impregnation will occur. Therefore compliance to use of PIC will be evaluated 
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fortnightly as well as through random spot-checks. Non- compliant 
households/participants will be recorded and excluded in the final analysis. 
7.6.8 Treatment of study participants  
 
During the active case detection, artemether–lumefantrine (Co-Artem) will be given 
to any participant with a temperature ≥37.5oC or a history of fever in the past 48hrs, 
with P. falciparum parasites detected by RDT (SD Bioline Malaria Antigen Pf/Pan™ 
SD, RDT). Iron supplementation will be given to any participant with anaemia (Hb<9 
g/dL) measured using the HemoCue instrument. Any participant treated for malaria 
will be asked to attend the nearest health facility if no improvement/recovery is made 
within 48 hours. Participants with severe malaria will be referred to Ifakara District 
Hospital for treatment. Also during the study, participants will be encouraged to visit 
the nearest health facility incase of febrile illness in between scheduled visits. Study 
participants with a positive RDT will be treated following Tanzanian treatment 
guidelines with Co-Artem [58], while those with anaemia (Hb < 9g/dL) will be given 
iron supplementation. Treatment for other conditions will be carried out in accordance 
with Tanzanian national guidelines. 
In case of a severe adverse effect related to the study, study participants will be 
referred to Ifakara District Hospital and treated according to the medical judgment of 
the local physician. The study will pay for transportation and any treatment required 
due to a study-related AE. 
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7.6.9 Selection of participants  
 
Study participants will be recruited during baseline household enrolment using pre-
defined inclusion/exclusion criteria. All community members in the study area will be 
eligible for inclusion into the study. Enrollment of study participants will occur at the 
household level. All participant households will be assigned household identification 
numbers (HIN). The aims and objectives of the study will be explained to the 
household head or parent/guardian and all present members of the participating 
household in local dialect, using local community health workers (CHWs) as needed 
and outlined in the informed consent form. All household members of the 
participating household will be assigned a unique identification number, (UIN). The 
name and UIN of each household member, subject to consent from the 
parent/guardian and all participating household members above 13 years old, will be 
recorded on a participant enrollment ledger. A Personal digital assistant (PDA) 
(Nanjing Corewise IC-7 Tablet PC, A370) with a biometric finger print scanner will 
then be used to scan the fingerprints of all household members of the participant 
household and link the each fingerprint with the respective HIN and UIN. Each study 
participant will be given an identification card with only their UIN but no name 
identifying the study participant. Informed consent will be given by each household 
head and each participating member above 13 years signing two informed consent 
forms: one for malaria testing and treatment and one for storage of blood samples 
(which will be used for PCR laboratory based parasite detection at the IHI 
laboratories).  
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7.6.10 Inclusion and exclusion criteria 
 
Recruitment of each study participant will be according to the specific criteria listed 
in Table 7.1 
Table 7:1 Outline of the inclusion/exclusion criteria of study participants  
Inclusion Criteria Exclusion Criteria 
Household members sleep in cluster >90% of 
nights during any given month 
Household members sleep in cluster <90% of 
nights during any given month  
Household members have no plans for 
extended travel (<1month) outside of home 
during study 
Household members have plans for extended 
travel (>1month) outside of home during study 
Household members not participating in 
another clinical trial investigating a vaccine, 
drug, medical device, or a medical procedure 
during the trial 
Household members participating or planned 
participation in another clinical trial investigating 
a vaccine, drug, medical device, or a medical 
procedure during the trial 
Provision of assent/informed consent form 
signed by the study participant >13 years and 
by the household head or another legally 
acceptable representative for participants < 13 
years  
No provision of assent/informed consent form 
signed by the study participant > 13 years and by 
the household head or another legally acceptable 
representative for participants <13 years 
 
7.6.11 Withdrawal of participants  
 
Study participants and households are free to withdraw from participating in the study 
at any time without any prejudice. 
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7.7 Summary of study schedule 
7.7.1 Introduction of study 
 
Consent to conduct the study will be sought from the District Executive Director 
(DED) and the District Medical Officer (DMO). A letter explaining the study will be 
drafted and a representative from the study will discuss the study aims and objectives 
and address any questions arising with the DMO and DED. 
After informed consent has been obtained from the DED, then village sensitization 
will begin. Representatives from the project will visit the study area to discuss the 
study and its objectives with the Village Executive Officers (VEO) and other local 
leaders as well as deliver copies of the letters sent to the DED. Information regarding 
the study area, like number of households in the study area and average number of 
household members will be obtained from the VEO and TCUL. An appointment for a 
community meeting will then be organised, with the help of the VEO and TCULs, 
where the project will be introduced to the community members in the study area. 
Posters and the social marketing team from IHI will be used to announce and sensitize 
the community on the dates of the meetings. 
7.7.2 Community sensitization 
 
Local leaders, including the VEO and TCULs will be the focal people used to endorse 
the study. Community sensitization meetings will be coordinated with the local 
District Health Management Team (DHMT) (or similar health authority present in the 
study area) and local community leaders. Refreshments will be provided and some 
light entertainment from members of the local arts college and IHI social marketing 
team will be organised to encourage attendance. A study team member, experienced 
in community education will deliver key messages. Information brochures detailing 
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key messages and including feedback from community meetings will be prepared and 
distributed during these meetings. 
The sensitization meeting will outline the study objectives, aims and procedures. The 
community members will be informed on the allocation procedures of the PIC and 
placebo-impregnated clothing between the study groups. The community members 
will also be sensitized on the right to withdraw from the study at any time without 
prejudice. A description and demonstration of how to impregnate clothing will also be 
conducted during this meeting. All questions and concerns of the community 
members will then be addressed after which the meeting will be closed.  
7.7.3 Training of health workers 
 
Health facility and CHWs will be trained on safe blood draw techniques to determine 
malaria infection in training sessions conducted by the study team with the help of an 
experienced phlebotomist from the Ifakara District hospital. The CHWs, including the 
clinical (CO) employed by the study, will also be trained to recognize signs and 
symptoms of uncomplicated and complicated malaria as well as AEs caused by 
malarial drugs and permethrin. Additional training for RDT use and interpretation of 
results will be conducted with the help of experienced health workers from the Ifakara 
District Hospital. Field technicians will receive additional training on standard 
operating procedures (SOPs) of human landing catches and impregnation of clothing 
with permethrin that will be carried out during this study. 
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7.7.4 Household enrolment 
During household recruitment visits, the study aims and objectives will be explained 
to the household head and members present at the time of the visit prior to requesting 
informed consent to recruit the household into the study. If informed consent is 
obtained, the GPS coordinates of the participant household will be recorded using a 
hand held GPS receiver (Garmin eTrex Legend H) and a HIN will be stapled on the 
doorframe. The HIN will be used to link all clinical, entomological and intervention 
allocation data. Participants will be informed that they are free to withdraw their 
participation from the study at any time and for any reason without prejudice. Socio 
demographic household data collected will include: household construction materials, 
age and gender of household members, education level of household members, asset 
ownership and presence and density of domesticated animals. Knowledge, attitude, 
practice and perceived effectiveness of impregnated clothing data will also be 
collected. These data will be collected using a PDA with a biometric fingerprint 
scanner. The fingerprints of each household member will be scanned and assigned a 
UIN, which will be linked, to the HIN. 
The census will be conducted from cluster to cluster using a team of 20 field workers, 
overseen by PL. The project will establish a base at the Village Headquarters where 
all CHWs and field workers will be allocated tasks and equipment will be stored. The 
PL will conduct regular spot checks to ensure that houses have been correctly 
enumerated and data recorded is consistent for a sample of households. Data will be 
checked at the end of the cluster census in case some houses have to be repeated due 
to data inconsistencies. Once all data is assured, the next cluster census will begin. 
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7.7.5 Cohort Follow-up 
 
All study participants will be tested monthly, throughout the 2-year follow-up period, 
for malaria, regardless of symptoms (active surveillance). A PDA with a biometric 
fingerprint scanner, populated with the socio-demographic data of the study 
participant households as well as the HIN, UIN and GPS coordinates of the household 
will be used to collect the data during the household visit. Each study participant’s 
history and symptoms will be recorded and results of the malaria diagnosis using 
RDT will be entered against the participants UIN in the PDA. This progression will 
be repeated for all household members. If a household member is absent on the first 
visit, a second visit will be attempted to collect clinical data. If still absent then that 
study participant will be excluded from the calculation of person-time for two weeks. 
Study participants positive for malaria parasites during active case detection will be 
given ALU (Co-artem), the first line drug for malaria treatment if Tanzania [58, 70] 
by the CHWs conducting the malaria diagnosis.  
Participants will also be passively screened for malaria infection 2 weeks after active 
screening during the clothing impregnation exercise, with only those participants 
having a history of fever (fever ≥38.0°C) or manifesting symptoms at the time of this 
exercise being tested for parasite diagnosis (symptomatic screening). Study 
participants positive for malaria parasites during passive  case detection will be given 
ALU (Co-artem), the first line drug for malaria treatment if Tanzania [58, 70]. Data 
will be captured in the same way as the active case detection using PDAs. Study 
participants will also be screened for anaemia using the HemoCue instrument during 
active case malaria detection. Study participants will therefore be screened for malaria 
fortnightly and once every month for anaemia. In addition, all participants will be 
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instructed to seek treatment at dedicated study health facilities, incase of febrile 
illness in between scheduled visits. A clinical officer and a nurse, both trained in 
malaria diagnosis using RDTs and collection of blood spots on filter paper for PCR 
diagnosis will be employed at each at each study recruited health facility. They will 
also be trained on recognizing the signs and symptoms of severe malaria cases and 
AE events related to permethrin for referral to the Ifakara District hospital. At this 
visit to the health facility, the participant will be examined and if history of fever or 
other signs or symptoms associated with malaria are present, the participant will be 
tested using RDT and if found positive, treated as per the Tanzania national 
guidelines[58, 70]. All study participants, will be given a card with their UIN to 
present at the clinic to receive screening and treatment if symptomatic. The card will 
contain the UIN identifying the participant, HIN and cluster number that the 
participant comes from as well as the treatment code assigned to that participant. The 
UIN will be used instead of the participant name to record of passive malaria 
detection of participants attending the health facilities. A PDA will be supplied to all 
study dedicated health facilities for collection of clinical data. Field workers will 
collect the captured information and upload from the PDA, via the mobile network to 
the central database at the IHI.   
7.7.6 Malaria incidence determination 
 
To determine malaria incidence, subjects will be followed up for malaria infection. In 
case of an infection, the study participant will be treated according to outlined 
national guidelines [58, 70] and follow-up continued (with each infection treated). 
Study participants infected with malaria will be excluded from the calculation of 
person-time for a period of one month. Trained CHWs will carry out the malaria 
diagnosis in their assigned clusters. Loss to Follow Up (LTFU) will be based only on 
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a study participant or household voluntarily leaving the study. A subject missing 
sample points (collection of blood samples to test for malaria, during active case 
detection) will be excluded from calculation of person-time for two weeks. All study 
participants retained in the cluster will be followed for a minimum period of 2 years 
to capture seasonal variations in malaria infections between the two study groups. 
At each monthly scheduled visit, blood samples will be taken for RDT diagnosis and 
blood spots, for PCR analysis. Malaria positive subjects, tested by RDT, will be 
treated using ALU (Co-Artem), the first line drugs for treatment of malaria in 
Tanzania [58, 70] .  
7.7.8 Passive Case Detection of Malaria episodes  
 
Passive case detection for malaria will be maintained throughout the transmission 
season.  Participants will be instructed to attend the nearest health facility to their 
household in case of febrile illness. The CO will perform the diagnosis of malaria 
using RDT and treatment of malaria if positive. The CO or nurse will also collect 
blood spots on a filter paper to be collected later by the field workers for PCR 
analysis at the IHI laboratories, at least once a week 
7.7.9 Clinical data collection 
 
7.7.9.1 Malaria diagnosis 
Rapid diagnostic test (RDT) kits will be used for field screening and treatment of 
malaria infection during active and passive follow up of study participants. In addition 
to RDTs, blood spots on filter paper will also be collected for PCR analysis. Blood 
spots will be dried and stored under desiccant until they are transported to the IHI 
laboratories for PCR analysis at the end of each week after which they will be stored 
at up to -80C. All blood spots will be processed using PCR techniques for detection 
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of malaria parasites [71]. A sample, 20% of all malaria positive RDTs used every 
week will be analyzed against their respective PCR blood spots collected. Discordant 
RDT and PCR results (positive RDT but negative PCR) will prompt re-training of 
CHWs in using RDTs. Used RDT kits will be stored in a locked shipping container at 
IHI until the data is completed and locked, then the samples will be destroyed on-site 
in the IHI incinerator. Blood spots sent to the IHI laboratory for PCR-based malaria 
diagnosis will be stored and destroyed according to IRB requirements and restrictions. 
7.7.9.2 Malaria treatment 
Malaria treatment in the field will be based on a positive RDT. Treatment of malaria 
positive study participants during follow-up visits will follow national policy 
guidelines on treatment of malaria [58, 70]. In case of severe malaria symptoms, the 
subject will be referred to the Ifakara district hospital for evaluation and treatment. 
The study will pay for transportation and treatment. In case of AE experienced as a 
result of participating in the study, the subject will be transported to Ifakara district 
hospital and treated according to the judgment of the local physician at study cost. 
7.7.10 Entomological data collection  
 
The evaluation of entomological end points will be carried out in both the intervention 
and control clusters to facilitate identification of the entomological correlates of using 
PIC. 
7.7.11 Human Landing catches (HLC) 
 
Human landing catches will be performed in the first year to establish the baseline 
entomological endpoints. The HLCs will then be conducted over the study period (2 
years) in the intervention and control groups to evaluate the effect of the PIC on the 
entomological correlates. The entomological correlates of year one will be compared 
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to those of the second and third year in the control group, and if a difference is 
observed, this difference will be adjusted for when analyzing the findings of the 
intervention and control group. Human landing catches (HLCs) will be performed 
every week to measure anopheline- landing densities. 
Two households each, from the intervention and control clusters will be randomly 
chosen at the beginning of every week for entomological sampling of mosquitoes. 
Mosquitoes will be collected from these households using all night HLCs. The 
entomological study will be conducted by an independent study entomologist to 
ensure that the rest of the study team remain blinded to treatment allocation. A team 
of four field workers trained on HLC will conduct these collections. The first pair of 
field workers will collect mosquitoes from 6 p.m. -12 a.m. The second pair will 
collect mosquitoes from 12 a.m. to 6 a.m. The collections will be conducted twice a 
week, for every week through out the study period and in both the intervention and 
control group simultaneously. Volunteers will alternate indoor and outdoor positions 
during each night of collection, throughout the study period. All mosquitoes landing 
on volunteers (both anophelines, and culicines) will be held in hourly marked paper 
cups so that it will be possible to determine the number of mosquitoes collected in 
each hour, from the first through to the sixth hour, and from the sixth to the 12 th hour. 
The sampled mosquitoes will then be transferred to the field office at the village 
headquarters, where they will be killed using petroleum vapours. All mosquito 
sampled will be sorted into anophelines and culicines. Culicine mosquitoes will be 
identified to species level using appropriate keys [72]. Mosquitoes identified to be 
anophelines will be transported to the IHI lab where PCR speciation will be 
conducted [73]. Data collected will be recorded by: mosquito species, household 
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identification number (HIN), date of collection, sampling hour, location of mosquito 
collector (indoor/outdoor) and name of collector.  
7.7.11.1 Sporozoite infection rates  
All anophelines captured from the HLC will be processed at the IHI laboratory using 
enzyme- linked immunosorbent assay (ELISA) techniques for detection of sporozoites 
of Plasmodium parasites [74]. A sample, (20%), will be processed at the NIMR 
laboratory as a quality check of ELISA techniques at the IHI laboratories. 
 7.7.11.2 Parity rates (Age structure) 
A subset of samples, (20%), of each morphologically identified adult anopheline 
species from HLC collections will be dissected for parity determination (nulliparous 
vs. parous) following standard WHO protocols [75]. Adult mosquitoes will be sorted 
in the field office following completion of HLC collections. Approximately 20% of 
females will be dissected by hour, indoor/outdoor location, collector’s identity, 
(name) and HIN. When hourly collections are 10, a minimum of 2 specimens will be 
dissected and characterized. For larger collections up to 30 mosquitoes will be 
dissected for parity determination. 
7.7.11.3 Vector species determination 
All adult anophelines captured will be identified to species level using PCR [72, 73]. 
Other mosquito genera identified will be counted and stored for potential future 
processing.  
7.7.11.4 Vector insecticide resistance 
Baseline vector permethrin resistance will be assessed in the first year prior to 
implementation of the intervention in the study groups using standard WHO methods 
for measuring insecticide resistance and susceptibility [76]. Mosquitoes tested will be 
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assessed for molecular species identification post insecticide resistance assays using 
PCR [73]. PCR assays will also be conducted to detect known resistance alleles as 
quality assurance method for standard WHO resistance evaluation bioassays [77].  
Assessments will be repeated mid and post study, to determine the effect of PIC on 
vector species-specific permethrin resistance levels between the study groups. 
7.8 Data Management and processing  
7.8.1 Data collection 
 
Data will be collected and recorded according to UIN and HIN. Socio-demographic 
data (age, place of birth, and gender), household census data (household construction 
materials), travel habits, past medical history, drug allergies and drug history, will be 
collected during household enrolment subject to consent. Knowledge, attitudes and 
practice of the household head/members in relation to PIC will also be recorded 
during household and participant enrollment. Data on malaria infection (clinical 
data) will be collected every two weeks by alternating active and passive case 
detection using RDTs and blood spots throughout the study period. The HIN and 
UIN codes of all study participants tested will be recorded in the subject case report 
forms (CRF), uploaded in the PDA. All, adverse events (AEs) experienced by study 
subjects, whether or not related to the study, will be captured in AE forms 
throughout the study period also uploaded in the PDA. Data on concomitant drugs 
use, such as antibiotics (Septrin), that directly affect malaria transmission, received 
during the intervention period will also be recorded. All this data will be linked by 
the HIN of the households and UIN of study participants in the PDA. 
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7.8.2 Data capture 
 
Data will be collected using standardized forms on PDAs with a biometric fingerprint 
scanner. In case of PDA failure, paper based data collection will be used as back up. 
The PI will oversee the accuracy of all data entered on the PDAs/forms. The field 
workers will be trained and instructed on proper data input methods to ensure data 
integrity. 
Collected data will be directly uploaded from the PDAs via the mobile network to a 
central database managed by a study data administrator at the IHI. The data 
administrator will check for data integrity and inconsistencies and advise if data 
collection should be repeated. After data entry, all data collected using paper data 
forms will be scanned and transferred to binders for storage. All the data collected 
electronically (PDAs) will be archived with a documented history of changes or 
corrections. 
7.8.3 Data storage 
 
All the data collected using paper format from the study subjects: history of illness, 
physical findings, consultations and laboratory results of will be stored in a secure 
storage facility in locked cabinets and will be maintained in compliance with IRB 
requirements. If these data are collected electronically, they will be stored in 
password secured databases at the IHI The study PI will be responsible for retaining 
copies of the completed CRFs, in both electronic and paper formats. All raw and 
cleaned data forms will be archived in a central data warehouse. 
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7.8.4 Data validation  
 
Data collected using paper forms will be double entered into a computer by two data 
entry clerks. These dataset will then be cross-referenced and errors and 
inconsistencies will be resolved by checking the data source forms, after which the 
dataset will be combined to produce a single data set. Data collected using PDAs, 
will be checked for quality before being incorporated into the central database. 
7.9 Data analysis 
An internal project statistician, as well as an external statistician, both blinded to the 
intervention allocation, together with study investigators will perform the data 
analysis, following a pre-defined statistical analysis plan.  
7.9.1 Clinical data 
 
An intention to treat analysis (ITT) will be performed on all data, after which, 
according to protocol (ATP) analysis excluding participants who were not compliant 
with the intervention or willingly withdrew from the study will be done. Person-time 
will be calculated as the number of months that the study subject was compliant with 
the interventions during the study. In case of malaria infection, the study subject will 
be excluded from the study for one month to avoid recording a single infection twice. 
If malaria data is not sampled from the study participant, after a second visit will be 
attempted, after which that participant will be excluded from the calculation of 
person-time for two weeks if unavailable for data collection. ITT analysis will include 
all months that the study participant was enrolled in the study regardless of 
compliance to the intervention. According to protocol analysis (ATP) will include 
only the person-time for which study participants were compliant with the 
intervention. A Poisson regression model, adjusted for intra-cluster variation by 
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random effects will be used for analysis. This model allows for repeated measures on 
a single individual (study participant). The results of the model will be presented as 
incidence rate ratios (IRR) of malaria between the intervention and control groups. 
All variables significantly associated with the intervention from univariate and 
multivariate analysis will be included in the model. 
7.9.2 Demographic data 
 
A principal component analysis (PCA) will be used to develop a socio-economic 
score for each household. Variable to be included in the PCA include, asset 
ownership, household construction materials, occupation and education level of 
household head.  
7.9.3 Compliance with interventions  
 
Compliance of participants will be compared between the intervention and placebo 
group using a chi-square test. LLIN and PIC use will be converted to proportions of 
use per two weeks and will also be included in the regression model for disease 
(malaria) incidence. 
7.9.4 Entomological data 
 
A Poisson regression model with a log link function and a random intercept will be 
used for analysis of entomological data. This model allows for repeated measures 
over time. The number of mosquitoes caught per hour will be the dependent variable, 
and time, position and individual will be used as independent variables in this model. 
Day, which accounts for abiotic factors will be fitted as a covariate and a random 
intercept will be fitted to account for over dispersion often seen in mosquito data.  
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7.9.5 Data dissemination 
 
Study results will be disseminated to the scientific community through peer-reviewed 
journals and international conference forums with yearly progress reports distributed 
to key stakeholders. Summary reports will be generated by the PI and sent to the 
study sponsor on a monthly basis. 
7.10 Potential risks and benefits  
7.10.1 Risks  
 
The risk of permethrin toxicity is minimal as permethrin has been approved for use as 
an insecticide by the EPA [36]. Permethrin has been used for an extended period of 
time to impregnate clothing by the US army for protection against arthropod bites in 
the field, [41], and has been shown to have low mammalian toxicity [41]. The least 
amount of permethrin demonstrating the most effective protection will be used to 
minimize unnecessary exposure of study participants to permethrin. 
Antimalarial drug treatment will be provided according to national guidelines [58] 
and national first and second line antimalarial drugs will be used for treatment of all 
malaria infections. Medically trained personnel will treat all malaria cases. Adverse 
Events (AEs) or Severe Adverse Events (SAEs) related to permethrin or malaria 
treatment will be documented and reported to the PI and Institutional Review Boards 
(IRBs). The study CO will provide treatment, or, if severe, the participant will be 
referred to the Ifakara district hospital for treatment. Transport and treatment costs at 
Ifakara District hospital will be paid for by the study.  
The amount of blood collected will be minimal: Blood samples by finger pricks will 
be drawn by trained personnel ensuring that these collections are done in as safe a 
manner as possible. WHO guidelines for blood collection will be followed [78]. 
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7.10.2 Benefits 
 
There will be no monetary incentives provided to the participants of this study. 
However, the cost of research and blood tests will be covered by the study as well as 
provision of free treatment. If study participants will be required to attend scheduled 
visits at the study clinic, travel reimbursements or transport will be provided so that 
participants incur no cost of participating in the study. The study will also pay for any 
malaria drug, permethrin related AEs/SAEs or any other study related injuries. 
Clinical trial insurance will be purchased for general liability and negligence 
protection. All study participants will receive free diagnosis and treatment for malaria 
if diagnosed at any point during the study. In addition all enrolled households will 
receive an LLIN for every sleeping space. All participants will be referred to a local 
clinic for any other illness. A pit latrine will also be put up in each cluster for 
community use at study cost. 
7.11 Ethical considerations 
7.11.1 Informed consent 
 
Informed consent will be obtained directly from all adults participating in the study. 
For subjects <18 years of age, consent will be obtained from parents or guardians; in 
addition, personal child assent will be obtained for children who are >13 but <18 
years and live with a parent or guardian. All consent forms will be translated into 
local languages, pretested on a sample of community members and back translated 
into English to ensure accuracy. The consent forms will then be amended accordingly 
into a final draft. During the consenting process, the study will be described and the 
consent form will be read to the household members. The consent form will detail the 
design of the study; outline the questionnaires to be administered and the blood draw 
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process. The purpose of collecting and storage of blood samples (to be used for 
laboratory based PCR malaria diagnosis) will also be explained to the household 
members and that no data on any other disease will be collected from blood samples. 
Each individual household member will be given an opportunity to ask any questions 
they might have in relation to the study, and if they agree, will be asked to sign the 
consent form. If they agree to have blood samples of household members stored, the 
household head will be asked to sign consent for blood sampling and long-term 
storage of samples. All households will be provided with signed copies of the consent 
forms after they have agreed to participate in the study. For households participating 
in entomological sampling, a script will be read to each household head or 
representative to explain the mosquito collection techniques and signed consent will 
be sought from the head of household. For incidence follow-up surveys, individual 
informed consent will be sought separately from parents/guardians and all eligible 
participants and household members >18 years. 
Informed consent will also be sought from field technicians conducting the HLCs and 
impregnation of clothing with permethrin. 
7.11.2 Confidentiality 
 
Household identification numbers (HIN) and unique identification numbers (UIN) 
will be used to identify the study households and participants instead of names. All 
study related information will be stored securely at the study site. All participant 
information will be stored in locked file cabinets in areas with access limited to study 
staff or in password protected databases. A UIN will be used to identify all laboratory 
specimens sampled and study data collected. Study participant names will only be 
used during baseline data collection after which assigned UINs will be used to 
identify study participants henceforth.  Names of study participants or other personal 
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identifiers will be stored separately from study records. The database will be secured 
with password-protected access systems. Written permission from the participant will 
be required before any information regarding the said participant is released, except as 
necessary for the independent monitoring; representatives of other government and 
regulatory authorities, and/or site IRBs/ECs. All data will be stripped of personal 
identifiers (personal details removed and replaced with codes and GPS information 
blurred)) prior to any subsequent analysis and/or sharing after explicit permissions 
according to IRB approvals. 
7.11.3 Study discontinuation  
 
The study will be stopped on suspicion of potential harm to the study participants or 
the environment such as a large number of participants reporting an excessive number 
of adverse events.  
7.11.4 Safety parameters 
 
Permethrin-treated long lasting nets and permethrin- impregnated clothing have been 
fully evaluated by the WHO Pesticide Evaluation Scheme and approved for vector 
control and the products will be used in compliance with their recommended use and 
guidelines [36].  
All study participants enrolled in the study will have access to malaria diagnosis and 
treatment according to Tanzanian National Treatment Guidelines and all visits to the 
health facilities will be recorded. 
7.12 Safety oversight 
 
The study CO will check all data regularly, at least once a week, and will inform the 
study PI of the numbers of malaria attacks and AE by cluster. 
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7.12.1 Adverse events  
 
Any undesirable event that occurs to a study participant during the course of the study 
will be designated an adverse event (AE); i.e., any event occurring from the time of 
consent into the study until study ends (until the last follow-up visit for that specific 
participant whether or not that event is considered related to malaria treatment drugs, 
PIC, concomitant drugs and/or malaria infection detection procedure). 
7.12.2 Serious adverse events  
 
An AE will be defined as a serious adverse event (SAE) if it results in any of the 
following outcomes: 1) death, 2) life-threatening event – this means that the 
participant was at immediate risk of death at the time of the event and required 
immediate medical intervention. It does not refer to an event that hypothetically might 
have caused death if it were more severe, 3) prolongation of existing hospitalization 
or re-hospitalization once discharged, 4) persistent or significant disability/incapacity 
(a substantial disruption of a person's ability to conduct normal life functions) and; 5) 
an important medical event that may not be immediately life-threatening or result in 
death or hospitalization but may jeopardize the patient or may require intervention to 
prevent one of the other outcomes listed in the definition above. 
7.12.3 Patient management of adverse events  
 
All adverse events will be treated as clinically recommended and treatment given 
recorded on the CRF in the PDA. If necessary, participants will be referred for 
specialist care at the Ifakara District hospital. The study CO will stop the study drugs 
or intervention if he/she determines that an AE is drug-or intervention-related and that 
stopping the drugs/ intervention is clinically indicated. 
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7.12.4 Adverse event reporting 
 
The occurrence of adverse event will require prompt reporting to the study PI, IRB 
and oversight committees 
These AEs will be reported by the site PI to the study sponsor as recommended in the 
IRB specifications. At consent, subjects will be provided with the local authority and 
study coordinator contact information in the informed consent form to use in case an 
adverse event occurs. 
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METHODOLOGY Open Access
Use of a semi-field system to evaluate the
efficacy of topical repellents under user
conditions provides a disease exposure free
technique comparable with field data
Onyango Sangoro1,2*, Dickson Lweitojera1, Emmanuel Simfukwe1, Hassan Ngonyani1, Edgar Mbeyela1,
Daniel Lugiko1, Japhet Kihonda1, Marta Maia1,3,4 and Sarah Moore1,3,4
Abstract
Background: Before topical repellents can be employed as interventions against arthropod bites, their efficacy must
be established. Currently, laboratory or field tests, using human volunteers, are the main methods used for assessing
the efficacy of topical repellents. However, laboratory tests are not representative of real life conditions under which
repellents are used and field-testing potentially exposes human volunteers to disease. There is, therefore, a need to
develop methods to test efficacy of repellents under real life conditions while minimizing volunteer exposure to disease.
Methods: A lotion-based, 15% N, N-Diethyl-3-methylbenzamide (DEET) repellent and 15% DEET in ethanol were
compared to a placebo lotion in a 200 sq m (10 m × 20 m) semi-field system (SFS) against laboratory-reared Anopheles
arabiensis mosquitoes and in full field settings against wild malaria vectors and nuisance-biting mosquitoes. The average
percentage protection against biting mosquitoes over four hours in the SFS and field setting was determined. A Poisson
regression model was then used to determine relative risk of being bitten when wearing either of these repellents
compared to the placebo.
Results: Average percentage protection of the lotion-based 15% DEET repellent after four hours of mosquito collection
was 82.13% (95% CI 75.94-88.82) in the semi-field experiments and 85.10% (95% CI 78.97-91.70) in the field experiments.
Average percentage protection of 15% DEET in ethanol after four hours was 71.29% (CI 61.77-82.28) in the semi-field
system and 88.24% (84.45-92.20) in the field.
Conclusions: Semi-field evaluation results were comparable to full-field evaluations, indicating that such systems could
be satisfactorily used in measuring efficacy of topically applied mosquito repellents, thereby avoiding risks of exposure
to mosquito-borne pathogens, associated with field testing.
Keywords: Repellent, Anopheles arabiensis, Semi-field system, Efficacy, N, N-diethyl-3-methylbenzamide (DEET)
Background
Evaluations of topical repellent efficacy against blood
feeding arthropods require standardized laboratory and
field tests [1-3]. However, conditions in the laboratories
are not representative of real life settings where repel-
lents are used. Therefore, experiments carried out in the
laboratory may not accurately estimate the efficacy of re-
pellents in the field [4]. Environmental factors such as
temperature, humidity and wind speed, all of which
affect the effectiveness of repellents, are controlled in
the laboratory, but in the field these factors may fluctu-
ate and affect repellent efficacy [5]. As a result, tests car-
ried out in the laboratory ideally should be verified using
representative field tests. On the other hand, field evalu-
ations, albeit representative of conditions under which
repellents are normally used, can expose volunteers
participating in these experiments to mosquito-borne
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pathogens [6]. Therefore, there is a need to develop
methods to test efficacy of repellents under representa-
tive user conditions while minimizing volunteer expos-
ure to vector-borne diseases.
There are several techniques that have been proposed
for testing topical repellents while reducing human ex-
posure to mosquito bites. These options include: 1) use
of synthetic mosquito attractants that mimic human vol-
unteers [7]; 2) use of animals instead of human volun-
teers [8,9]; 3) use of in vitro blood feeding membrane
[10-12]; 4) In vitro olfactometry [13]; and, 5) use of a
semi-field system (SFS) [14,15]. Although techniques 1
to 4 are convenient because of their high throughput in
screening of repellents and do not use human partici-
pants, they have well-documented limitations: as the
skin is the site of action of topical repellents, and mos-
quitoes are attracted to cues produced by the host, dif-
ferent hosts will elicit varying degree of responses in the
mosquito which will affect both duration and degree of
repellency observed [8,10]. The use of in vitro blood-
feeding membrane is unlikely to give similar results to
repellents applied to human skin, as the feeding mem-
brane used in these tests are structurally and physiolo-
gically different from the human skin and produce no
odour [10]. Use of in vitro olfactometry, used mainly to
test spatial repellents, is more suitable for screening pur-
poses as it’s used in confined spaces and shorter dis-
tances in the laboratory and results cannot be correlated
to the field, where there are wide open spaces for the
mosquitoes to forage [13]. The use of synthetic blends to
test repellency has also proved unreliable as different
repellent-blend combinations produced disparate results
[7]. Use of SFS may overcome these shortcomings be-
cause efficacy tests can be performed in a large enclos-
ure under ambient conditions, allowing mosquitoes to
elicit similar behavioural responses as under field condi-
tions. The other advantage of SFS is that it uses mosqui-
toes reared under laboratory conditions and therefore
does not expose volunteers to potential mosquito-borne
disease. The species, numbers and physiological status of
mosquitoes used in the SFS are standardized to provide
more controlled conditions and therefore reduce data
variability associated with field studies. However, the ef-
fectiveness of SFS has not been evaluated against full-
field conditions when testing topical repellents. This
study examined whether tests carried out in a SFS would
yield comparable results to tests conducted in field
setting.
Methods
Study area
Semi-field evaluation of repellents was carried out at
Ifakara Health Institute (IHI), Morogoro, Tanzania. The
field evaluation of repellents was conducted in Mbingu
village, Ulanga district, situated 55 km west of Ifakara
town at 8.195°S and 36.259°E. Rapid diagnostic test
(RDT) results from passive case detection at a local
clinic between December 2012 and July 2013 confirmed
malaria incidence estimates from the village were 0.67
cases/person-years, (Jabari Mohammed Namamba, pers
comm), only one-and-half years after the end of a na-
tional campaign to achieve universal coverage with long-
lasting, insecticide-treated bed nets (LLINs) [16]. There
is high malaria transmission all year round, with peak
transmission occurring in the months of May and June
after the long rains. The village experiences an annual
rainfall of approximately 1,200-1,800 mm and an annual
temperature range of between 20 and 32.6°C. The village
borders an extensive field cleared for irrigation, which
provides an ideal breeding site for malaria vectors [17].
Semi-field evaluations of topically applied repellents
The semi-field evaluation was carried out in the IHI
SFS. A SFS is an enclosed environment, situated in the
natural ecosystem of a target vector and exposed to am-
bient conditions necessary for the completion of the life
cycle of the vector. It is made up of a greenhouse frame
with walls of mosquito netting and a polyethylene roof,
mounted on a raised concrete platform [14,15].
Mosquitoes
The mosquitoes used in these experiments were laboratory-
reared Anopheles arabiensis (Ifakara strain, originally
sourced from Sagamaganga village, Kilombero district in
2008) from the IHI insectaries. The larvae were fed on
Tetramin® fish food and maintained at temperatures of
28 ± 1°C. Pupae were placed in emergence bowls inside a
30 × 30 × 30 cubic cm netted cage in a separate room
where temperatures were maintained at 27 ± 3°C and rela-
tive humidity at 70-90%. A 10% glucose solution was sup-
plied in the cages for the emergent adults. The insectary
was maintained at 12:12 (light: dark) photoperiod, from
0600 hrs to 1800 hours (light period) and 1800 hrs to
0600 hrs (dark period). The mosquitoes used in these ex-
periments were three to eight day-old nulliparous females.
The mosquitoes were starved from sugar solution for six
hours.
Volunteers
Male volunteers, aged between 18 and 40 years were ed-
ucated on aims, benefits and risks of the study and re-
cruited on written informed consent. The use of strictly
male volunteers was to prevent potential risk of malaria
infection to pregnant female volunteers. All volunteers
were highly experienced in performing human-landing
catches. During the SFS experiments, volunteers were
screened daily for parasitaemia using RDTs and if found
positive, excluded from participating any further in the
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experiments and treated with artemether-lumefantrine
(ALU), first-line drug for treatment of malaria in
Tanzania. During the field evaluation, in addition to daily
screening, volunteers were provided with mefloquine
prophylaxis. The volunteers were instructed not to use
any fragranced soap or perfume, tobacco or alcohol
12 hours before the start and throughout the experiments.
Repellents
The repellent tested was donated by SC Johnson & Sons
Inc (Racine, WI, USA). Three treatments were tested: 1)
a lotion-based formulation containing 15% DEET as the
active ingredient, being the test product; 2) 15% DEET
diluted in absolute ethanol, being the standard control,
and 3) a placebo made of a similar lotion formulation as
the test product, but lacking the active ingredient, being
the negative control. Technicians were blinded to the
repellent application.
Repellent application
To establish the amount of repellent required for appli-
cation in the SFS experiments, surface area of the lower
limbs of three adult male volunteers was determined by
first measuring the length from ankle to the knee and
the circumference of the ankle and knee using a tape
measure. The surface area was then calculated using the
formula that expresses the lower limb surface as a tra-
pezium or cylinder:
Area ¼ 0:5 ca þ ckð ÞDka ð1Þ
where ca is the circumference of the ankle in cm, ck cir-
cumference of the knee, and Dka is the distance between
ca and ck.
Three volunteers were initially asked to apply the
repellent ad libitum (the amount they felt was safe to
protect from mosquito bites) to their legs. While apply-
ing the repellent, the volunteers wore latex gloves to
avoid absorption of repellents into their skin, which
would otherwise reduce the net quantity of repellent ap-
plied. The product bottles were then weighed using a
precision weighing balance (Ohaus Corp, Pine Brook,
NJ, USA) after this initial application to determine the
amount applied by each volunteer. The average amount
of repellent per volunteer was then calculated from these
results. The average amount applied per volunteer was
determined to be 2 mg per volunteer-leg. The average
surface area of a volunteer’s leg was 1,041 cm2. The
amount of DEET applied was 0.002 mg/cm2 (2 mg/
1,041 cm2). After amount of repellent required for appli-
cation was determined, the PI (SO) premeasured these
amounts in a Petri dish for each volunteer every evening.
The volunteers were then asked to wear latex gloves and
apply their respective amounts on their lower limbs
every evening before the start of each experiment.
Study design
The SFS experiments used a partially randomized, 3 × 3
unbalanced Latin square design. The three treatments
used in these experiments were assigned numbers: 1
(15% DEET lotion), 2 (15% DEET ethanol) and, 3 (pla-
cebo lotion). Three volunteers were used in these experi-
ments and were randomly assigned to each of the three
treatments using the lottery method. The volunteers
were also randomly assigned sitting positions inside the
SFS using the lottery method, and moved between the
positions in the same order every night. One round of
repellent evaluation was made up of three nights of
mosquito collections, with each volunteer wearing a dif-
ferent treatment and sitting at a different position on
each of these nights. A single set of three volunteers
conducted these experiments for six nights (two rounds
of repellent evaluation). For logistical reasons, the sec-
ond set of three volunteers conducted the experiments
for three nights (one round of repellent evaluation).
Therefore, the mosquitoes were collected for a total of
nine nights in the SFS, but with two different sets of vol-
unteers. Data from the three rounds was pooled. The au-
thors are aware that this limitation may have increased
data variance because of individual variability in attraction
of mosquitoes and efficiency in mosquito collections.
The PI (SO) premeasured the amounts of treatments
15 min prior (17.45), to the start of the experiments and
asked the volunteers to apply their respective amounts
on their lower limbs while wearing latex gloves. The vol-
unteers had also been asked to put on knee-length
shorts and ankle high boots, so as to standardize the
area of exposure. The volunteers sat on low stools 10 m
equidistant from each other in a triangular formation. A
cage holding 100 mosquitoes was placed at the centre of
this triangle formation. It was determined from literature
that the biting rate in the study area was 62.5 bites/per-
son/night [18]. Therefore, 100 mosquitoes were released
in each hour in the SFS containing three volunteers to
simulate the high biting pressure of the field setting. It
was assumed that only half the number of all mosquitoes
released would bite the volunteers. Therefore, each vol-
unteer would have received approximately 67 bites/per-
son/night. The average landing rates/volunteer/hour was
also determined. At the top of every hour (18.00 h-
22.00) the mosquitoes were released by one of the vol-
unteers. The experiments were conducted from 18.00
because this was the reported time of the start of biting
activity of vectors in the study area [19]. In total, four
cages containing 100 mosquitoes each were used during
each night of the SFS experiment. Each volunteer was
given a head torch, which they switched on only when
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they felt a mosquito landing on their limb or when scan-
ning the legs every 30 seconds for mosquitoes [20]. The
volunteers were also given four paper cups, marked from
the first to the fourth hour, and instructed to place the
catches for each hour in their respective cups. The paper
cups were covered with netting that had a hole at the
centre to place the mosquitoes into the paper cups,
which were plugged using a cotton wool to prevent mos-
quitoes from escaping. At the end of the experiment
(22.00), the mosquitoes collected in the four paper cups
were stored in the freezer at the IHI laboratory until the
next morning. At 09.00 the next day, the mosquitoes in
each paper cup were counted and recorded for each
hour. The mosquitoes were then discarded and the
paper cups cleaned ready for the day’s experiment.
Field evaluation of topically applied repellents
Field evaluation of repellents was conducted in Mbingu
village, described above. The experiments were con-
ducted next to the rice fields and away from human
dwellings to avoid potential bias in the number and be-
haviour of mosquitoes [21].
The field evaluation of repellents was conducted using
a partially randomized, 3 × 3 balanced Latin square de-
sign, in the same manner as the SFS repellent evaluation
described above. All field experiments were conducted
at the site identified and described above. Six volunteers,
two of whom also performed the SFS evaluations, were
recruited for field evaluation of repellents. A first set of
three volunteers conducted the repellent evaluation for
nine nights, followed by the second set of volunteers
who also conducted the experiment for nine nights at
the same site. Therefore six volunteers evaluated the re-
pellents for a total of 18 nights in the field as it was
hypothesised that there would be greater variability in
field data and more replicates would be required. The
volunteers sat 20 m equidistant from each other in a tri-
angular formation. They collected mosquitoes from
18.00 to 22.00, and placed them in the different paper
cups marked one to four hours. At the end of the collec-
tions, the paper cups holding the mosquitoes were
placed in a cool box containing a piece of cotton wool
impregnated with chloroform, which killed the mosqui-
toes. The next morning the mosquitoes in each paper
cup were counted by the respective volunteer and the
numbers recorded. The mosquitoes were sorted into
anophelines and culicines and stored in separate Petri
dishes that were layered with cotton wool and silica gel
to prevent desiccation. The mosquitoes were brought
back to the IHI laboratory where the culicines were
identified to species level by an experienced entomolo-
gist using taxonomic keys [22]. The Anopheles gambiae
complex was identified to species level using polymerase
chain reaction (PCR) [23].
Statistical analysis
Calculation of percentage protection
Data from the SFS and field trials were recorded in a
Microsoft Excel spreadsheet (Microsoft Corporation),
with columns for the date, name of volunteer, treatment
the volunteer was wearing, position the volunteer was
sitting and the number of mosquitoes caught during
each hour. This data was then exported into STATA 11
(StataCorp LP, College Station, Texas, USA), where the
total number of mosquitoes caught when using 15%
DEET lotion and 15% DEET in ethanol were compared
to the total number of mosquitoes caught when using
the placebo lotion for each night regardless of who was
using it, and an average was calculated. The reductions
in number of mosquitoes in these two treatments (15%
DEET lotion and 15% DEET in ethanol) were designated
protection and expressed as a percentage, (percentage
protection). The formula used to calculate percentage
protection is shown below:
P ¼ C‐T½ =C 100 ð2Þ
where C is the number of mosquitoes caught when the
volunteer was using the placebo lotion and T is number
of mosquitoes caught when the volunteer was using ei-
ther the 15% DEET lotion or 15% DEET ethanol.
These results for each night of collection were then
aggregated and the average percentage protection when
using either 15% DEET ethanol or 15% DEET ethanol
calculated using STATA 11.
Poisson regression analysis
Count data was then fitted into a Poisson model in
STATA 11, with a log link function and a random inter-
cept for each row of data to account for over dispersion,
so as to determine relative risk of being bitten by a mos-
quito. A Poisson model was chosen because it is used to
model count data over a specified period of time, i.e. the
number of mosquito bites occurring in one hour. It is
also used to model rare events (mosquito bites), which is
what was expected when a volunteer was wearing either
15% DEET lotion or 15% DEET ethanol. A Poisson
model also allowed for analysis of repeated measures
over time on the same individual, i.e. the number of
mosquitoes caught by each individual on each day while
wearing a different repellent and sitting at a different
position. The number of mosquitoes caught/hour was
fitted as the dependent variable, and interaction of
repellent with time, individual variability and position
fitted as predictors. Day (which also accounted for con-
founders like temperature, humidity and wind speed),
was fitted as a random covariate, and a random inter-
cept, in this case a Unique ID, was fitted into the model
to account for over dispersion of the data.
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The percentage protection of 15% DEET lotion and
15% DEET ethanol per hour and regression coefficients
relative to the placebo (Incidence Rate Ratio, IRR) were
determined to assess the decay of repellents through
time.
Ethical considerations
The volunteers used in these experiments were recruited
on written informed consent. In case of any positive
blood slide for malaria parasites, ALU combination
therapy, the first-line drug for malaria treatment in
Tanzania, was available. The volunteers were also in-
formed of the study objectives and that they were free to
withdraw their participation at any time during the ex-
periments. The volunteers were experienced in human
landing catch techniques and were issued with loose net
jackets to prevent the mosquitoes biting the upper parts
of the body. For field experiments, the volunteers were
provided with mefloquine prophylaxis to protect them
against contracting malaria. Ethical approval was granted
by the Ethical Review Boards of Ifakara Health Institute
(IHRDC IRB A46), the Tanzanian National Institute of
Medical Research (NIMR/HQ/R8a/VOL IX/780), and
London School of Hygiene of Tropical Medicine (LSHTM
5174).
Results
Semi-field experiments
Average percentage protection
The average percentage protection of 15% DEET lotion
in the SFS as calculated from Equation 2 above was
82.13% (95% CI 75.93-88.82) and 71.29% (95% CI 61.77-
82.28) for 15% DEET in ethanol over four hours of mos-
quito collection.
Poisson regression analysis
The relative risk of being bitten by a mosquito over the
four hour test when using 15% DEET lotion compared
to placebo lotion was reduced by 91.8% (95% CI 85.73-
95.79%, IRR = 0.082 z = −8.23, P <0.0001). When 15%
DEET ethanol was compared to the placebo lotion, the
relative risk of being bitten by mosquitoes was also re-
duced by 92.30% (95% CI 85.06-95.45%, IRR = 0.077, z =
−8.21, P <0.0001) (Table 1). The relative risk of being bit-
ten increased in hours two and three relative to hour one,
although these differences were not significant. There was,
however, a significant increase in the risk of being bitten
in hour four compared to hour one for both 15% DEET
lotion IRR = 3.71 (95% CI 1.78-7.78, z = 3.47, P = 0.001)
and 15% DEET ethanol IRR = 3.43 (95% CI 1.60-7.39, z =
3.17, P = 0.002). This is an indication of repellent decay
over time. There was location bias, with position 3 having
a higher risk of being bitten compared to location one,
IRR 2.00 (95% CI 1.51-2.66, z = 4.79, P <0.0001). Position
3 within the SFS was located closest to a nearby restaurant
and the mosquitoes were probably more attracted to the
light and human cues. There was variability in individual
attractiveness to mosquitoes, (Table 1).
Field trial experiments
Mosquito species composition in the study area
A total of 4,844 mosquitoes were caught in 72 hours
over 18 nights. The catch included: 295 (5.4%) An. gam-
biae s.l. ,3,082 (64.6%) Mansonia africanus, 467 (9.8%)
Mansonia uniformis, 673 (14.1%) Coquillettidia aureus,
210 (4.4%) Culex univattus and 177 (3.7%) other Culex
species (Figure 1).
Anopheles gambiae s.l. composition in the study area
All the An. gambiae s.l. caught were identified to species
level by PCR. Out of the 295 successful PCR amplifications,
Table 1 Effect of 15% DEET repellent over time, treatment,
position and person on Anopheles arabiensis in a four-hour
repellent evaluation in the semi-field system at Ifakara
Health Institute
Treatments Hours Incidence rate ratio
(IRR)1 [95% CI]
Z-test
statistic2
P-value3
15% DEET
in ethanol
1 - - -
2 1.744 [0.796-3.819] 1.39 0.164
3 1.223 [0.559-2.675] 0.51 0.613
4 3.708 [1.767-7.780] 3.47 0.001
15% formulated
DEET repellent
1 - - -
2 0.877 [0.359-2.140] −0.29 0.774
3 1.674 [0.756-3.709] 1.27 0.204
4 3.439 [1.601-7.386] 3.17 0.002
Treatments
Placebo - - - -
15% DEET
in ethanol
- 0.082 [0.045-0.149] −8.23 <0.0001
15% DEET in
lotion format
- 0.077 [0.042-0.142] −8.21 <0.0001
Position
1 - - - -
2 - 0.818 [0.587-1.139] −1.19 0.236
3 - 2.000 [1.506-2.656] 4.79 <0.0001
Person
1 - - - -
2 - 0.619 [0.441-0.868] −2.78 0.005
3 - 2.372 [1.796-3.133] 6.08 <0.0001
1The data for position one, person one and effect of treatments in hour one
were used as a reference values for calculating the incidence rate ratios (IRR)
for mosquito bites. 2The test statistic z is the ratio of the Coefficient to the
Standard error of that respective predictor and is used to test against a
two-sided alternative hypothesis that the Coefficient is not equal to zero. 3The
probability (P) that a particular z test statistic is different to what has been
observed under the null hypothesis.
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12.88% (n = 38) were An. gambiae s.s, while 87.12%
(n = 257) were An. arabiensis (Figure 1).
Average percentage protection
The average percentage protection, of 15% DEET lotion in
the field was 85.10% (95% CI 78.97-91.70) and 88.24%
(95% CI 84.45-92.20) for DEET ethanol over four hours of
mosquito collection, as calculated from Equation 2.
Poisson regression analysis
The relative risk of being bitten by a mosquito over the
four hour test when using 15% DEET lotion was reduced
by 94.78% (95% CI 91.46-96.81%, IRR = 0.052, z =
−11.74, P <0.0001) compared to the placebo lotion and
96.41% (95% CI 93.94-97.88%, IRR = 0.035, z = −12.42,
P <0.0001) while using 15% DEET in ethanol (Table 2).
The risk of being bitten in the fourth hour increased
three-fold compared to the first hour when using 15%
DEET in ethanol IRR = 3.03 (95% CI 1.52-6.01, z = 3.17,
P = 0.001). There was, however, no significant increase
in the risk of bitten through hours 1 to 4 when using
15% DEET lotion repellent (Table 2). There was lower
variability in individual attractiveness to mosquitoes,
with only volunteer 2 being significantly more attractive
to mosquitoes, IRR = 4.89 (95% CI 3.51-6.82, z = 9.38,
P <0.0001). This individual was consistently more attract-
ive in all field experiments. In this field study, the volun-
teers recruited had differing body mass. There were
volunteers who had a larger body mass than this individ-
ual but caught fewer mosquitoes when they were
compared. Also, even though all team members were
highly experienced, there were more experienced field
technicians who did not catch as many mosquitoes as this
individual. All volunteers use the same concentration and
gram/cm2 repellents per body surface area, ruling out the
potential bias of one volunteer applying more repellent.
Studies have shown variable responses of mosquitoes to
singular or constituent host attractive cues. It is therefore
likely that, the combination of this volunteers body cues/
odours [24], made him more attractive to mosquitoes than
the combination of cues that were emitted by the other
volunteers.
Anopheles gambiae experiments
Data on An. gambiae s.l. from the study area was ana-
lysed separately to determine the efficacy of repellents
on this species of major medical importance.
Figure 1 Pie chart showing mosquito species composition
caught in Mbingu village during human landing catches
sampled over 18 nights in field experiments at Mbingu village.
Table 2 Effect of 15% DEET repellent over time, treatment,
position, and person on total number of mosquitoes in a
four-hour repellent evaluation in the Mbingu village
Treatments Hours Incidence rateratio1 [95% CI]
Z-test
statistic2
P-value3
15% DEET in lotion
format
1 - - -
2 0.839 [0.422-1.667] −0.50 0.618
3 1.133 [0.578-2.222] 0.37 0.714
4 1.699 [0.873-3.307] 1.56 0.118
15% DEET in ethanol
1 - - -
2 0.791 [0.381-1.641] −0.63 0.529
3 2.049 [1.027-4.090] 2.04 0.042
4 3.027 [1.524-6.011] 3.17 0.002
Treatments
Placebo - - - -
15% DEET in lotion
format
- 0.052 [0.038-0.085] −11.74 <0.0001
15% DEET in
ethanol
- 0.035 [0.021-0.060] −12.42 <0.0001
Position
1 - - - -
2 - 1.091 [0.851-1.400] 0.69 0.498
3 - 0.876 [0.684-1.123] −1.04 0.299
Person
1 - - - -
2 - 4.892 [3.511-6.816] 9.38 0.000
3 - 1.392 [0.973-1.987] 1.81 0.070
4 - 1.065 [0.624-1.820] 0.23 0.815
5 - 0.933 [0.54 0–1.611] −0.25 0.804
6 - 1.377 [0.808-2.347] 1.18 0.239
1The data for position one, person one and effect of treatments in hour one
were used as a reference values for calculating the incidence rate ratios (IRR)
for mosquito bites. 2The test statistic z is the ratio of the Coefficient to the
Standard error of that respective predictor and is used to test against a two-
sided alternative hypothesis that the Coefficient is not equal to zero. 3The
probability (P) that a particular z test statistic is different to what has been
observed under the null hypothesis.
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Average percentage protection
The average percentage protection of 15% DEET lotion
in the field was 93.40% (95% CI 89.21-97.79) and 91.45%
(95% CI 85.79-97.47) for 15% DEET in ethanol over
four hours of mosquito collection, as calculated from
Equation 2.
Poisson regression analysis
The relative risk of being bitten when using 15% DEET
lotion was reduced by 82.86% (95% CI 53.26-93.71, IRR =
0.171, z = −3.45, P = 0.001) when compared to placebo lo-
tion and by 83.43% (95% CI 55.81-93.79, IRR = 0.165, z =
−3.59, P <0.0001) when using15% DEET in ethanol over
the four hours of the test. There was no significant differ-
ence in the average number of An. gambiae s.l. caught at
the different positions in the field, in each hour or by each
treatment in each hour over the four hours of mosquito
collections demonstrating consistent protection. There
was however a significant difference in the average num-
ber of An. gambiae s.l. caught by volunteer 2: IRR = 2.66
(95% CI 1.42-4.98, z = 3.06, P = 0.002) and volunteer 6:
IRR 0.26 (95% CI 0.81-0.84, z = −2.25, P = 0.025) relative
to volunteer 1 (Table 3).
Comparison of full field and semi-field system data
Decay of repellent from the Poisson regression equations
(Tables 1 and 2) and the linear regression demonstrated
that 15% DEET in lotion format decayed at a slower rate
than 15% DEET in ethanol in both the SFS and field set-
tings. A linear regression also demonstrated a similar
trend with regression coefficients showing a more rapid
decay of 15% DEET in ethanol in the SFS and against all
mosquitoes in the field, with equal decay of the two for-
mulations against An. gambiae s.l. in the field (Table 4).
However, the results from the linear regression equations
(regression coefficients) should be interpreted with cau-
tion as the data were over dispersed even after transform-
ation to a proportion (percentage protection) and Linear
regression is a parametric test that assumes equal vari-
ance around the mean. The percentage protection pro-
vided by 15% DEET lotion and 15% DEET in ethanol was
similar in the SFS and field settings and on both occa-
sions both treatments provided greater protection in the
field than in the SFS (Figure 2). When the two treatments
(15% DEET lotion and 15% DEET ethanol) were com-
pared statistically there was no difference between the
two measured in the SFS IRR = 0.904 (95% CI 0.44-2.80,
p = 0.833) nor the field IRR = 0.621 (95% CI 0.316-1.221,
p = 0.168).
Discussion
The epidemiology of malaria in sub-Saharan Africa is ex-
periencing a subtle shift. Before the advent of LLINs and
indoor residual spraying (IRS), malaria transmission was
mediated indoors and late in the night mainly by An.
gambiae s.s. This species of the An. gambiae complex is
known to be predominantly anthropophilic, endophagic
and endophilic [25,26]. This characteristic is responsible
for the success of LLINs and IRS in controlling An. gam-
biae s.s., as these tools predominantly target indoor bit-
ing and resting malaria vectors. However, An. arabiensis,
the other dominant vector species of the An. gambiae
complex [26] exhibits a more plastic behaviour [27]. In
areas where the host is predominantly human and found
indoors, this vector displays anthropophilic, endopahgic
and endophilic behaviour, similar to its sibling species,
An. gambiae s.s. However in areas where the host are
Table 3 Effect of 15% DEET repellent over time, treatment,
position, and person on Anopheles arabiensis in a four-hour
repellent evaluation in the Mbingu village
Treatments Hours Incidence rate ratio(IRR)1 [95% CI]
Z-test
statistic2
P-value3
15% DEET in lotion
format
1 - - -
2 0.403 [0.083-1.956] −1.13 0.260
3 0.326 [0.068-1.550] −1.41 0.159
4 0.722 [0.185-2.812] −0.47 0.639
15% DEET in
ethanol
1 - - -
2 1.229 [0.343-4.399] 0.32 0.750
3 1.963 [0.583-6.621] 1.09 0.277
4 1.370 [0.400-4.693] 0.86 0.500
Treatments
Placebo - - - -
15% DEET in lotion
format
- 0.171 [0.063-0.467] −3.45 0.001
15% DEET in
ethanol
- 0.165 [0.062-0.441] −3.59 <0.0001
Position
1 - - - -
2 - 0.932 [0.542-1.602] −0.25 0.800
3 - 1.262 [0.750-2.126] 0.88 0.380
Person
1 - - - -
2 - 2.660 [1.420-4.979] 3.06 0.002
3 - 1.801 [0.924-3.510] 1.73 0.084
4 - 0.381 [0.127-1.141] −1.72 0.085
5 - 0.328 [0.106-1.015] −1.93 0.053
6 - 0.262 [0.081-0.841] −2.25 0.025
1The data for position one, person one and effect of treatments in hour one
were used as a reference values for calculating the incidence rate ratios (IRR)
for mosquito bites. 2The test statistic z is the ratio of the Coefficient to the
Standard error of that respective predictor and is used to test against a two-
sided alternative hypothesis that the Coefficient is not equal to zero. 3The
probability (P) that a particular z test statistic is different to what has been
observed under the null hypothesis.
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found outdoors and are non-human, An. arabiensis
readily shifts to exophagic, exophilic and zoophagic be-
haviour [25]. Therefore, extensive and long-term em-
ployment of LLINs and IRS is likely to significantly
diminish and in some situations completely eliminate
the populations of An. gambiae s.s., thereby selecting for
the highly adaptable An. arabiensis that predominantly
bites early in the evening and outdoors [27]. As a result,
even though LLINs and IRS will decrease malaria trans-
mission as a whole, there will be a substantial proportion
of residual transmission occurring outdoors and in the
early evenings that these intradomiciliary tools cannot
tackle [27].
Consequently, there is a need to develop novel tools
or methods that can tackle this residual transmission.
Repellents, both topical and spatial, provide a promising
solution for controlling outdoor transmission [28-30].
However before topical repellents are employed in the
community, their performance needs to be correctly and
accurately measured under user conditions. It is, there-
fore, essential to develop a robust methodology for test-
ing repellent efficacy that is representative of conditions
under which the repellents are used (the community),
but does not expose individuals conducting these experi-
ments to potential malaria vectors [1,2]. It was hypothe-
sized that locating the SFS in regions representative of
ambient conditions for the targeted disease vector and
testing repellents on humans against these vectors is
likely to yield results that correlate well with field tests.
Therefore, to qualify the effect of these treatments in
these two settings, data for An. arabiensis in the SFS was
analyzed against data of An. gambiae s.l. in the field ex-
periments (as > 80% of this species complex was found
to be An. arabiensis).
Table 4 Comparison of rate of decay of repellents, percentage protection and log-transformed means of mosquito
catches per hour in the semi-field system against Anopheles arabiensis and in the field against all mosquito species
and Anopheles arabiensis
Experiment Hour Regression equation Treatments GEOMEAN Percentage protection (CI)*
Semi-field evaluation against An. arabiensis
1
Y = −0.0765 + 1.0315 Lotion-based 15% DEET
repellent
2.69 90.88 (84.25-98.03)
2 1.7 91.85 (84.85-99.43)
3 3.1 82.60 (70.39-96.93)
4 R2 = 0.29138 4.63 65.97 (52.28-83.24)
1
Y = −0.119x = 0.9685
15% DEET in ethanol
4.65 75.55 (51.79-110.20)
2 3.63 70.76 (54.63-91.65)
3
R2 = 0.08181
3.17 82.18 (61.19-110.36)
4 6.26 58.42 (40.45-84.36)
Field evaluation against all
mosquito species
1
Y = −0.0077x + 0.8921 Lotion-based 15% DEET
repellent
4.77 87.39 (76.49-99.83)
2 4.03 88.92 (79.15-99.88)
3 5.44 85.99 (76.30-96.90)
4 R2 = 0.00174 8.03 83.98 (73.78-94.19)
1
Y = −0.0427x + 1.0009
15% DEET in ethanol
4.22 91.98 (84.14-100.55)
2 5.94 95.11 (91.02-99.37)
3
R2 = 0.11871
10.89 87.87 (83.08-92.95)
4 13.5 79.03 (69.14-90.33)
Person
Field evaluation against An. arabiensis
1
Y = 0.0311x + 0.7904
Lotion-based 15% DEET
repellent
1.22 92.58 (83.18-103.05)
2 1.25 100.00 (100.00-100.00)
3 1 92.60 (84.30-101.72)
0.06763
4 1.64 88.02 (76.15-101.75)
1
Y = 0.0208 + 0.6235
15% DEET in ethanol
0.72 95.20 (87.33-103.78)
2 0.94 94.93 (87.85-102.57)
3
R2 = 0.045263
1.5 82.26 (61.18-110.61)
4 1.17 91.15 (83.82-101.31)
*Some confidence intervals exceed 100% because the ranges were calculated by regression analysis using continuous data. They should therefore be read as
100% efficacy.
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The findings demonstrated that 15% DEET lotion pro-
tected against 82.13% (95% CI 75.93-88.82) of the bites
in the SFS compared to 93.40% (95% CI 89.21-97.79)
protection against bites in the field, while 15% DEET in
ethanol protected against 71.29% (95% CI 61.77-82.28)
bites in the SFS compared 91.45% (95% CI 85.79-97.47)
bites in the field against An. gambiae s.l. These results
demonstrate that both 15% DEET lotion and 15% DEET
repellent were more efficacious in the field than in the
SFS. A plausible explanation for this might be the high
biting pressure observed in the SFS compared to the
field. Mosquitoes were exposed to fewer hosts than they
normally would in the field and their numbers were con-
tinuously increased from 100 mosquitoes in the first
hour to 400 mosquitoes in the fourth hour (Figure 2,
Tables 5 and 6). By simulating high biting pressure
that increased over time as is seen in the field due to
the circadian rhythm of the local malaria vectors [19],
the authors ensured that the repellent worked ex-
tremely well against the predominant malaria vector
species before going to the more dangerous field set-
ting. It is known that repellents have varying effects
on the other mosquito species present in the field
[6,31]. As a result, the effect of the repellent in the
field might be over or underestimated depending on
the other species present in the field. It is, therefore,
prudent, that before the effect of a repellent is estab-
lished, it should be tested against different mosquito
species to assess its efficacy. These data showed that
DEET efficacy against one Anopheline species only in
the SFS was similar to that for a range of non-
anophelines in the full field although this needs to be
validated for other repellent classes, as not all repel-
lents are broad-spectrum.
It is often assumed that formulated repellents provide
longer protection against arthropod bites, especially
those that have a high vapour pressure. However, find-
ings from this study demonstrate that this may not
always be true, and that different formulations of
Figure 2 Comparison of percentage protection of 15% DEET lotion repellent and 15% DEET ethanol against Anopheles arabiensis in
the semi-field system, all mosquito species in the field and Anopheles arabiensis in the field after four hours of mosquito collection.
L-Field total is 15% DEET lotion tested against all mosquito species in the field. L-Field Arabiensis is 15% DEET lotion against An. arabiensis in the
field. L-SFS is 15% DEET lotion against An. arabiensis in the semi-field system. D-Field total is 15% DEET in ethanol tested against all mosquito
species in the field. D-Field Arabiensis is 15% DEET in ethanol against An. arabiensis in the field. D-SFS is 15% DEET in ethanol against An. arabiensis
semi-field system.
Table 5 Mean landing rates (MLR) of An. arabiensis/
volunteer/hour in a four hour repellent evaluation in the
Semi-field system at the Ifakara Health Institute
Volunteer 1
median (IQR)
Volunteer 2
median (IQR)
Volunteer 3
median (IQR)
Placebo
Hour 1 17 (6–20) 22 (11–27) 41 (19–46)
Hour 2 16 (13–19) 18 (8–18) 17 (16–43)
Hour 3 14 (10–24) 24 (6–29) 37 (18–56)
Hour 4 14 (11–30) 16 (8–20) 28 (12–36)
15% DEET in ethanol
Hour 1 0 0 12 (1–13)
Hour 2 1 (0–3) 1 (0–5) 8 (7–10)
Hour 3 1 (0–1) 0 (0–1) 9 (6–19)
Hour 4 4 (1–10) 4 (0–4) 19 (7–18)
15% DEET in lotion
formulation
Hour 1 2 (0–4) 0 (0–1) 4 (2–6)
Hour 2 1 (1–5) 2 (0–2) 1 (1–5)
Hour 3 3 (2–15) 2 (0–2) 3 (2–4)
Hour 4 3 (2–17) 3 (2–5) 8 (4–10)
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repellents containing the same amount of active ingredi-
ent (AI) provide relatively similar efficacy against arthro-
pod bites. These findings are similar to a study carried
out to test the efficacy of different formulations of repel-
lents against ticks [32,33].
This is the first study known to have compared the ef-
ficacy of topical repellent in both the SFS and field and
to determine a correlation between these two settings.
However, the current study did suffer from some short-
comings, and an attempt to outline a rationale proced-
ure for conducting future studies incorporating the
lessons learnt from this study is suggested below.
A fully randomized, balanced Latin square design
should be employed, so that each volunteer tests each of
the repellents in all positions available in the SFS. Each
volunteer should test each treatment for an equal num-
ber of days in each position. The treatments and posi-
tions should be randomly assigned to the volunteers and
the movement through these positions should be also be
randomized. The exact number volunteers testing the
repellents should be established, and this number used
to calculate the average repellent dose to be applied per indi-
vidual/surface area. This is to avoid under or overestimating
the repellent dose required per person in a case where
fewer or more individuals are used to establish the
amount of repellent required than those actually testing
the repellents. Each group of volunteers testing the repel-
lents should perform an equal number of replicates so that
the results are not confounded by individual variability in
attractiveness of mosquitoes, a bias that is minimised
when all volunteers have equal number of replicates. All
repellent application should be done by an individual
wearing gloves, either by the volunteers themselves or an
assistant, to prevent repellent absorption into the skin,
thereby reducing net amount of repellent being applied.
The local dominant vector species, the biting rate per
night and time of biting should be established and the
number of mosquitoes representative of the biting rate
used in the study. The experiments should also be started
at the beginning of peak biting activity of the dominant
vector in the local area, to avoid interfering with the circa-
dian rhythm. Varying the biting pressure and peak biting
times may vary the results of the SFS.
Using a new model of repellent efficacy as a function
of user compliance and malaria intensity developed by
SJM and Briet (personnal communication), the predicted
reduction in malaria provided by the repellent in this
scenario would be 44%, assuming 80% repellent efficacy
and 80% compliance among users with a sporozoite
index of 0.005637 (Okumu, personnal communication),
a transmission season of 200 days per year and biting
pressure of 32 bites per night from the major malaria
vector An. arabiensis [34].
Conclusion
The findings of this study support the hypothesis that
repellent testing conducted in SFS yields similar results
to field tests, and could be used in place of field tests, to
avoid unnecessary exposure of volunteers to potentially
infectious disease vectors, provided repellent efficacy is
established against a range of representative mosquito
species.
Table 6 Mean landing rates of An. gambiae s.l/volunteer/hour in a four hour repellent evaluation in Mbingu village
Volunteer 1
median (IQR)
Volunteer 2
median (IQR)
Volunteer 3
median (IQR)
Volunteer 4
median (IQR)
Volunteer 5
median (IQR)
Volunteer 6
median (IQR)
Placebo
Hour 1 10 (2–10) 2 (0–3) 4 (1–5) 0 (0–2) 0 (0–6) (0)
Hour 2 2 (1–7) 4 (2–4) 3 (1–4) 2 (0–5) 1 (0–3) 1 (0–3)
Hour 3 4 (1–22) 3 (0–6) 10 (1–13) 0 (0–3) 0 (0–4) 0 (0–4)
Hour 4 4 (0–6) 3 (1–7) 11 (3–12) 0 (0–8) 2 (0–3) 0 (0–5)
15% DEET in ethanol
Hour 1 0 (0–0) 2 (1–9) 0 (0–1) 0 (0–0) 0 (0–0) 0 (0–0)
Hour 2 0 (0–1) 1 (0–7) 2 (0–6) 0 (0–0) 0 (0–0) 0 (0–0)
Hour 3 0 (0–3) 4 (1–8) 2 (0–4) 0 (0–5) 0 (0–0) 0 (0–0)
Hour 4 0 (0–0) 4 (1–5) 3 (1–6) 0 (0–0) 0 (0–0) 0 (0–1)
15% DEET in lotion
Hour 1 0 (0–0) 0 (0–1) 0 (0–1) 0 (0–1) 0 (0–2) 1 (0–1)
Hour 2 0 (0–0) 0 (0–2) 0 (0–0) 1 (0–1) 0 (0–0) 0 (0–0)
Hour 3 0 (0–1) 1 (0–1) 0 (0–0) 0 (0–0) 0 (0–1) 0 (0–0)
Hour 4 0 (0–0) 2 (0–3) 0 (0–2) 0 (0–0) 0 (0–0) 0 (0–0)
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A cluster-randomized controlled trial to assess the
effectiveness of using 15% DEET topical repellent
with long-lasting insecticidal nets (LLINs) compared
to a placebo lotion on malaria transmission
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Abstract
Background: Long-lasting insecticidal nets (LLINs) have limited effect on malaria transmitted outside of sleeping
hours. Topical repellents have demonstrated reduction in the incidence of malaria transmitted in the early evening.
This study assessed whether 15% DEET topical repellent used in combination with LLINs can prevent greater
malaria transmission than placebo and LLINs, in rural Tanzania.
Methods: A cluster-randomized, placebo-controlled trial was conducted between July 2009 and August 2010
in a rural Tanzanian village. Sample size calculation determined that 10 clusters of 47 households with five
people/household were needed to observe a 24% treatment effect at the two-tailed 5% significance level, with
90% power, assuming a baseline malaria incidence of one case/person/year. Ten clusters each were randomly
assigned to repellent and control groups by lottery. A total of 4,426 individuals older than six months were enrolled. All
households in the village were provided with an LLIN per sleeping space. Repellent and placebo lotion was
replaced monthly. The main outcome was rapid diagnostic test (RDT)-confirmed malaria measured by passive
case detection (PCD). Incidence rate ratios were estimated from a Poisson model, with adjustment for potential
confounders, determined a priori. According-to-protocol approach was used for all primary analyses.
Results: The placebo group comprised 1972.3 person-years with 68.29 (95% C.I 37.05-99.53) malaria cases/1,000
person-years. The repellent group comprised 1,952.8 person-years with 60.45 (95% C.I 48.30-72.60) cases/1,000
person-years, demonstrating a non-significant 11.44% reduction in malaria incidence rate in this group, (Wilcoxon
rank sum z = 0.529, p = 0.596). Principal components analysis (PCA) of the socio-economic status (SES) of the two
groups demonstrated that the control group had a higher SES (Pearson’s chi square = 13.38, p = 0.004).
Conclusions: Lack of an intervention effect was likely a result of lack of statistical power, poor capture of malaria
events or bias caused by imbalance in the SES of the two groups. Low malaria transmission during the study
period could have masked the intervention effect and a larger study size was needed to increase discriminatory
power. Alternatively, topical repellents may have no impact on malaria transmission in this scenario. Design and
implementation of repellent intervention studies is discussed.
Trial registration: The trial was registered ISRCTN92202008 - http://www.controlled-trials.com/ISRCTN92202008
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Background
In the past decade, considerable financial and political re-
sources have been mobilized for malaria control [1]. This
has in turn led to extensive coverage and use of existing
control tools, like long-lasting insecticidal nets LLINs and
indoor-residual spraying (IRS) [1]. Implementation of these
highly effective vector control tools has resulted in substan-
tial decrease in malaria transmission, morbidity and mortal-
ity [2-4]. Despite both extensive coverage and use, the sole
use of these tools have not and will not be able to eliminate
malaria in all malaria endemic regions [5]. Because LLINs
and IRS target mainly indoor biting and indoor resting
vectors their implementation may select for outdoor resting
and biting vector populations that often become dominant,
so that even though there is a diminished malaria transmis-
sion as a result of extensive LLINs and IRS use, there is
likely to be a larger proportion of this residual transmission
occurring outdoors compared to indoors [6].
Increased urbanization and rural electrification pro-
grammes have also had an impact on malaria transmission
dynamics. As a result of this, individuals stay up later in
the evenings than they usually would in a situation where
electricity was not available [7], and are, therefore, exposed
to potentially infective mosquito bites for longer.
With the renewed push for malaria elimination [8], it is
evident that new tools need to be developed to augment
existing vector control tools to achieve this goal. Topical
repellents provide excellent personal protection [9] and
could potentially be used to complement LLINs for add-
itional protection from residual transmission [5]. Several
studies demonstrated that topical repellents offer additional
protection from malaria transmission either when used
alone, or in combination with LLINs, in areas with high
early evening and outdoor malaria transmission [10-12].
This study assessed the potential additional benefit of
using topical repellents in combination with LLINs
compared to using only LLINs on early evening malaria
transmission in a rural community in Kilombero valley,
south-west Tanzania.
This community mainly relies on subsistence farming
of rice, which provides for a large breeding site for both
malaria vectors and nuisance biting mosquitoes [13]. It
is customary that the community in the study area cook
outdoors in the early evenings, a situation that is likely
to expose them to mosquito bites and potential malaria
transmission. Rural development is also rapidly taking place
in this study area. As a result, many members of the com-
munity usually gather in the early evening and stay late into
the night at local entertainment spots that are springing up
in the study area owing to rural electrification programmes,
thereby increasing the potential of malaria transmission at
these times. A recent report estimates a malaria incidence
rate of 0.67 cases/person/year confirmed by rapid diagnos-
tic test (RDT) from passive case detection at a local clinic
between December 2012 and July 2013 (Jabari Mohammed
Namamba, pers. comm.).
In the past two decades, extensive malaria intervention
programmes have taken place in this area, and it is there-
fore expected that the community be highly sensitized on
malaria transmission and control methods [14-17]. There
is high LLIN use in the study area [18]. Repellent aware-
ness and knowledge as assessed using a Knowledge, Atti-
tude and Practice (KAP) baseline questionnaire at the
inception of the clinical trial determined that this commu-
nity did not use topical repellents as a mosquito control
tool. Awareness and availability were reported as the major
reasons for not using topical repellents [Sangoro O, Sarah
M, Ann HK, Sarah M: Feasibility of repellent use in a
context of increasing outdoor transmission: A Qualitative
study in rural Tanzania, submitted to Malaria Journal for
publication].
The major malaria vector in the study area is Anopheles
arabiensis [19], which has been shown to exhibit elastic
feeding behaviour depending on the availability and loca-
tion of the host [6] and is known to exhibit early evening
biting [20]. The dominance of this vector in this area is
also likely to be the result of extensive LLIN use in the
study area [21,22].
A field study conducted in the study area to determine the
efficacy of this repellent (15% DEET) against An. arabiensis
demonstrated >80% protection from bites over four hours
of mosquito collection [19]. Therefore, 15% DEET was
considered appropriate to provide protection against early
evening biting.
This study area was chosen because there are no studies
that have been conducted to assess the additional benefits
of topical repellents to LLINs in malaria control in East
Africa, although this technology has been shown to work
elsewhere in sub-Saharan Africa [23,24]. Also the vectors
present in the area, An. arabiensis, exhibit early evening bit-
ing [20], a trait that made the use of repellents in the early
evening ideal in this area. Therefore, even though extensive
employment of current control tools will lower malaria
transmission in this area, its is likely that residual transmis-
sion will continue occur at times when the effectiveness of
these tools is diminished, like outdoors in the early evenings
and mornings, [6] and will require supplementary tools that
target this scenario.
Therefore, it was hypothesized that combined use of
LLINs and topical repellents in this community would
have a greater impact on malaria transmission in the
early evening compared to sole use of LLINs.
Methods
Study area
The study was carried out in Mbingu village, Ulanga dis-
trict, situated 55kms west of Ifakara town at 8.195°S and
36.259°E. At the time of the study inception, (July 2009),
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the village was estimated to have 7,609 inhabitants [25].
There is moderate malaria transmission in the study area,
with peak transmission occurring in the months of May
and June after the long rains. The village experiences an
annual rainfall of approximately 1,200-1,800 mm and an
annual temperature range of between 20°C and 32.6°C.
The village borders an extensive field cleared for rice irri-
gation, which provides an ideal breeding site for malaria
vectors [13].
Sample size rationale
The only available data from the study area were commu-
nity reported fever incidence rate estimates of 3.2 cases/
person/year for children under the age of five years [26].
Assuming fever rates in children under five years are
higher than the rest of the population, and that not all
fevers reported are caused by malaria, a rate of one mal-
aria case/person/year was used to calculate the sample size
needed for this study. Available reports also indicated that
30% of mosquito bites occurs in the early evening [20].
Therefore, assuming that mosquitoes have an equal prob-
ability of carrying sporozoites regardless of time of night,
it was assumed there was a potential 30% malaria trans-
mission occurring in the early evenings. Expecting that re-
pellents would reduce 80% of this potential 30% early
evening transmission, as observed from the field study [19],
it was reasoned that repellents would reduce the overall
transmission of malaria from one case/person/year to 0.76
cases/person/year. Using the methods of Hayes et al. [27]
for sample size calculation for cluster randomized trials, it
was estimated that to observe this treatment effect (24%),
with 90% power at the two-tailed 5% significance level, 10
clusters of 47 households with five members each was
required per treatment group. A coefficient of variation (k)
of 0.20 was used based on published recommendations as
the inter-cluster variation could not be estimated [28].
Household recruitment
Households were recruited into the study in two phases.
In phase one, the study investigators and field team visited
the study village for reconnaissance and introduction to
the community leaders and members in December 2008.
A week later, the study team returned to the study village
and aided by community leaders, identified the centre of
the village. Here, the field team spun a ballpoint pen and
visited all the households that the writing end of the pen
pointed to with the intention of recruiting all consenting
households into the study. After all households in this dir-
ection had been exhausted, the field team went back to the
village centre and spun the pen to choose the next direction
in which to visit the households. If the pen pointed in the
direction where the households were already visited, then,
the pen was spun again until a new direction was identi-
fied. This progression was repeated until approximately,
1,000 households had been visited and recruited. The vil-
lage had 2,000 households [25] and, therefore, by visiting
and potentially enrolling at least 50% of the households,
the study team were confident that they had captured a
representative sample of households in the study area.
Enrolment of households into the study
During the household recruitment visits, each household
head was informed of the purpose of the visit. They were
educated on the objectives, risks and benefits of the
study to their household and the community. They were
encouraged to ask questions and after all their concerns
had been addressed, they were asked if they were willing
to participate in the study. If willing, each household
head was asked to sign a written informed consent form,
confirming their participation and that of all household
members. As data was being collected at the household
level, only the household head was asked for informed
consent. It was assumed that once that household head
gave consent then all household members would likely
comply with repellent use following instructions of the
household head as the authority in each household. A
structured questionnaire on the socio-economic status
(SES) of the household and knowledge, attitude and
practice (KAP) in relation to malaria and repellents was
then administered [Sangoro O, Sarah M, Ann HK, Sarah
M: Feasibility of repellent use in a context of increasing
outdoor transmission: A Qualitative study in rural
Tanzania, submitted to Malaria Journal for publication].
The GPS coordinate of the household enrolled was then
recorded using a handheld GPS receiver (Garmin eTrex
Legend® H). These coordinates were then plotted using
Arc GIS software (Arc GIS 9.0, ESRI, UK), to generate a
map of all the households enrolled in the study area.
Second phase of household recruitment, household
enrolment and cluster generation
In phase two, the map generated during the first phase of
recruitment was used to delineate 20 clusters of households
each while ensuring a buffer zone of 200 metres between
clusters to prevent diversion of mosquitoes from the inter-
vention group to the control group. As a result of creation
of this buffer area, some households that had been re-
cruited in the first phase fell within this 200 metre buffer
area. These households were excluded from the study
during this second phase of recruitment. Therefore, even
though about 1,000 households were recruited in the first
phase, more households needed to be recruited in the
second phase as a result of loss of households within the
buffer area. These households were excluded because they
would have potentially confounded the outcome of the
study in case of diversion of mosquitoes. All households
within the buffer area were issued with an LLIN per sleep-
ing space to protect them from potentially greater than
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normal bites from diverted mosquitoes. In practice, the sec-
ond phase of recruitment proceeded as follows: The field
team visited the 20 clusters, using the household consid-
ered to be at the centre of these clusters (identified from
the Arc GIS map), as the starting point. The household
head of the central household in the cluster was informed
of the purpose of the visit. If the household had been
enrolled during the first phase of household recruitment,
then the field team issued an LLIN for every sleeping space,
stapled a unique identifier number on the door frame and
moved to the next nearest household. If the households
had not been enrolled, the household head was informed of
the objectives, risks and benefits of the study, enrolled on
written informed consent, provided with a unique household
identifier and LLINs for each sleeping space, and a SES and
KAP questionnaire administered. This progression was
repeated until 47 households close together were enrolled
to form a single cluster. All 47 households in each of the 20
clusters were enrolled in this manner. The newly enrolled
households that did not appear on the map generated in
the first phase of recruitment were plotted and the map
updated to produce the final map of households recruited
into the study (Figure 1).
Clusters were used as the unit of randomization for
three reasons: 1) since the intervention would be applied
to a community, if proven to be effective, 2) to limit con-
tamination of treatments between households, and 3) to
avoid diversion of mosquitoes from individuals who used
repellents to those who did not use repellent within the
same household of from households using repellents to
households that used the placebo, thereby putting non-
repellent using individuals and households at a potentially
higher risk of contracting malaria [29,30].
Eligibility criteria
All households were eligible to be recruited into the trial
and no household was excluded on the basis of household
structure, asset or livestock ownership. All individuals
older than six months of age were eligible to be recruited
into the trial. This age cut-off was used because re evalu-
ation of DEET insect repellent [31] estimated the margin
of exposure (MOE) in children less than six months to be
less than 100. Margin of exposure is defined as the ratio of
dose of DEET used daily to the no observed effect level
dose recommended by regulation agencies, which usually
consider doses, which result in MOEs of less than 100,
unacceptable. Based on this risk assessment, use of DEET
was not recommended for children under six months [32].
Randomization of clusters to treatments
All the 20 clusters in the map (Figure 1) were assigned
numbers 1 to 20, starting from the left hand side to the
right. The cluster numbers were then written down on
small pieces of paper, which were placed in a bowl. The
principal investigator (PI) and project leader (PL) then drew
the pieces of paper from the bowl one at a time. Two three
digit numbers (258 and 305) were used to classify clusters
in to two groups. The first cluster number to be drawn
was assigned treatment 258 and the second cluster
number assigned treatment 305. This progression was re-
peated until all the clusters had been assigned to one of
the two groups.
Blinding
The repellent and placebo lotion smelt and felt the same and
were placed in identical tubes, distinguishable only by the
two three-digit numbers known only to the independent
Figure 1 Map of households recruited into the trial in the study village.
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code keeper (SC Johnson and Sons). However, the PI and PL
had previously conducted efficacy test of these two treat-
ments [19], and could identify the repellent and placebo
from the results of this study. Therefore, it was only the field
team, study statistician and study participants who were
blinded in this study. Blinding was broken after analysis.
Repellent issuance, application and compliance
In June 2009, the field team visited all households en-
rolled in the study to distribute treatments to study par-
ticipants. The treatments, (15% DEET and placebo), both
formulated as a pourable lotion that is applied by hand,
were supplied by SC Johnson, Racine, USA, and pack-
aged in 100 ml plastic tubes. During this visit, the field
team informed the household members on how to apply
the treatments provided on exposed areas of the body.
They also advised the participants not to apply the treat-
ments on open wounds, eyes, mouth and areas with mu-
cous membranes. The repellent lotion was applied at an
approximate rate of 0.002 mg DEET/cm2, the quantity
of repellent that prevented >80% mosquito bites for
4 hours in a controlled environment and in the study
area [19]. Even though a repellent with a higher concen-
tration would have provided greater protection, the
Tanzania National Institute of Medical Research ethical
approval board did not allow the use of a repellent that
had more than 15% DEET due to safety concerns, despite
the initial request of the PI to use 30% DEET and submis-
sion of detailed experimental justification and dossier of
safety data justifying the use of a higher concentration.
The participants were issued measuring caps, with
amounts of repellent required for adults (7mls) and chil-
dren below 12 years (3mls) marked on the cap. Each
tube held 100mls of repellent. Therefore, two tubes were
considered enough to last an adult one month, i.e. if
they applied the recommended dosage of 7 mls per day,
while one tube was enough to last a child < 12 years for
one month, if they used 3mls per day. Children > 12 years
were advised to use up to 7mls a day, and were therefore
issued with 2 tubes for the month. All the tubes issued
per cluster and households were identical, and it is pos-
sible that the household members shared a single tube
of repellent until it ran out. As all households member
were issued with enough treatment to last them month,
either 15% DEET repellent lotion or placebo, and dos-
ages for adults and children had been marked out, it was
assumed that sharing of repellents within the household
would have no effect on the outcome as long as there
was daily compliance to the recommended dose by the
participants. The amounts recommended were adjusted
to accommodate for individuals with greater than average
body mass as it was determined from semi-field and field
experiments that an average sized volunteer required 6
mls [19]. This amount was, therefore, adjusted upwards
by an extra millilitre. The community members were
instructed to apply the repellent at dusk (1800 hrs) and
to reapply it if they felt any mosquito bites or remained
active for more than four hours after sunset.
Compliance to lotion use (both repellent and placebo)
was assessed by the field team visiting the enrolled house-
holds at the beginning of each subsequent month (monthly
monitoring surveys) to issue new tubes of repellent and
placebo lotion. Therefore compliance was assessed on a
monthly basis using a short structured questionnaire,
where the household head or an adult household member,
was asked if all household members had used the repel-
lents and reasons for non-compliance where relevant.
However, as self-reported data are unreliable, the number
of repellent/placebo tubes issued every month was also re-
corded as a secondary measure of compliance, to deter-
mine if there was a difference in the number of tubes
issued in each month per treatment group. Data on use of
LLINs the previous night, malaria infection, recalled febrile
illness and visit to the health centre during that month was
also collected. If, during these monthly monitoring surveys,
the household head or any other adult household member
was not available to answer the questionnaire on compli-
ance, the field team visited that particular household daily
for seven consecutive days. If still no household member
able to take the monitoring survey was available during
these repeated visits, then that household, and all it mem-
bers, was excluded from the calculation of person-time for
that month.
In addition to the compliance, malaria and recalled fe-
brile illness data collected during each month of the
study period, an after study questionnaire was adminis-
tered at the close of the study to assess the participants’
knowledge, attitudes and practice in relation to repel-
lents. These results are reported elsewhere [Sangoro O,
Sarah M, Ann HK, Sarah M: Feasibility of repellent
use in a context of increasing outdoor transmission:
A Qualitative study in rural Tanzania, submitted to
Malaria Journal for publication].
Clinical data collection
A single government health facility in the study area was
recruited into the study. At this facility, health services
were provided for free by the project if the participants
showed their project identification card with a house-
hold unique identification number on it. Community
members that were not enrolled into the study were is-
sued with a different kind of identification card to also
allow them free consultation and treatment at the re-
cruited health facility. This was done to discourage com-
munity members attending the health facility under the
guise of being a study participant and, therefore, contam-
inating the study by recording malaria status of commu-
nity members not enrolled in the study as participants. It
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was assumed that since services were provided for free
at this facility, it would attract most community mem-
bers seeking health services. A clinical officer (CO) and
a nurse were employed by the project at this health fa-
cility. A ledger with the household unique identifier and
names of each household member was drawn up and
placed at this health facility. When a study participant
visited the health facility with febrile illness, the CO
checked against their name and household unique ID in
the health facility ledger. This way household and health
facility data could be reconciled using the household
unique identifier. Febrile participants were tested for
malaria using rapid diagnostic test (RDT) (ICT Malaria
cassette tests HRPII/pf test kit). A proportion of partici-
pants also had diagnosis by thick film microscopy to
confirm the accuracy of the RDTs for diagnosis under
field conditions. The result of the RDT and the date of
diagnosis were marked against the Household ID on the
health facility ledger. Those found positive for malaria
parasites were given artemether-lumefantrine (ALu), the
first-line drug for treatment of malaria in Tanzania.
Only participants that were RDT or slide positive for
malaria parasites were treated. This was to avoid treat-
ing non-malaria patients with ALu, which might have
affected malaria incidence rate in the village. The RDT’s
were labelled with the patient’s unique identifier, date
and status (+ve or –ve) and stored for verification.
These were later checked against the clinical trial data-
base to ensure that no cases had been incorrectly en-
tered into the database by the clinic staff.
Data management
Data from the structured questionnaires on SES of house-
holds and KAP in relation to malaria and repellents ad-
ministered at baseline; follow-up data on compliance and
recalled febrile illness administered throughout the study
period; and the after study KAP survey, were double en-
tered into a computer using an Epi –Info™ template with a
drop down lists of values that corresponded to the format
of the questionnaires. Data was then exported to Micro-
soft Access 2008 (Microsoft Corporation), to check for
lack/excesses of data, inconsistencies and outliers. All data
from the above mentioned questionnaires were linked
using the household unique identifier. The household
unique identifier was made up of the household number,
cluster number and treatment number.
Statistical analysis
Data was collected and presented at household and clus-
ter level as the study aimed at assessing the effectiveness
of the repellents at the community level. Individual level
data was not collected.
Socio-economic status (SES)
All data cleaning and analysis was performed using STATA
11.2 software (StataCorp LP, College Station, Texas, USA).
Baseline household-level socio-economic indicators
were collected using a structured questionnaire. All vari-
ables representing asset ownership, household construc-
tion materials, source of fuel and light and the education
level of the household head were examined individually
before being combined using principal component ana-
lysis (PCA) to generate the socio-economic index of each
household, [33], and are presented in here: (Additional
file 1: Stata output showing Eigen scores of each variable
used in calculation of socio economic status of house-
holds). The households were grouped into quintiles of the
socio-economic index generated and ranked from the
poorest to the least poor. This data was cross tabulated
with treatment group using Pearson’s chi-square (χ2) to as-
sess whether there was a significant difference in the socio-
economic status of the households in the two treatment
groups (not accounting for the clustered design due to the
exploratory nature of this analysis.
The number of treatment tubes issued was analysed by
linear regression against month, treatment and an inter-
action of month and treatment to determine if there was a
significant difference in the number of tubes issued in each
month and per treatment group.
Clinical data
Clinical data was adjusted for covariates identified a priori
to be confounders and analysed using the according-to-
protocol approach, where person-time at risk was excluded
when a participant reported or was observed to be non-
compliant to the lotion (placebo or repellent) and for those
with malaria for three weeks after they were diagnosed. The
total number of cases in each treatment group was divided
by the sum of person years at risk to give the incidence
rates in person years at risk. Rate ratio and rate differences
were then estimated.
For comparison, a secondary analysis using the
intention-to-treat approach, where malaria incidence
rates in the clusters were compared using all person-
time at risk regardless of whether they complied with
the study protocol but also adjusted for covariates
identified a priori as confounders. Such an approach
would be expected to underestimate the treatment
effect. It was not possible to effectively blind the PI
and PL as they had carried out both the semi field and
field efficacy evaluations of these treatments [19] and
could identify the intervention and placebo. The clinical
data was, therefore, re-blinded by an independent statisti-
cian (ET), who was not aware of the intervention and pla-
cebo codes.
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Person-time at risk estimation for according-to-protocol
analysis
The study was conducted for 14 months from July 2009
to August 2010. To calculate the person-time at risk, a
closed cohort was assumed, so that the number of house-
hold members above six months recorded at baseline for
each household was assumed to be constant throughout
the study period. Monitoring surveys were conducted for
each month of the study to establish compliance.
Person time at risk of each household was estimated
according to one of the following three possible scenarios:
1. In a case where all individuals were susceptible to
malaria infection and complied with the study
protocol by applying the treatment issued on a
nightly basis, each individual in the household was
assumed to contribute one-person month at risk to
the study.
2. In a case where the household head or an able
household member was not available to take the
monthly monitoring surveys, it was assumed that all
members of that household did not comply with
lotion (repellent or placebo) use for that month and
one-person month at risk for each member of that
household was excluded from the person time at risk
of the study.
3. In a case where a household member contracted
malaria, that individual was excluded from
calculation of person time at risk for three weeks.
Person-time for all household members was calculated
according to the appropriate scenario above.
Malaria incidence rates and regression analysis of the
intervention effect
Using data on the total number of confirmed malaria
cases and person-time for each household, we used a
two-stage approach to estimate intervention effects (rec-
ommended by Hayes et al. for studies with fewer than
15 clusters/group) [27]. In the first stage, cluster-specific
incidence rates were calculated using random effects
Poisson regression modelling with adjustment for con-
founding variables. Specifically, the outcome of total
number of confirmed cases of malaria/household was
regressed on the set of confounding variables (age cat-
egories of the household, education of the household
head, and quintile of SES), with an offset for person-
time at risk per household and a random intercept for
cluster to account for the clustered study design. As per
Hayes et al., treatment was not included as a factor in
the model. In the second-stage, residuals, calculated
from the regression model were aggregated by clusters.
The covariate-adjusted treatment effect was then esti-
mated by comparing the residuals in the intervention
relative to the control group using the Wilcoxon rank
sum test, because the data were not normal.
Knowledge attitude and practice (KAP) of community
members in relation to malaria and repellent
Baseline data on knowledge of malaria and malaria pre-
vention practices and knowledge and practice in relation
to repellents were analysed using descriptive statistics in
STATA 11.2 to assess whether there was an imbalance
between the treatment arms. Data that recorded attitude
with regards to repellents, perceived effectiveness and
willingness to continue use and pay were also analysed
and these results are presented elsewhere [Sangoro O,
Sarah M, Ann HK, Sarah M: Feasibility of repellent
use in a context of increasing outdoor transmission:
A Qualitative study in rural Tanzania, submitted to
Malaria Journal for publication].
Ethical and safety considerations
During recruitment, the household head was asked for
written informed consent for themselves and all household
members. If consent was obtained, all members of the
household were recruited into the study. Study participants
were free to withdraw from the trial at any time. All house-
holds in the village were issued with an LLIN for every
sleeping space to ensure equity. All individuals from the
study village were allowed free consultation, treatment and
drugs (ALu) from the village dispensary at project cost.
Participant confidentiality was maintained by using gener-
ated unique identifiers instead of individual names during
analysis.
Participants were educated on correct repellent use
and application. Children under 6 months were excluded
from the trial. An illustrated label giving instructions in
the native language (Swahili) on safe repellent use was
provided on each tube. DEET repellent used in this
study has undergone extensive toxicological tests and
has been endorsed as safe for human use [32]. The con-
centration of DEET (15%), used in this trial was approved
by the Tanzanian Pesticides Research Institute, the Tanza-
nian Bureau of Standards and is available in Tanzanian
shops. Guardians to children < six months were reminded
to put their children under an LLIN early to prevent them
contracting malaria. A clinical officer (CO) was employed
at the village dispensary by the project to perform RDTs
and to investigate and treat any adverse effects arising
from repellent use.
Ethical approval for the study was obtained from Ifa-
kara Health Institute (IHI) (IHRDC IRB A46), Tanzanian
National Institute of Medical Research (NIMR/HQ/R8a/
VOL IX/780) and the London School of Hygiene and
Tropical Medicine Ethical Review Board (LSHTM ERB
5174). IHI provided study monitoring.
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Results
Trial profile and baseline data
The trial profile is summarized in Figure 2. In the inter-
vention group 2,224 individuals were enrolled and 2,202
in the placebo group. Loss-to-follow up was higher in
the placebo group: n = 34 versus n = 16, and no individ-
uals withdrew from the trial. Similar numbers of person-
years were analysed: 1952.81 in the intervention group
and 1972.38 in the control group of the trial. Baseline
household level socio-economic data on education and
gender of household head, age-groups of all study partic-
ipants, household construction material, source of cook-
ing fuel and lighting and asset ownership were examined
individually and are presented in Table 1. The gender of
the household heads was comparable between the two
treatment groups, with 55.33% (n = 514) females and
44.67 (n = 415) males. Most of the household heads had
received some form of formal education, 82.81% (n = 702)
while only 17.18% (n = 161) had no formal education. Of
all participants recruited in the study, 17.55% (n = 771)
were children under five years of age, 34.37% (n = 1,510)
were between five to 18 years of age and 48.08% (n = 2,112)
were above 18 years of age and age-category distribution
was similar in the two treatment groups. The predominant
source of energy used by the households was wood fire,
89.96% (n = 883), while the predominant source of lighting
used was the traditional lamp, 93.76% (n = 871). Assess-
ment of household construction materials demonstrated
that most households in the study area had floors made
from mud, 82.78% (n = 769), while tin and thatch were used
equally as roofing materials, 49.35% (n = 457). Also, most
households in the study area had walls made from bricks,
79.87% (n = 742). Socio-economic indices generated from
PCA suggested an imbalance between the two treatment
groups, with the control group demonstrating a higher
SES than the intervention group, (Pearson’s χ2 = 17.5519,
p = 0.002), (Table 2).
The use of repellents as a mosquito control tool was
low in the study area, with only 1% (n = 6) of those inter-
viewed reporting to have ever used repellents. Results on
Figure 2 Trial Profile.
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Table 1 Baseline household characteristics by treatment group
Intervention arm n (%) Control arm n (%) Totals n (%)
No. of households 469 (50.05) 468 (49.95) 937 (100)
No. of participants 2224 (50.05) 2202 (49.95) 4426 (100)
Gender of household head
Male 215 (46.24) 200 (43.10) 415 (44.67)
Female 250 (53.76) 264 (56.90) 514 (55.33)
Education of household head
No education 83 (17.74) 78 (16.63) 161 (17.18)
Educated 385 (82.26) 391 (83.37) 702 (82.82)
Age group distribution of all participant/household
Under 5’s 412 (18.50) 359 (16.57) 771 (17.55)
5-18 years 721 (32.38) 789 (36.43) 1510 (34.37)
Above 18 years 1094 (49.12) 1018 (47.00) 2112 (48.08)
Source of energy
Wood fire 431 (92.89) 402 (86.83) 883 (89.86)
Other sources 33 (7.11) 61 (13.17) 94 (10.14)
Source of lighting
Traditional lamp 445 (95.70) 426 (91.81) 871(93.76)
Other source 20 (4.30) 38 (8.19) 58 (6.24)
Flooring material
Mud 404 (86.88) 365 (78.66) 769 (82.78)
Cement 61 (13.12) 99 (21.34) 160 (17.22)
Roofing materials
Thatch 256 (55.41) 201 (43.32) 457 (49.35)
Tin 203 (43.94) 254 (54.74) 457 (49.35)
Other 3 (0.65) 9 (1.94) 12 (1.30)
Wall materials
Mud 121 (26.08) 66 (14.19) 187 (20.13)
Bricks 343 (73.92) 399 (85.81) 742 (79.87)
Assets ownership
Motorbike
Yes 72 (15.48) 52 (11.18) 124 (13.33)
No 393 (84.52) 413 (88.82) 806 (86.67)
Bicycle
Yes 246 (52.90) 198 (42.58) 513 (55.16)
No 219 (47.10) 267 (57.42) 417 (44.84)
Stove
Yes 344 (73.98) 314 (67.53) 658 (70.75)
No 121 (26.02) 151 (32.47) 272 (29.25)
Mobile phone
Yes 197 (42.37) 211 (45.38) 408 (43.87)
No 268 (57.63) 254 (54.62) 522 (56.13)
Radio
Yes 140 (30.11) 156 (33.55) 296 (31.83)
No 325 (69.89) 309 (66.45) 634 (68.17)
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KAP of repellents are presented in details elsewhere
[Sangoro O, Sarah M, Ann HK, Sarah M: Feasibility of
repellent use in a context of increasing outdoor
transmission: A Qualitative study in rural Tanzania,
submitted to Malaria Journal for publication].
The average number of tubes issued per household was
6.73 (95% C.I. 6.51 – 6.95) and 6.92 (95% C.I. 6.68 – 7.16)
in the intervention and control group respectively and
there was no significant difference per treatment group,
1.68 (95% C.I. 0.32 – 84.25, P = 0.803) from linear regres-
sion analysis. Likewise there was no significant difference
on the number of treatment tubes issued per month
throughout the study period.
Clinical outcomes
According-to-protocol analysis
When data was analysed as per protocol there was a non-
significant difference in cluster and household malaria inci-
dence rates among repellent users and non-users (Table 3).
In the cluster-level analysis (data averaged over cluster spe-
cific rates), the malaria incidence rates differed by 11.48%;
with 68.29 (95% C.I. 37.05-99.53) cases/ 1,000 person-years
in the control group and 60.45 (95% C.I 48.30-72.60)
cases/1,000 person-years (95% C.I. 44.55 – 81.73) in inter-
vention group, (Wilcoxon rank sum z = 0.529, p =0.5967).
For household-level malaria incidence rates (data averaged
separately over household specific rates), the incidence
rates differed by 28.88%: with 84.54 (95% C.I. 61.04-
108.05), cases/1,000 person-years in the control group and
60.12 (95% C.I. 45.08-75.15) cases/1,000 person-years in the
intervention group, (Wilcoxon rank sum z =−1.267, p =
0.2051). These result should however be interpreted with
caution as there is still an ongoing debate on whether it is
correct to estimate incidence rate ratios using regression
models on less than 10 clusters [28]. Cluster aggregated
rates were reported because it measured the overall effect
of the intervention at the population level [34] and this was
the major objective of the study. Age was a significant risk
factor with risk decreasing with increase in age. SES did not
influence the risk of malaria in the model.
Intention-to-treat analysis
Cluster-level analysis of malaria rates in the two treatment
arms demonstrated a non-significant, 14.62% difference in
malaria rates with 53.21 cases/1,000 person-years (95%
C.I. 30.98 – 104.16) in the control group and 45.43 cases/
1,000 person-years (95% C.I 36.02 – 59.79) in the inter-
vention group, (Wilcoxon rank sum z = 0.227, p = 0.8206),
(Table 3). Household-level analysis of malaria incidence
rates demonstrated a 30.71% difference in malaria inci-
dence rates, with 68.21 cases/1,000 person-years (95% C.I.
49.59 to 86.84) in the control group and 47.26 cases/1,000
person-years (95% C.I. 35.49 – 59.04), in the intervention
group, (Wilcoxon rank sum z = − 1.268, p = 0.2047). Age
was a significant risk factor: malaria risk decreased with
increase in age although SES did not influence the risk of
malaria in the model.
Discussion
This randomized controlled trial demonstrated that 15%
DEET topical repellents have no effect on malaria inci-
dence transmitted in the early evening. Although there was
a consistent decrease in malaria risk among repellent users
in both the cluster and household malaria rates, as seen
from the results above, this reduction was not significant.
This finding is consistent with a study carried out in
southern Lao PDR using an identical 15% DEET repellent
[35]. It should be noted that, findings from other studies
using a higher concentration of 20% DEET with Permeth-
rin in soap that gave over 12 hours of complete protection
from mosquito bites [11] and Para-menthane 3–8 diol re-
pellents with close to 100% efficacy for over six hours
[30,36] did demonstrate a significant protective effect in
Pakistan [11], Bolivia [10] and Ghana [23] and this could
be one of the potential explanations for the observation of
a treatment effect in these studies. It can be argued that in
the Lao-PDR study, 15% DEET provided ~ 100% protec-
tion against mosquito bites. However, the number of major
malaria vectors, Anopheles minimus and Anopheles macu-
latus, caught in entomological collections in the Lao-PDR
study was very low and that the effect observed, was
probably that of 15% DEET against Stegomyia and Culex
mosquitoes which made up the bulk of the collections.
Therefore, as Anophelines are known to show less response
to repellents compared to Stegomyia and Culex mosquitoes
[37,38], the repellent effect observed in the Lao-PDR study
was greater than at higher densities with a greater propor-
tion of Anophelines as tested in Tanzania [19].
Table 2 Ranking of households using Socio-economic scores generated for PCA analysis by treatment group
Intervention arm n (%) Control arm n (%) Total n (%) Pearson’s Chi2 P value
SES generated from PCA
Poorest 39 (8.33) 28 (5.97) 67 (7.15)
Poor 164 (35.04) 121 (25.80) 285 (30.42) 17.5519 0.002
Median 165 (35.26) 174 (37.10) 339 (36.18)
Less poor 77 (16.45) 107 (22.81) 184 (19.64)
Least poor 23 (4.91) 39 (8.32) 62 (6.62)
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Power
There are several factors that are likely to have masked
any treatment effect in this study, the most likely being
the lack of power to discriminate a statistically signifi-
cant difference between study arms. The lack of power
in the study was likely caused by four factors:
First, rapid scale-up of LLINs to achieve universal
coverage has been actively taking place in Tanzania [16].
This had led to a substantial decline in malaria in the
country and by extension the study area [39]. As a re-
sult, the incidence of malaria in the village was likely
lower than the incidence assumed for calculation of
sample size for this study. This likely led to an underesti-
mation of the sample size required to observe a differ-
ence between the two treatment groups. Secondly,
during the study period, Tanzania experienced a drought
that likely further reduced malaria transmission, and as
a result, there were too few malaria episodes in the study
area to accurately discriminate any reduction in malaria
attributable to the repellent [40], highlighting the need
for such studies to be carried out for more than one
transmission season to avoid such problems. Third, most
of the participants recruited in to the study come from a
farming community. Therefore, during the planting and
harvesting seasons, these participants relocated to their
farmhouses [41]. As a result it was difficult to establish
compliance during these periods and those participants
were excluded from the study. This lowered the study
sample size further and with it the power to detect a
treatment effect. Lastly was the likely overestimation of
the assumed malaria incidence in the study area that
was used for sample size calculations. Malaria incidence
in this study was estimated from reported fever rates in
children less than 5 years of age in the study area [26].
Therefore, even though scale up of LLINs and the
drought experienced during the study might have low-
ered the malaria incidence in the study area, it is also
likely malaria rates used for estimation of sample size
might have been overestimated and hence undermined
the study power to observe a difference between the
treatment groups.
Compliance
Compliance in this study was measured by self-reporting
of use every evening by the household head or a household
member that was able to engage with the field workers
during the monitoring surveys. However self-reporting is
an unreliable measure of compliance, as it have been
shown to overestimate compliance [42]. As a result, the
ATP analysis used to measure malaria incidence is likely to
underestimate the actual malaria incidence in the interven-
tion and control arms, as a larger value of person-time will
be used than that of individuals that actually complied to
the study reducing discriminatory power. However, if the
Table 3 Estimated incidence rates by treatment arm and estimated intervention effects
Intervention arm Control arm % Reduction in rates Wilcoxon rank-sum on
residuals (p-value)
Malaria cases 115 137
ATP analysis
Individuals randomized 2208 2168
Households randomized 463 462
Total person-years 1952.81 1972.38
Average Household rates/1000
person-years
60.12 (95% C.I 45.08-75.15) 84.54 `(95% C.I 61.04 108.05) 24.42% −1.267 (0.2051)
S.D. 164.42 257.07
Average cluster rates/1000
person-years
60.45 (95% C.I 48.30 72.60) 68.29 (95% C.I 37.05-99.53) 8% 0.529 (0.596)
S.D. 16.98 43.66
ITT analysis
Individuals randomized 2224 2202
Households randomized 468 469
Total person-years 2580.44 2554.92
Household rates/1000 person-years 47.26 (95% C.I. 35.49-59.04) 68.21 (95% C.I. 49.59-86.84) 20.95% −1.268 (0.2047)
S.D. 129.60 205.23
Cluster rates/1000 person months 45.43 (95% C.I 36.02–59.79) 53.21 (95% C.I. 30.98–104.16) 7.78% 0.227 (0.8206)
S.D. 11.32 34.90
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randomisation between the two treatment groups was
done correctly then the overestimation of compliance and
its resultant effect of the study outcome, is likely to be
similar in both treatment groups, ruling out the likelihood
of overestimation of the treatment effect. This underlines
the importance of correctly estimating the compliance in
studies of personal protection in order to avoid confound-
ing the outcomes of such studies.
Active versus passive case detection
Due to logistical reasons, this study recruited a single gov-
ernment health facility for collection of clinical data by
passive case detection. As a result, the study is likely to
have lost malaria cases to the other health facility present
in the area. Anecdotally, some participants complained
that they went to the other health facility because the
study facility always told them that they did not have mal-
aria even though they knew they had malaria, so they did
not trust the diagnosis. Also some individuals might have
opted to use traditional medicine, treat diseases at home
or buy drugs directly from the numerous drug stores in
the study area if they felt sick. All these are potential mal-
aria cases that the study might have lost, lowering both
the sample size and estimates of malaria incidence in the
area. It would have been advantageous to collect data from
both health facilities or carry out active case detection.
Since malaria was still most common in children under
five years in the study site as seen elsewhere [43,44], tar-
geted active case detection in under fives may have gath-
ered more reliable and realistic data on the true impact of
repellents in this scenario. Performing supplementary test-
ing of blood spots from all participants attending the
health facility with polymerase chain reaction (PCR) diag-
nosis of subclinical malaria parasitaemia may have also
yielded more accurate estimation of transmission preven-
tion by repellents [45].
Sources of bias
Bias was introduced into the study by an imbalance in
socio-economic status between the two study groups. The
control group demonstrated a higher socio economic sta-
tus than the control arm. This study however, did not
demonstrate a statistically significant association between
SES and malaria incidence. However, it is well known that
improved housing, whose representative covariates had
been adjusted for during analysis, is protective against
malaria [46]. A plausible explanation for this is that the
participants in this study came from a single village or
from villages located closely together. As result they were
exposed to the same levels of malaria transmission regard-
less of their socio-economic status. As socio-economic
status is positively associated with seeking treatment at a
medical facility [47], it is likely that participants with
higher SES sought treatment at the health facility in the
study area at a higher rate compared to participants in the
lower SES. Therefore as malaria data was only collected
from a single health facility, it is likely that more cases of
malaria were observed in participants with higher SES
relative to participants from lower SES. Another reason is
that no association was seen may be because studies using
material ownership as a proxy for measuring SES, to
evaluate the relationship between SES and malaria inci-
dence have yielded inconsistent results, at the household
level [48].
The study participants were blinded up to some point
after allocation of treatments, because of the identical
packaging labelled with a three-digit code. However,
after a while, field workers reported that study partici-
pants in the placebo group complained that they wanted
to swap treatment. Participants could differentiate the
intervention from the placebo, as mosquitoes would still
bite them after applying the ‘treatment’ while those in
the treatment group bragged to their neighbours that
they got the good lotion that was effective. This is a
source of bias and could have caused treatment contam-
ination between clusters. This problem would have been
better overcome with clusters that were geographically
isolated, for instance randomization on a village scale, so
that individuals were less likely to be able to compare
their treatment allocation. Some participants may have
sold or given their repellent to relatives in other clusters.
Another potential confounder may have been diver-
sion of mosquitoes from the intervention group to the
placebo group. However, this was controlled by allowing
for a buffer area of 200 metres between clusters. Diver-
sion in repellent studies has usually been recorded over
short distances, one metre [30]. However, distances of
15–20 metres are recommended as the limit for short
range attraction of host seeking mosquitoes [49,50] and,
therefore, distances of 200 metres between clusters were
thought to be adequate to prevent diversion. Treatments
were also issued at the household level to prevent intra
and inter-household diversion within the cluster. It has
been later observed in the study area that mosquito di-
version between households does occur [29] and could
have confounded data if compliance with the interven-
tion was low by diverting mosquitoes from complying to
non-complying households or individuals.
The community was highly knowledgeable about mal-
aria transmission, prevention and control. This is likely a
result of the malaria intervention programmes that have
taken place in the study village for over two decades
[14,17]. The community awareness about topical repel-
lents as a mosquito control tool was poor at the study
inception. However, after the study, the community was
highly aware of repellents and community members
were willing to take up this intervention against malaria
if available. This finding demonstrates the feasibility of
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topical repellents as a potential tool to supplement LLINs
to prevent early evening transmission. In a separate study
[Sangoro O, Sarah M, Ann HK, Sarah M: Feasibility of
repellent use in a context of increasing outdoor
transmission: A Qualitative study in rural Tanzania,
submitted to Malaria Journal for publication], the
community members reported bite avoidance as the
major reason for using repellents in the early evenings.
A posteriori analysis of data for children under six
months was carried out to check whether this age group
experienced high malaria transmission because of mos-
quitoes diverted to them as it was recommended that
they not use the repellent [29,30]. This might also have
affected the incidence of malaria in the treatment groups
if there was uneven distribution of this age category be-
tween these groups. However, it was observed that there
were only three children and a single case of malaria in
this age category, and it can be confidently concluded
that this age group did not have any influence on the
outcomes observed.
Net usage was also analysed to determine whether there
was a difference between the two treatment groups, which
would have confounded the outcome. It was observed that
reported net usage the previous night was 100% in both
treatment groups. These results are presented in detail
elsewhere [Sangoro O, Sarah M, Ann HK, Sarah M: Feasi-
bility of repellent use in a context of increasing outdoor
transmission: A Qualitative study in rural Tanzania,
submitted to Malaria Journal for publication].
Recommendations
It was observed that estimation of a sample size with
sufficient power was a major shortcoming of this study.
Therefore, it is advisable to establish baseline disease in-
cidence rates if a similar study is to be implemented in
the future to avoid under powering the study. This can
be established from health facility records. However
these records may not necessarily be accurate and the
more appropriate measure may be to conduct a small
cross-sectional or longitudinal survey of the community
disease prevalence or incidence and then power accord-
ingly. Another important factor when testing personal
protection tools is accurate establishment of compliance.
Better methods of establishing compliance are needed.
This can be done through frequent follow-up and spot
checks or use of indirect methods, such as mosquito sal-
iva antigens, that are a proxy of individual exposure to
mosquito bites [51]. Also, development of new tools that
require reduced compliance such as long lasting spatial
repellents [52] would likely offer greater protection be-
cause people often forget to comply daily with a topical
repellent unless they feel mosquito bites [53]. Finally, in
a time when malaria is becoming more scant due to suc-
cessful control, active case detection using RDT for
clinical diagnosis followed up by PCR for malaria para-
sites is most likely the most appropriate means of meas-
uring the impact of additional malaria control tools used
in combination with LLINs.
Conclusion
Findings of this trial could not demonstrate if 15% DEET
topical repellents had any impact on incidence of mal-
aria transmission in the early evening because the study
lacked sufficient statistical power and had several im-
portant sources of bias. A better-designed study with
sufficient power and fewer sources of bias and ideally a
higher concentration of repellent is required to fully
understand if topical mosquito repellents are a feasible
malaria control tool in the early evenings in Eastern
Africa, particularly as repellents have reduced malaria
elsewhere in sub-Saharan Africa [23,24]. The acceptabil-
ity of this intervention is an encouraging finding toward
exploring supplementary malaria control tools.
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Abstract
Background: Extensive employment of long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) has
substantially reduced malaria morbidity and mortality in sub-Saharan Africa. These tools target indoor resting and
biting vectors, and may select for vectors that bite and rest outdoors. Thus, to significantly impact this residual
malaria transmission outdoors, tools targeting outdoor transmission are required. Repellents, used for personal
protection, offer one solution. However, the effectiveness of this method hinges upon its community acceptability.
This study assessed the feasibility of using repellents as a malaria prevention tool in Mbingu village, Ulanga,
Southern Tanzania.
Methodology: Change in knowledge, attitude and practice (KAP) in relation to repellent use was assessed before
and after the implementation of a cluster randomized clinical trial on topical repellents in rural Tanzania where
repellent and placebo lotion were provided free of charge to 940 households for a period of 14 months between
July 2009 and August 2010. Compliance, defined as the number of evenings that participants applied the
recommended dose of repellent every month during the study period, was assessed using questionnaires,
administered monthly during follow up of participants in the clinical trial. Focus group discussions (FGDs) were
conducted in the same community three years later to assess the community’s KAP in relation to repellents and
preference to different repellent formats.
Results: At baseline, only 0.32% (n = 2) households in the intervention arm and no households in the control arm
had ever used topical repellents. During follow-up surveys, significantly more households, 100% (n = 457) in
intervention arm relative to the control, 84.03% (n = 379), (p = <0.001) perceived the repellent to be effective.
Post-study, 99.78% (n = 462) and 99.78% (n = 463), (p = 0.999) in the intervention and control arms respectively,
were willing to continue repellent use. Mosquito nuisance motivated repellent use. From the FGDs, it emerged that
most respondents preferred bed nets to repellents because of their longevity and cost effectiveness.
Conclusion: High repellent acceptability indicates their feasibility for malaria control in this community. However,
to improve the community’s uptake of repellents for use complimentary to LLINs for early evening and outdoor
protection from mosquito bites, longer lasting and cheap formats are required.
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Background
Long-lasting insecticidal nets (LLINs) and indoor residual
spraying (IRS) have had a great impact on malaria morbid-
ity and mortality in the past decade in sub-Saharan Africa
[1-3]. While effective, these tools are intra-domiciliary and
predominantly target indoor biting and resting vectors [4].
This favours outdoor resting and biting vectors as IRS and
LLINs are less effective against those vectors that exhibit
exophily and exophagy [5]. Therefore, as malaria moves
from sustained control to elimination, new tools that
tackle residual outdoor malaria transmission are needed.
Repellents used outdoors and in the early evenings and
mornings, where IRS and LLINs cannot be employed,
present one strategy that can be used to push towards the
goal of eradication. Topical (skin applied) repellents have
been used as a form of personal protection for hundreds
of years [6], and have been shown to protect against
malaria in South America (80% reduction) [7] and Southern
Asia (60% reduction) [8], and more recently in Ghana
(34% reduction) [9] and Ethiopia (19% reduction) [10].
The major drawback to using topical repellents is compli-
ance. Topical repellent use requires daily use and frequent
re-application as their effects is usually short-lived over a
few hours and therewith a change in daily routine (per-
sonal behaviour). While changing personal behaviour to
use new interventions is not impossible as has been dem-
onstrated in bed net campaigns [11], oral hygiene [12] and
hand washing strategies [13], it is influenced by a number
of other factors including: cost, perceived quality of the
intervention, accessibility, information and ease of use. An
intervention is likely to be used by the community if its
affordable, perceived to be effective, the community is
aware and has knowledge of its uses and finally, the inter-
vention is simple to apply, i.e. it does not require consi-
derable deviation from daily routine [14]. Therefore to
influence behaviour change towards uptake of interven-
tions: the community must be educated to improve infor-
mation on the appropriate measures to employ to prevent
disease e.g. use of bed nets to prevent mosquito bites and
hence malaria infection. Secondly, the interventions must
be made physically accessible to the community, such as
considering the distance to shops where bed nets are sold
or re-treated. Third, the cost of the intervention must be
affordable and perceived as reasonable among community
members to encourage use. Perception of the effectiveness
of the intervention will also influence uptake, with the
community more likely to use interventions they perceive
as beneficial to them, for instance LLINs prevent mos-
quito bites. Lastly, is the ease of use of the intervention
being implemented, as the community is more likely to
use interventions that require the least deviation from
daily routine, like use of drugs with simple dose regi-
mens compared to those that have complicated regi-
mens [14].
Therefore, in an effort to determine the feasibility of
using repellents as a mosquito control tool, this study
assessed the knowledge/awareness, acceptability, percep-
tions on effectiveness and preference to different kinds of
repellents in a rural community in Kilombero valley,
Southwest of Tanzania. The community in this setting has
experienced extensive malaria research projects and inter-
vention programmes spanning two decades [15-17] and
was expected to be highly knowledgeable about malaria
prevention and control. Cooking mainly takes place out-
doors and in the early evening, a situation that exposes the
community to nuisance mosquito bites and potential mal-
aria transmission before they have employed bed nets. Fur-
ther, like the rest of sub-Saharan Africa, the study area is
experiencing rapid rural development, shifting the spaces
and protocols of social behavior. Where once it was cus-
tomary to retire shortly after sundown, now, owing to
rural electrification programmes, residents usually gather
in the early evening and stay late into the night at local
bars and social centres springing up in the study area,
thereby increasing perception of mosquito nuisance and
malaria transmission potential at these times.
The dominant vector in this area is Anopheles arabiensis
[18] that has been shown to shift to early evening and out-
door biting when hosts are unavailable late in the night in-
doors as a result of high bed net use [19,20]. The presence
of rice fields in the study area, as the community’s main
occupation is farming, provides for a large breeding site of
mosquitoes [21]. The presence of this large breeding site
is likely increase mosquito abundance in the study area,
and with it potential malaria transmission and nuisance
biting.
Before the start of the clinical trial, the community
were sensitised to the potential for repellents as a mal-
aria prevention tool through skits, community meetings
and leaflets. Therefore, they are likely to understand the
importance of topical repellents in prevention of early
evening malaria transmission potentially occurring in
the study area before they go to sleep under bed nets,
and are therefore more likely to be receptive to this
intervention. Secondly, the customary practice of cook-
ing outdoors as well as presence of electricity exposes
this community to nuisance biting in the evenings as a
result of the extensive rice fields present in the area, a
situation likely to encourage use of repellent. Finally, re-
pellents were provided free so the community were
likely to use them and form an opinion on their efficacy.
Methods
Study area and population
This study was conducted in Mbingu village, Ulanga dis-
trict, Tanzania, situated 55kms west of Ifakara town at
8.195°S and 36.259°E. There is malaria transmission all
year round, with peak transmission occurring in the
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months of May and June after the long rains. The village
experiences an annual rainfall of approximately 1,200-
1,800 mm and an annual temperature range of between
20°C and 32.6°C. The village borders an extensive field
cleared for irrigation, which provides an ideal breeding
site for malaria vectors. The houses in the village are
clustered in groups of 3–5 households, which mainly be-
long to one family, but in a few instances the houses
may be rented by different families. In July 2009 (at the
inception of the clinical trial), the population of the
study area was estimated to be 7, 609, with each house-
hold having approximately 5 members [22]. Most houses
are constructed from mud walls and thatched roof, with
one‐third made from brick walls and corrugated iron
roof.
Outline of study
Between July 2009 and August 2010, a placebo-controlled
cluster randomized clinical trial was conducted in the
study village where 15% DEET (N, N-Diethyl-3-methyl-
benzamide) topical repellent and an identical placebo lo-
tion were randomly issued to 940 households in the study
village [23]. The clinical trial participants were also issued
with double size LLINs per sleeping space to ensure
equity. Treatments were issued to two study arms of 10
clusters with 47 households each. One study arm was
issued with topical repellent lotion while the other study
arm received a placebo lotion and both arms were followed
up for 14 months to assess the malaria incidence between
these two groups. Concurrent with the clinical trial, a
knowledge, attitude and practice survey (KAP) of the re-
pellents issued during the clinical trial was conducted by
administering a questionnaire (Additional file 1: Repellent
KAP survey tool) at the baseline of the clinical trial (be-
fore/entry survey) to assess community knowledge of re-
pellents; at the beginning of every month when field
workers visited the households to replace repellents that
had run out (follow-up survey) throughout the study
period, to assess the acceptance and compliance of the
community to the repellent issued and perceived effective-
ness; and at the end of the clinical trial (after/exit survey)
to assess willingness to continue use of repellents. A sep-
arate Focus Groups study was conducted three years later
in June 2013.
Procedure
Baseline survey
At baseline, written informed consent was sought from
the household heads that were willing to participate in the
clinical trial. The household heads gave consent for all
household members who were below 18 years. Household
members above 18 years were asked to sign their own
written consent forms. As the household was analysed as
a unit, a structured questionnaire of KAP in relation to
repellents was administered to the household head. A
unique ID was stapled on the door of each household that
was recruited into the study.
Follow-up survey
To assess acceptability and use, at the beginning of every
month after the baseline survey, field workers visited the
households recruited in the study to replace the tubes of
repellent issued the previous month. A KAP questionnaire
was administered during these visits, where the house-
holds were asked if they liked the repellent issued and their
perceptions on the effectiveness of the repellent. The field-
workers also administered a compliance questionnaire,
where household members were asked if any household
member had skipped a day of repellent use in the past
month and reasons for missing that day. However, if dur-
ing the follow up survey there were no household mem-
bers present to answer the questionnaire on compliance,
and continued to be absent for seven consecutive days
after the first visit to assess compliance, that household
was considered non-compliant to repellent use for that
month. If the households reported that any household
member did not use the repellent, that household member
was removed from follow up time for the period they did
not use the repellent. Thus, if all household members re-
ported using repellent each night in the past week and an
adult member of the household was present to be issued
with new repellent, that household was considered compli-
ant for the previous month. In addition, the number of
treatment tubes (repellent and placebo tubes) issued per
month was recorded, to determine if there was a difference
in the number of tubes issued in each month per treat-
ment group. Differences between recalled and observed
compliance were not measured.
Post-study survey
At the end of the clinical trial, (August 2010), an exit
KAP (post-study) questionnaire to assess perceptions on
effectiveness and willingness to pay if repellent was pro-
vided at cost was administered. In particular, the respon-
dents were asked what was their perceived cost for the
repellent issued during the clinical trial. The were also
asked how much they were willing to pay for the tube of
repellent they were given during the clinical trial.
Focus group discussions
In-depth discussions
Seeking an in-depth understanding of the knowledge, at-
titude, perceptions and practice in relation to repellents
as a vector control intervention, a descriptive explora-
tory study, consisting of seven Focus-Group-Discussions
(FGDs) and one Small Group Interview (SGI) was con-
ducted in the study village from 10th – 28th June 2013,
three years after the clinical trial. The participants may
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or may not have participated in the initial clinical study of
topical repellents, as prior participation in the previous
trial was not an inclusion or exclusion criterion. Several
different formats of repellents were provided to partici-
pants to measure perceived preferences in delivery formats
of repellents among members of a community that had
previous familiarity with repellents.
Sampling of FGD participants
This study initially used convenient sampling to enrol
household heads in the village. A purposive sample of
households with the following characteristic were drawn
from the community:
 Households that had the males as household heads.
 Households that had females as household heads
(widows, divorced, separated etc.).
 Households that had males as household heads but
from which their female partners were invited for
the FGDs and SGI.
 Households that had children of school going age
(both primary and secondary schools).
From this sample, 6 – 12 individuals from households
with each of the above characteristics were interviewed
in seven FGDs and one 5-member SGI. The FGDs were
dynamic in nature consisting of individuals from 10 to
60 years of age and sampling was stopped at the ‘point
of saturation’ (no further ‘new’ information generated).
Study tools
Based on literature on knowledge and practice in rela-
tion to repellent use and on a priori experience of
repellent work with the community in the study area, an
interview guide on perceptions and practices around
repellent use in Mbingu village was developed for con-
ducting the FGDs. This guide was pre-tested on four
villagers, two men and two women before undergoing
further changes based on the feedback from these vil-
lagers. The outcome was a simple interview guide that
consisted of six open ended questions that were struc-
tured in a flexible manner to allow for any emerging
ideas from the participants to be incorporated there in.
Repellents explored
The different types of repellents issued to the participants
of this study were; Permethrin impregnated ‘kangas’ (a
sheet of fabric worn around the waist by women in
Africa), 15% DEET (N, N-Diethyl-3-methylbenzamide)
topical repellent in petroleum jelly format, 15% DEET top-
ical repellent in spray format, 30% PMD (Para-Methane 3-
8-diol) topical repellent in lotion format, 30% PMD topical
repellent in spray format, 2% transfluthrin impregnated
sisal strip (sack), that was hung in a common area where
all household members sat, (Figure 1) [24] and 2% per-
methrin impregnated net fencing that was designed to
protect individuals sitting outdoors, especially around the
cooking area (Figure 2).
Procedures
Participants were verbally informed on the objectives and
aims of the study, its voluntary nature, risks and benefits.
Thereafter verbal informed consent was sought from the
purposive and final sample of participants after all ethical
considerations of the study had been outlined. Interview
schedules, including convenient interview times and venues
were then negotiated between the study investigators and
participants and the study commenced from the 10th to
28th of June 2013. The interviews were all conducted in
Swahili and lasted between 30mins and 1 hour in the vari-
ous local settings preferred by the participants. Consent
was sought to use a tape recording device for the sessions
with all villagers agreeing to be tape recorded prior to com-
mencement of the interviews. First, four FGDs with the
four different respondent groups: households that had the
males as household heads, households that had females as
household heads (widows, divorced, separated etc.), house-
holds that had males as households heads but from which
their female partners were invited for interviews, and
households that had children of school going age (both
Figure 1 Testing the efficacy of transfluthrin impregnated sisal strip in the semi-field system at the IHI.
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primary and secondary schools), were conducted where
community knowledge (familiarity) and use of repellents as
a mosquito control tool was assessed. At the end of these
first four FGDs, the respondent groups were issued with
different formats of repellents to use for a week. After using
the different repellent formats for one week, these respon-
dents groups were recalled for a further three FGDs and a
single SGI where experiences of repellent use and prefer-
ence to different repellent formats were assessed.
Data management
Data from the baseline, follow-up, and post-study sur-
veys were linked using the household unique identifier.
Data from these questionnaires were entered into and
coded using an Epi-info template that corresponded to
the format of the questionnaires. All data was double
entered into Epi-info, where it was checked for excesses
or missing of data. Data was then exported to Microsoft
Access 2010 database where it was checked for dupli-
cates. Data from the FGDs was collected using tape re-
corders and imported into the computer where they
were stored as audio files ready for transcription and
analysis.
Data analysis
All data analysis was carried out in STATA 11.2 (Stata-
Corp LP, College Station, Texas, USA) software. Data
from the baseline, follow-up and post-study surveys were
analysed using descriptive statistics and are presented in
tables (Tables 1, 2 and 3).
Data from the socio-economic status (SES) was ana-
lysed using principal component analysis (PCA). A
socio-economic index was generated using PCA and the
generated score used to show wealth index of each house-
hold. Indicators of (SES) used were; asset ownership,
household construction materials and education level of
household head. These results are reported in detail else-
where [23]. Data for KAP collected during the follow-up
survey was analysed by determining trend over time, using
descriptive statistics. Compliance data collected using the
follow-up survey was also stratified by SES quintiles to de-
termine if there was a difference in repellents use by SES
quintile.
Data for KAP collected at baseline and post-study sur-
vey was analysed by comparing the before and after
studies using descriptive statistics. Likewise, in the post-
study survey, willingness to pay was compared across
the SES quintiles.
The number of repellent and placebo tubes issued was
analysed by linear regression against month, treatment
group and an interaction of month and treatment group
to determine if there was a significant difference in the
number of tubes issued in each month and per treat-
ment group.
Data collected over the study period (follow-up survey)
was used to report outcomes on compliance, community
liking the repellent and perception of effectiveness of re-
pellents because it was assumed to be less prone to re-
call bias compared to data collected at the end of the
clinical trial (post-study survey).
Audio files from FGDs were transcribed verbatim in
Microsoft Office and imported into Nvivo 9 (QSR inter-
national Pty Ltd 2006–2010) qualitative analysis soft-
ware. The data was the then coded into themes as they
emerged from the response data in the transcripts. This
content analysis also allowed for themes emerging from
the data to be considered during iterative coding. The
final coding tree (structure of categorizing data) con-
sisted of identified themes from the data as well as un-
anticipated themes from the respondents. The final stage
of the analysis involved re-organization of the themes
into larger categories of themes communicating the key
messages from each of the smaller themes under them
(Table 4).
Ethical consideration
Participants were recruited on written informed con-
sent. Ethical approval for the study was obtained from
Ifakara Health Institute (IHI) (IHRDC IRB A46), Tanzanian
National Institute of Medical Research (NIMR/HQ/R8a/
Figure 2 Installation of permethrin impregnated fencing around an outdoor kitchen/cooking area in the study area.
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VOL IX/780) and the London School of Hygiene and
Tropical Medicine Ethical Review Board (LSHTM ERB
5174). IHI provided study monitoring.
Results
Baseline survey
At baseline, only 0.32% of the households had ever used re-
pellents in the intervention arm, while no households had
ever used repellents in the control arm (Table 1). Two
households reported burning mosquito coils, five house-
holds repelled mosquitoes with a smoky fire and one
household reported using repellent plants (data not
shown). Most households (95.7%) used bed nets as these
had been delivered through various governmental and
non-governmental schemes from 1997 onwards. When
asked about malaria a similar proportion of the house-
holds in the intervention and control arms reported that
malaria is a disease: 93.44% (n = 285) and 95.50% (n = 284),
Table 1 Baseline perceptions on malaria and repellents
Repellent n (%) Placebo n (%) Totals n (%) P- value
What is malaria
Disease 285 (93.44%) 270 (95.07%) 555 (94.23%) 0.397
Don’t know 20 (6.56%) 14 (4.93%) 34 (5.77%)
Causes of malaria
Mosquitoes 302 (99.01%) 280 (98.59%) 582 (98.81%) 0.634
Other 3 (0.99%) 4 (1.41%) 7 (1.19%)
Knowledge of malaria prevention methods 0.664
Bed nets 286 (94.38%) 271 (95.42%) 557 (94.89%)
Environmental management 7 (2.31%) 3 (1.05%) 10 (1.70%)
Going to hospitals 4 (1.32%) 2 (0.70%) 6 (1.02%)
Using repellents 1 (0.33%) 1 (0.35%) 2 (0.34%)
Don’t know 5 (1.65%) 7 (2.46%) 12 (2.04%)
Knowledge of mosquito breeding site 0.998
Water puddle 291 (95.40%) 270 (95.40%) 561 (95.41%)
Other 14 (4.60%) 13 (4.60%) 27 (4.59%)
Protection methods used
Bed nets 294 (95.14%) 277 (96.85%) 571 (95.97%) 0.600
Mosquito coils 3 (0.97%) 3 (1.04%) 6 (1.01%)
Environmental management 7 (2.26%) 5 (1.74%) 12 (2.02%)
Covering oneself 4 (1.29%) 1 (0.34%) 6 (0.84%)
Using repellents 1 (0.32%) - 1 (0.17%)
Reasons for using protection methods
Effective 174 (56.31%) 154 (54.03%) 328 (55.22%) 0.008
Readily available 34 (11.00%) 22 (7.71%) 56 (9.34%)
Cheap 23 (7.44%) 8 (2.80%) 31 (5.22%)
Easy to use 76 (24.59%) 100 (35.08%) 176 (29.63%)
Other 2 (0.64%) 1 (0.35%) 3 (0.51%)
Reasons for not using repellents
Don’t understand use 139 (45.27%) 118 (41.40%) 257 (43.41%) 0.057
Not aware of repellents 38 (12.37%) 28 (9.82%) 66 (11.15%)
Not available 109 (35.50%) 115 (40.35%) 224 (37.84%)
Expensive 16 (5.21%) 24 (8.42%) 40 (6.76%)
Other 5 (1.62%) - 5 (0.84%)
Willingness to use repellents
Yes 309 (99.67%) 286 (100%) 595 (99.83%) 0.336
No 1 (0.32%) - 1 (0.17%)
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Table 2 Assessment follow up of households, repellent use and perceptions during the study period
Repellent n (%) Placebo n (%) Total proportions/treatment P value
Like repellent
Yes 462 (99.35%) 390 (84.41%) 852 (91.91%) <0.0001
No 3 (0.65%) 72 (15.59%) 75 (8.09%)
Compliant
Yes 379 (81.50%) 361 (78.13%) 740 (79.83%) 0.202
No 86 (18.49%) 101 (21.86%) 187 (20.17%)
Perceived effectiveness
Yes 457 (100.00%) 379 (84.03%) 836 (92.07%) <0.0001
No 0 (0.00%) 72 (15.96%) 72 (7.93%)
Table 3 Assessment of perceptions on repellent use, effectiveness and cost after the study period
Repellent n (%) Placebo n (%) Total proportions/treatment P- value
Reasons for non-compliance
Forgot 35 (70.00%) 89 (60.13%) 124 (62.63%) 0.241
Away in the field 13 (26.00%) 56 (37.83%) 69 (34.85%)
Don’t like repellent 1 (2.00%) - 1 (0.51%)
No mosquitoes 1 (2.00%) 2 (1.35%) 3 (1.52%)
Ran out of repellent - - -
Other - 1 (0.67%) 1 (0.51%)
Perceptions about repellents
Effective 455 (98.69%) 208 (45.61%) 663 (72.30%) <0.0001
Easily available 5 (1.08%) 50 (10.96%) 55 (6.00%)
Nice smell - 99 (21.71%) 99 (10.80%)
Smooth on skin - 98 (21.49%) 98 (10.69%)
Other 1 (0.21%) 1 (0.21%) 2 (0.22%)
Willingness to use repellent again
Yes 462 (99.78%) 463 (99.78%) 925 (99.78%) 0.999
No 1 (0.21%) 1 (0.21%) 2 (0.22%)
Willingness to pay
Yes 458 (99.78%) 455 (98.48%) 913 (99.13%) 0.034
No 1 (0.21%) 7 (1.51%) 8 (0.87%)
Perceived cost of repellent
< 0.6 USD 99 (21.80%) 111(26.74%) 210 (24.17%) 0.023
0.6 – 1.2 USD 280 (61.67%) 212 (51.08%) 492 (56.62%)
1.2 – 1.8 USD 61 (13.43%) 75 (18.07%) 136 (15.65%)
1.8 – 3.05 USD 13 (2.86%) 17 (4.09%) 30 (3.45%)
> 3.05 USD 1(0.22%) - 1 (0.12%)
Amount participants were willing to pay 0.347
< 0.30 USD 388 (83.43%) 402 (87.77%) 790 (86.06%)
0.30 – 0.60 USD 64 (13.91%) 52 (11.35%) 116 (12.64%)
0.60 – 1.20 USD 7 (1.52%) 4 (0.87%) 11 (1.20%)
1.20 – 1.52 USD 1 (0.21%) - 1 (0.11%)
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respectively. When asked about malaria transmission,
most households in the intervention arm 99.01% (n = 302)
and control arm 98.59% (n = 280) reported that mosqui-
toes transmit malaria. Bed nets were the major prevention
tool used in the study village, with a similar proportion of
reported bed net use in the intervention 95.14% (n = 294)
and control arm 96.85% (n = 277). When households that
reported bed net use, were further asked why the preferred
bed nets to other tools, a significantly larger proportion
cited effectiveness relative to other reasons: 56.31% (n =
174) and 54.03% (n = 154) in the intervention and control
arm, respectively. Other reasons for use of bed nets as well
as other mosquito bite protection methods are reported in
Table 1. It should be noted that the bed nets reported by
the respondents, were not those issued during the clinical
trial, but they were reporting on tools they used before the
onset of the clinical trial. However, bed nets were given at
the start of the clinical trial to ensure equity between the
study arms. An equal proportion of households in both
the intervention 95.40% (n = 291) and control 95.40% (n =
270), arms reported that mosquitoes breed in standing
water. The major barrier to repellent use in this commu-
nity was lack of knowledge on how to use repellents, with
45.27% (n = 139) households in the intervention and
41.40% (n = 118), in the control arm reporting that they
did not understand how topical repellents were used. Lack
of awareness of repellents was also reported as a barrier to
repellent use, with 35.50% (n = 109) and 40.35% (n = 115)
of the households in the intervention and control arms re-
spectively, indicating that they were not aware of repellents
as a mosquito control tool. However, when repellents were
made available knowledge was no longer a barrier to com-
pliance. All households were willing to use repellents to
prevent mosquito bites: 99.67% (n = 309) of the house-
holds in the intervention and 100% (n = 286), (p = 0.336),
in the control arm were willing to use repellents, even
though this tool was novel in this community after com-
munity sensitization, (Figure 3).
Follow-up survey
A follow up survey was conducted to assess household
compliance to repellent use. Compliance in this context
is defined as having recalled use of the repellent every
night in the past month. However, if during the follow
up survey there were no household members present to
answer the questionnaire on compliance, and continued
to be absent for seven consecutive days after the first
visit to assess compliance, that household was consid-
ered non-compliant to repellent use for that month. If
the households reported that any household member did
not use the repellent, the household member was re-
moved from follow up time for the period they did not
use the repellent. Reported household compliance with
repellent use was not significantly different between the
study arms: 81.50% (n = 379) in the intervention and
78.13% (n = 361) in the control arm, (p = 0.202) during the
study period. Significantly more households liked using the
repellent in the intervention arm 99.35% (n = 462) com-
pared to the control arm, 84.41% (n = 390), (p = <0.0001).
When asked about effectiveness, significantly more house-
holds in the intervention arm, 100% (n = 465) compared to
the control arm 84.03% (n = 379), (p = <0.0001), perceived
repellents to be effective (Table 2). Also, significantly more
households that perceived the repellent to be effective
complied with repellent use (72.31%) compared to those
households that did not comply (27.68%), (p = <0.0001).
This indicates that relief from mosquito bites was a motiv-
ating factor in repellent compliance.
When the perceptions of effectiveness of repellents
was analysed over the study period, it was observed that
there was an increase in the number of households
reporting the repellent to be effective over time. This
trend was also observed for households that reported to
like the repellents. Compliance was observed to increase
over the study period, with more households reporting
repellent use at the end of the study compared to the
start of the study. Because the repellents were given out
Table 4 Major themes generated from the Focus group discussions (FGD’s) and Small group interviews (SGI)
Major results
theme
Theme 1 Respondents were aware of the link between malaria and mosquitoes, but their knowledge on malaria aetiology and
transmission was shallow. This did not however, effect their compliance with an intervention that was available free of charge.
Theme 2 Although respondents had adequate knowledge of repellents as a mosquito control tool, they preferred to use the bed net over
repellents.
Theme 3 Those respondents aware of topical repellents had adequate knowledge on their proper use
Theme 4 Availability (access) and cost of repellents were major barriers to repellent use after the trial ended and repellents were no
longer supplied.
Theme 5 The respondents perceived the repellents to be effective against mosquito bites, mostly in the early evenings.
Theme 6 Respondents recommended repellents be made more available and insecticides (permethrin) used to treat clothing be provided
to enable self treatment.
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for free there was no difference in repellent compliance
between the most poor and least poor socioeconomic
quintiles (p = 0.369), data not shown.
There average number of tubes issued per household
was 6.73 (95% C.I. 6.51 – 6.95) and 6.92 (95% C.I 6.68 –
7.16) per household per month in the intervention and
control groups, respectively and there was no significant
difference between the treatment arms: Odds Ratio 1.68
(95% C.I. 0.32 – 84.25, P = 0.803) and this remained con-
stant for the duration of the study period.
Post-study survey
The main reason for non-compliance to interventions
was forgetfulness, with 70% (n = 35) of the households in
the intervention and 60% (n = 89), (p = 0.241) in the con-
trol arm reporting that the major reason they did not
comply with the intervention at some point during the
study was because they forgot to apply the repellent.
Travel also lead to non-compliance with 26% of house-
holds in the intervention arm and 37.83% of households
in the control arm not complying for a month because
they had gone to work in the fields.
When asked why they liked using the repellents, sig-
nificantly more households in the intervention arm
98.69% (n = 455) relative to the control arm 45.56% (n =
208) cited effectiveness, (p = <0.0001). It is worth noting
that all households who mentioned nice smell and
smooth feeling on the skin as reasons for using repel-
lents were from the placebo arm of the trial. When
asked if anyone in their household suffered from malaria
during the trial, significantly more participants from the
placebo arm answered yes: 32.9% versus 15.5%, (p <
0.0001).
Equal proportions of households were willing to con-
tinue using repellents after the clinical trial (Table 3).
When asked if they would be willing to pay if the repellent
was made available at a fee, 99.78% (n = 458) of the house-
holds in the intervention and 98.48% (n = 455), (p = 0.999),
in the control arm reported that they were ready to pay a
small fee, with majority of the households in the interven-
tion, 84.34% (n = 388) and control arms 87.77% (n = 402),
(p = 0.347) willing to pay at most $ 0.30 for a tube of
repellent (Table 3), even though all participants perceived
that the value of the repellent was at least double that
figure. There was no difference in willingness to pay when
SES quintiles were compared (p = 0.668).
Focus group discussions
Perceptions around malaria control and transmission
To provide a general picture of the community’s know-
ledge, attitude and practice in relation to malaria and
ways to control malaria, participants were questioned
about their knowledge of malaria transmission and
methods of prevention and control used. Some of the
participants had a comprehensive understanding of mal-
aria and control, as observed from the response of one
female respondent below: “Malaria is caused by a female
mosquito when it bites you at midnight” (Meeting group
5, 16th June 2013).
Interestingly however, and especially in a region where
there has been consistent malaria control, research and
intervention implementation by both non-governmental
and governmental organizations for over 20 years [15-17],
the community members did not appear to have an in
depth knowledge of malaria transmission. In trying to as-
sess the depth of community knowledge on the malaria
Figure 3 Community sensitization meeting on repellents conducted by the social marketing team from IHI.
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transmission process, the respondents were asked how
many times a mosquito had to bite a person for it to trans-
mit malaria. Most of the respondents did not seem to
know:
“We do not know unless you tell us”- (Meeting group
4, 14th June 2013).
“Many times”- (Meeting group 1, 14th June 2013).
This indicates the community knowledge on malaria
transmission is superficial, so that whilst the community
are aware that mosquitoes transmit malaria, their know-
ledge on this transmission process is scant. These gaps
in knowledge might suggest a bias during implementa-
tion of malaria control programmes, so that, rather than
promoting community sensitization and education on
the objectives of the intervention, the link between inter-
vention and disease, and the benefits of the intervention
to the individual and the community, these programmes
likely focus more on coverage of the control tools.
Preference of malaria prevention tools used in the
community
All respondents had used some form of personal protec-
tion against mosquito bites even for those who weren’t
quite sure what malaria was. It also emerged that they
had been using these tools for a long time and were con-
vinced that the tool each one of them had been using
was the most effective. The most commonly reported
malaria prevention tool used was the bed net, when re-
spondents were asked which tool they used to protect
themselves from mosquitoes and malaria:
“We use nets” – (Meeting group 1, 14th June 2013).
Even though some of the respondents were aware of
mosquito repellents and/or had acquired topical and
spatial repellents at some point in the past 2 years, dur-
ing or after the clinical trial, most of them still preferred
using the bed net;
“I would prefer the net” – (Meeting group 3; 25th
June 2013)
When the respondents were questioned on why they
preferred the bed net to other mosquito control tools, two
major reasons were given. The first was cost effectiveness:
“Because mosquitoes will not bite you when you are
sleeping under a net but for the repellents they last for
a short time and when the smell wears off then the
mosquitoes bite you” – (Meeting group 2, 26th
June 2013).
The second was generally the ease of use:
“MG: FR: 03: Because it is not cumbersome”- (Meeting
group 3, 25th June 2013).
Familiarity of topical repellents
At the onset of the FGDs, most respondents’ awareness
of repellents was thin, with almost half of them largely
unaware of topical repellents as a malaria control tool.
However, those who had heard of topical repellents had
adequate knowledge on the proper technique of using/
applying the repellents as illustrated by the following
quotes when respondents were asked how repellents
were used;
“You can apply and then it stays for a few hours after
that it is no longer effective and the mosquitoes can bite
you. After you apply it you have to wash your hands
well with soap” – (Meeting group 5, 16th June 2013).
For those who knew about repellents, the primary
source of information was outreach from the Ifakara
Health Institute (IHI), previously Swiss Tropical Institute
Field Laboratory (STIFL), which is the institute under
which the clinical trial project was conducted. When
asked how they came to know of repellents most re-
spondents mentioned the clinical trial, which distributed
the repellents free of charge:
“They were being distributed by people from STIFL
(IHI)” – (Meeting group 1, 14th June 2013).
Reported experience of use after topical repellent
distribution and use
After repellent distribution, all respondents reported that
they had used the repellent intervention issued to them
during the second phase of FGDs. The most commonly
reported reasons for continued use of the repellents by
the respondents were mainly because of their effective-
ness against mosquito bites and also because of the ap-
peal in odour and presentation:
“I liked it because it prevented mosquitoes and its
smell did not affect us in any way like causing flu or
any other effects”- (Meeting group 3, 20th June 2013).
Another reason that emerged from the interviews was
that every member of the household could use the
repellent as opposed to other interventions issued which
only a few household members used:
“I would choose the applying repellent because it can
be used by the children, my husband and even
visitors”- (Meeting group 3, 20th June 2013).
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There was one report of side effects to repellent use,
however this was during the clinical trial and not in the
FGD study:
“Yes I know my sibling he used to get rashes all over
the body so he was told not to apply the repellents
anymore”- (Meeting group 5, 16th June 2013).
Preference for different applications of repellents
After exposing the respondents to typical topical repellents
containing active ingredients such as DEET and PMD and
in various formats such as lotion, jelly, spray, permethrin
impregnated clothing, (kanga), transfluthrin impregnated
sack cloth and permethrin impregnated net fencing, the re-
spondents expressed the following views and preferences;
“I found the smell to be too strong” when asked about
DEET in spray format –(Meeting group 2, 25th June 2013).
“I liked the smell “ when asked about PMD in lotion
and spray formats – (Meeting group 2, 25th June 2013).
“I did not like the smell because it was too strong “
when asked about DEET in jelly format – (Meeting
group 2, 25th June 2013).
“The applying repellent because everyone can use it
but the kangas cannot be used by everyone” when
asked to choose between topical repellents and
insecticide treated clothing ‘kanga’ – (Meeting group
3, 20th June 2013)
.
“If you sat near the sack repellent then the mosquitoes
couldn’t bite you but if you sat just a distance away
then they would bite”– when asked about the
transfluthrin impregnated sack, (Meeting group 6,
20th June 2013).
“I got the net so I used to sit inside it and the
mosquitoes were very few. They used to bite the feet
only but I could stay for like half an hour without
bothering with any mosquitoes” – when asked about
the permethrin impregnated net fencing, (Meeting
group 6, 20th June 2013).
Factors that determine the continued use of topical repellents
For those who did not use repellents during the clinical
trial, repellents were generally not popular. There were a
several barriers to repellent use in this community; the
first being access to the repellents:
“We were given repellents for applying but after they
got finished I have not used anything else apart from
nets” – (Meeting group 1, 16th June 2013).
Repellents were provided of free during the clinical
trial. However after the clinical trial, the community was
unable to access repellents as they were not available in
shops and drugs stores in the study area, as was
highlighted by the respondent above.
The costs of the repellents according to most respon-
dents limited their affordability with most respondents
prioritizing other living essentials over the repellents.
When asked to choose between buying a soda or the
repellent (subject to availability), most of the respon-
dents opted to buy the refreshment:
“I would buy the refreshment or a net otherwise I
would just use a lot of clothing to cover myself ” –
(Meeting group 1, 16th June 2013).
Community recommendations on improving repellent use
In an effort to understand how to improve the use of re-
pellents, participants were questioned on what they felt
was necessary to make the interventions better. While
most of the responses revealed that the repellent appli-
cation was fine the way it was, other recommendations
included the cost of the repellent:
“I wouldn’t buy them because that is expensive unless
you sold them in 500 shillings bottles ” – (Meeting
group 1, 16th June 2013).
It should be noted that the bottle the respondent was
recommending to be sold for 500 TZS/$0.30 contained
120 ml of repellent.
Odour of DEET repellent:
“I did not like the smell because it was too strong” –
(Meeting group 2: Male respondent).
Issuing extra insecticides so that they could re-treat
the impregnated clothing issued:
“I also think that you should give us repellents for the
kangas so that we can treat them once we wash them” –
(Meeting group 3, 25th June 2013).
Discussion
Despite the proven efficacy and acceptability of repellents
for prevention of malaria [7-10], knowledge and utilization
of repellents as a malaria control tool is low in sub-
Saharan Africa. Lack of awareness of repellents as a mal-
aria control tool is one of the major barriers to repellent
use in sub-Saharan Africa. As observed from the baseline
survey at the start of this study, most respondents had not
used repellents before the implementation of the clinical
trial. Therefore, use of topical repellents was completely
new in this community as similar to several other studies
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conducted in the African continent [25-27]. It is evident
that improving community knowledge and awareness
[26-29] as well as retooling interventions to community
needs and preferences [30] will improve the acceptability
and uptake of interventions being advocated. The most
commonly used malaria control tool in the study area was
bed net. Social marketing of LLINs started in Kilombero
and Ulanga district in July 1997, under the KINET project.
At the launch of this programme the community was edu-
cated on malaria transmission and control [15]. This cam-
paign was followed by the launch of the Tanzania National
Voucher System (TNVS), implemented by the National
Insecticide Treated Nets programme (NATNET), under
the National Malaria Control Programme (NMCP) of
Tanzania, from 2004. In 2007, the Ministry of Health and
Social Welfare (MoHSW), collaborating with other part-
ners launched the under five Catch-up Campaign, parallel
to the TNVS programme. In 2008, the MoHSW and part-
ners launched the Universal Coverage Campaign (UCC)
[31]. Therefore, if repellents and indeed any other novel
tools are to be accepted and used to complement LLINs
and IRS, there will be a need for social marketing, com-
munity education and sensitization to be employed for a
substantial period of time. It is also essential to determine
community preferences. Tools that require daily compli-
ance are initially likely to have limited uptake, as the com-
munity has to remember to adhere to them on a daily
basis. As observed from the FGDs study, ease of use was
one of the reasons why the community preferred bed
nets to repellents. This was because, once hung, the bed
net was used over a long period of time as you simply
pull it down when you get into bed, compared to having
to remember to apply the repellent every evening. How-
ever, ease of use was not the only factor that effected
compliance. In the follow-up surveys, it was observed
that there was lower compliance in the control arm
relative to the intervention arm. Likewise, in the after
study, it was observed that more households in the
intervention arm relative to the control arm used the
repellent because it was effective. This finding demon-
strates that compliance to interventions does not only
depend on its availability and ease of use but also on its
effectiveness.
In the FGDs it was also observed that even though
sisal impregnated sisal strips did not require daily com-
pliance and were easy to use, they were reported to be
effective over very short distances, and this discouraged
the community from using it.
These finding demonstrates that to impact compliance,
the efficacy of the tools being recommended need to be
established. A recent mathematical model demonstrated
that the effectiveness of any repellent is extremely de-
pendent on two factors: efficacy and compliance (Moore
and Briet, in preparation). The most effective tools are
those that have high efficacy and require little user compli-
ance such as house screening [32].
The major reason for use of topical repellents by the
community in Mbingu village is to prevent nuisance bit-
ing by mosquitoes. Although a proportion of the com-
munity could associate mosquito bites with malaria, the
results of this study imply that they used repellents to
avoid being bitten by mosquitoes rather than to avoid
contracting malaria. These results were similar to a
study carried out in a coastal community in Mexico,
where 80% of the respondents said they allowed IRS in
their households to reduce mosquito bites while only 2%
said they allowed IRS to avoid contracting malaria [33];
and in rural Tanzania, where respondents reported that
main reason for using LLINs was to prevent mosquito
bites: 73% of the respondents reported they allowed IRS
in their households to reduce mosquito bites and only
17% related protection from mosquito bites with reduc-
tion of malaria in the family [25]. These findings demon-
strate that tools being advocated as interventions,
especially in malaria control should address both short
and long-term goals, i.e. address the problem of nuis-
ance biting or mosquito densities (efficacious to enhance
uptake) as well as reduce disease prevalence/incidence
in the long run (resultant effectiveness). This is likely to
encourage uptake and acceptability as opposed to tools
whose benefits are realized in the long-term, and high-
lights the need to test new vector control interventions
against nuisance biting insects as well as target vectors
during development for a better understanding of how
effective that tool will be in the real world for disease
control purposes.
The major reason for not using repellents in this com-
munity was reported to be lack of knowledge of
repellent use and is similar to findings in other studies
[26], where low repellents use was associated with poor
knowledge of repellents. Availability of repellents in this
community was another barrier to repellents use as ob-
served from the baseline survey.
Also, in the FGDs, after the clinical trial, when asked
why they did not use repellents, the respondents cited
availability as a barrier, reporting that they did not know
where to access repellents. Observations carried out by
the study investigators during the clinical trail and
FGDs, indicated that no topical repellents were available
in the shops and drug stores the study area. Therefore,
despite most households indicating willingness to con-
tinue repellent use, and even pay a small fee, access to
repellent was a major barrier to repellent use.
Another barrier to the use repellents was cost [34].
During the FGDs, even though all respondents were
aware of repellents as a mosquito control tool, they all
preferred using LLINs as they reported that repellents
were more expensive in the long run because they had
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to be replaced every end of the month compared to
LLINs, which could last up to five years before replace-
ment, if well taken care of. This finding was consistent
with outcomes from other KAP studies assessing uptake
of interventions [25,28,35]. As seen from the above stud-
ies, cost of mosquito control interventions greatly influ-
ences the acceptability and uptake in communities where
they are to be employed. In rural and urban areas in
Tanzania, a 150 ml bottle of 15% DEET repellent costs
USD $1.00. On average, respondents were willing to pay
$0.32 for a 150 ml tube of repellent that would last one
adult less than one month. The current price of repellents
is too expensive for the subsistence farmer, who lives on
$1.50 USD per day. Therefore, even though incorporation
of repellents into malaria control programmes on a com-
munity scale, is likely to use a cheaper but efficacious op-
tion of repellent, as was the case in Ghana [10], it is
unlikely that the repellents would be subsidized down to
or lower than $0.32. Also, scale up and extensive use of re-
pellents under programmatic conditions as well as emer-
gence of a repellent market is bound to drive the cost of
repellents down. However these cost are unlikely to be
lower than the cost of delivering a single LLIN, which
costs USD $5.30 and protects two people for up to 5 years
($0.50 per person per year) [31]. Therefore if we are to en-
courage up take of repellents as a malaria control tool, the
cost needs to be greatly reduced, potentially through
government and non-governmental organizations offering
subsidies on repellents following the example of LLINs
[23]. The government may also encourage local pro-
duction of repellents through tax exemption for local
repellent manufacturers.
From the FGDs, it was observed that knowledge on mal-
aria transmission and control was relatively superficial.
While most respondents associated mosquitoes with mal-
aria, when probed, few were able to detail processes of
transmission, aetiology and prevention in any depth. There-
fore, although all respondents from the FGDs reported that
they used the repellents issued, it is likely that they did so
with only a superficial understanding of the objectives of
using repellents. This might have been because the com-
munity were more concerned with preventing mosquito
bites than contracting malaria, as observed in other studies
[25,33]. As all respondents reported that they had complied
with repellent issued it was not possible to assess the rela-
tionship between compliance and level of knowledge of
malaria transmission. The superficial knowledge of malaria
transmission observed in this community underscores the
importance of incorporating community education and
sensitization before implementation of any intervention to
achieve its desired objective. Social marketing the product,
and neglecting key messages regarding how these inter-
ventions benefit the communities in which they are being
implemented, is likely to negatively effect uptake of that
intervention. It is therefore essential for the community to
be involved in designing and implementation of interven-
tion programmes so that they have a better understanding
of the objectives and use of tools being employed.
Several studies have shown that there has been better
uptake of interventions in communities where awareness
and sensitization have been conducted [36]. Promoting
knowledge and awareness also deters any misconcep-
tions that the community may have towards a particular
intervention and it is essential for effective implementa-
tion of that intervention [37,38]. During FGDs for this
study, some respondents reported that they had ‘heard’
that LLINs caused infertility and also claimed that if/
when they use repellents then their skin pores will be
blocked and they will get sick. However in a KAP study
in Rukungiri, Uganda, women who had previous know-
ledge of the use of ivermectin were more involved in
making decisions of how ivermectin should be distrib-
uted to the community compared to those women who
had no prior knowledge of this drug [39]. It is therefore
essential to acknowledge and address the community’s
misconceptions and misinformation about intended in-
terventions in order to improve acceptability, uptake and
effectiveness. Rather than the implementing organiza-
tions solely marketing the product to achieve extensive
coverage, it is beneficial to also educate the community
on the safe use of these interventions and the correlations
between their products, the disease and its benefits.
The respondents’ preference of LLINs to repellents is
attributable to cost effectiveness, convenience of use and
availability. The major reason given for non-compliance
to repellent use was that the respondents ‘forgot’ to use
it, while ease of use was ranked second among reasons
why respondents preferred using bed nets. It was cum-
bersome to remember to re-apply the repellent after
every few hours, unlike simply sleeping under a LLIN.
Repellents should therefore be presented in a format
that will encourage uptake. As the major occupation in
the study area is subsistence farming, most community
members bathe in the evening after coming from their
farms. Repellents can be incorporated into body lotions
so that they are applied after taking the evening bathe.
Repellents can also be impregnated in clothing, especially
in kangas used by women in the evening when cooking
outdoors. Development of tools that do not require daily
compliance such as long lasting spatial repellents that act
over long distance should also be explored [40].
Respondents also preferred LLINs because it protected
them when they were asleep and vulnerable to mosquito
bites as opposed to when they were awake and could
chase mosquitoes away. The community however pre-
ferred to use repellents in the early evenings when sitting
outside their houses to have a chat with other family
members and friends without being bothered by mosquito
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bites. This finding is important because it suggests that re-
pellents can be used complimentary to LLINs in the early
evening, before LLINs are employed, which was a major
objective of this study.
Perceived irritating odour of DEET topical repellents
reduced its use by the community in this study, a finding
similar to studies in North Tanzania and Mexico where
participants refused to use IRS because of the ‘bad smell’
of insecticides used [25,33], emphasizing that interven-
tions should be tailored to be perceived as pleasing by
users. PMD was perceived as pleasant as found in sev-
eral other studies [7,10,41].
The most salient recommendation that came out of this
study was that interventions advocated to the community
should fit the community needs, such as providing re-
pellents that have a pleasant smell and feels good when
applied to the skin. Respondents that were issued with
Permethrin impregnated kangas, reported that even
though effective, it only protected a single individual at a
time and suggested that all members in the household be
issued with a treated kangas, and like LLINs, be issued
with the ‘chemicals’ (insecticides) used for re-treatments
so that when the effect of the insecticide was diminished
they could treat the clothing on their own. Insecticide
Treated Clothing (ITC), has been successfully imple-
mented in other settings [42-45] and therefore this tool
would easily be introduced in this community. Another
outcome of this study was the effectiveness of the topical
repellents that were issued. The respondents found topical
repellents to be effective in protecting against early even-
ing biting outdoors. This finding is similar to other stud-
ies, where repellents have been used to protect against
vectors biting outdoors and by extension reduce the inci-
dence of malaria [7,8,46]. Therefore both topical repellents
and ITC, if designed to meet the needs and preferences of
the community, could offer potential interventions that
could be introduced for malaria control and would be
readily accepted by the community.
Conclusion
In this setting, the major limitations to use of repellents,
similar to those identified from other studies were lack of
knowledge, availability of repellent, cost and need to
remember to use it every evening or even more than once
in a single evening. While the community was highly
knowledgeable about malaria, their knowledge was found
to be superficial, indicating poor community education
and sensitization. Although currently LLINs are the most
commonly used and preferred malaria prevention and
control tool, their introduction to the community was ini-
tially marked by similar limitations emerging from this
study such as the need to use it daily and the cost being
prohibitive. When repellents were provided free of charge
to all trial participants compliance was high. It is therefore
likely that uptake will improve if accessibility of repellents
is improved through lower costs and greater availability
through the commercial sector, comprehensive social mar-
keting and community sensitization on use of repellents,
as well as delivery of repellents in formats that respond to
community desires. Even though LLINs were the preferred
mosquito protection tool, the community saw a benefit in
the use of topical repellents in the early evening, especially
to prevent mosquito nuisance indicating the potential of
using repellents complimentary to LLINs. However, longer
lasting repellents are an essential requirement to avoid the
need for frequent reapplication that most people find off-
putting. The difference in compliance reported during and
after the study is likely due to recall bias at the end of the
study. Other avenues such as long lasting spatial repellents
might be used if they are effective enough to protect the
peridomestic space occupied by the family and visitors in
the evening.
Limitations to the study
A ranking of repellent preference had previously been re-
ported in this study, but as there were too few repellents
types/formats to issue to each FGD participant, these re-
sults were discarded along with some themes that had
earlier been reported as they did not represent true results
of community preference to different repellent formats.
As the participants were only issued with one repellent,
it was not possible to explore whether the participants
would use the repellents complimentary to each other if
they had been issued with different formats of repellents.
However, findings from the FGDs indicated the commu-
nity members used the tools complimentarily.
Another limitation of this study is that compliance,
during the follow up and post-study surveys, was estab-
lished by self-reporting of use by the study participants.
It was not logistically possible to observe compliance of
households to repellents use for each household every
evening and therefore observed and reported compliance
could not be compared, and this should be taken into
consideration when interpreting the results of this study.
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Chapter 7
evaluation of repellent efficacy in 
reducing Disease Incidence
Sangoro P. Onyango and Sarah J. Moore
INtrODUCtION
Repellents are currently used by millions of people worldwide to prevent nuisance bites from 
blood-feeding insects, and it is now a multi-million-dollar global industry.1 Until recently, there was 
limited scientific evidence on the efficacy of repellents to reduce disease. However, several groups 
of animals, including passerine birds and white-faced capuchin monkeys, anoint themselves with 
leaves, fruit, and even millipedes that contain compounds that are proven deterrents of ticks and 
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mosquitoes.2–3 This behavior is observed to increase at times when attacks from such arthropods are 
higher, as observed in capuchin monkeys of South and Central America.4 This fascinating observa-
tion is an indication that the use of personal protection from blood-feeding arthropods must improve 
the biological fitness of the animal that applies such repellents by reducing energy expended on 
“host defensiveness” or reducing its susceptibility to arthropod-borne diseases.5
Although the inhabitants of tropical countries with low per capita incomes may still use smoke 
and plant materials to keep biting arthropods at bay, the majority of research into the highly  effective 
mosquito repellents that are available today has been carried out by scientists employed by or funded 
by the military to protect troops stationed in high-disease-risk areas. Some of the world’s most 
important programs involved in the understanding and prevention of  arthropod-borne diseases 
have risen as a result of conflicts in tropical regions that lead to massive loss of life from diseases 
such as yellow fever, louse-borne typhus, and malaria.6 Two of these discoveries, N,N-diethyl-3-
methylbenzamide (deet), which is a topical repellent,7 and long-lasting permethrin-treated clothing,8 
are reviewed in this chapter. Two other repellents are also reviewed: p-menthane-3,8-diol (PMD), a 
topical repellent discovered in China,9 and mosquito coils that were developed by the private sector 
in Japan10 are examples of area or spatial repellents (see the section “Mosquito Coils”).
Topical repellents are oils or lotions applied to the exposed skin or clothes of the consumer, 
with the most safe and effective being deet, picaridin, and PMD. Picaridin will not be reviewed 
here, because there is, to date, no epidemiological evidence of its efficacy, although a well-designed 
trial to evaluate its efficacy against malaria is currently underway with results available in 2014.11 
Permethrin-treated clothing is impregnated with a safe pyrethroid insecticide and binding agent 
to allow the permethrin to adhere to the fabric even after several washes. Permethrin is a syn-
thetic pyrethroid, which has been extensively tested by the military,12–15 and is the only insecticide 
approved for this use category by the U.S. Environmental Protection Agency.16 It is nonstaining, 
odorless, and resistant to ultraviolet light and safe for regular use as an excellent tool for long-term 
prevention of arthropod bites. Mosquito coils are spirally shaped coils made from organic fillers, 
binders, and additives that allow the organic components to smolder evenly and continuously, to 
which a volatile pyrethroid insecticide is added that evaporates as the coil smolders over several 
hours after it is ignited. They are classified as area (spatial) repellents. Spatial repellency is used 
here as a general term to refer to a range of insect behaviors induced by airborne chemicals that 
result in a reduction in human–vector contact. This can include knockdown, interference with host 
detection (attraction–inhibition), or movement away from a chemical stimulus.17 Other forms of spa-
tial repellents include vaporizers and mats that have available extensive phase II (laboratory) data 
demonstrating excellent efficacy18 but no epidemiological evidence of efficacy to date.19 Vaporizers 
and mats require electricity to evaporate the insecticide from a small liquid reservoir containing the 
insecticide and a cellulose mat impregnated with the insecticide, respectively. This feature limits 
their application for disease prevention in the rural tropics where the majority of vector-borne dis-
eases occur, because electricity is not available. Another intervention of note is passive emanators 
that have a large surface area, allowing the passive diffusion of insecticides from the surface. There 
is extensive evidence from studies with dichlorvos that passive emanation of insecticides is effec-
tive against malaria vectors (Table 7.1). However, dichlorvos does not have a suitable toxicity profile 
for public health use.20 The discovery of the extremely nontoxic pyrethroid insecticides metofluth-
rin and transfluthrin (reviewed in the section “Mosquito Coils”) means that passive emanation of 
such compounds is an area of current research interest21,22 and large-scale epidemiological trials 
regarding this topic will begin in the near future. This has been publicized on the Notre Dame web-
site (http://news.nd.edu/news/46769-second-largest-research-award-at-notre-dame-fights-malaria-
and-dengue-fever/). Development of such products will be of great value because although the 
 pyrethroid insecticides used in coils are not harmful to humans, often the smoke produced from 
the combustion of coils is a nuisance to people, reducing consumer acceptance, and some brands 
 generate products of incomplete combustion, which are harmful to humans.23,24
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The annual market value of personal protection consumer products is over $2 billion for pow-
ders, gels, and repellents and $2.6 billion for spatial repellents including vaporizers and coils. It is 
estimated that 45–50 billion mosquito coils are used annually by approximately 2 billion people 
worldwide,25 mainly in Southeast Asia, but with a growing market in South America and Africa. 
These products present a great opportunity for public health, because such products could provide a 
means of disease control that is already proved to be highly acceptable to end users, because those 
who can afford them are willing to buy them.
VeCtOr BehaVIOr MODIFICatION FOr DISeaSe preVeNtION
The World Health Organization (WHO) has recommended that all travelers to disease-endemic 
areas should minimize exposure to insect bites by selecting a combination of personal protection 
methods including insect repellents, mosquito nets, mosquito coils, aerosol sprays, protective cloth-
ing, screening, and air-conditioning.26 The U.S. Department of Defense spent $4 million in develop-
ing the insect repellent system that comprises the proper wearing of a permethrin-treated uniform, 
and the application of extended-duration deet lotion to exposed skin that, if used correctly, provides 
close to complete protection from arthropod-borne diseases.27 However, there has been no discus-
sion on the implementation of repellents for public health use. The main explanation behind this is 
that until recently there were insufficient studies conducted to convincingly demonstrate that repel-
lents can be effective against disease transmission.
Public health vector control tools such as indoor residual spraying (IRS) and the use of long-
lasting insecticide-treated nets (LLINs) are extremely effective in sub-Saharan Africa.28 Massive 
mobilization of both financial and political resources of the past decade29 has resulted in the 
scale-up of LLINs and IRS and has had a great impact on malaria transmission.28 However, 
there is a substantial amount of disease transmission both within and outside of Africa,30 where 
 vector behavior evades control through conventional means such as insecticide-treated  materials 
because vectors bite outdoors and at times when people are still active (Tables 7.2 and 7.3). 
Recent estimates are that 16% of global malaria burden and 8% of malaria mortality occur out-
side of Africa, whereas outbreaks of dengue and other arboviruses are increasing and spreading 
geographically.31 Thus, tools targeting these outdoor and day biters are required. With the new 
impetus for malaria eradication of the past decade and the realization that the existing control 
tools LLINs and IRS cannot solely achieve this, repellents are increasingly being considered as 
the supplementary tool in appropriate scenarios.32 Modern repellents are extremely effective in 
preventing human–vector contact. The burden of vector-borne disease remains elevated despite 
substantial gains in control. There remains a challenge to develop repellency as a vector control 
option to complement existing tools in scenarios where the vector33 (Table 7.1) or the human 
population32 (Table 7.2) exhibits behaviors that require their use.
how repellents Work to reduce Vectorial Capacity and Vector-Borne Disease
When considering vector control for disease prevention, it is useful to consider how repellents could 
reduce the vectorial capacity (VC) of the disease vector population of interest and thus reduce disease 
transmission. The concept of VC was derived from models of malaria transmission first devised by Ross 
and was developed to guide the first global malaria eradication plan.34 VC is described by an  equation 
(Box 7.1) and is defined as “the average number of inoculations with a specified parasite, originating 
from one case of malaria in unit time, that the population would distribute to man if all the vector females 
biting the case became infected.”35 The concept of VC is sufficiently simple that it can be applied with 
some modifications to account for varying vector behavior, competence, and ecology, as well as dif-
ferences in the dynamics of infection, disease, and immunity in vertebrate hosts, and has been used to 
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es
t J
av
a)
 
w
as
 a
m
on
g 
m
in
er
s 
fr
om
 s
um
at
ra
 w
ho
 
w
or
ke
d 
ni
gh
t s
hi
fts
 in
 
m
in
es
57
, 5
8
p
ro
vi
si
on
 o
f p
er
m
et
hr
in
-
tr
ea
te
d 
w
or
k 
w
ea
r 
by
 
co
m
pa
ni
es
 fo
r 
th
os
e 
on
 
ni
gh
t s
hi
ft 
re
co
m
m
en
de
d.
u
se
 o
f p
er
m
et
hr
in
-t
re
at
ed
 
un
ifo
rm
s 
di
d 
no
t p
re
ve
nt
 
m
al
ar
ia
 a
m
on
g 
so
ld
ie
rs
 in
 
t
ha
ila
nd
, a
lth
ou
gh
 th
e 
de
si
gn
 o
f t
he
 s
tu
dy
 m
ay
 
ha
ve
 in
flu
en
ce
d 
th
e 
re
su
lts
59
o
rg
an
iz
ed
 
op
en
 p
it 
go
ld
 m
in
in
g
Id
ua
pr
ie
m
, 
o
bu
as
i, 
g
ha
na
; 
s
ig
ui
ri,
 
g
ui
ne
a;
 
s
ad
io
la
/
ya
te
la
, M
al
i; 
an
d 
g
ei
ta
, 
ta
nz
an
ia
M
al
ar
ia
20
10
 M
al
ar
ia
 in
ci
de
nc
e 
pe
r 
10
0 
em
pl
oy
ee
s 
Id
ua
pr
ie
m
 1
04
.6
2,
 
o
bu
as
i 1
9.
4,
 s
ig
ui
ri 
22
.7
4,
 s
ad
io
la
/y
at
el
a 
9.
04
, g
ei
ta
 6
.6
8 
de
sp
ite
 u
s
$2
 m
ill
io
n 
an
nu
al
 in
ve
st
m
en
t i
n 
co
nt
ro
l a
t t
he
 s
ite
s 
in
 
ll
In
s,
 IR
s
, a
nd
 h
ea
lth
 
ed
uc
at
io
n
A
no
p
he
le
s 
g
am
b
ia
e,
 
A
no
p
he
le
s 
fu
ne
st
us
, 
A
no
p
he
le
s 
ar
ab
ie
ns
is
60
, 6
1
p
er
m
et
hr
in
-t
re
at
ed
 w
or
k 
w
ea
r 
fo
r 
ni
gh
t s
hi
ft 
w
or
ke
rs
. I
ns
ec
tic
id
e-
tr
ea
te
d 
cl
ot
hi
ng
 p
re
ve
nt
ed
 
m
al
ar
ia
 b
y 
70
%
 o
R
 =
 0
.3
1 
(9
5%
 c
I n
ot
 r
ep
or
te
d)
 in
 
k
en
ya
 w
ith
 A
no
p
he
le
s 
g
am
b
ia
e,
 A
no
p
he
le
s 
fu
ne
st
us
, A
no
p
he
le
s 
ar
ab
ie
ns
is
 a
s 
th
e 
pr
im
ar
y 
ve
ct
or
s
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h
u
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r 
t
h
at
 N
ec
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si
ta
te
 t
h
e 
U
se
 o
f 
C
o
m
p
le
m
en
ta
ry
 C
o
n
tr
o
l t
o
o
ls
 
(c
on
tin
ue
d
)
a
ct
iv
it
y
r
eg
io
n
D
is
ea
se
In
cr
ea
se
d
 r
is
k 
o
f 
D
is
ea
se
V
ec
to
r
r
ef
er
en
ce
p
re
ve
n
ti
o
n
 S
tr
at
eg
y
r
ef
er
en
ce
M
ili
ta
ry
t
he
 
n
et
he
rla
nd
s
ly
m
e 
di
se
as
e
Ix
od
es
 r
ic
in
us
u
se
 o
f p
ro
te
ct
iv
e 
cl
ot
hi
ng
 
an
d 
bo
ot
s 
re
du
ce
d 
th
e 
ris
k 
of
 ly
m
e 
di
se
as
e 
in
 
d
ut
ch
 s
ol
di
er
s 
ba
se
d 
ou
td
oo
rs
 to
 th
at
 o
f t
he
 
co
nt
ro
l g
ro
up
 b
as
ed
 
in
do
or
s
63
n
ew
 g
ui
ne
a
s
cr
ub
 ty
ph
us
Tr
om
b
ic
ul
a 
sp
p.
f
ie
ld
 te
st
s 
w
ith
 d
ib
ut
yl
 
ph
th
al
at
e 
ap
pl
ie
d 
ev
er
y 
2 
w
ee
ks
 to
 u
ni
fo
rm
s 
of
 
a
us
tr
al
ia
n 
so
ld
ie
rs
 
re
su
lte
d 
in
 a
 6
0%
 a
nd
 
70
%
 d
ec
re
as
e 
in
 s
cr
ub
 
ty
ph
us
 w
he
n 
it 
w
as
 g
iv
en
 
to
 t
w
o 
br
ig
ad
es
64
s
ou
th
 p
ac
ifi
c
s
cr
ub
 ty
ph
us
u
ni
fo
rm
s 
w
er
e 
sp
ra
ye
d 
w
ith
 
di
m
et
hy
l p
ht
ha
la
te
 o
r 
an
 
em
ul
si
on
 fo
rm
ul
at
io
n 
of
 
di
m
et
hy
l p
ht
ha
la
te
 w
ith
 a
n 
un
tr
ea
te
d 
co
nt
ro
l. 
a
ll 
of
 
th
e 
so
ld
ie
rs
 th
en
 
pe
rf
or
m
ed
 c
om
ba
t 
op
er
at
io
ns
 fo
r 
7–
10
 d
ay
s 
in
 a
re
as
 w
ith
 s
cr
ub
 ty
ph
us
 
tr
an
sm
is
si
on
. t
he
 d
im
et
hy
l 
ph
th
al
at
e 
sp
ra
y 
re
du
ce
d 
th
e 
nu
m
be
r 
of
 c
as
es
 b
y 
64
%
 (
fr
om
 4
5 
ca
se
s 
in
 th
e 
co
nt
ro
l g
ro
up
 to
 1
6 
ca
se
s 
in
 th
e 
sp
ra
ye
d 
gr
ou
p)
, a
nd
 
th
e 
em
ul
si
on
 r
ed
uc
ed
 th
e 
nu
m
be
r 
of
 c
as
es
 b
y 
94
%
 
(t
o 
7 
ca
se
s)
65
H
ai
ti
d
en
gu
e
16
/2
41
 It
al
ia
n 
a
rm
y 
tr
oo
ps
S
te
g
om
yi
a 
(A
ed
es
) 
ae
g
yp
ti
s
ki
n 
re
pe
lle
nt
s 
pr
ot
ec
tiv
e 
o
R
 =
 0
.1
6 
(9
5%
 c
I =
 
0.
05
–0
.5
6)
, p
er
m
et
hr
in
-
tr
ea
te
d 
un
ifo
rm
 p
ro
te
ct
iv
e 
o
R
 =
 0
.3
5 
(9
5%
 c
I =
 
0.
11
–1
.1
7)
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(c
on
tin
ue
d
)
30
/4
06
 u
.s
. a
rm
y 
tr
oo
ps
a
lth
ou
gh
 9
3 
(9
3.
0%
) 
of
 a
ll 
fe
br
ile
 p
at
ie
nt
s 
re
po
rt
ed
 
in
se
ct
 b
ite
s,
 o
nl
y 
18
 
(1
8.
2%
) 
an
d 
40
 (
40
.4
%
) 
al
w
ay
s 
us
ed
 a
 to
pi
ca
l 
in
se
ct
 r
ep
el
le
nt
 a
nd
 a
 b
ed
 
ne
t, 
re
sp
ec
tiv
el
y.
 f
ew
 h
ad
 
us
ed
 p
er
m
et
hr
in
 to
 tr
ea
t 
th
e 
be
d 
ne
t (
30
.3
%
) 
or
 
un
ifo
rm
 (
13
.1
%
)
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c
ol
um
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a
c
l
Le
is
hm
an
ia
 
p
an
am
en
si
s
t
he
 g
re
at
es
t o
ut
br
ea
k 
of
 
c
l 
oc
cu
rr
ed
 b
et
w
ee
n 
20
05
 a
nd
 2
00
9,
 w
ith
 
m
or
e 
th
an
 3
5,
00
0 
ca
se
s 
in
 th
e 
m
ili
ta
ry
 
fo
rc
es
, 8
0%
 c
au
se
d 
by
 
Le
is
hm
an
ia
 b
ra
zi
lie
ns
is
 
an
d 
20
%
 c
au
se
d 
by
 
Le
is
hm
an
ia
 
p
an
am
en
si
s
Lu
tz
om
yi
a.
 
tr
ap
id
oi
, 
Lu
tz
om
yi
a 
g
om
ez
i, 
Lu
tz
om
yi
a 
p
an
am
en
si
s,
 
Lu
tz
om
yi
a 
yu
ill
i
68
t
he
 s
ol
di
er
s 
w
ith
 tr
ea
te
d 
un
ifo
rm
s 
ex
po
se
d 
in
 a
n 
ar
ea
 w
ith
 in
fe
ct
ed
 
sa
nd
fli
es
 fo
r 
6.
6 
w
ee
ks
 
ha
d 
83
%
 le
ss
 
le
is
hm
an
ia
si
s 
(4
 c
as
es
 o
ut
 
of
 1
43
 s
ol
di
er
s)
 c
om
pa
re
d 
w
ith
 s
ol
di
er
s 
w
ith
 
un
tr
ea
te
d 
un
ifo
rm
s 
(1
8 
ca
se
s 
ou
t o
f 1
43
 s
ol
di
er
s)
46
e
gy
pt
s
an
df
ly
 fe
ve
r
P
hl
eb
ot
am
us
 
p
ap
ita
si
t
he
 a
tta
ck
 r
at
e 
(p
ro
ba
bl
e 
im
m
un
es
 w
er
e 
di
sr
eg
ar
de
d 
fr
om
 th
e 
da
ta
) 
am
on
g 
us
er
s 
w
as
 2
/7
7 
an
d 
am
on
g 
co
nt
ro
ls
 w
as
 
9/
83
 =
 0
.2
4,
 w
hi
ch
 is
 a
 
76
%
 r
ed
uc
tio
n
69
s
ie
rr
a 
le
on
e
M
al
ar
ia
93
 c
as
es
 a
m
on
g 
de
pl
oy
ed
 u
.k
. t
ro
op
s 
w
ith
in
 1
 m
on
th
A
no
p
he
le
s 
g
am
b
ia
e
70
In
se
ct
ic
id
e-
tr
ea
te
d 
cl
ot
hi
ng
 
w
as
 p
ro
te
ct
iv
e 
o
R
 =
 0
.4
7 
(9
5%
 c
I =
 0
.2
0–
1.
05
). 
u
se
 
of
 n
o 
pe
rs
on
al
 p
ro
te
ct
io
n 
in
cr
ea
se
d 
th
e 
ris
k 
of
 
m
al
ar
ia
 o
R
 =
 2
.2
0 
(9
5%
 
c
I =
 0
.7
9–
6.
17
)
70
R
el
ig
io
us
 
ga
th
er
in
gs
v
en
ez
ue
la
M
al
ar
ia
e
va
ng
el
ic
 a
nd
 c
at
ho
lic
 
re
vi
va
lis
t s
ec
ts
 g
at
he
r 
ou
td
oo
rs
 e
ve
ry
 e
ve
ni
ng
 
fo
r 
hy
m
n 
si
ng
in
g 
la
te
 
in
to
 th
e 
ni
gh
t
A
no
p
he
le
s 
A
lb
ita
rs
is
, 
A
no
p
he
le
s 
os
w
al
d
oi
, 
A
no
p
he
le
s 
nu
ne
tz
to
va
ri,
 
A
no
p
he
le
s 
tr
ia
nn
ul
at
us
71
e
ns
ur
e 
ad
eq
ua
te
 
pr
ev
en
tio
n 
fr
om
 m
os
qu
ito
 
bi
te
s 
us
in
g 
re
pe
lle
nt
s 
an
d 
lo
ng
 c
lo
th
in
g
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t
h
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ec
es
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h
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U
se
 o
f 
C
o
m
p
le
m
en
ta
ry
 C
o
n
tr
o
l t
o
o
ls
 
(c
on
tin
ue
d
)
a
ct
iv
it
y
r
eg
io
n
D
is
ea
se
In
cr
ea
se
d
 r
is
k 
o
f 
D
is
ea
se
V
ec
to
r
r
ef
er
en
ce
p
re
ve
n
ti
o
n
 S
tr
at
eg
y
r
ef
er
en
ce
M
is
si
on
ar
ie
s
H
ai
ti
d
en
gu
e
a
fte
r 
re
tu
rn
in
g 
fr
om
 a
 
1-
w
ee
k 
m
is
si
on
ar
y 
tr
ip
 
to
 H
ai
ti,
 d
e
n
v
 in
fe
ct
io
n 
w
as
 c
on
fir
m
ed
 in
 s
ev
en
 
(2
5%
). 
n
on
e 
pr
ac
tic
ed
 
co
rr
ec
t v
ec
to
r 
bi
te
 
pr
ev
en
tio
n 
st
ra
te
gi
es
S
te
g
om
yi
a 
(A
ed
es
) 
ae
g
yp
ti
72
W
or
ke
rs
 in
 
th
e 
pa
rk
s 
an
d 
fo
re
st
ry
 
di
vi
si
on
n
or
th
 a
m
er
ic
a
ly
m
e 
di
se
as
e
6.
3%
 s
er
op
re
va
le
nc
e 
am
on
g 
fo
re
st
ry
 w
or
ke
rs
 
an
d 
th
e 
od
ds
 o
f a
 
re
ca
lle
d 
tic
k 
bi
te
 w
er
e 
fiv
e 
tim
es
 h
ig
he
r 
am
on
g 
ou
td
oo
r 
w
or
ke
rs
I. 
d
am
m
in
i
t
ho
se
 w
ho
 r
ep
or
te
d 
th
at
 
th
ey
 a
lw
ay
s 
us
ed
 a
 
re
pe
lle
nt
 h
ad
 a
 t
w
of
ol
d 
lo
w
er
 s
er
op
os
iti
vi
ty
 fo
r 
ly
m
e 
di
se
as
e
73
p
ol
an
d
ly
m
e 
di
se
as
e
In
 p
ol
an
d 
in
 2
00
9,
 6
64
 
/1
0,
33
3 
(6
.4
%
) 
ca
se
s 
w
er
e 
ce
rt
ifi
ed
 a
s 
re
su
lti
ng
 fr
om
 a
n 
oc
cu
pa
tio
na
l e
xp
os
ur
e 
am
on
g 
fo
re
st
 w
or
ke
rs
I. 
ric
in
us
74
t
he
 u
se
 o
f p
er
m
et
hr
in
-
tr
ea
te
d 
w
or
k 
w
ea
r 
re
du
ce
s 
th
e 
pr
ob
ab
ili
ty
 o
f t
ic
k 
bi
te
s 
by
 9
3%
75
H
ik
in
g
n
or
th
 a
m
er
ic
a 
(a
pp
al
ac
hi
an
 
tr
ai
l)
ly
m
e 
di
se
as
e
4%
 o
f l
on
g-
di
st
an
ce
 
hi
ke
rs
 c
on
tr
ac
te
d 
ve
ct
or
-b
or
ne
 d
is
ea
se
—
pr
in
ci
pa
lly
 l
ym
e 
di
se
as
e
n
ot
 
m
en
tio
ne
d,
 
bu
t m
os
t 
lik
el
y 
I. 
d
am
m
in
i
76
s
ub
je
ct
s 
w
ea
rin
g 
tr
ea
te
d 
su
m
m
er
-w
ei
gh
t o
ut
fit
s 
(s
ne
ak
er
s,
 s
oc
ks
, s
ho
rt
s,
 
an
d 
t-
sh
ir
ts
) 
w
er
e 
3.
36
 
tim
es
 (
o
R
 =
 3
.3
6 
w
ith
 a
 
95
%
 c
I =
 [2
.4
99
, 4
.5
26
])
 
le
ss
 li
ke
ly
 to
 h
av
e 
ny
m
ph
al
 
I. 
sc
ap
ul
ar
is
 a
tta
ch
 to
 th
ei
r 
bo
dy
 th
an
 s
ub
je
ct
s 
w
ea
rin
g 
un
tr
ea
te
d 
cl
ot
hi
ng
. t
he
 o
dd
s 
of
 
ny
m
ph
al
 a
tta
ch
m
en
t, 
be
lo
w
 th
e 
w
ai
st
 o
n 
th
e 
le
g 
w
he
re
 ti
ck
s 
w
er
e 
ap
pl
ie
d 
to
 s
ho
es
, w
er
e 
74
 ti
m
es
 
le
ss
 (
o
R
 =
 7
3.
60
, 9
5%
 c
I 
=
 [2
.4
, 5
51
.4
5]
) 
fo
r 
th
e 
pe
rm
et
hr
in
-t
re
at
ed
 g
ro
up
 
th
an
 th
e 
un
tr
ea
te
d 
gr
ou
p
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o
ut
do
or
 
re
cr
ea
tio
n—
w
al
ki
ng
, 
ca
m
pi
ng
, 
an
d 
hu
nt
in
g
n
or
th
 a
m
er
ic
a 
(n
or
th
w
es
t 
c
al
ifo
rn
ia
)
ly
m
e 
di
se
as
e,
 
hu
m
an
 
gr
an
ul
oc
yt
ic
 
eh
rli
ch
io
si
s
n
um
be
r 
of
 n
ym
ph
s 
at
ta
ch
in
g 
fr
om
 s
itt
in
g 
on
 
lo
gs
: 1
.4
4 
pe
r 
ho
ur
; 
ga
th
er
in
g 
w
oo
d:
 0
.4
2 
pe
r 
ho
ur
, s
itt
in
g 
ag
ai
ns
t 
tr
ee
s:
 0
.5
2 
pe
r 
ho
ur
, 
w
al
ki
ng
: 1
.4
 p
er
 h
ou
r, 
st
irr
in
g 
an
d 
si
tti
ng
 o
n 
lit
te
r:
 0
.3
2 
pe
r 
ho
ur
, 
si
tti
ng
 o
n 
le
af
 li
tte
r:
 0
.2
4 
pe
r 
ho
ur
I. 
p
ac
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cu
s
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at
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 p
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n
e
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S
iz
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V
e
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S
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p
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m
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V
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V
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g
 
B
eh
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r
C
o
m
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n
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O
th
er
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o
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4 
×
 0
.0
09
75
 
M
et
of
lu
th
rin
 c
oi
ls
 p
er
 
ho
us
e 
pe
r 
ni
gh
t
0.
39
 
(0
.2
4–
0.
62
)
32
.9
%
 R
ed
uc
tio
n 
in
 
m
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ito
 la
nd
in
gs
 b
y 
hu
m
an
 la
nd
in
g 
ca
tc
h 
(H
lc
)
A
no
p
he
le
s 
su
nd
ai
cu
s
33
%
 o
f b
iti
ng
 
be
fo
re
 
10
 p
m
80
n
ig
ht
ly
81
2 
×
 0
.0
3%
 t
ra
ns
flu
th
rin
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ils
 p
er
 h
ou
se
 p
er
 
ni
gh
t
0.
22
 
(0
.1
3–
0.
39
)
88
%
 R
ed
uc
tio
n 
in
 
in
do
or
 m
os
qu
ito
 
de
ns
iti
es
 b
y 
c
d
c
 
lig
ht
 tr
ap
A
no
p
he
le
s 
si
ne
ns
is
47
%
 o
f b
iti
ng
 
be
fo
re
 
10
 p
m
82
>
90
%
to
p
ic
al
 r
ep
el
le
n
ts
83
15
%
 d
ee
t l
ot
io
n 
in
 
ad
di
tio
n 
to
 p
er
m
an
et
 
2.
0 
ll
In
s
0.
94
 
(0
.5
9–
1.
48
)
98
.9
%
 p
ro
te
ct
io
n 
fo
r 
5 
ho
ur
s 
in
 fi
el
d 
te
st
s
A
no
p
he
le
s 
d
iru
s,
 
A
no
p
he
le
s 
m
in
im
us
, a
nd
 
A
no
p
he
le
s 
m
ac
ul
at
us
20
%
–5
0%
 o
f 
bi
tin
g 
be
fo
re
 
10
 p
m
84
a
bo
ut
 5
0%
85
b
uz
z 
o
ff 
re
pe
lle
nt
 p
lu
s 
p
er
m
an
et
 l
lI
n
1.
16
 
(0
.7
5–
1.
80
)
>
80
%
 e
ffe
ct
iv
e 
ag
ai
ns
t A
no
p
he
le
s 
g
am
b
ia
e 
fo
r 
8 
ho
ur
s 
in
 la
bo
ra
to
ry
 te
st
s
A
no
p
he
le
s 
ar
ab
ie
ns
is
70
%
 b
ef
or
e 
10
 p
m
 8
6
n
ot
 m
ea
su
re
d
R
ep
el
le
nt
 a
rm
 h
ad
 
m
or
e 
m
al
ar
ia
 to
 b
eg
in
 
w
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understand the transmission of other vector-borne diseases, including dengue,36 bluetongue,37 onchocer-
ciasis,38,39  bancroftian filariasis,40,41 and schistsomiasis.42 VC describes the potential intensity of trans-
mission by mosquitoes as a function of the (1) human-biting rate, representing the incidence of biting 
contact between the mosquito and humans in terms of the number of bites per person per day and indicat-
ing the number of vector females that could become infected per case per day; (2) expectation of infected 
life, which is days of infective life per mosquito infected with the given parasite species; and (3) human-
biting habit, which is bites on a person per day by an individual female mosquito,35 all of which can be 
measured using standard field collection techniques.94 This exceedingly elegant means of considering 
the process and impact of vector control on human–vector contact and mosquito survival has been veri-
fied with field data35 and provides a convenient logical framework to consider the impact of new vector 
controls. The majority of work involving the VC equation has considered insecticides that reduce both 
numbers and life expectancy of mosquitoes and have an excellent impact on reducing malaria intensity. 
However, in the original article in which VC was described, the author showed that by reducing the 
human-biting rate by 50% there was a consequent 75% reduction in the VC of the mosquito population.35 
VC is extremely sensitive to changes in the biting rate because a vector needs to bite twice to obtain and 
then transmit a pathogen—hence, human biting is squared in the equation (Ma2). Thus, the use of repel-
lents will have a strong effect on overall VC by reducing the probability of infecting or being infected by 
a vector, as described by Ma2. Thus, when considering disease control we will define repellents as those 
interventions that reduce human–vector contact without killing a large proportion of the vector popula-
tion, that is, those interventions that keep the human population and the vector population apart.
raNDOMIZeD CONtrOLLeD trIaLS FOr MeaSUrING 
the DISeaSe IMpaCt OF repeLLeNtS
Different kinds of evaluations have been conducted to determine the effect of repellents on  disease 
incidence. Randomized controlled trials (RCTs) are currently considered to be the gold  standard 
for testing the effectiveness of interventions for disease reduction in a population,95  provided that 
they are well conducted.96 The most important feature of an RCT is that the  individuals recruited 
into the trial are randomly assigned to the intervention or a control, thereby minimizing selection 
and allocation bias to control as much as possible for both known and unknown confounders that 
BOX 7.1 VECTORIAL CAPACITY
=
− ln
2
C
ma bpn
p
C = new infections disseminated per person per day by each mosquito
m = number of mosquitoes per person
a =  probability a vector feeds on a host /day i.e the proportion of females feeding on man 
divided by the duration of the gonotrophic cycle in days
ma = the number of bites/man/day
p = probability of daily vector survival
1/-lnp =  duration of the vector’s life in days once it has survived the intrinsic incubation 
period
n = duration of the extrinsic incubation period in days
b = proportion of sporozoite positive mosquitoes that are infectious
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could influence the correct measurement of impact of the intervention.97 Other advantages of a 
well-conducted RCT are that it facilitates blinding of treatments from investigators, participants, 
and assessors to prevent bias in the estimation of intervention effect.98 It allows for the use of prob-
ability theory that any difference seen between the different arms outside the treatment effect is due 
to chance. A large body of guidance is available to researchers on the importance of correct trial 
design,99 implementation,100,101 and reporting.102
The main disadvantage of RCTs is the limitation of external validity, that is, the results of an RCT 
may not be applicable to the general population, due to differences in geographical location, charac-
teristics of the patients recruited, trial procedures, and methods of measuring the outcomes in the trial. 
For this reason, it is advised that standard methods to ensure quality and reporting guidelines are fol-
lowed that will allow systematic review and meta-analysis, which aims to collate and synthesize data 
from multiple studies that meet prespecified eligibility criteria using methods that attempt to minimize 
bias.99 The other disadvantages are cost and time. RCTs are quite expensive103 and take several years 
until the results are published; thus, they may be less relevant at the time of publication.104 However, 
when considering the public health implementation of a new vector control product the investment in 
an RCT is small when considering the importance of implementing a proven intervention that will save 
lives rather than wasting money on implementing an ineffective intervention (Christian Lengeler, pers. 
comm.). The cost of the series of RCTs used to generate  evidence that bed nets prevented malaria105 
was less than $10 million; but between 2004 and 2010, $17 billion was spent on bed nets.106
randomized Controlled trials of topical repellents
Southeast Asia
In a refugee settlement in Pakistan, a household randomized trial of Mosbar (a soap contain-
ing 20% deet and 0.5% permethrin, which was lathered on but not rinsed off) versus a placebo 
lotion demonstrated a 56% reduction in P. falciparum malaria with an odds ratio (OR) of 0.44 
(95% confidence interval [CI] = 0.25–0.76, p = .004) and a nonsignificant effect on P. vivax 
malaria with an OR of 1.29 (95% CI = 0.86–1.94, p = .226).92 The study was carried out on a 
waterlogged land endemic for malaria, and transmission was effected by Anopheles culicifacies, 
Anopheles stephensi, Anopheles nigerrimus, and Anopheles pulcherrimus, which are predomi-
nantly early evening biting vectors.92 This characteristic makes topical repellent use ideal as it is 
applied in the early evening, coinciding with the peak activity of these vectors. This local vector 
bionomic may have meant that the repellent reduced a substantial amount of malaria transmission 
and demonstrated the importance of studying the local vector bionomics to determine if the pro-
posed intervention will have any impact on the vector population. The study used simple random-
ization to allocate treatment to the participants. Randomization minimized the allocation bias of 
the treatments and confounding factors that were not taken into account. Passive case detection 
of malaria cases was used, which might have led to the loss of cases that were not reported to 
the health clinic. Compliance was established by self-reporting of use every fortnight and there-
fore could not be conclusively ascertained. Field staff, laboratory technicians, and participants 
were blinded to the intervention. Although this study demonstrated an effect of repellents, it did 
not take into account the whole malaria transmission season. This study took place for only 6 
months, during the P. falciparum transmission season and, therefore, demonstrated an effect only 
against P. falciparum malaria. No effect was shown against P. vivax malaria because the study 
was carried out when the transmission of P. vivax malaria was low and there were not enough 
cases to demonstrate a treatment effect. This study would have been stronger if it had been carried 
out longer to take into account both P. falciparum and P. vivax malaria transmission seasons. As 
P. vivax malaria is known to recrudesce, the study investigators should have cleared all malaria 
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cases through an appropriate treatment regimen after checking for individuals deficient in glu-
cose-6-phosphate dehydrogenase (G6PD)107 so that any cases that were observed would be clas-
sified as new malaria cases and not recurrent P. vivax cases. Thus, the investigators would have 
avoided losing malaria cases that they classified as recrudescent cases while they were actually 
new cases, which reduced the power of the study. It would also have been prudent if the investiga-
tors had used active case detection, where they visited all households recruited into the study and 
screened for malaria, instead of waiting for study participants to report to the camp’s health facil-
ity. Thus, the investigators would have captured malaria cases of those individuals who visited 
alternative health facilities or chose to buy drugs directly from drugstores. Active case detection 
would have also allowed the inclusion of individuals who were too weak to visit the health facility 
for treatment or found the facility to be too far to seek services. Compliance could also have been 
better established by conducting frequent spot checks to determine if the study participants did 
indeed use the treatments they were issued.
In a refugee camp in Thailand, a double-blind randomized clinical trial on the effect of deet 
mixed with thanaka (a root paste made from pulp of the wood apple tree, Limonia acidissima, 
used locally as a cosmetic) compared to thanaka alone in pregnant women demonstrated a 28% 
reduction in malaria incidence, 10.6% (95% CI: 7.5%–13.5%) in women who used thanaka and 
deet, compared to the ones who used thanaka alone 14.8% (95% CI: 9.9%–19.7%) in P. falciparum 
malaria, although the difference was not statistically significant.89 There was also no significant 
difference in the transmission of P. vivax malaria between the two treatment arms. The lack of a 
treatment effect was most likely because of malaria transmission being too low to demonstrate a 
treatment effect as a result of effective and timely diagnosis and treatment of malaria in the camp. 
As women who were parasitemic during the study were more likely to be anemic on admission 
than women who had no documented malaria, the authors concluded that they were probably 
infected before the start of the study, although randomization was performed correctly because 
anemia was similar between those allocated to treatment and those allocated to control. By treat-
ing all the malaria cases before the start of the study so that all cases seen were contracted during 
the study period, may have reduced prior infection status to bias results, although this would have 
required a larger sample size and longer study period to observe any treatment effect. The study 
used both active and passive case detections, which were well correlated. This demonstrates that 
among individuals with lower immunity to malaria and thus more likely to suffer symptoms, and 
where malaria screening and treatment is accessible, free passive case detection may be closely 
related to the actual malaria burden existing in the community and this method can be used as an 
effective malaria surveillance tool. However, under other conditions, for example, where there are 
nonsymptomatic malaria carriers or health care is of low quality or is costly to the user, this may 
not be case. The principal vectors in this area are Anopheles maculatus and Anopheles minimus, 
vectors that exhibit a tendency to bite in the early evenings.90 This vector behavior demonstrates 
a circumstance in which repellent use is beneficial, and the fact that no treatment effect was 
observed suggests that the sample size used was too small to observe the treatment effect or that 
it may have been useful to use a higher concentration than 20% deet to increase the duration of 
nightly protection. However, the major finding of the study was that there was no difference in the 
proportion of congenital abnormalities following the use of deet between treatment and control 
arms. Also, no deet was detected in the umbilical cord of 46 of 50 samples that were analyzed 
and none of the 30 samples of urine analyzed were found to contain more deet than the acceptable 
levels of 0.1 μg/mL. This study reaffirms that deet is safe to use in the second and third trimesters 
of pregnancy.89
In another household randomized, double-blinded placebo-controlled trial recently conducted 
in Lao-PDR, to determine the effect of 15% deet lotion topical repellent in addition to use of 
PermaNet 2.0 LLINs on incidence of malaria did not demonstrate any intervention effect.83 Field 
trials of 10%–20% deet that were carried out demonstrated a 94% protection against all mosquito 
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bites. The major malaria vectors in this region are the Anopheles dirus complex and A. minimus, 
which are both outdoor and early evening biting vectors in the area,82 a characteristic that made 
the repellent an ideal tool for controlling malaria transmission in this setting. However, although 
the repellent was well received with over 90% of participants reporting that they liked using the 
lotions, compliance was still low with fewer than 60% of the participants using the lotions more 
than 90% of the time. Focus group discussions revealed that the assumption that local popula-
tions were protected from night biting if they were provided with LLINs was not always true. 
Adult men and children reported spending time outdoors at night hunting and fishing; they may 
have benefited from using a longer lasting repellent or even permethrin-treated clothing when 
engaging in nighttime outdoor activities. These behavioral factors, no doubt, increased bias and 
reduced the power of the study to detect an effect, if any. The treatment and placebo lotions both 
smelt and felt the same when applied on skin and were presented in identical bottles identifiable 
only by a three-digit numerical code. Households were randomized to the treatments by draw-
ing straws labeled with the codes of either the repellent or the placebo lotion. Follow-up visits 
were done on random dates to ascertain compliance, and the field staff, data entry clerks, and 
participants were blinded. However, it may have been possible for the participants to distinguish 
between the two treatments because placebo users were more likely to experience mosquito bites. 
Treatments were administered at the household level and to no more than 25% of households in 
any one village. This minimized the chances of treatment contamination, through diversion of 
mosquitoes from repellent to placebo users, and confusion of treatments, if individuals in the 
same household were issued different treatments. This might have led to treatment contamina-
tion, which can occur through treatment nonadherence (not using the recommended intervention 
because of perceived lack of effect) and treatment crossover (receiving the intervention intended 
for the other group in a trial, e.g., repellent users might give or sell their repellent to a neighbor). 
Both of these scenarios are common in repellent trials and create bias, resulting in an underes-
timation or overestimation of the treatment effect in either arm of the study. In future trials, this 
shortcoming can be addressed by using clusters of participants that do not interact with each 
other, for example, use of villages that are far apart to minimize the chances of participants 
interacting with each other.
A study carried out in a forest fringe in India to determine the effect of 12% deet used in 
 conjunction with insecticide-treated mosquito nets (ITNs) on malaria incidence demonstrated 
a threefold (OR = 3.63, 95% CI = 2.27–5.79, p < .001) and a fivefold (OR = 5.14, 95% CI = 
2.78–9.78, p < .001) protective efficacy of the intervention in the first and second years of the 
study,  respectively, when compared to the control arm.108 This study demonstrated a substantial 
effect of the use of mosquito repellents and ITNs against malaria. The major malaria vectors in 
this area are A. dirus, Anopheles philippinensis, and A. minimus which are generally early eve-
ning biting vectors109 where the repellents would protect against early evening biting which may 
explain why the repellents were additionally effective in reducing malaria among users of ITNs 
compared to ITN-only users. The ITNs may confer communal protection by reducing vector 
populations,110 with additional protection from repellent use. This integrated vector management 
(IVM) using different tools (repellents and ITNs) would therefore have reduced vector popula-
tions and host parasite reservoirs by reducing human–vector contact, thereby lowering malaria 
transmission in the community. The study investigators collected baseline data on malaria inci-
dence and vector bionomics before implementation of the intervention and were therefore able 
to establish the correct baseline incidence, reducing the chances of underpowering the study by 
using a smaller sample size. The study was also carried out for 2 years after 1 year of baseline 
data collection. This increased the sample size of the study, further minimizing the chances of 
underpowering the study. The study had several positive features: it used active case detection, 
minimizing the chances of missing malaria cases in the community and making the estima-
tion of treatment effect more robust. The research team also conducted random sniff checks to 
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ascertain compliance of use of mosquito repellents and ITNs. Another aspect of this study that 
might have led to such a big treatment effect being observed was the promotion of interven-
tions through information, education, and communication (IEC). For an intervention to be effec-
tive, it has to be acceptable by the community. Unlike other repellent studies, this study used 
IEC, which motivated the community to take up the intervention. This approach demonstrated 
that repellents can be an effective malaria control strategy if the community is well informed 
and educated and the intervention is made available. Another finding of significance of this 
study is the further reduction of malaria incidence in the second year compared to the first year. 
This demonstrates that continuous implementation of an effective IVM tool can have a great 
impact on malaria transmission. However, the major shortcoming of this study was the paucity 
of  information on how the findings were analyzed. This omission makes the findings question-
able and surprising that the article was published owing to the lack of information on even what 
method was used to analyze the data, the lack of data on slide positivity rates for the second and 
third years of the study, and the highly questionable reliance on a converse interpretation of the 
risk ratio that was presented in the publication. The authors should have provided (1) raw data 
on the number of cases per 100 man-years per cluster or positivity rates in the first and second 
years, (2) information on which model was used to analyze the findings, (3) the reason why this 
model was preferred over other models, (4) information on how the data were interpreted, and 
(5) information on how bias was accounted for to make the findings credible to readers without 
having to rely on the interpretation of the authors. The study as presented could not be used in 
a systematic review.
South America
A household-randomized, double-blind placebo-controlled clinical trial was conducted in 
Bolivia among the users of a freshly impregnated ITN (25 mg/m2 deltamethrin) plus either the 
insect repellent (Corymbia maculata citriodon) with a PMD concentration of 30% (MASTA, United 
Kingdom) for the treatment group or 0.1% clove oil for the placebo group.45 The study demonstrated 
an 80% reduction incidence rate ratio (IRR) (0.2) (95% CI = 0.11–0.38, p < 0.001) in P.  vivax 
malaria. However, the effect on P. falciparum malaria was not significant most likely due to a lack 
of power as the number of P. falciparum cases was too low to demonstrate any treatment effect. 
This might be because of an unexpected round of fogging as explained by the authors, but they 
also offer the more likely explanation that the study took place when transmission of P. falciparum 
was low. Sequential randomization of households was used to allocate treatments, and both the 
participants and field staff were blinded. Both these attributes increased the robustness of the study, 
as there was minimal chance of  selection bias by the field staff or the participants not using the 
placebo. The use of a clove oil repellent was useful in this circumstance as both PMD and clove oil 
have a strong odor, which would suggest to the users that both were active repellents. However, there 
was always the chance of the control group realizing that they were issued with the placebo as the 
trial went on and dropping out of the study, thereby reducing its power because of decreased sample 
size. The study took place for only 4 months, and thus the effect of repellent over the whole malaria 
transmission period could not be determined. If the study had been conducted for longer to take into 
account the whole transmission season, then a treatment effect is more likely to have been observed 
against P.  falciparum malaria or even a larger, more robust estimate of treatment effect observed as 
the sample size would have been larger, consequently reducing sampling error and improving effect 
estimates. The major vector found in this region Anopheles darling has a peak biting time from 8 to 
10 pm88 and is strongly exophagic and exophillic;111 therefore, it is recommended that repellents be 
used at this time as people are not under their LLINs. The PMD is extremely effective against even 
high densities of local malaria vectors and is likely to have provided users relief from high densities 
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of mosquitoes during the wet season.87 Overall, the study demonstrated that the use of mosquito 
repellents in the early evening in conjunction with LLINs in regions of early evening vector biting 
did have an impact on malaria incidence, strengthening the case for employment of IVM in malaria 
control. The compliance of the study participants was reported to be very high, underlined by their 
preference for PMD measured by focus groups,112 and this was confirmed by random sniff checks 
by the field staff. The large treatment effect was likely a combination of a well designed and imple-
mented trial methodology conducted in an area where vector bionomics precluded control by other 
means and where the repellent was well complied with because it was both highly effective against 
mosquitoes, and cosmetically acceptable to the local population using it.
Sub-Saharan Africa
In a cluster RCT conducted in Ethiopia to determine the effect of Buzz Off repellent on malaria, 
the odds of contracting malaria was reduced by 43% (OR = 0.57, 95% CI = 0.35–0.94, p = .028) 
for the participants using repellents to supplement PermaNet 2.0 LLINs.85 In this study, data were 
collected by three cross-sectional surveys during the 4-month study. It would have been more pru-
dent for the study investigators to conduct the study throughout the year to take into account the 
whole malaria transmission season and during the wet and dry seasons. This would have produced 
a more realistic estimate of malaria in this region. It would also have increased the sample size 
of the study, thereby decreasing the chances of occurrence of a type II error. Also, some cases of 
malaria may have been omitted as data were collected for only part of the transmission season. 
The authors of this trial did not outline the active ingredient and amount present in the repel-
lent. Information on how randomization was conducted was missing; although there was good 
 similarity between socioeconomic variables between the treatment arms, randomization could not 
have been performed correctly because at baseline the two treatment groups were not similar in 
terms of malaria prevalence. There was twice as much malaria in the repellent arm of the trial, the 
control arm complied with and had more LLINs, and two of the eight clusters were sprayed with 
dichloro diphenyltrichloroethane (to which arm of the study these were allocated is not stated) and 
this might have confounded the results of the trial. This resulted in the investigators altering the 
analysis plan of the study. When the authors followed the analysis plan, outlined in their protocol, 
there was no difference seen between the treatment arms. As a consequence, the authors changed 
their analysis, which might have altered the treatment effect observed because the data were not 
designed to be analyzed in this way.
A double-blind placebo-controlled cluster-randomized trial of 15% deet topical repellent car-
ried out in southwest Tanzania demonstrated a nonsignificant protective effect of 27% reduction 
in household malaria rates from 91.17 cases per 1000 person-years (95% CI = 198.42–380.76) in 
the control arm to 65.37 cases per 1000 person-years (95% CI = 110.10–240.84) in the intervention 
arm (p = .40, z = 0.84) using the intention-to-treat analysis.91 These findings were, however, not 
significant, possibly because the study was underpowered. The major vector is Anopheles arabien-
sis, which bites both indoors and outdoors from 6 pm to 6 am, and it was estimated that a repellent 
could reduce around 30% of exposure based on the average time to bed of 9 pm. Both semifield and 
field evaluations of the efficacy of 15% deet repellent demonstrated >90% protection for 4 hours 
against A. arabiensis mosquitoes. However, the effectiveness of an intervention is a component of 
both efficacy and acceptability by the community of that intervention. Therefore, to ensure effec-
tiveness the study team conducted three rounds of social marketing of the repellent in the study 
area to encourage usage. This had positive results as usage was reported at 95%. However, despite 
all these checks that were put in place during project implementation a treatment effect was still 
not observed. This was mainly due to two reasons: first, the study team overestimated the baseline 
malaria incidence by extrapolating incidence from all-cause fever data and therefore estimated a 
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sample size smaller than what was needed to observe a treatment effect. Second, a drought that 
occurred during the study period lowered malaria transmission such that a treatment effect could 
not be observed. In future studies, it would be useful to conduct baseline malaria incidence studies 
to establish correct incidence estimates for sample size calculation. Compliance was determined by 
self-reporting, which was done at the end of every month when field-workers visited the households 
to issue new bottles of repellent/placebo. Therefore, compliance in between the visits could not be 
ascertained. However, random sniff checks were conducted and these spot checks determined that 
the participants did indeed use the treatments issued. It would, however, have been practical to 
conduct the checks every fortnight and compare them with self-reported compliance to establish a 
correlation between the two methods of determining compliance. Passive case detection of malaria 
by rapid diagnostic tests (RDTs) was used at the local dispensary where participants were offered 
free diagnosis and treatment. People did not believe the results of negative RDTs and some stopped 
attending the dispensary, preferring to self-medicate with antimalarial drugs or attend the other 
health facility in the village that used clinical diagnosis. Also, the health dispensary recruited into 
the trial may have been sufficiently far from the homes of some participants to prompt them to 
access alternative health facilities or go to a nearby drugstore. In the future, it would be useful to 
recruit all health facilities and drugstores in the study area to avoid loss of malaria cases and carry 
out active case detection. All these factors might have contributed to a reduction in malaria cases, 
lowering the sample size, thereby underpowering the study. The randomization of interventions and 
blinding was done as effectively as possible for this case by using treatment and placebo lotions 
in identical bottles identifiable only by a three-digit code. Even then, as time went by participants 
realized that they were issued a placebo because they were continuously being bitten. As a result, 
there was some treatment contamination where placebo users did not use their intervention and 
repellent users sold their repellents to their neighbors, lowering the power of observing a treatment 
effect. It was also suspected that study participants gave their identification cards to relatives and 
friends to benefit from free health care. This would also lead to treatment contamination, which 
could be overcome with the use of a fingerprint scanner or photographic identification to identify 
study participants.
A field clinical trial conducted in Isfahan, Iran, to determine the effectiveness of deet sticks 
against leishmaniasis in 430 students (50% male, 50% female) did not demonstrate any treat-
ment effect.113 The intervention was reported to be effective for 18–20 hours, and its minimum 
effective concentration was 55–77 μg/cm2. Deet placebo was randomized to 330 individuals and 
placebo stick was randomized to 100 controls, and the treatment allocation code of sticks was 
revealed only at the end of the study. The children were followed up for 10 months. The effi-
cacy of these sticks was evaluated in terms of the reduction in infection by leishmaniasis using 
relative risk (RR). Confusingly, in the results section of the study the investigators reported a 
different number of treatments and controls: out of 200 students who were protected using the 
placebo pen 2 students acquired leishmaniasis, and out of 230 students who were protected 
using the deet pen 8 students acquired leishmaniasis. Thus, the study cannot be accurately 
interpreted.
CaSe-CONtrOL StUDIeS
Apart from RCTs, case-control studies have been conducted to evaluate the impact of repellents 
on disease. Case controls are observational studies of people with disease and a suitable  control 
group of persons without disease, where a potential risk factor is examined by comparing the 
 frequency of occurrence of the risk factor between these two groups.114 A number of case-control 
studies have been conducted to determine the effects of repellents on malaria incidence.
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In Afghanistan, a case-control study was conducted through social marketing of Mosbar, a repellent 
soap containing 20% deet and 0.5% permethrin.115 Cases and controls were recruited through passive 
case detection at a local clinic. The combined use of Mosbar and ITNs demonstrated a 69% reduction 
in the odds of contracting malaria (OR = 0.31, 95% CI = 0.13–0.72, p = .007) compared to control (nei-
ther Mosbar nor ITN). The local mosquito vectors Anopheles stephensi and Anopheles nigerrimus bite 
shortly after dusk, and throughout the night, a characteristic that makes the repellent a suitable control 
tool for evening protection before LLINs can be used. The repellent selected was highly efficacious and 
gave 100% protection for the whole night, which might have promoted the observation of treatment 
effect. However, as a hospital-based case control this study was prone to selection bias and therefore 
could not be generalized to the rest of the population, as individuals attending the clinics recruited into 
the trial might have had different characteristics from individuals in the general population. There are 
a number of anecdotal case-control studies that were not specially designed to measure the effect of 
repellents as shown in this study but to identify risk factors among those with malaria.
In a case control study of risk factors among British travellers returning from the Gambia less use 
of repellents was associated with a greater risk of contracting malaria.116 The use of repellents, applied 
either on the skin or on clothes, is a key strategy for bite avoidance recommended in travel medi-
cine. This finding illustrates the importance of using repellents when traveling to malaria-endemic 
regions. Therefore, all individuals traveling to malaria-prone areas should be advised to use malaria 
control strategies to protect against malaria. Also, tourist destinations should provide information on 
the vectors that are present in these regions so that the tourist can be better advised and prepared on 
which tools to use. It also emphasizes the importance of having international guidelines for travelers 
visiting malaria-endemic regions to avoid importing malaria cases to their mother countries.
In Kilifi, Kenya, in a large (>1500 participants), well-designed case-control study the use of local 
repellents, mosquito coils, and insecticide sprays was significantly associated with protection from 
developing severe malaria after adjusting for confounders (OR = 0.57, 95% CI = 0.35–0.94, p = .02). 
The cases and the controls were chosen from the same area in the community. Consequently, the 
results could also not be generalized to the whole population as the individuals from this area of 
the community might be different from other members of the community. It would have been better 
to select more than one study area to make the findings more general to the population.117 A study 
from Gambia that used a design almost identical to the study in Kenya showed an association with 
the use of coils in preventing severe malaria in a univariate analysis, but this effect disappeared on 
multiple logistic regression.118
The overall evidence generated by the aforementioned studies demonstrates that the use of 
repellents can be effective against malaria transmission if these interventions are used correctly 
and with sufficient frequency. In studies where an association cannot be established, it is usually 
because of poor study design. The following series of studies are inconclusive due to a number of 
factors including poor marching; poor attention to sample size; and poor measurement of compli-
ance, which is the single most important factor in the effectiveness of any repellent.
In another case study in India, individuals who did not use repellents had nonstatistically sig-
nificant lower odds of malaria, with an OR of 0.85 (95% CI = 0.57–1.28, p = .41), compared to those 
who used repellents. This finding is not consistent with other repellent trials and there are various 
factors that might have led to this conclusion, especially as those exposed to higher levels of mos-
quito bites are more likely to use mosquito prevention tools. In addition, the cases and controls were 
not matched because the controls were recruited from the same clinic, assumed to have come from 
the same socioeconomic, demographic, and geographical area as the cases. Because of the study 
design, there was no way to establish compliance to repellent use. Also, the longevity and quality of 
these repellents could not be established, although the mosquito coils and mats used were reported 
to be allethrins and the topical repellents used contained diethyltoluamide, for which the concentra-
tion was not mentioned. The bionomics of the local vectors was not discussed to determine whether 
the use of repellents would be an appropriate tool.119
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Similarly, in another case-control study in Burkina Faso use of mosquito coils and burning of 
plant leaves for smoke (spatial repellents) were not associated with a lower risk of malaria, with an 
OR of 1.24 (95% CI = 0.73–2.00, p = .47) and an OR of 0.74 (95% CI = 0.35– 1.56, p = .43), respec-
tively. Like the aforementioned study, use of mosquito coils and burning of plant leaves for smoke 
were self-reported. The study participants might have overreported or underreported, biasing the 
findings on the study. The controls were recruited from the same residential area. As a result, these 
findings cannot be generalized to the whole population, as the individuals from this area might 
not have similar characteristics to the general population. The controls were not actively tested for 
malaria and were assumed to be malaria negative. This might have biased the study toward the null 
hypothesis if the controls were positive for malaria.120
In Ecuador and Peru, a community-randomized trial of Mosbar, a mosquito-repellent soap con-
taining 20% deet and 0.5% permethrin, did not show any significant reduction in malaria incidence 
between the intervention and control groups.121 The effect of the repellent soap was studied under 
 different settings. It was found to be efficacious only when individuals wearing the soap were inac-
tive after application. This contrasts with the findings from Pakistan92 where the repellent was 
extremely effective in preventing mosquito bites. The differences observed might be due to the 
higher relative humidity in the Ecuadorian site that caused more rapid loss of repellent through 
sweating. Compliance to repellent use was not established and lack of treatment effect may have 
been due to poor compliance, as many people did not like the smell of the repellent and in Ecuador, 
because of humidity, a thick layer of soap remained on the skin, which was not pleasing to the users. 
As compliance requires a high degree of motivation, it was necessary for the study team to socially 
market their intervention to encourage its use and user acceptability. Interestingly, user compliance 
was drastically reduced when the soap was only made available from shops and was no longer avail-
able free of charge. This was similar to findings in other studies and underscores the importance 
of developing low-cost or highly subsidized interventions that can be accessed by those of low 
socioeconomic status in disease-endemic countries who are also those most at risk from disease 
morbidity and mortality. For an intervention to be effective, it has to be acceptable, affordable, or 
free to the community.
CrOSS-SeCtIONaL StUDIeS
Cross-sectional studies are research methods that involve observing all of a population or a 
representative subset at a specific point in time. They collect data on outcomes and/or exposures 
 collected on each participant at one moment in time. Thus, although they are simple and quick 
to perform, they are more robust at measuring associations with chronic diseases because they 
measure prevalent rather than incident outcomes. Cross-sectional studies that collect data on both 
outcome and exposure are not very robust in establishing the causal effect of an intervention, as they 
are prone to bias from confounding factors, but they can be used to test hypotheses about interven-
tions and to justify a research objective.
A cross-sectional survey was carried out in the Thailand–Myanmar border in Northern 
Thailand to determine the risk factors that contribute to malaria infection. Malaria prevalence 
was extremely high in 46% of the participants. It was a well-designed study that had correctly 
used sample size calculation and demonstrated a clear relationship between working or stay-
ing overnight in the forest and having malaria in univariate and multivariate analyses, although 
the use of topical repellents and long clothing was protective against contracting malaria on 
 univariate analysis, but this treatment effect was not seen when confounders were taken into 
account. This study shows some of the practical scenarios where topical repellents can be used, 
like individuals working in the forest or in crop fields who are not able to use conventional control 
measures like LLINs.128
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A cross-sectional survey to determine the effect of personal protective measures (PPMs) against 
malaria in travelers demonstrated a significant reduction in malaria among travelers who used pro-
tective clothing covering their arms and legs. However, no significant reduction was associated 
with the use of repellents and coils. As explained in this study, compliance to PPMs was very poor 
among a large proportion of the study participants. This would likely explain the lack of treatment 
effect. Also, it is advisable that more stringent measures by responsible agencies are introduced to 
ensure compliance to PPMs by people traveling to malaria-endemic regions to avoid the exposure 
of nonimmune individuals to malaria and also reduce the importing of cases to their mother coun-
tries.123 Compliance to personal protection is surprisingly low among those with access to the cor-
rect preventive measures. A recent survey among 2205 individuals from the French military during 
and after a stay in malaria-endemic areas were exposed to malaria incidence of 2.98 cases per 100 
 subject-years in malaria-endemic areas.124 The “correct” compliance rates were 48.6% (95% CI: 
46.5%–50.7%; ranging from 2.6% to 88.2%), 50.6% (95% CI: 48.5%–52.7%; ranging from 1.7% to 
97.3%), and 18.5% (95% CI: 16.8%–20.1%; ranging from 4.9% to 59.6%) for wearing long clothing 
at night, using LLINs while sleeping, and using insect repellents, respectively. Factors that often 
influence compliance are gender, the rainy season, mosquito bite burden, and perceived mosquito 
attractiveness compared with other people, while perception of the severity of malaria was not 
associated with regular use of any of the methods measured. A further cross-sectional survey of 
89,617 travelers returning from East Africa was conducted between 1988 and 1991.123 Only 2% of 
respondents stated that they regularly complied with air-conditioned rooms and/or bed nets, ade-
quate clothing, and use of insecticides and/or coils. Regular use of personal protection resulted in a 
small but significant reduction in malaria incidence when travelers were interviewed 12 weeks after 
returning home, but each method alone showed no significant effect. Unlike the situation among the 
French military travelers, the holidaymakers increased their compliance during periods when more 
mosquito bites were noticed; but similar to the French study, gender had no significant influence on 
compliance and, surprisingly, neither did diagnosed or suspected pregnancy. Those using no chemo-
prophylaxis were not more vigilant in preventing mosquito bites. Compliance diminished continu-
ously with the length of stay in Africa: among those who stayed up to 2 weeks the compliance rate 
was 77.2%, whereas in those staying 2 months or more the rate was 63.3% (p < .001).
OUtBreaK repOrtS
In South Africa, topical application of 15% deet to feet and ankles reduced overall Anopheles 
 arabiensis bites by 69% in field observations. This led to the testing of this intervention under 
operational conditions during a malaria outbreak in Mpumalanga, 15 km south of the Kruger 
National Park. The implementation of the intervention was associated with an immediate drop in 
malaria incidence from 42 to 10 cases per week. This effect is, however, difficult to interpret as it 
could have been due to repellent use and it could also have been due to the fact that the epidemic 
curve had peaked and was dropping naturally. The repellent may, however, have helped in main-
taining the low incidence of malaria. But this study does give situations where repellents can be 
used. The most likely reason why the more effective LLINs were not used in this particular sce-
nario is that the major vector in this area, A. arabiensis, had behaviorally adapted to outdoor biting 
and the secondary vector, Anopheles funestus, had developed resistance to IRS.125 Although the 
results are not clear, this study represents a useful scenario in which repellents might be employed 
against malaria.
In an outbreak report that described the outbreak of P. vivax malaria in Far North Queensland, 
Australia, individuals who used topical repellents (deet) were at 0.01 (95% CI: 0.00–0.19) the odds of 
developing malaria compared to those not using repellents. The findings of this study reinforce the 
need to use other PPMs in areas when conventional malaria control tools are not applicable.126
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During an outbreak in India, a well-designed investigation was conducted where malaria cases 
were slide-confirmed and compared with matched neighborhood controls. For both groups, infor-
mation on personal protection use was gathered by questionnaires and data was compared using 
matched odds ratios (MORs).127 In total, 7303 cases and 17 deaths were reported between April 
2005 and March 2006 with a peak during the October rains (attack rate: 50 per 1000, case fatality: 
0.2%), and half of the cases were detected by active case detection. Use of repellents was associated 
with an odds ratio of 0.1 (95% CI: 0.06–0.3) of contracting malaria, and failure to use repellents 
was associated with 69% of malaria cases in the population. Compared with controls, cases were 
more likely to sleep outdoors (MOR: 3.8, 95% CI: 2.2–6.5) and less likely to use mosquito nets and 
repellents (MOR: 0.3, 95% CI: 0.1–0.5). In this outbreak investigation, the villagers reported the use 
of repellents and coils and, therefore, correct and consistent compliance could not be established. 
This might have biased the treatment effect seen. Also, being a retrospective case control this study 
might have been prone to recall bias. Despite these shortcomings, this study demonstrated a protec-
tive trend of mosquito repellents against malaria.
There are a large number of disease outbreak reports among military personnel related to non-
compliance with standard PPMs.128 A report from the French Army monitoring leishmaniasis among 
troops stationed in Guinea showed four separate outbreaks of leishmaniasis in which the troops 
admitted that they did not use personal protection correctly.129 In a malaria outbreak in French 
Guiana, a retrospective cohort study found that malaria was associated with a low compliance of 
impregnated battle dress uniforms (BDUs).130 This study also shows the problem of compliance to 
repellent use. As studies mentioned earlier have shown, for repellents to be effective they must be 
acceptable to the individuals to whom they are issued and must be used correctly and consistently. 
Similarly, in a malaria outbreak in Sierra Leone among British soldiers a case-control study dem-
onstrated that the use of insecticide-treated clothing offered significant protection against malaria 
with almost 50% fewer cases being reported among those individuals who used their impregnated 
BDUs (OR = 0.57, 95% CI = 0.20–1.05, p = .045). Interestingly, the use of multiple protection mea-
sures gave even better protection (OR = 0.29, 95% CI = 0.10–0.80, p = 0.007). However, the use 
of repellents and chemoprophylaxis showed no significant effect.70 In a malaria outbreak in 2003, 
44 U.S. Marines were evacuated from Liberia with either confirmed or presumed P. falciparum 
malaria.131An outbreak investigation showed that only 19 (45%) used insect repellents, 5 (12%) used 
permethrin-treated clothing, and none used bed netting, demonstrating further the importance of 
compliance in personal protection from vector-borne diseases.
perMethrIN-treateD CLOthING eVaLUatION
randomized Controlled trials
Southern and Southeast Asia
In Afghanistan, an RCT on 1 g/m2 permethrin-impregnated chaddars (cloth used as a 
head  covering [and veil and shawl] by Muslim and Hindu women) reduced the odds of having 
P.  falciparum and P. vivax malaria by 64%, OR = 0.36 (95% CI = 0.20, p = .001), and 38%, OR 
= 0.62 (95% CI = 0.36–1.06, p = .069), respectively. There was a significant effect in the 0-  to 
10-year and 10- to 20-year age groups. This trial, however, showed no effect on malaria  incidence 
in refugees >20 years of age.93 In this study, no information was given on how the randomization 
was carried out. The trial took place over 5 months and, therefore, did not capture the effect of 
repellents over the entire malaria transmission season. The study was carried out at the end of the 
P. vivax transmission season and at the start of the P. falciparum season; this might explain why 
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there was a larger treatment effect seen on P. falciparum transmission compared to P. vivax trans-
mission. It is possible that if the study had been carried out longer, then a larger effect would have 
been observed. As P. vivax malaria is known to recrudesce, the study investigators should have 
cleared all malaria cases through an appropriate treatment regimen after checking for G6PD-
deficient individuals57 so that any cases that were observed would be classified as new malaria 
cases and not as recurrent P. vivax cases. The study used passive surveillance of malaria cases; 
consequently some cases not reporting to the health clinic might have been missed, lowering the 
sample size and power of the study to observe a treatment effect. This might explain why a treat-
ment effect was not seen among females, because they were less likely to leave their homes due to 
the practice of purdah. In the evening, they might also have been using their chaddars as bedding 
for their children as a protective effect was seen only among those individuals <20 years of age. 
Compliance was established by visiting the households every 2 months. As frequent compliance 
inspection was not done compliance in between the months cannot be ascertained, and hence the 
findings of the study are less robust. As with all intervention studies, compliance is essential for 
an intervention to be considered effective, although the chaddar is a piece of clothing that is used 
on a daily basis.
A second single-blind RCT by the same group that investigated the effect of ITNs, insecticide-
treated chaddars used to sleep in, and residual pyrethroid spraying of individual houses for the 
prevention of cutaneous leishmaniasis (CL) in Kabul, Afghanistan, also demonstrated a significant 
protective effect.132 The incidence of CL among those randomized to the control was 7.2%, among 
ITN users 2.4% (OR: 0.31, 95% CI: 0.2–0.5), among impregnated chaddar users 2.5% (OR: 0.33, 
95% CI: 0.2–0.6), and among those living in λ-cyhalothrin-sprayed houses 4.4% (OR: 0.60, 95% CI: 
0.3–0.95). ITNs and impregnated chaddars were equally effective, providing about 65% protective 
efficacy, with approximately 40% protective efficacy being attributable to individual house spray-
ing. The study was well powered: it was conducted in 1997–1998 among a nonimmune population 
of 3666 people over 15 months. New cases of CL were diagnosed based on clinical criteria diag-
nosed by the inspection of lesions, but parasitological confirmation could not be completed after 
aid organizations were ejected from Kabul in July 1988. Another difficulty of working in such a 
challenging environment was that compliance could not be measured, because spot checking would 
have invaded the privacy customs strongly upheld in the region. No significant differences for age 
or sex were found between new cases in the intervention and control groups. No serious side effects 
were reported, and interventions were generally popular; ITNs were the most popular, followed 
by residual spraying and then impregnated chaddars. Both ITNs and chaddars are useful in this 
region, as the population tends to be quite mobile. This population mobility caused massive loss to 
follow up (45%) as people moved out of the study area, but the study investigators had anticipated 
this and accounted for it during the recruitment of study participants. This demonstrates the impor-
tance of recruiting the appropriate sample size in any study.
A double-blind placebo-controlled trial to determine the efficacy of permethrin-impregnated 
uniforms among Iranian soldiers in Isfahan demonstrated a reduction in the odds of contracting 
CL. However, this effect was not significant, possibly because the study had only 134 people per 
treatment arm for 3 months of exposure in the field (1608 person-weeks per arm). Compliance 
was high, as the soldiers were required to wear the uniforms day and night and compliance was 
monitored. As compliance was ascertained, the results of this study may be credible. However, 
the method used for randomization was not described. This may have been done incorrectly, 
biasing the study and hence the observation of no treatment effect in the treatment arm. Both 
the participants and the study investigators were blinded to the treatments, reducing chances of 
selection bias.133 The study, however, showed that permethrin-impregnated uniforms are safe for 
human use and no adverse effects were observed. Therefore, they present a potential tool that can 
be explored for malaria control. The fact that all the lesions (sites of infection) among the treated 
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uniform group were on sites unprotected by the uniform (face and wrist) is of importance; but in 
the control group, lesions were found on the arm and trunk. If the soldiers had been using full 
personal protection including a topical repellent for use on their face and hands,13 they may not 
have contracted leishmaniasis.
In the Thailand–Cambodia border, a randomized placebo-controlled trial evaluating the effect 
of 2 gm permethrin per treated uniforms versus kerosene-treated uniforms on preventing malaria 
among the Royal Thai Army demonstrated no effect. The population was 403 male soldiers on 
active duty for 6 months. The randomization method was not outlined in this study, and compliance 
could not be established at all times. Both these factors could have confounded the findings of this 
study as the selected study participants might have had confounding characteristics. Also, as com-
pliance could not be established both groups might not have used the repellent, therefore biasing the 
study toward the null hypothesis. One study arm may also have not complied with the intervention 
and similarly driving the effect toward the null.59
South America
A double-blinded placebo-controlled study in Colombia among 86 soldiers randomized to 
 600–712 mg/m2 permethrin-treated uniforms and 86 soldiers randomized to water-treated uniforms 
over 4.2 weeks showed the uniforms to be 79% protective against malaria, 3% versus 14% among 
treated and control groups, respectively, and 75% protective against CL, 3% versus 12% among 
treated and control groups, respectively.46
The same double-blind RCT carried out in Colombia to determine the efficacy of permethrin-
impregnated uniforms against both malaria and CL demonstrated a reduction in the RR of malaria 
(RR = 0.29, p = .015) and CL (RR = 0.21, p = .002).46 As adherence to instructions to wear the 
permethrin-treated clothing day and night could not be monitored, the findings of this study are 
debatable, as with all studies in which compliance could not be established. However, the monitor-
ing of disease was actively done every day and it is unlikely that any cases of malaria or CL could 
have been missed. There were very few reports on the adverse effects of insecticide-treated cloth-
ing. This is similar to other studies where very few adverse effects were reported, reinforcing the 
proposition that insecticide-impregnated clothing is safe for human use. This intervention can be 
applied to normal clothing, thereby tackling the problem of adherence so often seen when using 
topical repellents.
Sub-Saharan Africa
In a randomized community trial among 198 Somali refugees of all ages and both genders 
with no known allergies or respiratory problems at the Dadaab refugee camp, participants were 
randomized to either 0.37% permethrin or water placebo used to treated clothing and bedding, 
retreated every 3 weeks for a period of 3 months. All clothing and bedding was treated, includ-
ing diras, saris, jalbaabs, ma'awis, shirts, sheets, and blankets. Use of the permethrin-treated 
clothing and bedding significantly reduced the odds of contracting malaria by 70% (CI was not 
reported).62 Methods for  randomizing treatments were described as systematic random sampling 
of households within treatment and control blocks 1.5 km apart, and compliance was maintained 
by regular retreatment of all clothing and bedding. The participants and laboratory technicians 
were blinded to the treatments. These aspects of the design are positive. However, the study was 
small and the statistical reporting was not good as it was unclear, it was overreliant on models, and 
p values and ORs were reported without CIs. However, the study reported the percentage positive 
in the treatment and intervention groups and the number of people tested, so these data could be 
used for a meta-analysis.
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In another randomized community trial in Kenya to determine the effect of appropri-
ate  permethrin-impregnated clothing against malaria, it was found that the IRR of contracting 
malaria in those aged over 5 years in the intervention group was 0.187 (95% CI = 0.046–0.770, 
p = .02) compared to the control group.134 For those under 5 years of age, however, no effect was 
seen. A total of 472 individuals were enrolled in a randomized community trial where the unit of 
randomization was the hamlet (manyatta) with 234 and 238 in the experimental and control arms, 
respectively. Baseline data included sociodemographic data, parasite prevalence data from thick 
and thin blood smears, and clinical measures of malaria. The intervention involved the dipping 
of shukas owned by the experimental group in permethrin, although the dose was not available 
in the publication. The prevalence of malaria in the study population (based on slide confirma-
tion) was considerably lower than that used for the power calculation based on clinical estimates 
(2.2% vs. 20%). For those aged 6 or over, the rate of malaria cases (events per 10,000 person-days 
at risk) was 1.41 in the experimental group versus 7.49 in the control group (IRR: 0.187, 95% CI: 
0.046–0.770). For children less than 5 years of age, results were imprecise with no clear benefit 
of the intervention. An attempt was made to impregnate all shukas of the experimental group. 
However, some children refused to have their shukas dipped in the cold early morning hours, as it 
was their only clothing. Other children, one-third of the 5 years and under in both groups, owned 
no shuka. The researchers had been aware of this before the study, but had felt that this would not 
affect results because preliminary research had indicated that the children without shukas slept 
under their mothers’ shukas at night. Of the four cases that occurred in the intervention group, 
three did not own shukas and the fourth owned a shuka that was not impregnated. This incomplete 
coverage, coupled with the fact that the study investigators did not establish the local baseline 
incidence rate, led to an underestimation of the sample size required to observe a treatment effect. 
This shortcoming underlines the importance of establishing baseline factors before any study is 
implemented. Clinical reports implied that 35% of all patients were seen for malaria, and the clini-
cians’ predicted prevalence of parasitemia was even higher (50%). Although a more conservative 
20% was used to calculate sample size, the 2.2% parasitemia observed at baseline clearly reduced 
the statistical power of the study. This highlights the unreliability of malaria reports based on 
clinical diagnoses, which was also one of the reasons for the Tanzanian study of deet repellent 
being underpowered.
Other Studies
In a clinical trial in Myanmar, the use of treated scarves and hand bands were significantly 
associated with a lower incidence of malaria compared to the control arm where these interventions 
were not used.135 The major local vector was Anopheles minimus, an outdoor and early evening bit-
ing mosquito. This makes treated scarves and hand bands appropriate control tools in this setting, 
as conventional tools cannot be used at these places and times. The study was carried out for a short 
period of time and did not take into account the low transmission season and was therefore not pos-
sible to establish the seasonal effect of this intervention. Compliance assessment was carried out 
in 10% of the study participants. From this sample, the compliance of the entire study population 
could be inferred. Also, the investigators carried out regular bimonthly checks on compliance and 
random spot checks. The compliance monitoring of this study was well conducted, and the results 
can be considered credible. The results from toxicity evaluations of this intervention did not dem-
onstrate any adverse effect. This was in agreement with other studies that assessed the toxicity of 
insecticide-treated clothing.
All the earlier mentioned studies are associated with a protective trend of repellents against 
malaria. Most studies had questionable study designs and, therefore, the results of these stud-
ies could not be conclusively relied on. However, the fact that a protective trend was observed 
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in all of them reinforces the need to conduct a well-designed, large-scale trial to ascertain the 
effect of repellents on disease incidence.
MOSQUItO COILS
randomized Controlled trials in Southeast asia
There have been two randomized trials evaluating the impact of burning mosquito coils every 
evening on malaria transmission, both conducted in Southeast Asia. The first study81 was a single-
blind, cluster-randomized comparative control clinical trial conducted in Ruili district, Yunnan 
province, People’s Republic of China, close to the Myanmar border between April and October 
2007. Yunnan is one of only two provinces in China that still has malaria cases and the Ruili district 
has a particularly high number of cases. The area is heavily forested, a high proportion of migrant 
populations moves over the border between countries, and it has many remotely located minority 
group habitations, making implementation of vector control and public health programs extremely 
difficult. All the communities enrolled were in rural areas.
The trial was designed to measure and compare the protection against malaria provided by 
mosquito coils, LLINs, or a combination of the two. The study recruited 2052 households com-
prising 7341 individuals, excluding individuals under 6 years and pregnant women. Households 
were randomized into one of four groups: coils (0.03% transfluthrin coils, SC Johnson), del-
tamethrin LLINs (TianJin-Yorkool, Ltd., Tianjian, People’s Republic of China; and Lantrade 
Global Supplies, Ltd., Gerrards Cross, United Kingdom), coils plus LLINs, and a control group 
without any intervention other than whatever control intervention they were already using. At 
baseline and every month post intervention, each individual was actively screened for malaria 
(both P. falciparum and P. vivax) by RDT. At the end of the 6-month study, there were 69 
confirmed malaria cases in the control group, 16 in the coil group, 14 in the LLIN group, and 
5 in the combined coil plus LLIN group. In the coils-only group, the age-adjusted OR for P. 
falciparum malaria was 0.23 (95% CI = 0.11–0.50, p = .0002) and protective efficacy against 
P. vivax was 80%, OR = 0.20 (95% CI = 0.09–0.44, p < .0001), and were not significantly dif-
ferent from those for LLINs or LLINs plus coils. The level of compliance with the allocated 
interventions was high: it was noted that >94% of individuals used coils and/or LLINs for 
>90% of the month prior to the surveys. Conversely, those in the control arm were less com-
pliant, with 13%–19% using local coils for 3 or more days per month. A per-protocol analysis 
including only those with >90% compliance gave almost identical results to the intention-to-
treat analysis.
A second, more recent double-blind, placebo-controlled cluster-randomized trial conducted in 
Sumba, Indonesia, to evaluate the effect of 0.0097% metofluthrin mosquito coils only (no LLINs 
were used in either study arm) against malaria79 comprised two clusters (1000 people) allocated to 
the treatment arm and two clusters (1000 people) allocated to the control arm. Of these, 45 healthy 
males who were >17 years, >40 kg, G6PD normal, and resident in the village for the study period in 
two clusters per arm (n = 90 per arm) were followed up as the study cohort for 26 weeks. Compliance 
with mosquito coils was monitored daily and malaria was monitored weekly among participants 
by active case detection. In addition, malaria vector abundance and biting time was measured by 
indoor and outdoor human landing catch; vector population age was estimated from parity rates by 
detinova ovarian dissections, and sporozoite rate in vectors was measured by CSP-ELISA (circum-
sporozoite protein enzyme-linked immunosorbent assay). Malaria incidence among the treatment 
group was 0.904 versus 2.324, which equates to a 61.1% protective efficacy (95% CI = 37%–75%, 
p < .00001).
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CONCLUSIONS
These two trials79, 81 of spatially acting pyrethroids used as mosquito coils were tested in isolation, 
without the addition of LLINs, and provided unambiguous evidence that individual malaria risk is signif-
icantly reduced by >60% simply through avoiding mosquito bites. These trials were conducted under 
rigorous conditions that should set the benchmark for future trials, because they were designed, pow-
ered, and analyzed with the help of a statistician; had adequate randomization; were placebo controlled, 
allowing adequate blinding11; and used active case detection with RDTs with polymerase chain reaction 
confirmation throughout the study. In addition, essential to the success of any repellent study, very high 
compliance was observed throughout, which was carefully monitored by study staff. Furthermore, both 
studies were conducted in suitable field sites. In both cases, a large proportion of mosquito bites occurred 
before bedtime (Table 7.1) and mosquito coils were culturally acceptable (a smoky environment is toler-
ated). Furthermore, repellents may be more effective in Southeast Asia because malaria transmission is 
low and seasonal and the main malaria vectors are opportunistic and will feed on other hosts.
Future trials should attempt to match the high standards of these trials and also include some 
further information on community-level measurements of the impact of mosquito coils on malaria 
vector population dynamics. These data were collected in some extremely detailed studies on 
dichlorvos during the 1960s and showed that at a high enough coverage of repellent interventions 
there can be a community protection demonstrated by decreased human–vector contact, vector 
infectiousness, and vector longevity.
This is the key piece of information that should be collected from any future trials of personal 
protection tools if they are ever to be considered as public health tools applied at a community 
scale to prevent disease transmitted outdoors, in the day or evening, rather than just niche tools for 
particular lifestyles or occupations. Furthermore, dichlorvos is an example of a repellent tool that 
requires little compliance—it just requires the replacement of dispensers every 2 weeks. It is essen-
tial that future research examines such low-compliance interventions that will help to address the 
two greatest barriers to repellent implementation: cost and compliance.
Findings from the review strongly support the theory that use of repellents has a beneficial pro-
tective effect against transmission of disease, mainly, malaria and leishmania as very little data are 
available on dengue. Even though individual studies had varying outcomes, the combination of all 
the available evidence does support the notion that specific repellents should be incorporated into 
current vector control strategies where appropriate. We recommend the use of repellents (both spatial 
and topical) at times when current control measures cannot be implemented. The other key finding 
from this review was the paucity of existing high-quality data. To improve the speed at which prod-
ucts are developed and approved by bodies such as the WHO, there is a clear need for harmonization 
of methodologies and outcomes measured in new trials and evaluation of vector control tools, in 
particular, the way they are reported. Researchers need to be encouraged to ensure that their piece 
of research contributes to the overall picture in a research field. Clear reporting of outcomes and use 
of guidance available for this task, for example, using CONSORT guidelines,136 should make future 
trials more robust and data easier to assimilate by means such as systematic review and meta-analysis 
for use by policy makers. It was also clear from this review that those trials collecting data through 
active case detection were far more powerful than those using passive case detection. Important 
secondary end points of any trial are entomological correlates of reduced infection, that is, human–
vector contact, parity rate, sporozoite rate through regular human landing catches, and human com-
pliance with the intervention. An exposure-free measurement of human landing is especially needed 
for large-scale epidemiological work particularly in areas where dengue or other arboviruses are 
prevalent. Measurements of compliance such as salivary antigen markers of exposure to mosquito 
bites137 are a key research need for rigorous and ethical research into disease prevention using vector 
control tools as the markers of exposure may be used as a measure of both exposure and compliance.
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